rsid	PheWasP	PheWasTrait	chr	n	vP	mP	MoBaTrait	MobaAF
rs10774847	1.89998e-06	Time spent using computer	12	58495	7.93980799142901e-09	1.87214723142088e-08	AsqMotor6mo	0.393376
rs10774847	4.40301e-06	Creatinine enzymatic in urine (UKB data field 30510)	12	58495	7.93980799142901e-09	1.87214723142088e-08	AsqMotor6mo	0.393376
rs10774847	8.1298e-06	Creatinine (enzymatic) in urine	12	58495	7.93980799142901e-09	1.87214723142088e-08	AsqMotor6mo	0.393376
rs2048711	2e-06	Time spent using computer	12	58516	8.24346882745888e-09	2.19189628207401e-08	AsqMotor6mo	0.393226
rs2048711	5.00564e-06	Creatinine enzymatic in urine (UKB data field 30510)	12	58516	8.24346882745888e-09	2.19189628207401e-08	AsqMotor6mo	0.393226
rs2048711	8.74561e-06	Creatinine (enzymatic) in urine	12	58516	8.24346882745888e-09	2.19189628207401e-08	AsqMotor6mo	0.393226
rs7297772	2e-06	Time spent using computer	12	58516	8.24346882745888e-09	2.19189628207401e-08	AsqMotor6mo	0.393226
rs7297772	5.46525e-06	Creatinine enzymatic in urine (UKB data field 30510)	12	58516	8.24346882745888e-09	2.19189628207401e-08	AsqMotor6mo	0.393226
rs7297772	9.39615e-06	Creatinine (enzymatic) in urine	12	58516	8.24346882745888e-09	2.19189628207401e-08	AsqMotor6mo	0.393226
rs3095155	1.1143988892536e-308	Non-cancer illness code  self-reported: malabsorption/coeliac disease	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.1289039792536e-308	ENSG00000204525	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.0797e-218	White blood cell count	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.0797e-218	white blood cell count	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.01837e-198	Lymphocyte count	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.01837e-198	lymphocyte cell count	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.18577e-189	Primary sclerosing cholangitis	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.69828e-184	White blood cell count	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.7378e-170	ENSG00000137331	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.39959e-165	Lymphocyte count	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	8.12831e-164	White blood cell leukocyte count (UKB data field 30000)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.94457e-156	ENSG00000214894	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	5.32108e-148	Lymphocyte count (UKB data field 30120)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.17687e-137	White blood cell count	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.46684e-137	White blood cell (leukocyte) count	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.96789e-132	Monocyte count	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.96789e-132	monocyte cell count	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.04089e-124	ENSG00000137312	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	7.92501e-122	Coeliac disease	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.4388e-120	Lymphocyte count	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.34423e-120	Lymphocyte count	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	8.531e-110	Monocyte count (UKB data field 30130)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.0797e-105	ENSG00000137411	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.57e-92	Neutrophil count	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.57e-92	neutrophil cell count	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.61994e-90	Monocyte count	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.41046e-90	Monocyte count	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.63027e-90	Eosinophil counts	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.63027e-90	eosinophil cell count	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.27585e-81	Aspartate aminotransferase levels (UKB data field 30650)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.59993e-81	Neutrophil count	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	6.27625e-81	Neutrophill count (UKB data field 30140)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	7.70016e-77	Eosinophil counts	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.54273e-76	Membranous nephropathy	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.80011e-75	Mean reticulocyte volume	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.16172e-74	Type 1 diabetes	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	6.54335e-74	Serum total protein level	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	7.1499e-74	Total protein	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	9.0469e-72	Systemic lupus erythematosus	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.09991e-71	Never eat eggs, dairy, wheat, sugar: Wheat products	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	5.88166e-71	White blood cell count	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	8.87565e-71	Eosinophill count (UKB data field 30150)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.60999e-70	Total protein	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.02589e-69	Other diseases of the digestive system (K11_OTHDIG)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	6.50429e-69	Lymphocyte counts	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	9.89692e-69	Neutrophil count	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.12254e-68	Neutrophill count	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	6.20012e-67	Non-cancer illness code, self-reported: hyperthyroidism/thyrotoxicosis	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	7.83971e-67	Aspartate aminotransferase	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	8.97842e-67	Aspartate aminotransferase levels	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.50003e-65	Hyperthyroidism or thyrotoxicosis	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.20226e-62	MHC class I polypeptide-related sequence B	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.9002e-62	Type 1 diabetes	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.334e-62	Type 1 diabetes	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.48047e-60	Non-cancer illness code  self-reported: hyperthyroidism/thyrotoxicosis	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.79954e-56	Sitting height	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.39991e-54	Reticulocyte count	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	7.14167e-53	Eosinophil counts	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.69999e-52	Thyroid problem (not cancer)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.13993e-49	Peak expiratory flow	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.14668e-48	Autoimmune diseases	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.66185e-47	Medication use (thyroid preparations)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.37987e-46	Hemoglobin concentration	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.50003e-43	Mean spheric corpuscular volume	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.50323e-43	Mean reticulocyte volume	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.2107e-43	Type 1 diabetes	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.10015e-43	Diabetes or endocrine disease	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.93731e-41	Haemoglobin concentration (UKB data field 30020)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	8.97842e-41	Monocyte count	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.59993e-40	Hemoglobin	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.59998e-40	Reticulocyte fraction of red cells	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.52616e-39	Myeloid white cell count	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	6.64661e-39	Sitting height	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	6.60998e-38	Red blood cell count	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	5.09448e-37	Sum eosinophil basophil counts	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	5.49667e-37	Hypothyroidism or myxoedema (Firth correction)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	7.18787e-37	Hypothyroidism or myxoedema (SPA correction)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.29987e-35	High light scatter reticulocyte count	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.1521e-35	Granulocyte count	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.97009e-35	Red cell distribution width	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.79954e-35	Lung function (FEV1/FVC)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	8.26038e-35	Hematocrit	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.19989e-34	Standing height	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.23594e-34	Sum neutrophil eosinophil counts	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.49676e-34	Red blood cell (erythrocyte) distribution width	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.7863e-33	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.53003e-32	Eosinophil counts	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.29985e-32	Treatment/medication code: levothyroxine sodium	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.81393e-32	FEV1	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	6.09958e-32	Red blood cell count	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.51131e-31	Haemoglobin concentration	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.72772e-31	Early-onset myasthenia gravis	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.85891e-31	Hemoglobin	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.3037e-31	Reticulocyte count	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.54674e-31	Platelet count (UKB data field 30080)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	7.29962e-31	Red cell distribution width	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.33352e-30	Cystatin C levels (UKB data field 30720)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.92013e-30	Platelet count	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.95731e-30	Sum basophil neutrophil counts	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.22182e-30	Triglyceride levels (UKB data field 30870)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	8.4004e-30	Hematocrit	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.0649e-29	Dermatitis herpetiformis	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.77398e-29	Neutrophil count	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.11995e-28	Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection, CLOZUK+PGC2	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.1749e-28	Glutamate receptor 4	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.39412e-28	Height	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.11203e-28	Schizophrenia	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.49977e-28	Non-cancer illness code, self-reported: hypothyroidism/myxoedema	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.01717e-28	Schizophrenia	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.19952e-28	Treatment/medication code: insulin product	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	5.57442e-28	Hyperthyroidism	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.3116e-27	Red blood cell erythrocyte count (UKB data field 30010)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.70023e-27	Hypothyroidism or myxedema	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.20332e-27	ENSG00000225851	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	5.50047e-27	apolipoprotein A-I	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	5.72532e-27	Thyrotoxicosis with diffuse goitre	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.9002e-26	High light scatter reticulocyte percentage of red cells	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.61517e-26	ENSG00000204613	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.68299e-26	Treatment/medication code: insulin product	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.71364e-26	Graves' disease	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.58353e-26	Standing height	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	6.00067e-26	Started insulin within one year diagnosis of diabetes	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	7.54745e-26	Platelet count	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	7.89951e-26	Platelet count	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	8.45668e-26	Platelet count	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.19812e-25	Schizophrenia	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.22462e-25	ENSG00000237669	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.44681e-25	Glycated haemoglobin HbA1c levels (UKB data field 30750)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.63572e-25	Disorders of thyroid, IBD co-morbidities	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.97989e-25	Basophil count	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.97989e-25	basophil cell count	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.57797e-24	Complement C2 measurement	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.92708e-24	Other bullous disorders	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.95299e-24	Apolipoprotein A levels (UKB data field 30630)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.67547e-24	Reticulocyte percentage	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.70023e-24	triglycerides	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.79071e-24	Reticulocyte count	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	7.97444e-24	Treatment/medication code: levothyroxine sodium	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.10103e-23	Hypothyroidism	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.57616e-23	Cystatin C	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.30622e-23	Cystatin C	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.31526e-23	Appendicular lean mass	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.81125e-23	IGF 1 (UKB data field 30770)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.26738e-23	ENSG00000204536	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.45143e-23	Triglycerides	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.45964e-23	Systemic connective tissue disorders	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	5.5616e-23	Triglycerides	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	9.9793e-23	Cholesterol levels (UKB data field 30690)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.76058e-22	ENSG00000225059	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.82293e-22	Apoliprotein A	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	6.07156e-22	diastolic blood pressure	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	6.47143e-22	Started insulin within one year diagnosis of diabetes	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	7.16803e-22	Hemoglobin A1c levels	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	7.39435e-22	Glycated haemoglobin	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.12642e-21	ENSG00000243753	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.64816e-21	Non-cancer illness code  self-reported: hypothyroidism/myxoedema	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.75914e-21	Aspartate aminotransferase	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.29985e-21	Leg fat-free mass (right)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.99985e-21	Leg predicted mass (right)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.10027e-21	HDL cholesterol	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	6.30376e-21	High light scatter reticulocyte count	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1e-20	Basal metabolic rate	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.50003e-20	telomere length	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.80011e-20	Whole body fat-free mass	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.19989e-20	Leg predicted mass (left)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.19989e-20	Leg fat-free mass (left)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.19989e-20	Whole body water mass	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.77907e-20	IgA nephropathy	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.09166e-20	Sj<U+00F6>gren's syndrome	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.10488e-20	IGF-1	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	6.24885e-20	Glycated haemoglobin	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	6.51328e-20	Mean sphered cell volume	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	8.4004e-20	Eosinophil percentage of white cells	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.10002e-19	Diagnoses - main ICD10: R31 Unspecified haematuria	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.47605e-19	schizophrenia	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.74916e-19	Psoriasis	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.76121e-19	Red blood cell (erythrocyte) count	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.80027e-19	Arm fat-free mass (left)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.84905e-19	Red blood cell count	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.1783e-19	Leg fat-free mass (right)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	5.04197e-19	Gamma glutamyltransferase levels (UKB data field 30730)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	5.07341e-19	Apoliprotein A	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	5.96211e-19	Thyrotoxicosis	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	8.08165e-19	Lung cancer	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	8.91251e-19	Leg predicted mass (right)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.15611e-18	Reticulocyte fraction of red cells	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.20005e-18	Trunk fat-free mass	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.23197e-18	High density lipoprotein cholesterol levels (UKB data field 30760)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.39991e-18	Arm predicted mass (left)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.41286e-18	ENSG00000204531	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.50003e-18	Trunk predicted mass	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.51356e-18	Complement C4	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.60546e-18	Haematocrit percentage	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.77296e-18	Hematocrit	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.39994e-18	Connective tissue disorder	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.32736e-18	Triglycerides	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.63078e-18	IGF-1	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.32713e-18	Varicella zoster virus glycoproteins E and I antibody levels	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	6.09958e-18	Weight	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	6.12774e-18	Other systemic involvement of connective tissue	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.01018e-17	Leg predicted mass (left)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.10357e-17	Leg fat-free mass (left)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.59993e-17	Weight	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.69981e-17	Time to complete round	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.69981e-17	Mouth/teeth dental problems: Dentures	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.79019e-17	Thyrotoxicosis, other and/or unspecified	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.80011e-17	Basophil count	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.19521e-17	Estimated glomerular filtration rate (creatinine)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.19963e-17	Operation code: thyroidectomy/partial thyroidectomy	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.44667e-17	Other systemic involvement of connective tissue (FG)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.10015e-17	Arm predicted mass (right)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.37522e-17	IDP_dMRI_TBSS_L1_Superior_longitudinal_fasciculus_L	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.49987e-17	Medication for pain relief, constipation, heartburn: None of the above	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.88652e-17	Cholesterol	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	5.37774e-17	Whole body fat-free mass	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	6.38705e-17	Whole body water mass	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	6.4003e-17	Arm fat-free mass (right)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	6.71274e-17	Basal metabolic rate	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	8.57433e-17	Other diseases of the digestive system	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	9.88098e-17	Weight	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.02259e-16	Cholesterol	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.04208e-16	Total cholesterol levels	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.16332e-16	ENSG00000204592	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.19207e-16	HDL cholesterol	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.24997e-16	HDL cholesterol	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.54989e-16	ENSG00000238024	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.58489e-16	T-cell surface protein tactile	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.99986e-16	Operative procedures - secondary OPCS: Z27.4 Duodenum	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.01512e-16	Psoriasis	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.71832e-16	Squamous cell lung carcinoma	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.90001e-16	Hot drink temperature	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.50026e-16	Comparative body size at age 10	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.86901e-16	Bullous disorders	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.75226e-16	Creatinine levels (UKB data field 30700)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	5.40008e-16	Platelet crit	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	7.31139e-16	High light scatter reticulocyte percentage	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	7.64716e-16	Estimated glomerular filtration rate (creatinine)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	9.82426e-16	White blood cell count (basophil)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1e-15	Comparative body size at age 10, Males and Females	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.10713e-15	Total bilirubin levels (UKB data field 30840)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.20005e-15	Diagnoses - secondary ICD10: E03.9 Hypothyroidism, unspecified	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.24337e-15	Total bilirubin levels (UKB data field 30840)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.69981e-15	Forced expiratory volume in 1-second (FEV1), predicted percentage	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.9002e-15	Plateletcrit	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.23357e-15	Medication for pain relief  constipation  heartburn: None of the above	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.90001e-15	Diastolic blood pressure, automated reading	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.99985e-15	Number of fluid intelligence questions attempted within time limit	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.27642e-15	Peak expiratory flow (UKB data field 3064)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.41979e-15	Diagnoses - main ICD10: R31 Unspecified haematuria	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.80014e-15	Medication for pain relief, constipation, heartburn: Paracetamol	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.13714e-15	Trunk fat-free mass	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.49987e-15	Ankle spacing width	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.66552e-15	Mean platelet thrombocyte volume (UKB data field 30100)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.86071e-15	Trunk predicted mass	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	6.09958e-15	Non-cancer illness code, self-reported: asthma	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	6.79986e-15	Non-cancer illness code, self-reported: psoriasis	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	9.28966e-15	Eosinophill percentage	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.27614e-14	Hemoglobin concentration	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.79308e-14	Sicca syndrome [Sj<c2><9a>gren]	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.9002e-14	Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor: Asthma	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.19837e-14	HDL cholesterol	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.19989e-14	FEV1/FVC < 0.7	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.90001e-14	3mm weak meridian (left)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.59998e-14	Age diabetes diagnosed	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.23741e-14	Cereal type: Other (e.g. Cornflakes, Frosties)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.6334e-14	Weight	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.68705e-14	Forced expiratory volume in 1-second (FEV1)  predicted percentage	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.79954e-14	Comparative body size at age 10, Females	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	5.50047e-14	Hip circumference	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	5.78895e-14	Sjogren's syndrome (Firth correction)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	5.79295e-14	Non-cancer illness code  self-reported: asthma	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	5.79963e-14	Asthma	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	5.97448e-14	Sjogren's syndrome (SPA correction)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	6.16879e-14	Arm predicted mass (left)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	6.26037e-14	Mean platelet volume	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	6.31103e-14	Blood clot  DVT  bronchitis  emphysema  asthma  rhinitis  eczema  allergy diagnosed by doctor: Asthma	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	7.25605e-14	Other predominantly sexually transmitted diseases, not elsewhere classified	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	7.43019e-14	Epstein-Barr virus ZEBRA antibody levels	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	8.46058e-14	Type 1 diabetes, wide definition, subgroup 1	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	9.40589e-14	Arm fat-free mass (left)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	9.60064e-14	3mm strong meridian (left)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.10002e-13	Oily fish intake	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.11301e-13	Type 1 diabetes with ophthalmic complications	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.18905e-13	Diastolic blood pressure automated reading (UKB data field 4079)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.20005e-13	Other serious medical condition/disability diagnosed by doctor	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.27497e-13	Autoimmune hyperthyroidism	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.77664e-13	Arm fat-free mass (right)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.79515e-13	Comparative body size at age 10	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.12324e-13	Type 1 diabetes	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.39994e-13	Bowel problem	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.48199e-13	Bread type: Other type of bread	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.60016e-13	3mm weak meridian (right)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.72961e-13	Lung cancer in ever smokers	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.89334e-13	Medication for cholesterol  blood pressure or diabetes: Insulin	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.90001e-13	Appendicular lean mass	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.37287e-13	Type 1 diabetes without complications	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.70766e-13	Platelet count	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.10015e-13	Mean platelet volume	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.60363e-13	Non-cancer illness code  self-reported: psoriasis	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.87528e-13	Mean corpuscular haemoglobin concentration	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	5.03269e-13	Mean corpuscular hemoglobin concentration	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	5.10505e-13	ThalamNuclei_rh_volume_LD	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	5.51061e-13	Systemic lupus erythematosus	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	6.37529e-13	SLE (Finngen)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	7.59626e-13	High light scatter reticulocyte count	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	8.30042e-13	3mm strong meridian (right)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.39991e-12	Duration screen displayed	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.58088e-12	ENSG00000204528	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.79804e-12	Medication for pain relief  constipation  heartburn: Paracetamol	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.80011e-12	Never eat eggs, dairy, wheat, sugar: I eat all of the above	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.23975e-12	Creatinine	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.24595e-12	Serum creatinine levels	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.38836e-12	Arm predicted mass (right)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.49977e-12	Polyunsaturated fatty acid levels	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.51189e-12	Beta-defensin 119	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.60016e-12	Esophageal disorder	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.71019e-12	Urate levels (UKB data field 30880)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.99985e-12	Medication for cholesterol, blood pressure or diabetes: Insulin	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.37287e-12	ThalamNuclei_rh_volume_LP	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.10015e-12	Glycoprotein acetyls levels	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.49987e-12	Main speciality of consultant (recoded): Urology	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.88877e-12	Gamma glutamyl transpeptidase	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.9136e-12	Gamma glutamyltransferase	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.97508e-12	Intestinal malabsorbtion	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.99229e-12	Hematocrit	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	5.08394e-12	ENSG00000204438	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	5.70033e-12	Peak expiratory flow (PEF)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	5.73852e-12	Mean platelet (thrombocyte) volume	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	5.83714e-12	Mouth/teeth dental problems: Dentures	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	6.36796e-12	IDP_dMRI_ProbtrackX_ICVF_ptr_r	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	6.59933e-12	Seen doctor (GP) for nerves, anxiety, tension or depression	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	6.62979e-12	Asthma (Firth correction)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	6.68344e-12	IDP_dMRI_TBSS_ICVF_Posterior_thalamic_radiation_R	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	6.8691e-12	Asthma (SPA correction)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	7.29962e-12	Low density lipoprotein cholesterol levels	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	7.84513e-12	Hip circumference (UKB data field 49)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	8.69961e-12	Ankle spacing width (right)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	9.12011e-12	ThalamNuclei_rh_volume_CL	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	9.7499e-12	IDP_dMRI_TBSS_MD_Posterior_thalamic_radiation_L	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.10002e-11	Operative procedures - main OPCS: M45.9 Unspecified diagnostic endoscopic examination of bladder	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.28825e-11	Trypsin-3	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.40605e-11	Urate	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.45111e-11	Basophil count	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.80011e-11	Seen a psychiatrist for nerves, anxiety, tension or depression	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.88365e-11	IDP_dMRI_TBSS_ICVF_Pontine_crossing_tract	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.00909e-11	IDP_dMRI_TBSS_L1_Sagittal_stratum_L	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.29034e-11	ENSG00000066379	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.29826e-11	SLE, strict definition	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.30887e-11	Systemic lupus erythematosus	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.90001e-11	Treatment/medication code: thyroxine product	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.28322e-11	Type 1 diabetes, wide definition	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.29989e-11	Number of days/week of moderate physical activity 10+ minutes	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.43084e-11	Plateletcrit	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.78443e-11	IDP_dMRI_TBSS_MD_Sagittal_stratum_R	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.81417e-11	Type 1 diabetes with coma	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.50817e-11	IDP_dMRI_TBSS_MD_Posterior_thalamic_radiation_R	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.51856e-11	IDP_dMRI_TBSS_OD_Superior_longitudinal_fasciculus_L	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	5.00035e-11	Linoleic acid levels	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	5.12861e-11	Rac GTPase-activating protein 1	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	5.24807e-11	HLA class II histocompatibility antigen, DQ alpha 2 chain	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	5.57057e-11	Red blood cell count	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	5.68853e-11	aparc-DKTatlas_lh_thickness_insula	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	6.39735e-11	Urate	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	6.4998e-11	6mm weak meridian (left)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	6.87068e-11	Lung function (FVC)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	6.98554e-11	Serum uric acid levels	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	7.10068e-11	Salad / raw vegetable intake	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	8.19974e-11	Treatment/medication code: paracetamol	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	8.27752e-11	Seen doctor for nerves anxiety tension or depression (UKB data field 2090) (SPA correction)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	8.27942e-11	Glucose	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	8.35795e-11	Seen doctor for nerves anxiety tension or depression (UKB data field 2090) (Firth correction)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	8.81049e-11	IDP_dMRI_TBSS_MD_Superior_longitudinal_fasciculus_L	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	9.72747e-11	Medication use (drugs used in diabetes)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	9.79941e-11	Mean corpuscular hemoglobin concentration	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.007e-10	Medication use (anilides)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.05901e-10	IDP_dMRI_ProbtrackX_ICVF_cst_r	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.09999e-10	Glycoprotein acetyls	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.118e-10	Eosinophil percentage of granulocytes	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.17004e-10	IDP_dMRI_TBSS_L1_Sagittal_stratum_R	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.24713e-10	Alanine aminotransferase levels (UKB data field 30620)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.309e-10	Neutrophil percentage of granulocytes	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.40799e-10	Medication use (drugs for peptic ulcer and gastro-oesophageal reflux disease)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.47299e-10	IDP_dMRI_ProbtrackX_ICVF_fma	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.5e-10	Omega-6 fatty acid levels	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.54568e-10	Treatment/medication code: thyroxine product	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.583e-10	Diabetic hypoglycemia	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.69602e-10	Bipolar disorder bip2021	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.73924e-10	Seen psychiatrist for nerves anxiety tension or depression (UKB data field 2100) (SPA correction)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.79999e-10	6mm strong meridian (right)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.81001e-10	Seen psychiatrist for nerves anxiety tension or depression (UKB data field 2100) (Firth correction)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.94245e-10	Hip circumference	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2e-10	6mm weak meridian (right)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.031e-10	Lichen planus	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.09098e-10	Complement C4 levels	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.1e-10	Operation code: varicose vein surgery	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.1e-10	Time to answer	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.73212e-10	IDP_dMRI_TBSS_MD_Retrolenticular_part_of_internal_capsule_R	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.90001e-10	Trunk fat mass	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.90001e-10	6mm strong meridian (left)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.6141e-10	IDP_dMRI_TBSS_MD_Sagittal_stratum_L	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.83796e-10	IDP_dMRI_TBSS_ICVF_Posterior_thalamic_radiation_L	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.08e-10	Bipolar disorder bip2021 noUKBB	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.70598e-10	Eosinophil percentage of white cells	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.90004e-10	Red cell distribution width	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	5.44891e-10	Type 1 diabetes (Firth correction)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	5.49997e-10	Type 1 diabetes (SPA correction)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	5.49997e-10	Childhood sunburn occasions	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	6.1546e-10	aparc-a2009s_lh_thickness_S-circular-insula-sup	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	6.75461e-10	IDP_dMRI_TBSS_L2_Anterior_corona_radiata_L	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	7.39997e-10	Neutrophil percentage of white cells	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	7.39997e-10	Polyunsaturated fatty acids	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	7.85001e-10	High light scatter reticulocyte percentage of red cells	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	8.19993e-10	Ankle spacing width (left)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	8.43296e-10	Type 1 diabetes with other specified/multiple/unspecified complications	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	8.45941e-10	Diastolic blood pressure  automated reading	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	9.90011e-10	Hearing difficulty/problems with background noise	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.00995e-09	IDP_T1_FAST_ROIs_L_thalamus	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.11199e-09	Medication use (adrenergics, inhalants)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.11699e-09	Diastolic blood pressure	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.29999e-09	Phospholipids in medium HDL	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.36239e-09	IDP_dMRI_TBSS_L3_Posterior_thalamic_radiation_R	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.5e-09	Age at menopause (last menstrual period)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.69899e-09	Other serious medical condition/disability diagnosed by doctor	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.7e-09	Linoleic acid	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.7746e-09	IDP_dMRI_TBSS_MD_Superior_corona_radiata_L	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.844e-09	Type 1 diabetes, strict (exclude DM2)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.91201e-09	Type1 diabetes, definitions combined	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.07582e-09	Total bilirubin	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.1e-09	Phospholipid levels in medium HDL	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.19938e-09	IDP_dMRI_ProbtrackX_L1_slf_l	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.24802e-09	Total bilirubin levels	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.261e-09	IDP_dMRI_TBSS_ICVF_Retrolenticular_part_of_internal_capsule_L	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.30675e-09	IDP_dMRI_ProbtrackX_ICVF_ptr_l	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.34423e-09	Interleukin-21	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.44625e-09	ThalamNuclei_lh_volume_VA	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.5e-09	Phospholipid levels in small HDL	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.51131e-09	IDP_dMRI_TBSS_ICVF_Posterior_corona_radiata_L	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.70402e-09	Proliferative diabetic retinopathy (DM_RETINA_PROLIF)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.90001e-09	Mean corpuscular hemoglobin concentration	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.96756e-09	IDP_dMRI_TBSS_ICVF_Retrolenticular_part_of_internal_capsule_R	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.06902e-09	IDP_dMRI_TBSS_L1_Posterior_thalamic_radiation_L	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.08532e-09	aparc-DKTatlas_rh_thickness_insula	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.2e-09	Pain type(s) experienced in last month: Headache	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.252e-09	Type 1 diabetes, strict definition, subgroup 1	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.36403e-09	Systemic lupus erythematosus, unspecified	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.39336e-09	Peak expiratory flow (PEF)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.47056e-09	IDP_dMRI_TBSS_MD_Retrolenticular_part_of_internal_capsule_L	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.508e-09	Diabetes diagnosed by doctor	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.74619e-09	Treatment/medication code: carbimazole	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.86901e-09	IDP_dMRI_TBSS_MD_Superior_corona_radiata_R	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.88597e-09	IDP_dMRI_ProbtrackX_L1_slf_r	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.89996e-09	Dried fruit intake	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.22377e-09	IDP_dMRI_TBSS_ICVF_Middle_cerebellar_peduncle	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.46067e-09	IDP_dMRI_ProbtrackX_L1_ilf_l	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.4617e-09	Severe autoimmune type 2 diabetes	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.49997e-09	Total fatty acid levels	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.82059e-09	IDP_dMRI_TBSS_ICVF_Sagittal_stratum_R	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.90004e-09	Total lipids in medium HDL	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	5.36908e-09	IDP_dMRI_ProbtrackX_L1_ilf_r	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	5.41377e-09	IDP_dMRI_ProbtrackX_ICVF_ifo_r	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	5.49997e-09	Monounsaturated fatty acid levels	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	5.49997e-09	Omega-3 fatty acid levels	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	5.74513e-09	IDP_dMRI_ProbtrackX_ICVF_cst_l	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	5.85895e-09	Type 1 diabetes, strict definition	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	5.99598e-09	Basophil count	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	6.09537e-09	IDP_dMRI_TBSS_L1_Superior_corona_radiata_R	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	6.28102e-09	Polymyositis	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	6.39661e-09	Seen doctor (GP) for nerves  anxiety  tension or depression	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	6.64202e-09	IDP_dMRI_TBSS_L1_Posterior_corona_radiata_L	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	6.93506e-09	Postprocedural endocrine and metabolic disorders, not elsewhere classified	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	7.12656e-09	Epstein-Barr virus EA-D antibody levels	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	7.28283e-09	IDP_dMRI_TBSS_MD_Cingulum_cingulate_gyrus_L	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	7.70495e-09	Dermatopolymyositis (FG)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	7.88497e-09	IDP_dMRI_TBSS_ICVF_Body_of_corpus_callosum	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	8.02971e-09	IDP_dMRI_TBSS_L2_Posterior_thalamic_radiation_L	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	8.19993e-09	Non-cancer illness code, self-reported: enlarged prostate	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	8.28495e-09	Number of days/week of moderate physical activity 10+ minutes	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	8.48985e-09	IDP_dMRI_TBSS_L1_Retrolenticular_part_of_internal_capsule_L	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	8.51491e-09	Dermatopolymyositis	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	8.9e-09	Total lipid levels in medium HDL	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	9.09997e-09	White blood cell count (lymphocyte)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	9.13671e-09	Treatment/medication code: paracetamol	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	9.20026e-09	aparc-a2009s_lh_area_S-temporal-sup	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	9.47764e-09	IDP_dMRI_ProbtrackX_ICVF_ilf_l	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	9.71404e-09	IDP_dMRI_TBSS_MD_Anterior_corona_radiata_L	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	9.72523e-09	IDP_dMRI_ProbtrackX_MD_ifo_r	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	9.78588e-09	ENSG00000204444	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.00501e-08	Diabetic ketoacidosis	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.0311e-08	IDP_dMRI_TBSS_ICVF_Superior_corona_radiata_R	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.03181e-08	aparc-DKTatlas_rh_area_insula	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.17571e-08	IDP_dMRI_TBSS_L3_Sagittal_stratum_R	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.20143e-08	IDP_dMRI_TBSS_L1_Superior_longitudinal_fasciculus_R	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.29999e-08	Omega-6 fatty acids	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.29999e-08	Fluid intelligence score	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.43999e-08	Red cell distribution width	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.47911e-08	Granulysin	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.5e-08	Free cholesterol levels in small HDL	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.5e-08	Total lipid levels in small HDL	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.5e-08	Phospholipids to total lipids ratio in large LDL	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.57906e-08	IDP_dMRI_ProbtrackX_ICVF_ilf_r	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.61176e-08	IDP_dMRI_TBSS_L3_Retrolenticular_part_of_internal_capsule_R	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.76999e-08	Stromal cell-derived factor 2 measurement	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.77599e-08	Disorders of the thyroid gland	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.79999e-08	Phospholipids in small HDL	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.80136e-08	ThalamNuclei_rh_volume_PuM	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.8412e-08	IDP_dMRI_ProbtrackX_MD_ilf_l	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.89998e-08	Phospholipids to total lipids ratio in large LDL	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.92602e-08	Infections with a predominantly sexual mode of transmission	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2e-08	Frequency of light DIY in last 4 weeks	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.06016e-08	IDP_dMRI_ProbtrackX_FA_ptr_r	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.1e-08	Phosphoglycerides levels	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.19999e-08	Concentration of medium HDL particles	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.22669e-08	ENSG00000240053	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.25476e-08	ThalamNuclei_lh_volume_VLa	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.30001e-08	Treatment speciality of consultant (recoded): Urology	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.30001e-08	Long-standing illness, disability or infirmity	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.38013e-08	IDP_dMRI_ProbtrackX_ICVF_ar_l	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.39999e-08	Non-oily fish intake	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.5e-08	Monounsaturated fatty acids	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.5787e-08	IDP_dMRI_TBSS_L2_Splenium_of_corpus_callosum	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.65216e-08	IDP_dMRI_ProbtrackX_FA_fma	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.65583e-08	wg_lh_intensity-contrast_insula	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.84839e-08	IDP_dMRI_TBSS_ICVF_Sagittal_stratum_L	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.87541e-08	aseg_rh_intensity_Pallidum	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.01009e-08	Pain type(s) experienced in last month: Headache (UKB data field 6159_1) (SPA correction)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.0493e-08	IDP_dMRI_TBSS_L3_Posterior_thalamic_radiation_L	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.05562e-08	IDP_dMRI_ProbtrackX_MD_slf_l	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.05886e-08	Pain type(s) experienced in last month: Headache (UKB data field 6159_1) (Firth correction)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.08461e-08	IDP_dMRI_TBSS_MD_Superior_longitudinal_fasciculus_R	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.33641e-08	ENSG00000204616	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.47536e-08	IDP_dMRI_TBSS_ICVF_Splenium_of_corpus_callosum	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.50002e-08	Hiatus hernia	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.50002e-08	Phospholipids to total lipids ratio in small LDL	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.57544e-08	Non-cancer illness code  self-reported: enlarged prostate	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.70084e-08	IDP_dMRI_ProbtrackX_L1_ifo_r	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.84503e-08	aparc-Desikan_lh_thickness_insula	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.90202e-08	Diabetic retinopathy (H7_RETINOPATHYDIAB)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4e-08	Omega-3 fatty acids	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4e-08	Whole body fat mass	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4e-08	Ever depressed for a whole week	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4e-08	Diabetes diagnosed by doctor	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.0059e-08	IDP_dMRI_TBSS_FA_Splenium_of_corpus_callosum	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.08319e-08	IDP_dMRI_TBSS_ICVF_Superior_corona_radiata_L	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.16256e-08	Creatinine	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.22931e-08	ENSG00000204520	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.60002e-08	Arm fat mass (left)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.72803e-08	Cholangitis (primary sclerosing, PSC), with reimbursement 202	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.73762e-08	C reactive protein levels (UKB data field 30710)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.79999e-08	Concentration of medium HDL particles	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.79999e-08	Total fatty acids	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	5.06291e-08	BA-exvivo_rh_volume_entorhinal	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	5.15858e-08	Direct low density lipoprotein levels (UKB data field 30780)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	5.19996e-08	Apolipoprotein A1	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	5.22637e-08	IDP_dMRI_TBSS_ICVF_Superior_longitudinal_fasciculus_R	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	5.30005e-08	Phospholipids in HDL	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	5.48909e-08	IDP_dMRI_ProbtrackX_ICVF_ifo_l	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	6.13988e-08	Any parental history of lung cancer (Firth correction)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	6.27784e-08	Any parental history of lung cancer (SPA correction)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	6.42895e-08	Diabetic retinopathy (DM_RETINOPATHY)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	6.44911e-08	IDP_dMRI_TBSS_MD_Posterior_corona_radiata_L	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	6.461e-08	IDP_dMRI_TBSS_ICVF_Corticospinal_tract_R	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	6.66899e-08	Direct low density lipoprotein levels (UKB data field 30780)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	6.77485e-08	wg_rh_intensity-contrast_insula	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	6.84668e-08	Seen a psychiatrist for nerves  anxiety  tension or depression	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	7.18621e-08	IDP_dMRI_ProbtrackX_ICVF_str_r	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	8.01457e-08	Trunk fat mass	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	8.12606e-08	Hypothyroidism, strict autoimmune	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	8.30004e-08	Cholesteryl esters to total lipids ratio in small LDL	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	8.70001e-08	Phosphoglycerides	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	8.78092e-08	Height	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	9.59997e-08	Moderate to vigorous physical activity levels	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	9.63829e-08	IDP_dMRI_TBSS_L1_Cingulum_hippocampus_R	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	9.85598e-08	aparc-Desikan_rh_thickness_isthmuscingulate	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1e-07	Apolipoprotein A1 levels	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1e-07	Breastfed as a baby	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.08618e-07	IDP_dMRI_ProbtrackX_L2_slf_l	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.08901e-07	Diabetes-related co-morbidities/complications (more controls excluded)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.09999e-07	Triglycerides in medium HDL	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.1023e-07	IDP_dMRI_ProbtrackX_ICVF_ar_r	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.11584e-07	IDP_dMRI_TBSS_L1_Retrolenticular_part_of_internal_capsule_R	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.17701e-07	Diabetic neuropathy	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.21843e-07	IDP_dMRI_TBSS_L2_Anterior_corona_radiata_R	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.2314e-07	IDP_dMRI_ProbtrackX_MD_ifo_l	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.29808e-07	IDP_dMRI_TBSS_L1_Posterior_thalamic_radiation_R	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.29999e-07	Free cholesterol in small HDL	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.33383e-07	IDP_dMRI_TBSS_L2_Posterior_thalamic_radiation_R	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.37278e-07	IDP_dMRI_ProbtrackX_ICVF_cgc_r	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.3807e-07	IDP_dMRI_ProbtrackX_MD_cgc_l	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.40001e-07	Concentration of HDL particles	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.40001e-07	Total lipids in small HDL	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.40001e-07	Free cholesterol in medium HDL	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.40001e-07	Non-cancer illness code, self-reported: hiatus hernia	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.41742e-07	IDP_dMRI_TBSS_ICVF_Medial_lemniscus_R	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.43483e-07	aparc-a2009s_rh_area_S-pericallosal	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.48902e-07	rfMRI connectivity (ICA100 edge 399)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.5e-07	Phospholipid levels in HDL	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.5e-07	Age started wearing glasses or contact lenses	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.54501e-07	Diabetes, several complications	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.547e-07	Type 1 diabetes with neurological complications	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.58402e-07	Rheumatoid arthritis	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.6e-07	Triglyceride levels in very small VLDL	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.6e-07	Psychological or psychiatric problem	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.7e-07	Why stopped smoking: Health precaution	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.71159e-07	IDP_dMRI_TBSS_L3_Splenium_of_corpus_callosum	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.80177e-07	IDP_dMRI_TBSS_L3_Anterior_corona_radiata_L	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.80801e-07	Height	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.83992e-07	IDP_dMRI_ProbtrackX_MD_ilf_r	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.85695e-07	IDP_dMRI_TBSS_L1_Superior_fronto-occipital_fasciculus_L	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.89998e-07	Gastroesophageal reflux disease or gastric reflux	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.89998e-07	Free cholesterol to total lipids ratio in small LDL	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.90055e-07	Potassium in urine	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.90502e-07	IDP_dMRI_ProbtrackX_L2_ifo_l	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.92886e-07	IDP_dMRI_ProbtrackX_OD_ar_r	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2e-07	Total concentration of lipoprotein particles	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2e-07	Triglycerides in HDL	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2e-07	Total lipids in HDL	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.1e-07	Total cholines levels	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.19999e-07	Concentration of HDL particles	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.21998e-07	Other metabolic disorders	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.24543e-07	IDP_dMRI_TBSS_MD_Anterior_corona_radiata_R	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.27405e-07	IDP_dMRI_ProbtrackX_ICVF_fmi	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.30001e-07	Height	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.40547e-07	IDP_dMRI_ProbtrackX_L2_ifo_r	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.46661e-07	IDP_dMRI_TBSS_OD_Posterior_corona_radiata_L	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.58547e-07	ENSG00000228789	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.6418e-07	aparc-DKTatlas_rh_thickness_isthmuscingulate	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.80001e-07	Phospholipids to total lipids ratio in small LDL	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.80001e-07	Triglyceride levels in IDL	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.80001e-07	Appendicular lean mass	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.80001e-07	Tyrosine levels	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.90001e-07	Phosphatidylcholine levels	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.90001e-07	Nervous feelings	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.93224e-07	IDP_dMRI_TBSS_OD_Superior_corona_radiata_R	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.98676e-07	IDP_dMRI_TBSS_ICVF_Superior_longitudinal_fasciculus_L	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.99999e-07	Treatment speciality of consultant (recoded): General medicine	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.2e-07	Triglycerides in very small VLDL	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.22797e-07	Malignant lymphoma	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.29997e-07	Cholesteryl esters to total lipids ratio in small LDL	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.29997e-07	Free cholesterol levels in medium HDL	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.33196e-07	Frequency of light DIY in last 4 weeks	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.43242e-07	IDP_dMRI_ProbtrackX_L3_ifo_r	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.46537e-07	ENSG00000206503	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.46601e-07	Peripheral artery disease	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.49357e-07	Number of incorrect matches in round	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.61202e-07	Finngen Rheumatological endpoints	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.6216e-07	IDP_dMRI_TBSS_ICVF_Genu_of_corpus_callosum	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.70101e-07	DNA methylation Hannum age acceleration	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.71535e-07	Ubiquitin-like protein ISG15	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.75898e-07	Other specified/unspecified systemic involvement of connective tissue	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.85798e-07	Diabetic retinopathy (more controls excluded)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.86678e-07	Endocrine, nutritional and metabolic diseases	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.89996e-07	Triglycerides in IDL	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.89996e-07	Number of days/week of vigorous physical activity 10+ minutes	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4e-07	Triglyceride levels in medium HDL	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.01948e-07	Neutrophill percentage	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.10488e-07	IDP_dMRI_TBSS_ICVF_Anterior_corona_radiata_L	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.24297e-07	Receptor for advanced glycosylation end products levels	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.57604e-07	Medication use (anti-inflammatory and antirheumatic products, non-steroids)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.77178e-07	Hearing difficulty/problems with background noise	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.77639e-07	IDP_dMRI_TBSS_MD_Superior_fronto-occipital_fasciculus_L	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.79999e-07	Height	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.81704e-07	Colitis, primary sclerosing	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.97096e-07	Diabethic neuropathy	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	5.1e-07	Lung function (FEV1/FVC)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	5.1e-07	Ratio of saturated fatty acids to total fatty acids	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	5.1606e-07	BA-exvivo_rh_thickness_entorhinal	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	5.16535e-07	wg_rh_intensity-contrast_parsorbitalis	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	5.30005e-07	Cholesterol to total lipids ratio in IDL	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	5.39995e-07	Cholesterol in medium HDL	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	5.47394e-07	IDP_dMRI_ProbtrackX_ICVF_slf_l	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	5.49997e-07	Total lipid levels in HDL	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	5.58985e-07	aparc-a2009s_lh_volume_S-temporal-sup	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	5.66291e-07	DNA methylation Hannum age acceleration	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	5.89997e-07	Parental longevity (mother's attained age)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	5.89997e-07	Triglycerides in large HDL	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	6.09537e-07	IDP_dMRI_ProbtrackX_ICVF_mcp	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	6.11773e-07	Cancer of primary lymphoid hematopoietic	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	6.12703e-07	Worry	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	6.19998e-07	Free cholesterol to total lipids ratio in large LDL	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	6.22014e-07	IDP_dMRI_TBSS_L2_Genu_of_corpus_callosum	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	6.29999e-07	Total concentration of lipoprotein particles	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	6.29999e-07	Corneal hysteresis (left)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	6.30957e-07	IDP_dMRI_TBSS_L3_Superior_corona_radiata_L	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	6.4121e-07	HippSubfield_rh_volume_hippocampal-fissure	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	6.49995e-07	Interval between previous point and current one in alphanumeric path (trail #2)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	6.6359e-07	IDP_dMRI_TBSS_L3_Retrolenticular_part_of_internal_capsule_L	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	6.64967e-07	Treatment/medication code: ventolin 100micrograms inhaler	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	6.73752e-07	IDP_dMRI_ProbtrackX_L3_ilf_l	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	6.88811e-07	IDP_T1_FAST_ROIs_R_parahipp_gyrus_post	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	6.8897e-07	IDP_dMRI_TBSS_OD_Retrolenticular_part_of_internal_capsule_L	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	6.90001e-07	Renal or urological disease	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	7.00003e-07	Total cholines	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	7.09088e-07	IDP_dMRI_ProbtrackX_OD_ilf_r	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	7.17216e-07	Potassium in urine (UKB data field 30520)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	7.17629e-07	IDP_dMRI_TBSS_L3_Superior_longitudinal_fasciculus_R	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	7.31139e-07	IDP_dMRI_TBSS_ICVF_Cingulum_cingulate_gyrus_R	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	7.43515e-07	Eye problems/disorders: Diabetes related eye disease	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	7.491e-07	Sarcoidosis	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	7.49998e-07	Triglycerides to total lipids ratio in very small VLDL	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	7.55092e-07	IDP_dMRI_ProbtrackX_OD_slf_r	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	7.55788e-07	IDP_dMRI_TBSS_L3_Anterior_corona_radiata_R	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	7.76426e-07	wg_lh_intensity-contrast_superiortemporal	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	7.90005e-07	Leg fat mass (left)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	7.97627e-07	IDP_dMRI_ProbtrackX_ICVF_slf_r	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	8.03711e-07	IDP_T1_FAST_ROIs_L_temp_fusif_cortex_post	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	8.08593e-07	Iridocyclitis	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	8.19993e-07	Ratio of saturated fatty acids to total fatty acids	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	8.29278e-07	IDP_dMRI_TBSS_FA_Middle_cerebellar_peduncle	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	8.30004e-07	Triglyceride levels in HDL	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	8.40001e-07	Phosphatidylcholines	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	8.40001e-07	Illnesses of father: Lung cancer	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	8.5153e-07	IDP_dMRI_TBSS_FA_Cerebral_peduncle_R	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	8.745e-07	Proheparin-binding EGF-like growth factor levels	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	8.9e-07	haemotological cancer	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	8.9e-07	Operative procedures - main OPCS: G45.1 Fibreoptic endoscopic examination of upper gastrointestinal tract and biopsy of lesion of upper gastrointestinal tract	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	9.13272e-07	wg_rh_intensity-contrast_superiorfrontal	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	9.16811e-07	Alanine aminotransferase	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	9.40005e-07	Arm fat mass (right)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	9.58098e-07	Alanine aminotransferase levels	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	9.59997e-07	Treatment/medication code: ventolin 100micrograms inhaler	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	9.64384e-07	Fluid intelligence score	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1e-06	Total phospholipid levels in lipoprotein particles	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.01414e-06	aparc-DKTatlas_lh_area_middletemporal	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.05487e-06	IDP_dMRI_TBSS_L1_Superior_corona_radiata_L	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.05701e-06	Asthma	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.07078e-06	IDP_dMRI_ProbtrackX_ICVF_unc_r	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.08638e-06	Non-cancer illness code  self-reported: diabetes	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.09499e-06	CX3CL1 levels	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.09999e-06	Triglycerides to total lipids ratio in small LDL	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.09999e-06	Cholesteryl esters in medium HDL	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.10129e-06	Familial combined hyperlipidemia defined by Consensus criteria	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.1838e-06	Ever had prolonged feelings of sadness or depression	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.2e-06	Depression	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.2e-06	Triglycerides in very large HDL	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.2e-06	Duration to complete alphanumeric path (trail #2)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.2e-06	Suffer from 'nerves'	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.20226e-06	17-beta-hydroxysteroid dehydrogenase 14	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.21451e-06	IDP_dMRI_TBSS_ICVF_External_capsule_R	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.27008e-06	Lymphomas	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.2815e-06	ENSG00000234127	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.29999e-06	Cholesterol levels in medium HDL	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.29999e-06	Forced expiratory volume in 1-second (FEV1)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.30299e-06	Psoriasis	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.34617e-06	IDP_dMRI_ProbtrackX_MD_slf_r	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.354e-06	Other retinal disorders	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.37848e-06	IDP_dMRI_ProbtrackX_OD_str_l	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.38644e-06	aparc-a2009s_rh_thickness_S-circular-insula-inf	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.40001e-06	Free cholesterol to total lipids ratio in small LDL	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.40001e-06	Triglycerides in small VLDL	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.40708e-06	ENSG00000234745	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.434e-06	Gonarthrosis [arthrosis of knee](FG)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.47201e-06	Gonarthrosis	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.47901e-06	Colitis, primary sclerosing, strict definition	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.5e-06	Tyrosine	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.5e-06	Cholesterol to total lipids ratio in very small VLDL	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.5e-06	Eye problems/disorders: Diabetes related eye disease	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.59111e-06	IDP_dMRI_TBSS_L1_Fornix_cres+Stria_terminalis_R	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.59735e-06	wg_lh_intensity-contrast_superiorfrontal	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.6e-06	Triglyceride levels in small VLDL	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.6e-06	Non-cancer illness code, self-reported: gastro-oesophageal reflux (gord) / gastric reflux	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.6125e-06	IDP_dMRI_TBSS_ICVF_Superior_fronto-occipital_fasciculus_L	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.6233e-06	IDP_dMRI_ProbtrackX_ICVF_ml_l	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.66498e-06	Varicose veins	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.68702e-06	Nephrotic syndrome	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.69301e-06	Type 1 diabetes with ketoacidosis	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.7053e-06	IDP_dMRI_ProbtrackX_L2_ilf_l	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.72302e-06	Certain disorders involving the immune mechanism	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.72783e-06	wg_lh_intensity-contrast_supramarginal	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.73285e-06	Calcium levels (UKB data field 30680)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.77664e-06	aparc-Desikan_rh_thickness_insula	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.79999e-06	Phospholipids to total lipids ratio in chylomicrons and extremely large VLDL	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.79999e-06	Ever smoked	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.79999e-06	Duration to entering value	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.80676e-06	IDP_dMRI_ProbtrackX_L2_fmi	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	1.96657e-06	Whole body fat mass	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2e-06	Guilty feelings	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.01512e-06	IDP_dMRI_TBSS_FA_Cerebral_peduncle_L	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.02526e-06	Comparative height size at age 10	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.05599e-06	Crohn's disease	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.07898e-06	Hypothyroidism, drug reimbursement	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.14487e-06	wg_rh_intensity-contrast_rostralmiddlefrontal	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.23718e-06	Phosphate	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.26798e-06	Pediatric asthma	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.30001e-06	Triglyceride levels in LDL	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.39999e-06	Cholesteryl ester levels in medium HDL	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.39999e-06	Triglyceride levels in medium LDL	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.474e-06	IBD (strict) with PSC	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.5e-06	Cholesterol to total lipids ratio in IDL	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.5e-06	Free cholesterol to total lipids ratio in very small VLDL	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.5e-06	Triglycerides to total lipids ratio in IDL	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.5e-06	Number of incorrect matches in round	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.5e-06	Age started hormone-replacement therapy (HRT)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.5e-06	Illnesses of siblings: Diabetes	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.50501e-06	Pain type(s) experienced in last month: Headache	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.54302e-06	Hypothyroidism,  other/unspecified	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.57336e-06	IDP_dMRI_TBSS_OD_External_capsule_R	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.61577e-06	IDP_dMRI_ProbtrackX_ICVF_unc_l	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.63403e-06	Autoimmune hepatitis	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.6595e-06	IDP_dMRI_ProbtrackX_L3_cgc_r	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.6644e-06	IDP_dMRI_TBSS_L3_Sagittal_stratum_L	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.69998e-06	Free cholesterol to total lipids ratio in large LDL	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.70583e-06	aseg_lh_intensity_Pallidum	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.73401e-06	IDP_dMRI_ProbtrackX_ICVF_str_l	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.76185e-06	IDP_dMRI_ProbtrackX_L3_ifo_l	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.77141e-06	Diagnoses - main ICD10: N40 Hyperplasia of prostate	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.80001e-06	Triglyceride levels in large LDL	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.80782e-06	ENSG00000204625	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.83589e-06	Ever smoked	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.90001e-06	Forced Expiratory Volume (FEV1), adjusted for sex	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.90001e-06	HbA1C	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.92981e-06	C-reactive protein	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	2.94401e-06	Neutrophil percentage of white cells	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.2e-06	Operation code: appendicectomy	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.2434e-06	IDP_dMRI_TBSS_ICVF_Medial_lemniscus_L	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.26814e-06	IDP_dMRI_ProbtrackX_L3_ilf_r	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.40001e-06	Triglyceride levels in large HDL	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.40001e-06	Free cholesterol to total lipids ratio in very small VLDL	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.41437e-06	Ever had prolonged loss of interest in normal activities	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.44897e-06	Acute and subacute iridocyclitis	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.49076e-06	ENSG00000137310	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.49462e-06	IDP_dMRI_TBSS_ICVF_Tapetum_L	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.51318e-06	wg_lh_intensity-contrast_postcentral	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.59667e-06	HippSubfield_rh_volume_presubiculum-body	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.59998e-06	Total phospholipids in lipoprotein particles	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.66944e-06	aparc-DKTatlas_rh_area_inferiorparietal	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.69999e-06	Lifetime number of sexual partners	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.79997e-06	Diagnoses - main ICD10: N40 Hyperplasia of prostate	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	3.81092e-06	Phosphate	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4e-06	Triglycerides in small LDL	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.0281e-06	IDP_dMRI_TBSS_FA_Anterior_corona_radiata_L	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.09996e-06	Cholesteryl esters to total lipids ratio in very small VLDL	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.13238e-06	aparc-a2009s_rh_thickness_S-pericallosal	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.20001e-06	Leg fat mass (right)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.20146e-06	IDP_dMRI_TBSS_L2_Superior_corona_radiata_L	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.35712e-06	rfMRI connectivity (ICA100 edge 955)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.36516e-06	T-cell surface glycoprotein CD3 epsilon chain	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.39997e-06	Diabetes	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.40048e-06	wg_lh_intensity-contrast_parsorbitalis	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.41133e-06	ENSG00000204386	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.41896e-06	Disorders of myonerural junction and muscle in diseases in classifeid elsewhere	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.49883e-06	IDP_dMRI_ProbtrackX_FA_fmi	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.60002e-06	Lymphocyte percentage of white cells	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.62104e-06	Glucose levels	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.63234e-06	IDP_dMRI_TBSS_ICVF_Fornix_cres+Stria_terminalis_L	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.68209e-06	Primary_lymphoid and hematopoietic malignant neoplasms	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.70002e-06	Strenuous sports or other exercises	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.70197e-06	Feeling nervous	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.7076e-06	aparc-a2009s_lh_thickness_G-Ins-lg+S-cent-ins	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.73369e-06	aparc-Desikan_rh_area_inferiorparietal	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.783e-06	ThalamNuclei_lh_volume_AV	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.81061e-06	aparc-Desikan_lh_area_middletemporal	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.84395e-06	Lupus erythematosus	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.90004e-06	Triglyceride levels in small LDL	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.90004e-06	Triglycerides in large LDL	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.91428e-06	Glucose	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	4.93151e-06	Ever sought or received professional help for mental distress	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	5.24699e-06	Calcium levels	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	5.30726e-06	Mouth/teeth dental problems: Mouth ulcers	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	5.33458e-06	IDP_dMRI_ProbtrackX_L2_unc_r	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	5.38704e-06	Prostate cancer	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	5.38704e-06	Prostate cancer	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	5.3915e-06	Calcium	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	5.39995e-06	Triglycerides to total lipids ratio in very small VLDL	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	5.39995e-06	Triglycerides in LDL	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	5.49997e-06	Triglycerides to total lipids ratio in small LDL	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	5.49997e-06	Vitamin and mineral supplements: Vitamin C	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	5.49997e-06	Operation code: tonsillectomy +/- adenoids	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	5.69194e-06	Immunodeficiency with predominantly antibody defects	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	5.69994e-06	Home location at assessment - east co-ordinate (rounded)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	5.75043e-06	IDP_dMRI_TBSS_FA_Genu_of_corpus_callosum	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	5.89997e-06	Triglyceride levels in very large HDL	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	5.91289e-06	aparc-a2009s_lh_thickness_Lat-Fis-ant-Vertical	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	5.96994e-06	Diseases of the genitourinary system	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	6.14455e-06	Endometrial cancer	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	6.8691e-06	ThalamNuclei_lh_volume_Whole-thalamus	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	7.12853e-06	IDP_dMRI_TBSS_L3_Superior_fronto-occipital_fasciculus_L	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	7.2277e-06	IDP_dMRI_TBSS_ICVF_Anterior_corona_radiata_R	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	7.49204e-06	IDP_T1_FAST_ROIs_R_temp_fusif_cortex_post	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	7.50775e-06	Depression (SPA correction)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	7.53182e-06	ThalamNuclei_rh_volume_AV	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	7.59994e-06	Cholesterol to total lipids ratio in very small VLDL	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	7.65597e-06	Gonarthrosis,primary	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	7.69839e-06	IDP_dMRI_TBSS_L1_External_capsule_R	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	7.69999e-06	Vigorous physical activity	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	7.69999e-06	Ratio of monounsaturated fatty acids to total fatty acids	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	7.73304e-06	Depression (Firth correction)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	7.77356e-06	Arm fat mass (left)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	7.79399e-06	Nasal polyps	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	7.83791e-06	wg_rh_intensity-contrast_parstriangularis	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	8.05378e-06	IDP_T1_FIRST_right_thalamus_volume	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	8.10588e-06	IDP_dMRI_ProbtrackX_L1_ifo_l	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	8.11335e-06	IDP_dMRI_ProbtrackX_MO_ar_r	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	8.26418e-06	aparc-Desikan_lh_area_bankssts	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	8.39305e-06	Ulcerative colitis (strict) with PSC	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	8.41201e-06	IDP_dMRI_ProbtrackX_OD_slf_l	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	8.49396e-06	Neurociticism	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	8.50002e-06	Forced expiratory volume in 1-second (FEV1), Best measure	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	8.50746e-06	IDP_T1_FAST_ROIs_R_thalamus	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	8.55067e-06	IDP_dMRI_TBSS_ICVF_Posterior_limb_of_internal_capsule_L	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	8.66303e-06	Arthropod-borne viral fevers and viral haemorrhagic fevers	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	8.70001e-06	Asthma (childhood onset)	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	8.70001e-06	Cholesteryl esters in chylomicrons and extremely large VLDL	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	8.73575e-06	IDP_dMRI_TBSS_OD_Fornix_cres+Stria_terminalis_R	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	8.99995e-06	Concentration of small HDL particles	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	9.12011e-06	UDP-N-acetylhexosamine pyrophosphorylase	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	9.20005e-06	Treatment/medication code: seretide 50 evohaler	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	9.23294e-06	ENSG00000235290	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	9.29994e-06	Tense / 'highly strung'	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	9.3491e-06	Sarcoidosis	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	9.35406e-06	KELA_REIMBURSEMENT_202	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	9.49292e-06	IDP_dMRI_TBSS_L2_Tapetum_L	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	9.59997e-06	Treatment/medication code: calcichew d3 tablet	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	9.67565e-06	Non-cancer illness code  self-reported: hiatus hernia	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	9.7949e-06	Neuroticism	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	9.90011e-06	Triglycerides in medium LDL	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs3095155	9.92293e-06	C-reactive protein	6	50746	0.436059748529573	2.80898875093363e-09	EasActiv18mo	0.129636
rs2596547	0	Non-cancer illness code  self-reported: malabsorption/coeliac disease	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.1289039792536e-308	ENSG00000204525	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	8.33681e-289	Lymphocyte count	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	8.33681e-289	lymphocyte cell count	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.58125e-288	White blood cell count	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.58125e-288	white blood cell count	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.99945e-244	White blood cell count	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.49945e-241	Lymphocyte count	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.74116e-228	ENSG00000224389	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.46218e-210	White blood cell leukocyte count (UKB data field 30000)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.93174e-210	Lymphocyte count (UKB data field 30120)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	7.7983e-176	White blood cell (leukocyte) count	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	9.66051e-173	Lymphocyte count	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.65273e-171	Monocyte count	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.65273e-171	monocyte cell count	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.34564e-160	Lymphocyte count	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.34195e-156	ENSG00000137331	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.49541e-151	Type 1 diabetes	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	9.4189e-148	ENSG00000214894	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.98107e-147	ENSG00000244731	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.64515e-142	ENSG00000231852	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.07399e-139	Monocyte count (UKB data field 30130)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.0797e-137	White blood cell count	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.79887e-116	Mean reticulocyte volume	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.50752e-116	Neutrophil count	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.50752e-116	neutrophil cell count	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.3387e-116	Type 1 diabetes	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.66686e-112	Monocyte count	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.83231e-109	ENSG00000137312	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	9.90832e-108	Aspartate aminotransferase levels (UKB data field 30650)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.05116e-104	Lymphocyte counts	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.30884e-103	Eosinophil counts	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.30884e-103	eosinophil cell count	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.82825e-102	Monocyte count	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.39994e-100	Neutrophil count	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.21004e-99	White blood cell count	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.5293e-97	Neutrophill count (UKB data field 30140)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.37676e-96	ENSG00000204338	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	9.19814e-96	Systemic lupus erythematosus	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.70023e-95	Never eat eggs, dairy, wheat, sugar: Wheat products	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1e-93	Non-cancer illness code, self-reported: hyperthyroidism/thyrotoxicosis	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.40017e-91	Hyperthyroidism or thyrotoxicosis	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.78997e-90	Membranous nephropathy	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.84386e-89	Aspartate aminotransferase	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.4003e-88	Eosinophil counts	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.21787e-87	Type 1 diabetes	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.34531e-86	Total protein	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.87354e-86	ENSG00000137411	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.69153e-84	MHC class I polypeptide-related sequence B	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.79319e-84	Aspartate aminotransferase levels	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.07771e-83	Non-cancer illness code  self-reported: hyperthyroidism/thyrotoxicosis	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	9.42323e-83	Neutrophill count	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.67793e-82	Serum total protein level	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.03393e-82	Eosinophill count (UKB data field 30150)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.82025e-82	Total protein	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.09991e-81	Sitting height	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	9.60064e-78	Thyroid problem (not cancer)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.20005e-77	Reticulocyte count	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	7.68953e-69	Neutrophil count	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	8.03526e-66	Mean reticulocyte volume	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.18933e-65	Medication use (thyroid preparations)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.29987e-63	Diabetes or endocrine disease	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	7.70549e-59	Monocyte count	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.29987e-58	Reticulocyte fraction of red cells	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.52e-58	Hemoglobin concentration	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1e-57	Mean spheric corpuscular volume	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.82096e-56	Sitting height	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.41324e-56	Eosinophil counts	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.38329e-52	Myeloid white cell count	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	8.77001e-52	Hypothyroidism or myxoedema (Firth correction)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.10002e-51	High light scatter reticulocyte count	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.31735e-51	Hypothyroidism or myxoedema (SPA correction)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.00035e-50	Standing height	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.20005e-48	Hemoglobin	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.20005e-48	Treatment/medication code: levothyroxine sodium	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.34099e-48	ENSG00000248290	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.48013e-47	Red blood cell count	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.65399e-47	Haemoglobin concentration (UKB data field 30020)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	7.50067e-46	Started insulin within one year diagnosis of diabetes	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.38388e-45	Granulocyte count	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.19963e-45	Treatment/medication code: insulin product	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.4578e-45	Sum eosinophil basophil counts	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.92013e-45	Platelet count	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.854e-45	Reticulocyte count	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.23595e-44	Appendicular lean mass	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.06681e-44	Sum neutrophil eosinophil counts	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	7.08272e-44	ENSG00000225059	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	9.6272e-44	ENSG00000225851	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.45471e-43	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.13333e-43	Cystatin C levels (UKB data field 30720)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	7.81988e-43	Red cell distribution width	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.61999e-42	Hematocrit	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.96735e-42	Platelet count (UKB data field 30080)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.08993e-41	Peak expiratory flow	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.59993e-41	Non-cancer illness code, self-reported: hypothyroidism/myxoedema	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.79954e-41	White blood cell count (lymphocyte)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.70033e-41	Hypothyroidism or myxedema	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.98199e-40	Early-onset myasthenia gravis	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	9.09913e-40	High light scatter reticulocyte percentage of red cells	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	9.31322e-40	Red blood cell (erythrocyte) distribution width	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.39091e-39	Eosinophil counts	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.30091e-39	Sum basophil neutrophil counts	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.10527e-39	Triglyceride levels (UKB data field 30870)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.03753e-38	Treatment/medication code: insulin product	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.70883e-38	Reticulocyte count	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.8197e-38	Glutamate receptor 4	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.59478e-38	Neutrophil count	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.20701e-38	Started insulin within one year diagnosis of diabetes	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.14286e-38	Height	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	8.91046e-38	Haemoglobin concentration	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.10002e-37	Red cell distribution width	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.30029e-37	Red blood cell count	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	7.29962e-37	Platelet count	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	7.39946e-37	Mean platelet volume	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.00346e-36	Treatment/medication code: levothyroxine sodium	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.32892e-36	Standing height	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.58592e-36	Reticulocyte percentage	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.84953e-36	Lung function (FEV1/FVC)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.29989e-35	Leg fat-free mass (right)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.48097e-35	ENSG00000204536	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.79954e-35	Whole body fat-free mass	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.79963e-35	Leg predicted mass (right)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.28927e-35	Basophil count	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.28927e-35	basophil cell count	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.79986e-35	Whole body water mass	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	9.09913e-35	Autoimmune traits	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	9.10332e-35	Hemoglobin	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.49977e-34	Leg fat-free mass (left)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.59998e-34	Leg predicted mass (left)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	8.9002e-34	Hematocrit	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.15001e-33	Complement C2 measurement	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.90283e-33	Platelet count	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.29985e-33	Basal metabolic rate	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.69488e-33	Non-cancer illness code  self-reported: hypothyroidism/myxoedema	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.89922e-33	triglycerides	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.00067e-32	Trunk fat-free mass	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	9.29394e-32	Cystatin C	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	9.51919e-32	Glycated haemoglobin HbA1c levels (UKB data field 30750)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	9.80393e-32	Red blood cell erythrocyte count (UKB data field 30010)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.64551e-31	High light scatter reticulocyte count	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.67687e-31	Platelet count	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.9829e-31	Triglycerides	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.99986e-31	Trunk predicted mass	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.98425e-31	Cystatin C	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.50047e-31	Autoimmune traits	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.06243e-30	Aspartate aminotransferase	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.93108e-30	Reticulocyte fraction of red cells	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.80027e-30	Arm predicted mass (left)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.79954e-30	Arm fat-free mass (left)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	7.37225e-30	Triglycerides	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	7.85959e-30	Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection, CLOZUK+PGC2	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.11173e-29	Gamma glutamyltransferase levels (UKB data field 30730)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.34896e-29	Complement C4	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.01649e-29	Type 1 diabetes	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.76706e-29	Cholesterol levels (UKB data field 30690)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.07572e-28	Mean platelet thrombocyte volume (UKB data field 30100)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.49796e-28	FEV1	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.834e-28	ENSG00000213676	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.4998e-28	apolipoprotein A-I	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	9.46673e-28	Leg fat-free mass (right)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.50003e-27	Arm fat-free mass (right)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.89583e-27	Schizophrenia	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.2475e-27	Leg predicted mass (right)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.29989e-27	Arm predicted mass (right)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.20012e-27	Ankle spacing width	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	9.59401e-27	Whole body fat-free mass	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.78033e-26	Whole body water mass	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.13599e-26	Schizophrenia	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.87475e-26	Leg fat-free mass (left)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.84061e-26	Leg predicted mass (left)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.51442e-26	Hypothyroidism	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1e-25	Appendicular lean mass	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.18005e-25	Mean platelet volume	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.29688e-25	diastolic blood pressure	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.59331e-25	Apolipoprotein A levels (UKB data field 30630)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.66686e-25	Mean sphered cell volume	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.74181e-25	MICB	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.29985e-25	Hypothyroidism	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.10027e-25	HDL cholesterol	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.5436e-25	Hyperthyroidism	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.72202e-25	Basal metabolic rate	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	7.19946e-25	Weight	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	8.2054e-25	Triglycerides	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	9.6272e-25	Glycated haemoglobin	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.13397e-24	High light scatter reticulocyte percentage	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.55346e-24	Glycated haemoglobin	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.9002e-24	Mean platelet volume	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.94984e-24	T-cell surface protein tactile	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.18675e-24	Trunk fat-free mass	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.41324e-24	Schizophrenia	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.43445e-24	Apoliprotein A	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.29989e-24	Basophil count	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.62827e-24	Trunk predicted mass	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.49987e-24	Operative procedures - secondary OPCS: Z27.4 Duodenum	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.38263e-24	Red blood cell count	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	8.11895e-24	Other diseases of the digestive system	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	8.60003e-24	Weight	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.59993e-23	Age diabetes diagnosed	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.76617e-23	ENSG00000204531	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.19952e-23	IGF 1 (UKB data field 30770)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.86968e-23	Mean platelet (thrombocyte) volume	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.30029e-23	telomere length	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.86752e-23	Cholesterol	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	8.50354e-23	Cholesterol	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.09219e-22	High density lipoprotein cholesterol levels (UKB data field 30760)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.76889e-22	IgA nephropathy	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.70583e-22	Hemoglobin A1c levels	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.59998e-22	Operation code: thyroidectomy/partial thyroidectomy	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.89251e-22	Red blood cell (erythrocyte) count	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.90065e-22	Connective tissue disorder	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.08693e-21	Weight	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.63493e-21	Arm predicted mass (left)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.80509e-21	High light scatter reticulocyte count	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.311e-21	Haematocrit percentage	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.90001e-21	Diagnoses - secondary ICD10: E03.9 Hypothyroidism, unspecified	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.79954e-21	Diagnoses - main ICD10: R31 Unspecified haematuria	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.83727e-21	Gamma glutamyltransferase	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.04088e-20	Arm fat-free mass (left)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.09799e-20	Estimated glomerular filtration rate (creatinine)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.21843e-20	Apoliprotein A	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.06538e-20	Arm fat-free mass (right)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.86418e-20	HDL cholesterol	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.98676e-20	Varicella zoster virus glycoproteins E and I antibody levels	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.45862e-20	White blood cell count (basophil)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.60045e-20	Non-cancer illness code, self-reported: asthma	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.7112e-20	Hematocrit	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	8.04081e-20	Total cholesterol levels	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	9.35406e-20	Psoriasis	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.32251e-19	Creatinine levels (UKB data field 30700)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.34586e-19	ENSG00000204304	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.72703e-19	MICA	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.9002e-19	Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor: Asthma	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.9002e-19	Time to complete round	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.99986e-19	Eosinophil percentage of white cells	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.09991e-19	Medication for pain relief, constipation, heartburn: Paracetamol	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.66686e-19	IGF-1	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.70023e-19	Plateletcrit	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.19963e-19	Comparative body size at age 10	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.70169e-19	Gamma glutamyl transpeptidase	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.72821e-19	HDL cholesterol	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.80014e-19	Other serious medical condition/disability diagnosed by doctor	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.90004e-19	Comparative body size at age 10, Males and Females	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.22998e-19	Arm predicted mass (right)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.60015e-19	Bowel problem	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.90065e-19	Height	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.36796e-19	Blood clot  DVT  bronchitis  emphysema  asthma  rhinitis  eczema  allergy diagnosed by doctor: Asthma	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	7.00003e-19	Hip circumference	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	7.44046e-19	schizophrenia	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	8.8247e-19	Platelet count	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.00809e-18	Non-cancer illness code  self-reported: asthma	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.08668e-18	ENSG00000204351	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.10002e-18	Medication for pain relief, constipation, heartburn: None of the above	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.31795e-18	ENSG00000204438	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.29985e-18	Diastolic blood pressure, automated reading	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.63496e-18	Hemoglobin concentration	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.73508e-18	Estimated glomerular filtration rate (creatinine)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.7627e-18	Bread type: Other type of bread	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.49987e-18	Medication for cholesterol, blood pressure or diabetes: Insulin	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.30029e-18	Asthma	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	7.19946e-18	Polyunsaturated fatty acid levels	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.16466e-17	IGF-1	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.6661e-17	HDL cholesterol	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.692e-17	Weight	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.90001e-17	Ankle spacing width (right)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.50026e-17	Operative procedures - main OPCS: M45.9 Unspecified diagnostic endoscopic examination of bladder	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.08319e-17	Total bilirubin levels (UKB data field 30840)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.55648e-17	Total bilirubin levels (UKB data field 30840)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.73324e-17	ENSG00000204528	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.59933e-17	Neutrophil percentage of white cells	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.67882e-17	Cereal type: Other (e.g. Cornflakes, Frosties)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	7.8614e-17	High light scatter reticulocyte percentage of red cells	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	8.66363e-17	Medication for cholesterol  blood pressure or diabetes: Insulin	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	8.93511e-17	Asthma (Firth correction)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	9.43626e-17	Asthma (SPA correction)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	9.79941e-17	FEV1/FVC < 0.7	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1e-16	Mean corpuscular hemoglobin concentration	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.10002e-16	Non-cancer illness code, self-reported: psoriasis	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.166e-16	Lung cancer	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.35706e-16	Mean corpuscular haemoglobin concentration	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.44245e-16	Hip circumference (UKB data field 49)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.72982e-16	IDP_dMRI_TBSS_L1_Superior_longitudinal_fasciculus_L	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.80011e-16	Platelet count	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.19989e-16	Age at menopause (last menstrual period)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.19952e-16	Mouth/teeth dental problems: Dentures	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.24717e-16	Platelet crit	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.81172e-16	Type 1 diabetes (SPA correction)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.89779e-16	HLA class II histocompatibility antigen, DQ alpha 2 chain	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.95222e-16	Type 1 diabetes (Firth correction)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.39759e-16	Diastolic blood pressure automated reading (UKB data field 4079)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.7544e-16	Trypsin-3	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.4003e-16	Number of fluid intelligence questions attempted within time limit	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.74994e-16	Squamous cell lung carcinoma	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	7.53876e-16	Psoriasis	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	8.4004e-16	Ankle spacing width (left)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.20809e-15	Complement C4 levels	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.77337e-15	Creatinine	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.85225e-15	Non-cancer illness code  self-reported: psoriasis	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.46945e-15	Other serious medical condition/disability diagnosed by doctor	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.78869e-15	ENSG00000204305	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.19963e-15	Main speciality of consultant (recoded): Urology	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.59998e-15	Omega-6 fatty acid levels	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.15336e-15	ENSG00000204444	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.23741e-15	Comparative body size at age 10	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.90065e-15	Polyunsaturated fatty acids	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.62064e-15	Medication for pain relief  constipation  heartburn: None of the above	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.89922e-15	Linoleic acid levels	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	7.07946e-15	Beta-defensin 119	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	7.20112e-15	Sj<U+00F6>gren's syndrome	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	7.78395e-15	Treatment/medication code: thyroxine product	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	8.47032e-15	Alanine aminotransferase levels (UKB data field 30620)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	9.70063e-15	Hot drink temperature	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.13214e-14	Basophil count	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.23994e-14	Mean corpuscular hemoglobin concentration	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.39991e-14	Appendicular lean mass	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.49279e-14	Severe autoimmune type 2 diabetes	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.50003e-14	Oily fish intake	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.67996e-14	Diagnoses - main ICD10: R31 Unspecified haematuria	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.69981e-14	Treatment/medication code: thyroxine product	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.9002e-14	Comparative body size at age 10, Females	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.34423e-14	Rac GTPase-activating protein 1	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.85922e-14	Plateletcrit	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.10015e-14	Total fatty acid levels	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.80729e-14	Sjogren's syndrome (Firth correction)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.82503e-14	Sjogren's syndrome (SPA correction)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.10035e-14	Never eat eggs, dairy, wheat, sugar: I eat all of the above	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.18561e-14	Hematocrit	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.64661e-14	Epstein-Barr virus ZEBRA antibody levels	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.89287e-14	Medication for pain relief  constipation  heartburn: Paracetamol	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	7.23769e-14	Mean corpuscular hemoglobin concentration	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	7.59976e-14	Phospholipids in medium HDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.10002e-13	3mm weak meridian (left)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.1695e-13	Eosinophill percentage	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.20088e-13	Medication use (anilides)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.33937e-13	ENSG00000250535	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.36207e-13	Red blood cell count	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.50003e-13	Phospholipid levels in medium HDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.58416e-13	Diastolic blood pressure  automated reading	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.80011e-13	Low density lipoprotein cholesterol levels	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.9002e-13	Long-standing illness, disability or infirmity	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.99986e-13	Glycoprotein acetyls levels	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.09991e-13	Omega-3 fatty acid levels	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.49977e-13	Monounsaturated fatty acid levels	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.49977e-13	3mm strong meridian (left)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.70023e-13	Forced expiratory volume in 1-second (FEV1), predicted percentage	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.80027e-13	Linoleic acid	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.40017e-13	Phosphoglycerides levels	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.40173e-13	Hip circumference	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.45041e-13	Peak expiratory flow (UKB data field 3064)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.60045e-13	3mm strong meridian (right)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.79954e-13	Phospholipid levels in small HDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.08276e-13	Serum creatinine levels	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.10035e-13	Impedance of leg (left)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.40008e-13	Duration screen displayed	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.50047e-13	Treatment/medication code: paracetamol	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.00067e-13	Total fatty acids	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.09958e-13	3mm weak meridian (right)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.20012e-13	Omega-6 fatty acids	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.88652e-13	ThalamNuclei_rh_volume_LD	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	7.31644e-13	C reactive protein levels (UKB data field 30710)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	9.60064e-13	Monounsaturated fatty acids	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1e-12	Total lipids in medium HDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.05148e-12	ENSG00000204592	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.20005e-12	Omega-3 fatty acids	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.51286e-12	Diastolic blood pressure	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.80011e-12	Operation code: varicose vein surgery	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.83231e-12	IDP_dMRI_TBSS_L1_Sagittal_stratum_L	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.9002e-12	ENSG00000204386	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.94446e-12	Glucose	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.09991e-12	Total lipid levels in medium HDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.12912e-12	Neutrophill percentage	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.39883e-12	Interleukin-21	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.49977e-12	Phosphoglycerides	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.60016e-12	White blood cell count	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.80027e-12	Impedance of leg (right)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.93495e-12	Lung cancer in ever smokers	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.19154e-12	Forced expiratory volume in 1-second (FEV1)  predicted percentage	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.19963e-12	Phospholipids in small HDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.50026e-12	Lymphocyte percentage of white cells	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.13714e-12	ENSG00000204520	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.49987e-12	Glycoprotein acetyls	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.79954e-12	Free cholesterol levels in small HDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	7.2644e-12	Eosinophil percentage of granulocytes	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	8.39267e-12	Neutrophil percentage of granulocytes	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	8.60003e-12	Total lipid levels in small HDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	8.60003e-12	Concentration of medium HDL particles	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.01765e-11	Epstein-Barr virus EA-D antibody levels	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.03276e-11	IDP_dMRI_TBSS_MD_Posterior_thalamic_radiation_L	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.10002e-11	Total cholines levels	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.10002e-11	Phospholipids in HDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.10154e-11	IDP_dMRI_ProbtrackX_ICVF_ptr_r	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.9002e-11	Phosphatidylcholine levels	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.9002e-11	Red cell distribution width	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.99986e-11	Apolipoprotein A1	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.29985e-11	6mm strong meridian (right)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.39001e-11	Creatinine	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.49977e-11	Concentration of medium HDL particles	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.6212e-11	Treatment/medication code: carbimazole	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.42768e-11	Comparative height size at age 10	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.50026e-11	Triglycerides in very small VLDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.19952e-11	Triglyceride levels in very small VLDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.49987e-11	Triglycerides in IDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.49987e-11	Time to answer	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.88652e-11	ThalamNuclei_rh_volume_CL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.19996e-11	Seen a psychiatrist for nerves, anxiety, tension or depression	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.40008e-11	Phospholipid levels in HDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.57442e-11	Red cell distribution width	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.70033e-11	Esophageal disorder	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.79963e-11	Total cholines	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.90065e-11	Apolipoprotein A1 levels	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.90065e-11	Salad / raw vegetable intake	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.03949e-11	IDP_dMRI_TBSS_L1_Sagittal_stratum_R	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.09958e-11	Treatment speciality of consultant (recoded): Urology	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.29941e-11	Free cholesterol in medium HDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.4003e-11	Free cholesterol in small HDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.59933e-11	Phospholipids to total lipids ratio in large LDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.59933e-11	6mm strong meridian (left)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.70039e-11	Triglyceride levels in IDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	7.19946e-11	Total phospholipid levels in lipoprotein particles	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	7.28618e-11	Long-standing illness  disability or infirmity	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	7.50067e-11	Total lipids in small HDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	7.70016e-11	Trunk fat mass	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	8.30042e-11	Phosphatidylcholines	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	8.69961e-11	Total concentration of lipoprotein particles	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	8.99912e-11	Triglycerides in medium HDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	9.70063e-11	Concentration of HDL particles	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	9.70063e-11	Phospholipids to total lipids ratio in small LDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	9.70063e-11	Total lipids in HDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	9.77237e-11	Granulysin	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1e-10	Phospholipids to total lipids ratio in large LDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.05862e-10	Any parental history of lung cancer (Firth correction)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.09308e-10	Any parental history of lung cancer (SPA correction)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.11712e-10	IDP_dMRI_TBSS_OD_Superior_longitudinal_fasciculus_L	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.2e-10	White blood cell count	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.2e-10	Concentration of HDL particles	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.23021e-10	C-reactive protein	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.2738e-10	ThalamNuclei_rh_volume_LP	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.40001e-10	Respiratory or ear-nose-throat disease	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.55998e-10	Eosinophil percentage of white cells	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.6e-10	Number of days/week of moderate physical activity 10+ minutes	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.68399e-10	Medication use (adrenergics, inhalants)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.70098e-10	IDP_dMRI_TBSS_MD_Posterior_thalamic_radiation_R	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.79999e-10	Cholesteryl esters to total lipids ratio in small LDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.79999e-10	Seen doctor (GP) for nerves, anxiety, tension or depression	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.92664e-10	IDP_dMRI_TBSS_MD_Sagittal_stratum_R	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.9756e-10	IDP_dMRI_TBSS_MD_Sagittal_stratum_L	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2e-10	White blood cell count (monocyte)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.1e-10	Free cholesterol levels in medium HDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.1e-10	Free cholesterol to total lipids ratio in small LDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.1e-10	Triglycerides in HDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.10087e-10	IDP_dMRI_ProbtrackX_L1_slf_l	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.18132e-10	ENSG00000240053	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.23578e-10	ENSG00000228789	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.39999e-10	Triglycerides in very large HDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.42293e-10	Calcium levels (UKB data field 30680)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.2e-10	Total concentration of lipoprotein particles	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.2056e-10	Impedance of leg (left)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.26513e-10	aseg_rh_intensity_Pallidum	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.39078e-10	IDP_dMRI_ProbtrackX_ICVF_cst_r	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.59998e-10	Total phospholipids in lipoprotein particles	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4e-10	6mm weak meridian (right)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.01698e-10	Neutrophil percentage of white cells	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.20001e-10	6mm weak meridian (left)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.39997e-10	Total lipid levels in HDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.53545e-10	Epstein-Barr virus EBNA-1 antibody levels	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.78564e-10	Impedance of leg (right)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.18681e-10	IDP_dMRI_TBSS_MD_Superior_longitudinal_fasciculus_L	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.20847e-10	Direct low density lipoprotein levels (UKB data field 30780)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.49997e-10	Diabetes diagnosed by doctor	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.99998e-10	Peak expiratory flow (PEF)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.1e-10	Triglycerides in small VLDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.14469e-10	IDP_dMRI_TBSS_ICVF_Retrolenticular_part_of_internal_capsule_L	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.2735e-10	ENSG00000204301	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.40472e-10	IDP_dMRI_TBSS_ICVF_Pontine_crossing_tract	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.61165e-10	Mouth/teeth dental problems: Dentures	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	7.14579e-10	Diabetes diagnosed by doctor	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	7.19996e-10	Non-oily fish intake	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	7.33618e-10	Direct low density lipoprotein levels (UKB data field 30780)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	7.49998e-10	Cholesteryl esters to total lipids ratio in small LDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	7.59994e-10	Phospholipids to total lipids ratio in small LDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	7.90679e-10	IDP_dMRI_TBSS_L2_Posterior_thalamic_radiation_L	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	8.10009e-10	Triglycerides in small LDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	8.24309e-10	Systemic lupus erythematosus	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	8.99995e-10	Triglyceride levels in medium HDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	9.36699e-10	Total bilirubin levels	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	9.43626e-10	IDP_dMRI_TBSS_ICVF_Posterior_thalamic_radiation_R	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	9.90011e-10	Asthma	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.02e-09	Receptor for advanced glycosylation end products levels	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.17001e-09	Medication use (drugs used in diabetes)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.23794e-09	IDP_T1_FAST_ROIs_L_thalamus	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.29999e-09	Triglycerides in large HDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.34524e-09	IDP_T1_FAST_ROIs_L_temp_fusif_cortex_post	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.35129e-09	Total bilirubin	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.43318e-09	IDP_dMRI_TBSS_L1_Posterior_corona_radiata_L	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.59071e-09	Alanine aminotransferase	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.6e-09	Triglyceride levels in small VLDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.6e-09	Hearing difficulty/problems with background noise	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.79999e-09	Triglyceride levels in LDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.87098e-09	Basophil count	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.89998e-09	Cholesterol in medium HDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.99402e-09	Bipolar disorder bip2021	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.1e-09	Triglyceride levels in medium LDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.1e-09	Illnesses of father: Lung cancer	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.30001e-09	Triglyceride levels in small LDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.30001e-09	Triglycerides in LDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.39999e-09	Treatment/medication code: calcichew d3 tablet	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.5e-09	Triglyceride levels in HDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.59998e-09	Operative procedures - main OPCS: G45.1 Fibreoptic endoscopic examination of upper gastrointestinal tract and biopsy of lesion of upper gastrointestinal tract	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.69998e-09	haemotological cancer	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.77779e-09	aparc-DKTatlas_lh_thickness_insula	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.79576e-09	IDP_dMRI_TBSS_ICVF_Posterior_thalamic_radiation_L	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.2e-09	Triglyceride levels in large LDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.29997e-09	Free cholesterol to total lipids ratio in small LDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.33542e-09	Seen doctor for nerves anxiety tension or depression (UKB data field 2090) (SPA correction)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.36078e-09	Seen doctor for nerves anxiety tension or depression (UKB data field 2090) (Firth correction)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.40001e-09	Triglycerides in large LDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.42373e-09	IDP_dMRI_ProbtrackX_ICVF_ptr_l	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.60894e-09	Primary_lymphoid and hematopoietic malignant neoplasms	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.66016e-09	IDP_dMRI_TBSS_MD_Retrolenticular_part_of_internal_capsule_L	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.72692e-09	Seen psychiatrist for nerves anxiety tension or depression (UKB data field 2100) (SPA correction)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.79769e-09	Treatment/medication code: paracetamol	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.79997e-09	White blood cell count	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.84813e-09	Seen psychiatrist for nerves anxiety tension or depression (UKB data field 2100) (Firth correction)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.96397e-09	Bipolar disorder bip2021 noUKBB	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.98997e-09	Alanine aminotransferase levels	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.15891e-09	Cancer of primary lymphoid hematopoietic	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.26481e-09	IDP_dMRI_TBSS_MD_Retrolenticular_part_of_internal_capsule_R	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.26737e-09	Lymphocyte percentage	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.27563e-09	IDP_dMRI_TBSS_L3_Posterior_thalamic_radiation_R	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.30002e-09	Arm fat mass (left)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.36224e-09	Lymphomas	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.917e-09	IDP_dMRI_TBSS_MD_Superior_corona_radiata_L	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.1e-09	Triglycerides in medium LDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.30005e-09	Free cholesterol to total lipids ratio in large LDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.39995e-09	Cholesterol levels in medium HDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.41377e-09	aseg_lh_intensity_Pallidum	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.43e-09	IDP_dMRI_ProbtrackX_MD_ilf_l	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.72532e-09	IDP_dMRI_ProbtrackX_ICVF_fma	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.80003e-09	Triglyceride levels in very large HDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.03101e-09	Medication use (drugs for peptic ulcer and gastro-oesophageal reflux disease)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.29999e-09	Pain type(s) experienced in last month: Headache	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.34395e-09	Pediatric asthma	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.4e-09	Cholesteryl esters in medium HDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.49995e-09	Moderate to vigorous physical activity levels	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	7.06204e-09	C-reactive protein	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	8.03008e-09	White blood cell count	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	9.3888e-09	Urate levels (UKB data field 30880)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	9.40005e-09	Docosahexaenoic acid	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	9.61192e-09	Psoriasis	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	9.69996e-09	Non-cancer illness code, self-reported: enlarged prostate	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.02188e-08	IDP_dMRI_ProbtrackX_L1_slf_r	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.07999e-08	Lung function (FVC)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.09999e-08	Whole body fat mass	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.2e-08	Mean corpuscular volume	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.27938e-08	IDP_dMRI_TBSS_L2_Anterior_corona_radiata_L	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.29999e-08	Triglycerides to total lipids ratio in small LDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.40001e-08	Lung function (FEV1/FVC)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.45271e-08	Endocrine, nutritional and metabolic diseases	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.6e-08	Dried fruit intake	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.61901e-08	Malignant lymphoma	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.63155e-08	IDP_dMRI_ProbtrackX_MD_slf_l	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.67225e-08	IDP_dMRI_TBSS_L3_Posterior_thalamic_radiation_L	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.6768e-08	Calcium	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.7e-08	Cholesteryl ester levels in medium HDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.7e-08	Free cholesterol to total lipids ratio in medium LDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.7e-08	Number of incorrect matches in round	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.01233e-08	IDP_dMRI_ProbtrackX_FA_ptr_r	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.1e-08	Total lipid levels in lipoprotein particles	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.1e-08	Triglyceride levels in large HDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.1e-08	Saturated fatty acid levels	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.11203e-08	IDP_dMRI_ProbtrackX_L1_ilf_r	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.1132e-08	Urate	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.33222e-08	Number of incorrect matches in round	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.60435e-08	BA-exvivo_rh_volume_entorhinal	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.62543e-08	aparc-a2009s_lh_area_S-temporal-sup	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.80001e-08	Free cholesterol to total lipids ratio in large LDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.82879e-08	IDP_dMRI_ProbtrackX_L1_ilf_l	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.83792e-08	IDP_dMRI_TBSS_L1_Superior_corona_radiata_R	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.869e-08	Lymphocyte percentage of white cells	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.90001e-08	Cholesteryl esters in chylomicrons and extremely large VLDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.93427e-08	IDP_dMRI_TBSS_ICVF_Retrolenticular_part_of_internal_capsule_R	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.09999e-08	Impedance of whole body	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.15646e-08	IDP_dMRI_TBSS_L3_Sagittal_stratum_R	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.27484e-08	Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.29997e-08	Cholesterol to total lipids ratio in IDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.52939e-08	IDP_dMRI_ProbtrackX_L2_ifo_l	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.59998e-08	Arm fat mass (right)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.7222e-08	aparc-DKTatlas_lh_area_middletemporal	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.89404e-08	IDP_dMRI_TBSS_ICVF_Sagittal_stratum_R	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.15815e-08	IDP_dMRI_ProbtrackX_ICVF_ifo_r	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.30002e-08	Asthma (adult onset)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.30002e-08	Saturated fatty acids	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.32912e-08	IDP_dMRI_ProbtrackX_MD_ifo_l	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.46098e-08	Serum uric acid levels	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.79999e-08	Total testosterone levels	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.79999e-08	Fluid intelligence score	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.90004e-08	Gastroesophageal reflux disease or gastric reflux	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5e-08	Docosahexaenoic acid levels	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.05999e-08	Neutrophil count	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.08604e-08	Calcium levels	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.19996e-08	Cholesterol in chylomicrons and extremely large VLDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.32844e-08	IDP_dMRI_ProbtrackX_ICVF_str_r	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.36562e-08	Pain type(s) experienced in last month: Headache (UKB data field 6159_1) (SPA correction)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.43075e-08	ENSG00000204308	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.44666e-08	Pain type(s) experienced in last month: Headache (UKB data field 6159_1) (Firth correction)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.46764e-08	Non-cancer illness code  self-reported: enlarged prostate	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.55495e-08	Asthma	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.59178e-08	Urate	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.60003e-08	Tyrosine levels	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.73852e-08	IDP_dMRI_TBSS_L3_Retrolenticular_part_of_internal_capsule_R	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.92652e-08	HippSubfield_rh_volume_hippocampal-fissure	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.0548e-08	aparc-DKTatlas_rh_area_insula	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.09677e-08	IDP_dMRI_ProbtrackX_ICVF_ifo_l	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.20155e-08	ThalamNuclei_rh_volume_PuM	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.49995e-08	Cholesteryl ester levels in chylomicrons and extremely large VLDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.59994e-08	Nervous feelings	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.63896e-08	IDP_dMRI_TBSS_MD_Posterior_corona_radiata_L	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.67421e-08	IDP_dMRI_TBSS_MD_Superior_corona_radiata_R	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.76083e-08	Granzyme A	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.80002e-08	Diabetes	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.80002e-08	Triglycerides to total lipids ratio in small LDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	7.08272e-08	IDP_dMRI_TBSS_L1_Posterior_thalamic_radiation_L	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	7.23419e-08	Number of days/week of moderate physical activity 10+ minutes	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	7.49998e-08	Forced expiratory volume in 1-second (FEV1), predicted	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	7.52333e-08	ENSG00000204314	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	7.58927e-08	IDP_dMRI_ProbtrackX_L3_ilf_l	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	7.69999e-08	Total triglycerides	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	7.77499e-08	wg_lh_intensity-contrast_superiorfrontal	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	7.87771e-08	IDP_dMRI_TBSS_MD_Anterior_corona_radiata_L	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	8.14517e-08	IDP_dMRI_ProbtrackX_ICVF_ilf_l	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	8.21297e-08	IDP_dMRI_ProbtrackX_ICVF_cst_l	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	8.23948e-08	IDP_dMRI_ProbtrackX_ICVF_ar_l	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	8.70001e-08	Concentration of small HDL particles	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	8.7271e-08	Diseases of the genitourinary system	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	9.12011e-08	Ubiquitin-like protein ISG15	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	9.20005e-08	Illnesses of siblings: Diabetes	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	9.80009e-08	Free cholesterol in HDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	9.94947e-08	IDP_dMRI_ProbtrackX_MD_ifo_r	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.02683e-07	IDP_dMRI_ProbtrackX_ICVF_cgc_r	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.09999e-07	Ever depressed for a whole week	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.10301e-07	Mean corpuscular volume	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.14446e-07	IDP_dMRI_TBSS_MD_Cingulum_cingulate_gyrus_L	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.15001e-07	IDP_dMRI_TBSS_ICVF_Posterior_corona_radiata_L	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.1798e-07	ENSG00000204315	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.19454e-07	wg_rh_intensity-contrast_superiorfrontal	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.2e-07	Cholesterol levels in small HDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.236e-07	CX3CL1 levels	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.24137e-07	IDP_dMRI_TBSS_L1_Superior_corona_radiata_L	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.24595e-07	IDP_dMRI_TBSS_OD_Posterior_corona_radiata_L	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.25864e-07	aparc-a2009s_lh_thickness_Lat-Fis-ant-Vertical	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.29999e-07	Cholesterol levels in chylomicrons and extremely large VLDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.36113e-07	IDP_dMRI_ProbtrackX_ICVF_ilf_r	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.40001e-07	Treatment speciality of consultant (recoded): General medicine	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.40185e-07	IDP_dMRI_ProbtrackX_MD_ilf_r	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.41938e-07	IDP_dMRI_TBSS_ICVF_Superior_corona_radiata_R	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.43179e-07	Treatment/medication code: ventolin 100micrograms inhaler	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.46009e-07	Calcium	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.5e-07	Total lipids in lipoprotein particles	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.58672e-07	IDP_dMRI_ProbtrackX_L2_ilf_l	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.6e-07	Triglycerides in small HDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.6e-07	Ratio of omega-6 fatty acids to omega-3 fatty acids	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.6e-07	Height	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.61261e-07	Non-cancer illness code  self-reported: diabetes	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.6819e-07	IDP_dMRI_ProbtrackX_ICVF_ar_r	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.7e-07	Corneal hysteresis (left)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.75914e-07	aparc-Desikan_lh_area_middletemporal	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.77828e-07	Polypeptide N-acetylgalactosaminyltransferase 1	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.82138e-07	IDP_dMRI_TBSS_L3_Retrolenticular_part_of_internal_capsule_L	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.89998e-07	Triglycerides to total lipids ratio in very small VLDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.89998e-07	Rheumatoid arthritis	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.94326e-07	Rheumatoid Arthritis	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.94626e-07	IDP_dMRI_ProbtrackX_OD_str_l	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2e-07	Cholesterol to total lipids ratio in IDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2e-07	Triglyceride levels in medium VLDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2e-07	Childhood sunburn occasions	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.1e-07	Cholesteryl esters to total lipids ratio in large LDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.1e-07	Free cholesterol to total lipids ratio in medium LDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.18791e-07	Peak expiratory flow (PEF)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.2228e-07	IDP_dMRI_TBSS_L1_Retrolenticular_part_of_internal_capsule_L	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.26178e-07	Potassium in urine	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.30001e-07	Respiratory or ear-nose-throat disease	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.31601e-07	Autoimmune hepatitis	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.38177e-07	IDP_dMRI_TBSS_OD_Superior_corona_radiata_R	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.39999e-07	Triglycerides to total lipids ratio in IDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.48485e-07	IDP_dMRI_TBSS_L1_Posterior_thalamic_radiation_R	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.59537e-07	IDP_dMRI_ProbtrackX_L2_unc_r	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.69588e-07	IDP_dMRI_TBSS_L3_Anterior_corona_radiata_L	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.69998e-07	Frequency of light DIY in last 4 weeks	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.69998e-07	Treatment/medication code: seretide 50 evohaler	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.69998e-07	Operation code: appendicectomy	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.74663e-07	IDP_dMRI_TBSS_ICVF_Superior_corona_radiata_L	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.80001e-07	Free cholesterol levels in HDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.84446e-07	IDP_dMRI_ProbtrackX_L2_fmi	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.85581e-07	LDL direct	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.95461e-07	IDP_dMRI_ProbtrackX_L3_ifo_l	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.9792e-07	BA-exvivo_rh_thickness_entorhinal	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.98607e-07	IDP_T1_FAST_ROIs_R_paracing_gyrus	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.99999e-07	Total triglycerides levels	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.07256e-07	IDP_dMRI_ProbtrackX_FA_fmi	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.07539e-07	IDP_T1_FAST_ROIs_R_temp_fusif_cortex_post	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.09999e-07	Cholesterol in small HDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.1268e-07	IDP_dMRI_TBSS_L1_Superior_longitudinal_fasciculus_R	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.1463e-07	IDP_dMRI_TBSS_ICVF_Medial_lemniscus_R	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.29997e-07	Ratio of monounsaturated fatty acids to total fatty acids	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.40001e-07	Mean corpuscular hemoglobin	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.42137e-07	Seen a psychiatrist for nerves  anxiety  tension or depression	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.50002e-07	Concentration of small HDL particles	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.50187e-07	aparc-Desikan_lh_thickness_insula	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.68129e-07	IDP_dMRI_TBSS_ICVF_Body_of_corpus_callosum	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.68876e-07	Phosphate	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.69999e-07	Eye problems/disorders: Diabetes related eye disease	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.78617e-07	IDP_dMRI_TBSS_ICVF_Sagittal_stratum_L	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.79997e-07	Total lipid levels in small VLDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.79997e-07	Free cholesterol in chylomicrons and extremely large VLDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.85212e-07	IDP_dMRI_TBSS_L2_Anterior_corona_radiata_R	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.99991e-07	Seen doctor (GP) for nerves  anxiety  tension or depression	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.01606e-07	IDP_dMRI_ProbtrackX_ICVF_fmi	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.09996e-07	Cholesteryl esters to total lipids ratio in IDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.09996e-07	Triglycerides in medium VLDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.09996e-07	Treatment/medication code: ventolin 100micrograms inhaler	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.30002e-07	Tyrosine	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.39258e-07	Illnesses of father: Lung cancer	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.49997e-07	Concentration of small VLDL particles	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.64088e-07	IDP_dMRI_TBSS_MD_Superior_longitudinal_fasciculus_R	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.70002e-07	Number of days/week of vigorous physical activity 10+ minutes	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.7228e-07	wg_lh_intensity-contrast_insula	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.80861e-07	LDL direct	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.90004e-07	HDL cholesterol	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.90004e-07	LDL cholesterol	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5e-07	Psychological or psychiatric problem	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.30005e-07	Leg fat mass (left)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.56878e-07	ENSG00000204469	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.92516e-07	IDP_dMRI_TBSS_L3_Superior_fronto-occipital_fasciculus_L	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.93198e-07	IDP_dMRI_ProbtrackX_FA_ifo_l	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.99998e-07	Liver iron content	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.0256e-07	Complement C1q tumor necrosis factor-related protein 5	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.13253e-07	Phosphate	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.19998e-07	Rheumatoid arthritis	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.26643e-07	Trunk fat mass	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.44125e-07	Familial combined hyperlipidemia defined by Consensus criteria	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.49995e-07	Ratio of omega-6 fatty acids to omega-3 fatty acids	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.49995e-07	Suffer from 'nerves'	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.50205e-07	Mean corpuscular hemoglobin	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.54485e-07	IDP_dMRI_ProbtrackX_L2_slf_l	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.59994e-07	Cholesteryl esters to total lipids ratio in large LDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.69993e-07	Non-cancer illness code, self-reported: gastro-oesophageal reflux (gord) / gastric reflux	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.81695e-07	DNA methylation Hannum age acceleration	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.83707e-07	Worry	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.90001e-07	Why stopped smoking: Health precaution	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.90558e-07	IDP_dMRI_TBSS_MD_Superior_fronto-occipital_fasciculus_L	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	7.05342e-07	wg_lh_intensity-contrast_inferiorparietal	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	7.19996e-07	Cholesterol to total lipids ratio in very small VLDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	7.23936e-07	IDP_dMRI_TBSS_L2_Posterior_thalamic_radiation_R	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	7.39605e-07	IDP_dMRI_ProbtrackX_L2_ifo_r	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	7.47309e-07	Nephrotic syndrome	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	7.69999e-07	Neutrophil count	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	7.69999e-07	Age started hormone-replacement therapy (HRT)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	7.70105e-07	Prostate cancer	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	7.70105e-07	Prostate cancer	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	8e-07	Rheumatoid arthritis	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	8e-07	Rheumatoid arthritis	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	8.0177e-07	Rheumatoid Arthritis	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	8.40001e-07	Triglycerides in VLDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	8.70964e-07	Spermatogenesis-associated protein 20	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	8.91251e-07	T-cell surface glycoprotein CD3 epsilon chain	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	9.18544e-07	aparc-DKTatlas_rh_thickness_insula	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	9.20005e-07	Free cholesterol levels in chylomicrons and extremely large VLDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	9.20662e-07	IDP_dMRI_TBSS_L2_Genu_of_corpus_callosum	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	9.32395e-07	Feeling nervous	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	9.45366e-07	IDP_dMRI_ProbtrackX_L1_str_l	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	9.77237e-07	Cadherin-7	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	9.8107e-07	IDP_dMRI_TBSS_L3_Anterior_corona_radiata_R	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1e-06	aparc-Desikan_rh_thickness_isthmuscingulate	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1e-06	Triglycerides to total lipids ratio in very small VLDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.01205e-06	IDP_dMRI_TBSS_L1_Cingulum_hippocampus_R	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.01242e-06	Apolipoprotein B levels (UKB data field 30640)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.01648e-06	aparc-a2009s_lh_thickness_S-circular-insula-sup	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.02353e-06	IDP_dMRI_TBSS_MD_Anterior_corona_radiata_R	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.03932e-06	Treatment/medication code: seretide 50 evohaler	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.05075e-06	Eye problems/disorders: Diabetes related eye disease	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.0539e-06	wg_lh_intensity-contrast_supramarginal	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.0595e-06	IDP_dMRI_ProbtrackX_MD_slf_r	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.07382e-06	Illnesses of siblings: Diabetes	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.08118e-06	rfMRI connectivity (ICA100 edge 509)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.09999e-06	Diagnoses - main ICD10: N40 Hyperplasia of prostate	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.09999e-06	Non-cancer illness code, self-reported: rheumatoid arthritis	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.09999e-06	Non-cancer illness code, self-reported: diabetes	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.1092e-06	ENSG00000206337	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.12124e-06	IDP_dMRI_ProbtrackX_OD_ar_r	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.128e-06	Mean platelet volume	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.13894e-06	IDP_dMRI_TBSS_MD_Uncinate_fasciculus_L	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.13899e-06	Iron deficiency anemia	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.1663e-06	Anti-varicella zoster virus IgG seropositivity	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.17031e-06	IDP_dMRI_ProbtrackX_L1_ifo_r	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.2e-06	Bone disorder	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.2e-06	Triglycerides to total lipids ratio in IDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.2e-06	Triglyceride levels in small HDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.2e-06	Cholesteryl esters in HDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.22067e-06	IDP_dMRI_TBSS_ICVF_Anterior_corona_radiata_L	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.24595e-06	IDP_dMRI_ProbtrackX_MD_unc_r	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.28825e-06	Palmitoyl-protein thioesterase 1	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.29999e-06	HDL cholesterol levels	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.30617e-06	IDP_dMRI_ProbtrackX_L3_ifo_r	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.31371e-06	IDP_dMRI_TBSS_FA_Middle_cerebellar_peduncle	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.31804e-06	Potassium in urine (UKB data field 30520)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.39508e-06	IDP_dMRI_ProbtrackX_L3_ilf_r	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.40001e-06	Ratio of monounsaturated fatty acids to total fatty acids	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.40001e-06	Operation code: tonsillectomy +/- adenoids	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.43483e-06	IDP_dMRI_TBSS_ICVF_Superior_longitudinal_fasciculus_R	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.5e-06	Cholesteryl esters to total lipids ratio in very small VLDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.5e-06	Ratio of omega-3 fatty acids to total fatty acids	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.516e-06	Binding antibody response to interferon beta therapy in multiple sclerosis (antibody levels; IFN<U+03B2>-1a subcutaneous)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.54632e-06	wg_lh_intensity-contrast_superiortemporal	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.6e-06	Leg fat mass (right)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.62742e-06	IDP_dMRI_TBSS_L3_Superior_longitudinal_fasciculus_R	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.63652e-06	ENSG00000166278	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.6661e-06	IDP_dMRI_TBSS_FA_Splenium_of_corpus_callosum	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.7e-06	Cholesteryl esters to total lipids ratio in IDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.75267e-06	IDP_dMRI_ProbtrackX_OD_slf_l	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.78764e-06	Epstein-Barr virus VCA p18 antibody levels	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.81501e-06	ENSG00000232810	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.89998e-06	Parental longevity (mother's attained age)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	1.96698e-06	Myocardial fractal dimension (slice 6)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.08459e-06	Fluid intelligence score	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.1e-06	Lifetime number of sexual partners	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.13206e-06	IDP_dMRI_TBSS_ICVF_Splenium_of_corpus_callosum	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.2444e-06	Impedance of whole body	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.24698e-06	IDP_dMRI_TBSS_L2_Splenium_of_corpus_callosum	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.27091e-06	aparc-DKTatlas_rh_thickness_isthmuscingulate	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.30001e-06	Parental longevity (combined parental attained age, Martingale residuals)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.30001e-06	Creatinine levels	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.30001e-06	Triglyceride levels in VLDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.30001e-06	Vitamin and mineral supplements: Vitamin C	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.30001e-06	Taking other prescription medications	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.33722e-06	IDP_dMRI_TBSS_ICVF_Genu_of_corpus_callosum	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.39613e-06	Glucose	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.39999e-06	Vigorous physical activity	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.45527e-06	IDP_dMRI_TBSS_L3_Sagittal_stratum_L	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.47002e-06	Mean corpuscular volume	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.49574e-06	IDP_dMRI_ProbtrackX_ICVF_slf_l	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.5e-06	Free cholesterol to total lipids ratio in very small VLDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.50957e-06	wg_rh_intensity-contrast_parsorbitalis	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.57371e-06	Frequency of light DIY in last 4 weeks	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.57881e-06	ENSG00000204428	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.59293e-06	Hearing difficulty/problems with background noise	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.59998e-06	Diagnoses - secondary ICD10: J45.9 Asthma, unspecified	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.65772e-06	Asthma	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.65772e-06	Childhood asthma (age<16)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.69339e-06	IDP_dMRI_TBSS_ICVF_Superior_longitudinal_fasciculus_L	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.69998e-06	Cholesterol to total lipids ratio in very small VLDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.69998e-06	Creatinine	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.69998e-06	Phospholipids in chylomicrons and extremely large VLDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.69998e-06	Free cholesterol to total lipids ratio in very small VLDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.69998e-06	Mineral and other dietary supplements: Zinc	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.74221e-06	IDP_dMRI_ProbtrackX_MD_cgc_l	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.90001e-06	Total lipid levels in VLDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	2.95461e-06	IDP_dMRI_ProbtrackX_L1_str_r	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.08156e-06	Asthma, hospital admissions 1	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.1492e-06	aparc-pial_lh_area_middletemporal	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.19867e-06	Ever had prolonged loss of interest in normal activities	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.2e-06	Renal or urological disease	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.24496e-06	Binding antibody response to interferon beta therapy in multiple sclerosis (antibody levels; IFN<U+03B2>-1a subcutaneous and intramuscular)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.29997e-06	Cholesteryl ester levels in HDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.29997e-06	Bioavailable testosterone levels	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.32897e-06	ENSG00000234745	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.35738e-06	aparc-a2009s_lh_volume_S-temporal-sup	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.38758e-06	ENSG00000137310	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.42926e-06	IDP_dMRI_ProbtrackX_ICVF_ml_l	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.49293e-06	Vitamin and mineral supplements: Vitamin C	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.58839e-06	IDP_dMRI_TBSS_L1_Retrolenticular_part_of_internal_capsule_R	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.69999e-06	Depression	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.74404e-06	Neutrophil count	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.82323e-06	Nervous feelings	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.88956e-06	IDP_dMRI_ProbtrackX_ICVF_str_l	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.91742e-06	wg_lh_intensity-contrast_postcentral	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	3.9931e-06	Diagnoses - main ICD10: J45 Asthma	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.09996e-06	Free cholesterol to total lipids ratio in very large HDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.09996e-06	Total lipids in VLDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.10856e-06	DNA methylation Hannum age acceleration	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.15585e-06	Diagnoses - main ICD10: N40 Hyperplasia of prostate	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.32514e-06	wg_lh_intensity-contrast_parsorbitalis	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.37925e-06	IDP_T1_FAST_ROIs_R_parahipp_gyrus_post	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.39997e-06	Total lipids in small VLDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.49262e-06	IDP_dMRI_TBSS_ICVF_Superior_fronto-occipital_fasciculus_L	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.49904e-06	Binding antibody response to interferon beta therapy in multiple sclerosis (antibody levels; all treatment preparations)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.54151e-06	IDP_dMRI_TBSS_ICVF_Corticospinal_tract_R	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.60002e-06	Concentration of small VLDL particles	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.60002e-06	Comparative body size at age 10, Males	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.60151e-06	IDP_dMRI_TBSS_L3_Superior_corona_radiata_L	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.61849e-06	IDP_dMRI_TBSS_FA_Genu_of_corpus_callosum	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.67595e-06	Graves' disease	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.69245e-06	IDP_dMRI_TBSS_FA_Anterior_corona_radiata_L	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.69905e-06	Medication use (anti-inflammatory and antirheumatic products, non-steroids)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.772e-06	aparc-a2009s_rh_area_S-pericallosal	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.79999e-06	Sex hormone-binding globulin levels adjusted for BMI	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.79999e-06	Triglycerides to total lipids ratio in medium LDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	4.90004e-06	Hiatus hernia	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5e-06	Phospholipids to total lipids ratio in chylomicrons and extremely large VLDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.04429e-06	IDP_dMRI_TBSS_L1_Fornix_cres+Stria_terminalis_R	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.06722e-06	Anti-human herpes<U+00A0>virus<U+00A0>6<U+00A0>IE1A IgG<U+00A0>seropositivity	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.08511e-06	IDP_dMRI_ProbtrackX_ICVF_unc_r	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.10199e-06	LDL cholesterol	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.11329e-06	IDP_dMRI_TBSS_ICVF_Cingulum_cingulate_gyrus_R	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.4275e-06	wg_rh_intensity-contrast_parstriangularis	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.45004e-06	wg_rh_intensity-contrast_insula	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.46764e-06	IDP_dMRI_ProbtrackX_MD_unc_l	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.47772e-06	IDP_dMRI_ProbtrackX_ICVF_slf_r	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.49997e-06	Main speciality of consultant (recoded): General medicine	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.54626e-06	IDP_dMRI_TBSS_FA_Cerebral_peduncle_R	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.63054e-06	Mineral and other dietary supplements: Zinc	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.67283e-06	rfMRI connectivity (ICA100 edge 356)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.75546e-06	COPD, early/later onset	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.90201e-06	wg_rh_intensity-contrast_parsopercularis	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.93198e-06	ThalamNuclei_lh_volume_VA	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	5.99998e-06	Phospholipid levels in chylomicrons and extremely large VLDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.08597e-06	C4	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.1e-06	Cholesteryl esters to total lipids ratio in very small VLDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.15517e-06	Major dietary changes in the last 5 years: Yes, because of illness	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.15744e-06	IDP_dMRI_ProbtrackX_ICVF_unc_l	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.18201e-06	Barrett's esophagus	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.19998e-06	Strenuous sports or other exercises	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.19998e-06	Ever had prostate specific antigen (PSA) test	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.29999e-06	Phospholipid levels in VLDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.30957e-06	17-beta-hydroxysteroid dehydrogenase 14	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.41653e-06	wg_rh_intensity-contrast_caudalmiddlefrontal	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.44911e-06	IDP_dMRI_ProbtrackX_L3_cgc_r	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.69993e-06	Prostate cancer	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.75305e-06	wg_rh_intensity-contrast_rostralmiddlefrontal	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.81318e-06	Phosphate levels (UKB data field 30810)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.87068e-06	HippSubfield_rh_volume_presubiculum-body	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.91146e-06	Gamma glutamyltransferase	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	6.91831e-06	UDP-N-acetylhexosamine pyrophosphorylase	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	7.00003e-06	Total lipid levels in medium VLDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	7.06643e-06	IDP_dMRI_ProbtrackX_OD_ar_l	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	7.45418e-06	IDP_dMRI_TBSS_ICVF_Middle_cerebellar_peduncle	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	7.69999e-06	Anemia	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	7.81088e-06	IDP_dMRI_ProbtrackX_FA_fma	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	7.90005e-06	Ratio of omega-3 fatty acids to total fatty acids	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	7.90005e-06	Concentration of chylomicrons and extremely large VLDL particles	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	8e-06	sepsis	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	8.07235e-06	Myocardial fractal dimension (slice 5)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	8.09469e-06	IDP_dMRI_ProbtrackX_FA_ilf_l	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	8.10326e-06	Glucose levels (UKB data field 30740)	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	8.26609e-06	IDP_dMRI_ProbtrackX_L3_slf_l	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	8.30004e-06	Free cholesterol to total lipids ratio in very large HDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	8.9e-06	Guilty feelings	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	8.96603e-06	Alanine aminotransferase	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	9.36483e-06	IDP_dMRI_ProbtrackX_L1_ar_r	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	9.38426e-06	IDP_dMRI_TBSS_FA_Anterior_corona_radiata_R	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	9.40005e-06	Cholesteryl ester levels in small HDL	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs2596547	9.54333e-06	aparc-Desikan_rh_volume_medialorbitofrontal	6	50788	0.333491677278253	6.21684443370724e-09	EasActiv18mo	0.130484
rs3128986	0	Non-cancer illness code  self-reported: malabsorption/coeliac disease	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.1289039792536e-308	ENSG00000204525	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.08893e-287	White blood cell count	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.08893e-287	white blood cell count	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.4914e-280	Lymphocyte count	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.4914e-280	lymphocyte cell count	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	7.31139e-246	ENSG00000224389	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.10204e-243	White blood cell count	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	5.70164e-235	Lymphocyte count	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	6.5013e-206	White blood cell leukocyte count (UKB data field 30000)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.98609e-201	Lymphocyte count (UKB data field 30120)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1e-200	Primary sclerosing cholangitis	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.63027e-172	White blood cell count	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.0738e-172	White blood cell (leukocyte) count	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.5527e-167	Lymphocyte count	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.84592e-167	Lymphocyte count	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	6.68344e-167	Monocyte count	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	6.68344e-167	monocyte cell count	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.76058e-161	Type 1 diabetes	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	7.90679e-159	ENSG00000244731	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1e-151	ENSG00000231852	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.09901e-138	ENSG00000214894	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	6.76083e-135	Monocyte count (UKB data field 30130)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.67301e-123	Type 1 diabetes	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.39883e-119	Mean reticulocyte volume	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	5.34564e-118	Neutrophil count	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	5.34564e-118	neutrophil cell count	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.69044e-108	Monocyte count	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.00909e-108	Monocyte count	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.38844e-108	Aspartate aminotransferase levels (UKB data field 30650)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.47713e-103	ENSG00000204338	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	7.01455e-103	Lymphocyte counts	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.36144e-102	ENSG00000137331	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.59956e-101	Neutrophil count	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.65959e-101	Eosinophil counts	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.65959e-101	eosinophil cell count	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.53993e-99	White blood cell count	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.29985e-97	Never eat eggs, dairy, wheat, sugar: Wheat products	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	9.36268e-97	Neutrophill count (UKB data field 30140)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	5.40008e-94	Non-cancer illness code, self-reported: hyperthyroidism/thyrotoxicosis	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	7.28115e-94	Systemic lupus erythematosus	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.59998e-92	Hyperthyroidism or thyrotoxicosis	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.5698e-90	Membranous nephropathy	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	6.38557e-89	Aspartate aminotransferase levels	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	7.14661e-89	Aspartate aminotransferase	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.02065e-87	Type 1 diabetes	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.29987e-86	Eosinophil counts	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	8.77607e-86	ENSG00000137411	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	5.9731e-85	Non-cancer illness code  self-reported: hyperthyroidism/thyrotoxicosis	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.90804e-84	Serum total protein level	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.27265e-84	Total protein	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.69153e-82	MHC class I polypeptide-related sequence B	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.69353e-82	Neutrophil count	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	5.1713e-82	Neutrophill count	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.19963e-80	Sitting height	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	6.03115e-80	Total protein	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.36865e-79	ENSG00000137312	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	7.39946e-79	Reticulocyte count	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.90032e-78	Thyroid problem (not cancer)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.24913e-78	Eosinophill count (UKB data field 30150)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.59832e-69	Medication use (thyroid preparations)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	6.61912e-67	Mean reticulocyte volume	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	6.29941e-64	Diabetes or endocrine disease	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.69981e-60	Mean spheric corpuscular volume	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.50003e-59	Reticulocyte fraction of red cells	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.41036e-58	Hemoglobin concentration	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	6.54184e-58	Monocyte count	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.10994e-54	Sitting height	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	9.39074e-54	Eosinophil counts	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.01906e-52	Myeloid white cell count	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.04033e-52	Hypothyroidism or myxoedema (Firth correction)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.07185e-52	Hypothyroidism or myxoedema (SPA correction)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.10002e-51	High light scatter reticulocyte count	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	6.59933e-50	Treatment/medication code: levothyroxine sodium	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.52988e-49	ENSG00000248290	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	6.59933e-49	Hemoglobin	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	8.4004e-49	Standing height	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.44012e-48	Red blood cell count	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	7.89951e-48	Treatment/medication code: insulin product	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.9002e-47	Started insulin within one year diagnosis of diabetes	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.6965e-47	Haemoglobin concentration (UKB data field 30020)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.24564e-46	Granulocyte count	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1e-45	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.89671e-45	Cystatin C levels (UKB data field 30720)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.63496e-45	Sum neutrophil eosinophil counts	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	5.52841e-45	Reticulocyte count	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	7.11869e-45	Appendicular lean mass	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	9.1601e-45	Platelet count	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.13501e-43	Sum eosinophil basophil counts	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.23367e-43	ENSG00000225059	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	9.12011e-43	Peak expiratory flow	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.17004e-42	Red cell distribution width	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.99986e-42	Non-cancer illness code, self-reported: hypothyroidism/myxoedema	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.1703e-42	Hematocrit	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.24796e-41	ENSG00000225851	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.80011e-41	Hypothyroidism or myxedema	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	5.595e-41	Treatment/medication code: insulin product	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.20226e-40	Glutamate receptor 4	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.52585e-40	Red blood cell (erythrocyte) distribution width	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	5.39262e-40	Sum basophil neutrophil counts	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	7.24436e-40	Early-onset myasthenia gravis	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	9.70063e-40	High light scatter reticulocyte percentage of red cells	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.84757e-39	Started insulin within one year diagnosis of diabetes	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.49804e-39	Platelet count (UKB data field 30080)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.27567e-39	ENSG00000204536	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.26383e-39	Triglyceride levels (UKB data field 30870)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	5.19757e-39	Neutrophil count	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	6.31684e-39	Height	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	7.71969e-39	Reticulocyte count	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.22775e-38	ENSG00000213676	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.408e-38	Eosinophil counts	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	5.52332e-38	Treatment/medication code: levothyroxine sodium	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	6.70039e-38	Red blood cell count	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	8.28705e-38	Hemoglobin	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	8.45668e-38	Haemoglobin concentration	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.29989e-37	Red cell distribution width	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.65997e-36	Lung function (FEV1/FVC)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.90001e-36	Platelet count	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.11908e-36	Reticulocyte percentage	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.80011e-35	Whole body fat-free mass	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.70023e-35	Whole body water mass	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	5.60015e-35	Leg fat-free mass (right)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	7.50067e-35	Standing height	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	7.63836e-35	Complement C2 measurement	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.20005e-34	Leg predicted mass (right)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.9002e-34	Autoimmune traits	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.9002e-34	Leg fat-free mass (left)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.29985e-34	Leg predicted mass (left)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.91005e-34	Basophil count	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.91005e-34	basophil cell count	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.96825e-34	Glycated haemoglobin HbA1c levels (UKB data field 30750)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.6779e-34	Non-cancer illness code  self-reported: hypothyroidism/myxoedema	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	6.59933e-34	Hematocrit	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.50003e-33	Basal metabolic rate	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.99986e-33	White blood cell count (lymphocyte)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.49977e-33	triglycerides	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.22914e-32	Red blood cell erythrocyte count (UKB data field 30010)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.9971e-32	Cystatin C	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.80027e-32	Trunk fat-free mass	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	5.41876e-32	Cystatin C	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	9.37778e-32	Triglycerides	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	9.51262e-32	Triglycerides	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	9.77237e-32	Complement C4	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.20005e-31	Trunk predicted mass	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.29987e-31	Autoimmune traits	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.51008e-31	Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection, CLOZUK+PGC2	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.71514e-31	Platelet count	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.7382e-31	Platelet count	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	8.72369e-31	Reticulocyte fraction of red cells	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	8.80035e-31	Arm predicted mass (left)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.69981e-30	Mean platelet volume	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.69981e-30	Arm fat-free mass (left)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.00863e-30	High light scatter reticulocyte count	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.70209e-30	Aspartate aminotransferase	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	7.9671e-30	Hyperthyroidism	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.89001e-29	Gamma glutamyltransferase levels (UKB data field 30730)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.09732e-29	Cholesterol levels (UKB data field 30690)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	9.52577e-29	FEV1	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.39994e-28	apolipoprotein A-I	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.49977e-28	Arm fat-free mass (right)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.75931e-28	Hypothyroidism	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.59998e-28	Arm predicted mass (right)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.06443e-28	Type 1 diabetes	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	6.70039e-28	Ankle spacing width	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	7.69308e-28	Schizophrenia	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.59809e-27	Schizophrenia	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.98198e-27	diastolic blood pressure	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.00771e-27	Leg fat-free mass (right)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.19989e-27	Hypothyroidism	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.55877e-27	Mean platelet thrombocyte volume (UKB data field 30100)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.83838e-27	Leg predicted mass (right)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	9.85825e-27	Mean sphered cell volume	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.20282e-26	Whole body fat-free mass	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.63305e-26	Hemoglobin A1c levels	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.65196e-26	Glycated haemoglobin	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.92752e-26	Whole body water mass	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.84619e-26	Leg fat-free mass (left)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	5.55009e-26	Leg predicted mass (left)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	6.23591e-26	Glycated haemoglobin	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	9.3713e-26	Schizophrenia	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	9.3994e-26	Appendicular lean mass	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.28204e-25	Apolipoprotein A levels (UKB data field 30630)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.18776e-25	T-cell surface protein tactile	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.69999e-25	HDL cholesterol	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.38127e-25	Other diseases of the digestive system	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.56983e-25	Mean platelet volume	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	7.19946e-25	Weight	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	9.59401e-25	Triglycerides	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.06316e-24	Basal metabolic rate	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.50003e-24	Operative procedures - secondary OPCS: Z27.4 Duodenum	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.8737e-24	Apoliprotein A	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.14992e-24	Trunk fat-free mass	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.19963e-24	Basophil count	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	5.10035e-24	Weight	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	6.75305e-24	Trunk predicted mass	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.01976e-23	High light scatter reticulocyte percentage	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.10002e-23	Mean platelet volume	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.16011e-23	Total cholesterol levels	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.16842e-23	Cholesterol	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.19757e-23	Cholesterol	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.2006e-23	ENSG00000204528	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.40017e-23	Age diabetes diagnosed	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.10015e-23	IGF 1 (UKB data field 30770)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	5.19996e-23	telomere length	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	5.74116e-23	ENSG00000204531	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.62361e-22	High density lipoprotein cholesterol levels (UKB data field 30760)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.25696e-22	Red blood cell count	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.2845e-22	Red blood cell (erythrocyte) count	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	6.66346e-22	IgA nephropathy	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	9.6917e-22	Mean platelet (thrombocyte) volume	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.10002e-21	Diagnoses - secondary ICD10: E03.9 Hypothyroidism, unspecified	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.23197e-21	Estimated glomerular filtration rate (creatinine)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.62181e-21	Arm predicted mass (left)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.19989e-21	Connective tissue disorder	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.40017e-21	Non-cancer illness code, self-reported: asthma	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.69999e-21	Hematocrit	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.72135e-21	Haematocrit percentage	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.90004e-21	Diagnoses - main ICD10: R31 Unspecified haematuria	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	5.10035e-21	Operation code: thyroidectomy/partial thyroidectomy	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	5.24324e-21	High light scatter reticulocyte count	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	5.33949e-21	Gamma glutamyl transpeptidase	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	5.36043e-21	Gamma glutamyltransferase	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	5.72137e-21	Weight	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	5.76368e-21	Arm fat-free mass (right)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	6.12632e-21	ENSG00000204351	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	6.82025e-21	Arm fat-free mass (left)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	9.70063e-21	Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor: Asthma	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.5181e-20	Apoliprotein A	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.16884e-20	Bread type: Other type of bread	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.59087e-20	HDL cholesterol	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.60662e-20	HDL cholesterol	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.75837e-20	White blood cell count (basophil)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	5.90065e-20	Medication for cholesterol, blood pressure or diabetes: Insulin	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	6.53131e-20	Estimated glomerular filtration rate (creatinine)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	8.60994e-20	ENSG00000204438	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.06586e-19	IGF-1	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.28825e-19	Creatinine levels (UKB data field 30700)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.29987e-19	Comparative body size at age 10	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.37848e-19	Arm predicted mass (right)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.4171e-19	schizophrenia	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.69981e-19	Comparative body size at age 10, Males and Females	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.72783e-19	Psoriasis	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.80011e-19	Bowel problem	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.97742e-19	Varicella zoster virus glycoproteins E and I antibody levels	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.32583e-19	Blood clot  DVT  bronchitis  emphysema  asthma  rhinitis  eczema  allergy diagnosed by doctor: Asthma	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.90032e-19	Plateletcrit	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.19952e-19	Asthma	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.79954e-19	Diastolic blood pressure, automated reading	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	5.70033e-19	Time to complete round	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	5.90065e-19	Eosinophil percentage of white cells	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	5.90337e-19	Non-cancer illness code  self-reported: asthma	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	6.09958e-19	Other serious medical condition/disability diagnosed by doctor	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	7.59976e-19	Medication for pain relief, constipation, heartburn: Paracetamol	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	7.70016e-19	Hip circumference	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	8.9002e-19	Platelet count	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.27409e-18	ENSG00000204444	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.50003e-18	Height	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.61473e-18	Lung cancer	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.19963e-18	Medication for pain relief, constipation, heartburn: None of the above	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.98382e-18	Medication for cholesterol  blood pressure or diabetes: Insulin	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.21697e-18	IGF-1	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	8.77809e-18	Total bilirubin levels (UKB data field 30840)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.01391e-17	Total bilirubin levels (UKB data field 30840)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.1471e-17	Hemoglobin concentration	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.89147e-17	Weight	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.9002e-17	Ankle spacing width (right)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.99986e-17	Polyunsaturated fatty acid levels	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.33615e-17	Cereal type: Other (e.g. Cornflakes, Frosties)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.70209e-17	Asthma (Firth correction)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.85891e-17	Asthma (SPA correction)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.90001e-17	Mouth/teeth dental problems: Dentures	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.10027e-17	FEV1/FVC < 0.7	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.22255e-17	HDL cholesterol	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.69999e-17	Operative procedures - main OPCS: M45.9 Unspecified diagnostic endoscopic examination of bladder	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.1783e-17	Complement C4 levels	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.62701e-17	ENSG00000204308	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.79954e-17	Mean corpuscular hemoglobin concentration	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	5.71874e-17	Mean corpuscular hemoglobin concentration	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	5.73984e-17	Mean corpuscular haemoglobin concentration	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	5.78895e-17	Squamous cell lung carcinoma	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	5.81835e-17	Type 1 diabetes (SPA correction)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	5.99239e-17	Type 1 diabetes (Firth correction)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	8.3618e-17	ENSG00000204304	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	8.74581e-17	Hip circumference (UKB data field 49)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.28825e-16	HLA class II histocompatibility antigen, DQ alpha 2 chain	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.59993e-16	Age at menopause (last menstrual period)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.62555e-16	IDP_dMRI_TBSS_L1_Superior_longitudinal_fasciculus_L	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.89104e-16	High light scatter reticulocyte percentage of red cells	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.20039e-16	Diastolic blood pressure automated reading (UKB data field 4079)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.00037e-16	Non-cancer illness code, self-reported: psoriasis	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.81504e-16	Psoriasis	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	6.00067e-16	Number of fluid intelligence questions attempted within time limit	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	6.0256e-16	Trypsin-3	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	9.70063e-16	Hot drink temperature	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.50003e-15	Ankle spacing width (left)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.08209e-15	Graves' disease	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.29087e-15	Beta-defensin 119	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.55329e-15	Serum creatinine levels	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.55623e-15	Creatinine	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.6509e-15	Other serious medical condition/disability diagnosed by doctor	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.69828e-15	Comparative body size at age 10	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.8539e-15	ENSG00000204386	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.00037e-15	Neutrophil percentage of white cells	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.16965e-15	Non-cancer illness code  self-reported: psoriasis	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.19952e-15	Platelet crit	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.30031e-15	Appendicular lean mass	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.70002e-15	Main speciality of consultant (recoded): Urology	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	5.67937e-15	Medication for pain relief  constipation  heartburn: None of the above	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	6.09958e-15	Omega-6 fatty acid levels	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	6.19013e-15	Mean corpuscular hemoglobin concentration	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	7.5405e-15	Treatment/medication code: thyroxine product	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	7.6913e-15	Alanine aminotransferase levels (UKB data field 30620)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	8.6139e-15	ENSG00000250535	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	8.69961e-15	Linoleic acid levels	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	8.76395e-15	Diastolic blood pressure	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.20005e-14	Polyunsaturated fatty acids	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.80011e-14	Comparative body size at age 10, Females	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.9081e-14	Diagnoses - main ICD10: R31 Unspecified haematuria	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.92044e-14	Epstein-Barr virus ZEBRA antibody levels	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.94984e-14	Rac GTPase-activating protein 1	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.09991e-14	Low density lipoprotein cholesterol levels	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.34909e-14	Plateletcrit	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.40658e-14	ENSG00000204305	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.49977e-14	Never eat eggs, dairy, wheat, sugar: I eat all of the above	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.93278e-14	Severe autoimmune type 2 diabetes	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.24229e-14	Basophil count	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.49987e-14	Long-standing illness, disability or infirmity	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	5.19996e-14	Treatment/medication code: thyroxine product	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	7.1351e-14	Medication for pain relief  constipation  heartburn: Paracetamol	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	7.70016e-14	Phospholipids in medium HDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	7.8886e-14	Diastolic blood pressure  automated reading	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	9.52138e-14	Sjogren's syndrome (SPA correction)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	9.53455e-14	Sjogren's syndrome (Firth correction)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.17463e-13	Peak expiratory flow (UKB data field 3064)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.29987e-13	Forced expiratory volume in 1-second (FEV1), predicted percentage	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.40799e-13	Red blood cell count	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.50003e-13	Impedance of leg (left)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.59993e-13	Total fatty acid levels	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.59993e-13	Oily fish intake	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.65882e-13	Lung cancer in ever smokers	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.80011e-13	Phospholipid levels in medium HDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.38122e-13	Medication use (anilides)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.41713e-13	Hematocrit	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.46604e-13	Sj<U+00F6>gren's syndrome	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.49977e-13	3mm weak meridian (left)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.72521e-13	Medication use (drugs used in diabetes)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.90001e-13	Linoleic acid	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.77051e-13	Hip circumference	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.00037e-13	Phosphoglycerides levels	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.35512e-13	IDP_dMRI_TBSS_L1_Sagittal_stratum_L	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	5.00035e-13	3mm strong meridian (left)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	5.21195e-13	IDP_dMRI_ProbtrackX_ICVF_ptr_r	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	6.30957e-13	Interleukin-21	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	6.4003e-13	Platelet count	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	7.00003e-13	Duration screen displayed	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	7.59976e-13	3mm strong meridian (right)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	7.89223e-13	ENSG00000204301	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	7.92136e-13	Glucose	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	8.19974e-13	Total lipids in medium HDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	8.30042e-13	Respiratory or ear-nose-throat disease	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	8.30042e-13	Omega-6 fatty acids	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	9.86279e-13	ThalamNuclei_rh_volume_LD	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.20005e-12	Treatment/medication code: paracetamol	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.21759e-12	Eosinophill percentage	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.27644e-12	IDP_dMRI_TBSS_MD_Posterior_thalamic_radiation_L	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.29987e-12	Phospholipid levels in small HDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.38261e-12	Forced expiratory volume in 1-second (FEV1)  predicted percentage	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.59993e-12	Omega-3 fatty acid levels	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.69981e-12	Impedance of leg (right)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.80011e-12	Monounsaturated fatty acid levels	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.9002e-12	Total fatty acids	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.99986e-12	Asthma	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.09991e-12	Total lipid levels in medium HDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.09991e-12	Operation code: varicose vein surgery	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.29985e-12	Phosphoglycerides	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.29985e-12	3mm weak meridian (right)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.43501e-12	C reactive protein levels (UKB data field 30710)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.59998e-12	Glycoprotein acetyls levels	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.38531e-12	Epstein-Barr virus EA-D antibody levels	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.90004e-12	Esophageal disorder	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	5.09918e-12	ENSG00000240053	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	5.50047e-12	Concentration of medium HDL particles	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	6.00067e-12	Phospholipids in HDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	6.20012e-12	Monounsaturated fatty acids	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	7.70903e-12	IDP_dMRI_TBSS_L1_Sagittal_stratum_R	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	8.00018e-12	Free cholesterol levels in small HDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	8.10028e-12	Omega-3 fatty acids	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	9.60064e-12	Phospholipids in small HDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	9.70063e-12	Total cholines levels	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.03467e-11	ENSG00000206337	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.10002e-11	Apolipoprotein A1	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.37911e-11	Medication use (adrenergics, inhalants)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.47299e-11	Treatment/medication code: carbimazole	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.80011e-11	Phosphatidylcholine levels	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.9002e-11	Concentration of medium HDL particles	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.09991e-11	Total lipid levels in small HDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.11349e-11	IDP_dMRI_TBSS_MD_Sagittal_stratum_R	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.55505e-11	Neutrophill percentage	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.5704e-11	IDP_dMRI_TBSS_MD_Posterior_thalamic_radiation_R	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.29989e-11	Time to answer	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.40017e-11	6mm strong meridian (right)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.40017e-11	Trunk fat mass	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.41193e-11	Creatinine	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.50026e-11	Free cholesterol in medium HDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.90841e-11	IDP_dMRI_TBSS_MD_Sagittal_stratum_L	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.00037e-11	Phospholipid levels in HDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.00037e-11	Total cholines	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.1783e-11	Eosinophil percentage of granulocytes	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.19952e-11	Apolipoprotein A1 levels	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.30031e-11	Total lipids in HDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	5.79963e-11	Red cell distribution width	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	6.20012e-11	Total concentration of lipoprotein particles	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	6.20012e-11	Phosphatidylcholines	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	6.20012e-11	Glycoprotein acetyls	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	6.38263e-11	IDP_dMRI_TBSS_ICVF_Posterior_thalamic_radiation_R	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	6.4003e-11	Total phospholipid levels in lipoprotein particles	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	6.51328e-11	Neutrophil percentage of granulocytes	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	6.70039e-11	Lymphocyte percentage of white cells	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	6.89922e-11	Long-standing illness  disability or infirmity	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	7.39946e-11	Concentration of HDL particles	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	7.50067e-11	Salad / raw vegetable intake	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	8.56446e-11	Basophil count	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	8.99912e-11	Concentration of HDL particles	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	9.01571e-11	IDP_dMRI_TBSS_ICVF_Retrolenticular_part_of_internal_capsule_L	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	9.30037e-11	Treatment speciality of consultant (recoded): Urology	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	9.48418e-11	IDP_dMRI_TBSS_OD_Superior_longitudinal_fasciculus_L	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	9.84011e-11	IDP_dMRI_ProbtrackX_ICVF_cst_r	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.01765e-10	ThalamNuclei_rh_volume_CL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.06554e-10	Impedance of leg (left)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.084e-10	Comparative height size at age 10	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.09999e-10	Phospholipids to total lipids ratio in small LDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.2e-10	Free cholesterol in small HDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.26803e-10	Mouth/teeth dental problems: Dentures	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.29999e-10	Peak expiratory flow (PEF)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.40001e-10	6mm strong meridian (left)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.563e-10	Systemic lupus erythematosus	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.56643e-10	Any parental history of lung cancer (Firth correction)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.6e-10	Free cholesterol levels in medium HDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.61603e-10	Any parental history of lung cancer (SPA correction)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.68267e-10	IDP_dMRI_ProbtrackX_L1_slf_l	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.75481e-10	ENSG00000204315	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.90941e-10	ThalamNuclei_rh_volume_LP	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.96002e-10	Medication use (drugs for peptic ulcer and gastro-oesophageal reflux disease)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2e-10	Triglycerides in very small VLDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2e-10	Total lipids in small HDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.01628e-10	Impedance of leg (right)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.1e-10	Triglycerides in IDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.1e-10	Cholesteryl esters to total lipids ratio in small LDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.19999e-10	Total concentration of lipoprotein particles	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.30001e-10	Diabetes diagnosed by doctor	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.45284e-10	Direct low density lipoprotein levels (UKB data field 30780)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.5e-10	Phospholipids to total lipids ratio in large LDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.69998e-10	Total phospholipids in lipoprotein particles	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.70271e-10	IDP_dMRI_TBSS_ICVF_Posterior_thalamic_radiation_L	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.71394e-10	IDP_dMRI_ProbtrackX_ICVF_ptr_l	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.80001e-10	Triglyceride levels in very small VLDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.80001e-10	Triglycerides in medium HDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.90001e-10	Total lipid levels in HDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.90001e-10	Non-oily fish intake	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.91199e-10	Red cell distribution width	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.94212e-10	ENSG00000204520	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.23467e-10	Direct low density lipoprotein levels (UKB data field 30780)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.40001e-10	Triglyceride levels in IDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.57684e-10	IDP_dMRI_TBSS_MD_Superior_longitudinal_fasciculus_L	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.74016e-10	Epstein-Barr virus EBNA-1 antibody levels	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4e-10	Number of days/week of moderate physical activity 10+ minutes	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.01698e-10	IDP_dMRI_TBSS_L2_Posterior_thalamic_radiation_L	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.09996e-10	Phospholipids to total lipids ratio in large LDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.1223e-10	Diabetes diagnosed by doctor	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.19479e-10	ENSG00000228789	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.20001e-10	Seen a psychiatrist for nerves, anxiety, tension or depression	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.39997e-10	6mm weak meridian (right)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.47394e-10	C-reactive protein	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.79999e-10	Triglycerides in very large HDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	5.60003e-10	Operative procedures - main OPCS: G45.1 Fibreoptic endoscopic examination of upper gastrointestinal tract and biopsy of lesion of upper gastrointestinal tract	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	5.88844e-10	Granulysin	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	6.16453e-10	IDP_dMRI_TBSS_L1_Posterior_corona_radiata_L	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	6.4e-10	White blood cell count	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	6.46249e-10	IDP_dMRI_TBSS_ICVF_Pontine_crossing_tract	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	6.59994e-10	Seen doctor (GP) for nerves, anxiety, tension or depression	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	6.90001e-10	Triglycerides in HDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	6.95505e-10	aseg_rh_intensity_Pallidum	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	7.39299e-10	Eosinophil percentage of white cells	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	7.55405e-10	Receptor for advanced glycosylation end products levels	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	7.75175e-10	IDP_dMRI_TBSS_MD_Retrolenticular_part_of_internal_capsule_L	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	7.79992e-10	Treatment/medication code: calcichew d3 tablet	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	8.10009e-10	Cholesteryl esters to total lipids ratio in small LDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	8.19993e-10	Phospholipids to total lipids ratio in small LDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	8.24708e-10	IDP_T1_FAST_ROIs_L_thalamus	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	8.30004e-10	6mm weak meridian (left)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	8.71907e-10	Total bilirubin levels	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	8.72509e-10	C-reactive protein	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	8.73635e-10	Total bilirubin	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	9.15588e-10	IDP_dMRI_TBSS_MD_Retrolenticular_part_of_internal_capsule_R	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	9.59997e-10	Free cholesterol to total lipids ratio in small LDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1e-09	Cholesterol in medium HDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.15001e-09	IDP_dMRI_TBSS_L3_Posterior_thalamic_radiation_R	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.19399e-09	IDP_dMRI_ProbtrackX_ICVF_fma	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.35077e-09	Primary_lymphoid and hematopoietic malignant neoplasms	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.5e-09	Triglycerides in large HDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.60879e-09	IDP_dMRI_ProbtrackX_MD_ilf_l	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.77701e-09	Neutrophil percentage of white cells	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.84714e-09	aparc-DKTatlas_lh_thickness_insula	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.1e-09	Illnesses of father: Lung cancer	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.20409e-09	ENSG00000234745	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.28097e-09	Cancer of primary lymphoid hematopoietic	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.33131e-09	IDP_dMRI_TBSS_ICVF_Sagittal_stratum_R	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.34099e-09	Malignant lymphoma	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.48302e-09	Alanine aminotransferase levels	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.48811e-09	Alanine aminotransferase	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.77007e-09	Calcium levels (UKB data field 30680)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.80001e-09	Triglyceride levels in medium HDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.99999e-09	Hearing difficulty/problems with background noise	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.14253e-09	Treatment/medication code: paracetamol	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.19396e-09	Asthma	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.19396e-09	Pediatric asthma	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.2e-09	haemotological cancer	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.2e-09	Arm fat mass (left)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.34272e-09	IDP_dMRI_ProbtrackX_ICVF_ifo_r	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.52452e-09	IDP_dMRI_TBSS_ICVF_Retrolenticular_part_of_internal_capsule_R	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.59998e-09	Cholesteryl esters in medium HDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.67029e-09	IDP_dMRI_TBSS_MD_Superior_corona_radiata_L	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.79997e-09	Cholesterol levels in medium HDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.80277e-09	IDP_dMRI_TBSS_L3_Posterior_thalamic_radiation_L	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.85727e-09	ENSG00000204428	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.20998e-09	Lymphomas	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.30002e-09	Pain type(s) experienced in last month: Headache	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.49997e-09	Triglycerides in small VLDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	5.1e-09	Triglycerides in small LDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	5.30005e-09	Whole body fat mass	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	5.76899e-09	IDP_dMRI_TBSS_L3_Sagittal_stratum_R	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	5.972e-09	Bipolar disorder bip2021	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	6.07715e-09	IDP_dMRI_ProbtrackX_FA_ptr_r	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	6.42984e-09	IDP_dMRI_ProbtrackX_L1_ilf_r	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	6.55737e-09	Endocrine, nutritional and metabolic diseases	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	6.90001e-09	Impedance of whole body	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	6.92787e-09	IDP_dMRI_ProbtrackX_L1_ilf_l	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	7.11705e-09	IDP_dMRI_ProbtrackX_ICVF_ifo_l	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	7.14167e-09	IDP_dMRI_TBSS_L1_Posterior_thalamic_radiation_L	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	7.45641e-09	Urate levels (UKB data field 30880)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	7.96526e-09	aparc-a2009s_lh_area_S-temporal-sup	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	8.10009e-09	Triglyceride levels in HDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	8.26e-09	Lung function (FVC)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	8.34392e-09	Crohn's disease	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	8.43529e-09	IDP_dMRI_TBSS_L2_Anterior_corona_radiata_L	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	8.70001e-09	Triglyceride levels in LDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	8.76193e-09	IDP_dMRI_ProbtrackX_MD_slf_l	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	9.94947e-09	IDP_T1_FAST_ROIs_L_temp_fusif_cortex_post	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1e-08	Dried fruit intake	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.02612e-08	Seen doctor for nerves anxiety tension or depression (UKB data field 2090) (SPA correction)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.03336e-08	Seen doctor for nerves anxiety tension or depression (UKB data field 2090) (Firth correction)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.0361e-08	aparc-DKTatlas_lh_area_middletemporal	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.08218e-08	aseg_lh_intensity_Pallidum	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.09999e-08	Cholesteryl ester levels in medium HDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.09999e-08	Triglyceride levels in medium LDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.09999e-08	Triglycerides in LDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.1023e-08	IDP_dMRI_TBSS_L3_Retrolenticular_part_of_internal_capsule_R	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.1896e-08	IDP_dMRI_ProbtrackX_MD_ifo_l	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.2e-08	Triglyceride levels in small VLDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.20099e-08	Bipolar disorder bip2021 noUKBB	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.23538e-08	IDP_dMRI_ProbtrackX_ICVF_ilf_l	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.25951e-08	IDP_dMRI_ProbtrackX_L2_ifo_l	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.29999e-08	Triglyceride levels in large LDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.36301e-08	IDP_dMRI_ProbtrackX_ICVF_ilf_r	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.40001e-08	Triglyceride levels in very large HDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.40001e-08	Moderate to vigorous physical activity levels	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.40001e-08	Asthma (adult onset)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.40001e-08	Triglycerides in large LDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.4032e-08	ENSG00000204314	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.45915e-08	aparc-DKTatlas_rh_area_insula	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.49968e-08	IDP_dMRI_ProbtrackX_ICVF_cst_l	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.5e-08	Triglyceride levels in small LDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.52721e-08	IDP_dMRI_TBSS_L1_Posterior_thalamic_radiation_R	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.57761e-08	IDP_dMRI_ProbtrackX_ICVF_str_r	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.58489e-08	Ubiquitin-like protein ISG15	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.61428e-08	Urate	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.7e-08	Free cholesterol to total lipids ratio in small LDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.72743e-08	IDP_dMRI_ProbtrackX_ICVF_ar_l	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.75186e-08	IDP_dMRI_ProbtrackX_L1_slf_r	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.84927e-08	IDP_dMRI_ProbtrackX_MD_ifo_r	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.85832e-08	Lymphocyte percentage	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.88712e-08	IDP_dMRI_TBSS_MD_Posterior_corona_radiata_L	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.1e-08	Docosahexaenoic acid	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.123e-08	CX3CL1 levels	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.1508e-08	IDP_dMRI_ProbtrackX_ICVF_ar_r	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.24683e-08	Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.39999e-08	Total lipid levels in lipoprotein particles	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.41102e-08	IDP_dMRI_ProbtrackX_L3_ilf_l	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.48714e-08	IDP_dMRI_TBSS_ICVF_Posterior_corona_radiata_L	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.59998e-08	Triglycerides in medium LDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.69998e-08	Triglyceride levels in large HDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.69998e-08	Gastroesophageal reflux disease or gastric reflux	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.72904e-08	Seen psychiatrist for nerves anxiety tension or depression (UKB data field 2100) (SPA correction)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.80001e-08	Non-cancer illness code, self-reported: enlarged prostate	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.8064e-08	Seen psychiatrist for nerves anxiety tension or depression (UKB data field 2100) (Firth correction)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.85562e-08	Number of incorrect matches in round	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.90001e-08	Illnesses of siblings: Diabetes	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.07044e-08	IDP_dMRI_ProbtrackX_ICVF_fmi	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.2e-08	Arm fat mass (right)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.2923e-08	IDP_dMRI_TBSS_L1_Superior_corona_radiata_R	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.40001e-08	Number of incorrect matches in round	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.49382e-08	wg_lh_intensity-contrast_superiorfrontal	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.89996e-08	Free cholesterol in HDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.89996e-08	Ever depressed for a whole week	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.09996e-08	Saturated fatty acid levels	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.17061e-08	IDP_dMRI_ProbtrackX_MD_ilf_r	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.25893e-08	IDP_dMRI_TBSS_MD_Anterior_corona_radiata_L	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.29932e-08	IDP_dMRI_TBSS_ICVF_Sagittal_stratum_L	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.39997e-08	Tyrosine levels	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.66498e-08	Serum uric acid levels	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.66638e-08	Urate	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	5.098e-08	aparc-Desikan_lh_area_middletemporal	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	5.1e-08	Treatment speciality of consultant (recoded): General medicine	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	5.38518e-08	IDP_dMRI_TBSS_MD_Cingulum_cingulate_gyrus_L	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	5.39014e-08	IDP_dMRI_ProbtrackX_ICVF_cgc_r	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	5.43125e-08	IDP_dMRI_ProbtrackX_L2_fmi	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	5.57314e-08	IDP_dMRI_TBSS_MD_Superior_corona_radiata_R	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	5.7544e-08	Polypeptide N-acetylgalactosaminyltransferase 1	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	5.9148e-08	Pain type(s) experienced in last month: Headache (UKB data field 6159_1) (SPA correction)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	6.0033e-08	Pain type(s) experienced in last month: Headache (UKB data field 6159_1) (Firth correction)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	6.11223e-08	IDP_dMRI_TBSS_ICVF_Superior_corona_radiata_R	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	6.23735e-08	wg_rh_intensity-contrast_superiorfrontal	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	6.51388e-08	Peak expiratory flow (PEF)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	6.53131e-08	IDP_dMRI_TBSS_ICVF_Body_of_corpus_callosum	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	6.61607e-08	IDP_dMRI_TBSS_L1_Retrolenticular_part_of_internal_capsule_L	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	6.89922e-08	IDP_dMRI_ProbtrackX_L3_ifo_l	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	7.00003e-08	Respiratory or ear-nose-throat disease	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	7.07441e-08	LDL direct	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	7.10003e-08	Diabetes	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	7.49549e-08	IDP_dMRI_TBSS_L3_Retrolenticular_part_of_internal_capsule_L	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	7.49998e-08	Nervous feelings	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	7.87046e-08	IDP_dMRI_ProbtrackX_L2_ilf_l	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	7.96159e-08	IDP_dMRI_ProbtrackX_FA_fmi	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	8.01493e-08	Treatment/medication code: ventolin 100micrograms inhaler	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	8.11521e-08	HippSubfield_rh_volume_hippocampal-fissure	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	8.30004e-08	Saturated fatty acids	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	8.39808e-08	Lymphocyte percentage of white cells	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	8.85931e-08	IDP_dMRI_TBSS_ICVF_Superior_corona_radiata_L	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	8.96396e-08	Psoriasis	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	9.09997e-08	Free cholesterol to total lipids ratio in large LDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	9.20005e-08	Triglycerides to total lipids ratio in small LDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	9.40005e-08	Eye problems/disorders: Diabetes related eye disease	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	9.59997e-08	Lung function (FEV1/FVC)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	9.63829e-08	ThalamNuclei_rh_volume_PuM	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	9.80009e-08	Cholesteryl esters in chylomicrons and extremely large VLDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	9.88189e-08	Calcium levels	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	9.89236e-08	Calcium	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	9.90011e-08	Free cholesterol to total lipids ratio in medium LDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.04496e-07	IDP_dMRI_TBSS_OD_Posterior_corona_radiata_L	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.08931e-07	Diseases of the genitourinary system	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.09999e-07	Docosahexaenoic acid levels	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.11148e-07	BA-exvivo_rh_volume_entorhinal	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.13399e-07	LDL cholesterol	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.1359e-07	LDL direct	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.2e-07	Concentration of small HDL particles	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.214e-07	Autoimmune hepatitis	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.278e-07	Nephrotic syndrome	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.29999e-07	Treatment/medication code: seretide 50 evohaler	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.4171e-07	IDP_dMRI_TBSS_L1_Superior_corona_radiata_L	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.4983e-07	aparc-a2009s_lh_thickness_Lat-Fis-ant-Vertical	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.5e-07	Cholesterol levels in small HDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.51147e-07	IDP_dMRI_ProbtrackX_FA_ifo_l	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.6e-07	Free cholesterol levels in HDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.6e-07	Frequency of light DIY in last 4 weeks	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.6e-07	Childhood sunburn occasions	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.6e-07	Treatment/medication code: ventolin 100micrograms inhaler	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.62544e-07	Non-cancer illness code  self-reported: diabetes	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.63305e-07	IDP_dMRI_ProbtrackX_L2_unc_r	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.7e-07	Total lipids in lipoprotein particles	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.7e-07	Cholesterol in chylomicrons and extremely large VLDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.7e-07	HDL cholesterol	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.7e-07	LDL cholesterol	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.7e-07	Fluid intelligence score	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.70318e-07	Non-cancer illness code  self-reported: enlarged prostate	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.78978e-07	IDP_dMRI_TBSS_L2_Anterior_corona_radiata_R	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.79999e-07	Operation code: appendicectomy	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.79999e-07	Corneal hysteresis (left)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.89998e-07	Cholesterol to total lipids ratio in IDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.9059e-07	IDP_dMRI_TBSS_L3_Anterior_corona_radiata_L	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.92886e-07	IDP_dMRI_ProbtrackX_L2_ifo_r	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.99177e-07	Eye problems/disorders: Diabetes related eye disease	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.06728e-07	IDP_dMRI_ProbtrackX_L3_ifo_r	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.1e-07	Psychological or psychiatric problem	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.19999e-07	Cholesteryl ester levels in chylomicrons and extremely large VLDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.273e-07	IDP_dMRI_TBSS_ICVF_Genu_of_corpus_callosum	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.427e-07	Height	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.59197e-07	Medication use (anti-inflammatory and antirheumatic products, non-steroids)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.59998e-07	Leg fat mass (left)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.80001e-07	White blood cell count (monocyte)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.81838e-07	aparc-Desikan_lh_thickness_insula	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.89521e-07	Number of days/week of moderate physical activity 10+ minutes	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.99999e-07	Tyrosine	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.04018e-07	Potassium in urine	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.13762e-07	IDP_dMRI_TBSS_L3_Anterior_corona_radiata_R	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.16665e-07	IDP_dMRI_TBSS_MD_Anterior_corona_radiata_R	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.17541e-07	IDP_dMRI_TBSS_OD_Superior_corona_radiata_R	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.2e-07	Non-cancer illness code, self-reported: gastro-oesophageal reflux (gord) / gastric reflux	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.28095e-07	IDP_dMRI_TBSS_L1_Superior_longitudinal_fasciculus_R	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.28118e-07	Illnesses of father: Lung cancer	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.28398e-07	IDP_dMRI_TBSS_ICVF_Anterior_corona_radiata_L	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.41901e-07	IDP_dMRI_ProbtrackX_L2_slf_l	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.43716e-07	IDP_dMRI_TBSS_ICVF_Medial_lemniscus_R	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.52996e-07	Worry	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.80189e-07	UDP-N-acetylhexosamine pyrophosphorylase	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.80294e-07	Trunk fat mass	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.84946e-07	IDP_dMRI_ProbtrackX_L1_ifo_r	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.87704e-07	IDP_dMRI_TBSS_L1_Cingulum_hippocampus_R	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.98107e-07	Palmitoyl-protein thioesterase 1	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4e-07	Total triglycerides	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.00212e-07	Illnesses of siblings: Diabetes	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.02346e-07	IDP_dMRI_ProbtrackX_OD_str_l	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.02856e-07	ENSG00000221988	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.04203e-07	IDP_dMRI_TBSS_MD_Superior_longitudinal_fasciculus_R	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.20001e-07	Cholesterol levels in chylomicrons and extremely large VLDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.20001e-07	Cholesteryl esters in HDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.23058e-07	IDP_dMRI_ProbtrackX_L3_ilf_r	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.30002e-07	Lifetime number of sexual partners	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.30002e-07	Forced expiratory volume in 1-second (FEV1), predicted	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.30537e-07	Familial combined hyperlipidemia defined by Consensus criteria	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.35341e-07	Height	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.36516e-07	Granzyme A	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.39997e-07	Cholesterol in small HDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.43507e-07	IDP_dMRI_TBSS_ICVF_Superior_longitudinal_fasciculus_R	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.49997e-07	Cholesteryl esters to total lipids ratio in large LDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.49997e-07	Free cholesterol to total lipids ratio in large LDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.49997e-07	Total testosterone levels	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.50215e-07	ENSG00000166278	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.83504e-07	IDP_dMRI_TBSS_ICVF_Splenium_of_corpus_callosum	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	5e-07	Triglycerides to total lipids ratio in small LDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	5.01187e-07	Spermatogenesis-associated protein 20	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	5.24385e-07	Apolipoprotein B levels (UKB data field 30640)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	5.29054e-07	IDP_dMRI_TBSS_L2_Genu_of_corpus_callosum	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	5.40256e-07	IDP_dMRI_TBSS_L3_Sagittal_stratum_L	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	5.55265e-07	aparc-DKTatlas_rh_thickness_insula	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	5.60003e-07	Concentration of small HDL particles	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	5.80003e-07	Bone disorder	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	5.86813e-07	IDP_T1_FAST_ROIs_R_temp_fusif_cortex_post	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	5.90024e-07	Impedance of whole body	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	6.02199e-07	Feeling nervous	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	6.27191e-07	Phosphate	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	6.59994e-07	Suffer from 'nerves'	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	6.65426e-07	IDP_dMRI_ProbtrackX_ICVF_slf_l	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	6.69993e-07	HDL cholesterol levels	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	6.80503e-07	Calcium	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	7.10003e-07	Ratio of omega-6 fatty acids to omega-3 fatty acids	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	7.19996e-07	Triglycerides in small HDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	7.25103e-07	IDP_dMRI_TBSS_L2_Posterior_thalamic_radiation_R	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	7.31206e-07	Treatment/medication code: seretide 50 evohaler	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	7.38754e-07	IDP_dMRI_ProbtrackX_MD_unc_r	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	7.38805e-07	DNA methylation Hannum age acceleration	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	7.57879e-07	IDP_dMRI_TBSS_ICVF_Superior_longitudinal_fasciculus_L	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	7.59994e-07	Leg fat mass (right)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	7.73393e-07	IDP_dMRI_ProbtrackX_MD_cgc_l	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	7.94749e-07	Anti-varicella zoster virus IgG seropositivity	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	7.95024e-07	Epstein-Barr virus VCA p18 antibody levels	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	8.08593e-07	Iron deficiency anemia	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	8.09991e-07	Hiatus hernia	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	8.25277e-07	IDP_dMRI_TBSS_FA_Middle_cerebellar_peduncle	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	8.30004e-07	Non-cancer illness code, self-reported: diabetes	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	8.31764e-07	Complement C1q tumor necrosis factor-related protein 5	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	8.46194e-07	ENSG00000204469	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	8.52315e-07	IDP_dMRI_TBSS_MD_Uncinate_fasciculus_L	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	8.62383e-07	IDP_dMRI_ProbtrackX_ICVF_ml_l	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	8.92689e-07	BA-exvivo_rh_thickness_entorhinal	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	8.9419e-07	Medication use (glucocorticoids)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	9.05545e-07	Glucose	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	9.05899e-07	Glucose levels	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	9.13061e-07	aparc-Desikan_rh_thickness_isthmuscingulate	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	9.16854e-07	IDP_dMRI_ProbtrackX_ICVF_str_l	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	9.40005e-07	Total lipid levels in small VLDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	9.49992e-07	Triglyceride levels in medium VLDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	9.56974e-07	IDP_T1_FAST_ROIs_R_paracing_gyrus	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	9.97654e-07	Seen doctor (GP) for nerves  anxiety  tension or depression	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.02101e-06	Phosphate	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.09396e-06	IDP_dMRI_ProbtrackX_MD_slf_r	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.09999e-06	Concentration of small VLDL particles	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.09999e-06	Depression	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.09999e-06	Free cholesterol to total lipids ratio in medium LDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.09999e-06	Creatinine levels	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.09999e-06	Cholesteryl esters to total lipids ratio in IDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.1471e-06	IDP_dMRI_TBSS_ICVF_Middle_cerebellar_peduncle	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.17598e-06	aparc-a2009s_lh_volume_S-temporal-sup	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.18005e-06	rfMRI connectivity (ICA100 edge 356)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.2e-06	Liver iron content	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.2e-06	Parental longevity (mother's attained age)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.2e-06	Free cholesterol in chylomicrons and extremely large VLDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.22349e-06	IDP_dMRI_TBSS_L3_Superior_longitudinal_fasciculus_R	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.22603e-06	wg_lh_intensity-contrast_insula	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.28292e-06	IDP_dMRI_ProbtrackX_L1_str_l	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.287e-06	Prostate cancer	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.287e-06	Prostate cancer	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.29999e-06	Cholesterol to total lipids ratio in IDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.29999e-06	Creatinine	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.40001e-06	Total triglycerides levels	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.40001e-06	Parental longevity (combined parental attained age, Martingale residuals)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.40001e-06	Cholesteryl esters to total lipids ratio in large LDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.414e-06	Proheparin-binding EGF-like growth factor levels	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.43847e-06	IDP_dMRI_TBSS_FA_Splenium_of_corpus_callosum	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.5e-06	Number of days/week of vigorous physical activity 10+ minutes	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.50093e-06	Frequency of light DIY in last 4 weeks	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.50245e-06	IDP_dMRI_ProbtrackX_ICVF_unc_r	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.53412e-06	Childhood asthma (age<16)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.53412e-06	Asthma	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.55096e-06	aparc-pial_lh_area_middletemporal	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.56942e-06	Potassium in urine (UKB data field 30520)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.57761e-06	IDP_dMRI_TBSS_L2_Splenium_of_corpus_callosum	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.59184e-06	IDP_dMRI_TBSS_L3_Superior_fronto-occipital_fasciculus_L	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.6e-06	Cholesteryl ester levels in HDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.61734e-06	wg_lh_intensity-contrast_inferiorparietal	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.67865e-06	COPD, early/later onset	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.69395e-06	rfMRI connectivity (ICA100 edge 509)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.74502e-06	Binding antibody response to interferon beta therapy in multiple sclerosis (antibody levels; IFN<U+03B2>-1a subcutaneous)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.7496e-06	Hearing difficulty/problems with background noise	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.77333e-06	DNA methylation Hannum age acceleration	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.78599e-06	Macrophage colony-stimulating factor 1 levels	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.78838e-06	Asthma, hospital admissions 1	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.79999e-06	Ratio of monounsaturated fatty acids to total fatty acids	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.81209e-06	Seen a psychiatrist for nerves  anxiety  tension or depression	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.83738e-06	wg_lh_intensity-contrast_supramarginal	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.84204e-06	wg_lh_intensity-contrast_superiortemporal	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.89933e-06	IDP_dMRI_TBSS_MD_Superior_fronto-occipital_fasciculus_L	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.89998e-06	Triglycerides in medium VLDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.89998e-06	Triglycerides to total lipids ratio in IDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.90985e-06	IDP_dMRI_TBSS_ICVF_Tapetum_L	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.92442e-06	Diagnoses - main ICD10: J45 Asthma	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.95128e-06	ENSG00000204387	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	1.95839e-06	wg_lh_intensity-contrast_parsorbitalis	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.02768e-06	wg_rh_intensity-contrast_caudalmiddlefrontal	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.066e-06	Mean platelet volume	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.11198e-06	Binding antibody response to interferon beta therapy in multiple sclerosis (antibody levels; all treatment preparations)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.16322e-06	IDP_dMRI_ProbtrackX_ICVF_slf_r	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.19999e-06	Triglycerides to total lipids ratio in very small VLDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.23049e-06	aparc-DKTatlas_rh_thickness_isthmuscingulate	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.23326e-06	Major dietary changes in the last 5 years: Yes, because of illness	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.28929e-06	IDP_dMRI_ProbtrackX_OD_ar_r	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.30001e-06	Comparative body size at age 10, Males	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.30001e-06	Age started hormone-replacement therapy (HRT)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.31206e-06	wg_rh_intensity-contrast_parsorbitalis	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.36211e-06	IDP_dMRI_ProbtrackX_ICVF_unc_l	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.37028e-06	IDP_dMRI_ProbtrackX_OD_slf_l	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.39999e-06	Why stopped smoking: Health precaution	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.42047e-06	aparc-a2009s_lh_thickness_S-circular-insula-sup	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.5e-06	Non-cancer illness code, self-reported: hiatus hernia	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.59298e-06	IDP_dMRI_TBSS_L1_Retrolenticular_part_of_internal_capsule_R	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.59998e-06	Main speciality of consultant (recoded): General medicine	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.69998e-06	Ratio of omega-6 fatty acids to omega-3 fatty acids	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.71394e-06	aparc-a2009s_rh_area_S-pericallosal	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.7874e-06	IDP_dMRI_TBSS_ICVF_Cingulum_cingulate_gyrus_R	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.80001e-06	Free cholesterol levels in chylomicrons and extremely large VLDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.869e-06	Glucose levels (UKB data field 30740)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.90603e-06	wg_lh_intensity-contrast_postcentral	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	2.99999e-06	Free cholesterol to total lipids ratio in very large HDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.01995e-06	Tapasin-related protein	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.02552e-06	Nervous feelings	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.09001e-06	Pulse pressure	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.09999e-06	Diagnoses - secondary ICD10: J45.9 Asthma, unspecified	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.12536e-06	wg_rh_intensity-contrast_rostralmiddlefrontal	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.15864e-06	IDP_dMRI_ProbtrackX_L3_fmi	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.28095e-06	IDP_dMRI_ProbtrackX_OD_ar_l	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.29997e-06	Mineral and other dietary supplements: Zinc	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.31894e-06	wg_rh_intensity-contrast_parsopercularis	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.43867e-06	Fluid intelligence score	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.45144e-06	Myocardial fractal dimension (slice 6)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.49623e-06	IDP_dMRI_TBSS_FA_Genu_of_corpus_callosum	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.52777e-06	wg_rh_intensity-contrast_parstriangularis	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.54813e-06	T-cell surface glycoprotein CD3 epsilon chain	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.63078e-06	PAX-interacting protein 1	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.79839e-06	IDP_dMRI_ProbtrackX_FA_ilf_l	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.79997e-06	Taking other prescription medications	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	3.89996e-06	Triglycerides in VLDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.0738e-06	Cadherin-7	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.10497e-06	Prostate cancer	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.16198e-06	IDP_dMRI_TBSS_L3_Superior_corona_radiata_L	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.20001e-06	Bioavailable testosterone levels	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.32514e-06	IDP_dMRI_ProbtrackX_L3_slf_l	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.39997e-06	Forced expiratory volume in 1-second (FEV1)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.40453e-06	IDP_dMRI_ProbtrackX_MD_unc_l	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.42395e-06	ENSG00000204592	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.45554e-06	IDP_dMRI_TBSS_FA_Anterior_corona_radiata_L	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.469e-06	Neurociticism	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.46992e-06	IDP_T1_FAST_ROIs_R_parahipp_gyrus_post	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.49997e-06	Anemia	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.49997e-06	sepsis	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.53942e-06	IDP_dMRI_TBSS_ICVF_Corticospinal_tract_R	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.60787e-06	IDP_dMRI_ProbtrackX_L1_str_r	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.61849e-06	IDP_dMRI_TBSS_L1_Fornix_cres+Stria_terminalis_R	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.74351e-06	IDP_dMRI_TBSS_ICVF_Anterior_corona_radiata_R	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.76804e-06	Ever had prolonged loss of interest in normal activities	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.79999e-06	Triglyceride levels in small HDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.79999e-06	Ratio of omega-3 fatty acids to total fatty acids	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.86968e-06	IDP_dMRI_ProbtrackX_L2_ilf_r	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	4.88304e-06	Chronic glomerulonephritis	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	5.02343e-06	IDP_dMRI_TBSS_FA_Anterior_corona_radiata_R	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	5.28689e-06	IDP_dMRI_ProbtrackX_L3_cgc_r	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	5.30005e-06	Forced Expiratory Volume (FEV1), adjusted for sex	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	5.30005e-06	HbA1C	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	5.30005e-06	Operation code: tonsillectomy +/- adenoids	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	5.46198e-06	Barrett's esophagus	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	5.49541e-06	17-beta-hydroxysteroid dehydrogenase 14	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	5.88437e-06	IDP_dMRI_TBSS_OD_Cingulum_hippocampus_R	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	5.91289e-06	IDP_dMRI_TBSS_ICVF_Superior_fronto-occipital_fasciculus_L	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	5.91303e-06	Mean corpuscular hemoglobin concentration	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	5.99998e-06	Cholesteryl esters to total lipids ratio in IDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	6.01534e-06	Gamma glutamyltransferase	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	6.03671e-06	IDP_T1_FAST_ROIs_R_thalamus	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	6.08695e-06	aparc-a2009s_rh_thickness_S-pericallosal	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	6.1e-06	Vigorous physical activity	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	6.29941e-06	IDP_dMRI_ProbtrackX_FA_fma	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	6.41106e-06	Binding antibody response to interferon beta therapy in multiple sclerosis (antibody levels; IFN<U+03B2>-1a subcutaneous and intramuscular)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	6.45654e-06	Vesicle-fusing ATPase	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	6.498e-06	Mean arterial pressure	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	6.49995e-06	Renal or urological disease	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	6.68806e-06	IDP_dMRI_TBSS_FA_Posterior_thalamic_radiation_L	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	6.73907e-06	Rheumatoid arthritis	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	6.74062e-06	IDP_dMRI_TBSS_L3_Splenium_of_corpus_callosum	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	6.80002e-06	Vitamin and mineral supplements: Vitamin C	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	6.89604e-06	IDP_dMRI_ProbtrackX_L1_ar_r	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	7.10003e-06	Cholesterol to total lipids ratio in very small VLDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	7.16968e-06	IDP_dMRI_ProbtrackX_L3_ptr_r	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	7.19996e-06	Diagnoses - main ICD10: N40 Hyperplasia of prostate	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	7.49998e-06	Prostate cancer	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	7.58019e-06	Whole body fat mass	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	7.69077e-06	Endometrial cancer	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	7.71259e-06	IDP_dMRI_TBSS_L2_Posterior_corona_radiata_L	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	7.71614e-06	IDP_dMRI_TBSS_FA_Cerebral_peduncle_R	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	7.83935e-06	Prospective memory result	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	7.93944e-06	Anti-human herpes<U+00A0>virus<U+00A0>6<U+00A0>IE1A IgG<U+00A0>seropositivity	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	8.09991e-06	Total lipid levels in VLDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	8.19596e-06	Myocardial fractal dimension (slice 5)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	8.30004e-06	Ratio of monounsaturated fatty acids to total fatty acids	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	8.50002e-06	Free cholesterol to total lipids ratio in very large HDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	8.70001e-06	Phospholipids in chylomicrons and extremely large VLDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	8.70001e-06	Bioavailable Testosterone	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	8.86543e-06	wg_rh_intensity-contrast_insula	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	8.9e-06	Triglycerides to total lipids ratio in IDL	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	9.12641e-06	ThalamNuclei_lh_volume_VA	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	9.25252e-06	Arm fat mass (left)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	9.43626e-06	IDP_dMRI_TBSS_ICVF_External_capsule_R	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	9.59997e-06	Asthma (childhood onset)	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	9.59997e-06	Facial ageing	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	9.69996e-06	Guilty feelings	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3128986	9.72747e-06	IDP_dMRI_ProbtrackX_L1_ifo_l	6	50774	0.347785122596417	2.22822991225974e-08	EasActiv18mo	0.129249
rs3094013	0	Non-cancer illness code  self-reported: malabsorption/coeliac disease	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.1289039792536e-308	ENSG00000204525	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.64754e-289	White blood cell count	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.64754e-289	white blood cell count	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.96789e-281	Lymphocyte count	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.96789e-281	lymphocyte cell count	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.35738e-256	ENSG00000253570	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.08159e-247	ENSG00000224389	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.09742e-243	White blood cell count	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	9.39723e-235	Lymphocyte count	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.74242e-206	White blood cell leukocyte count (UKB data field 30000)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.22331e-201	Lymphocyte count (UKB data field 30120)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1e-200	Primary sclerosing cholangitis	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	6.35331e-192	Type 1 diabetes	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.50035e-181	Coeliac disease	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.25944e-172	White blood cell count	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.49945e-172	White blood cell (leukocyte) count	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.97852e-167	Lymphocyte count	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.4978e-167	Lymphocyte count	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	6.88652e-167	Monocyte count	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	6.88652e-167	monocyte cell count	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.03704e-159	ENSG00000244731	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	9.2045e-152	ENSG00000231852	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.02094e-138	ENSG00000214894	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	7.56833e-135	Monocyte count (UKB data field 30130)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	9.52796e-124	Type 1 diabetes	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.49945e-119	Mean reticulocyte volume	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.55955e-118	Neutrophil count	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.55955e-118	neutrophil cell count	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.42103e-108	Monocyte count	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.86418e-108	Monocyte count	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.08319e-108	Aspartate aminotransferase levels (UKB data field 30650)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.2106e-103	ENSG00000204338	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.2723e-103	Lymphocyte counts	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	7.87046e-103	ENSG00000137331	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.80189e-102	Other diseases of the digestive system (K11_OTHDIG)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.09901e-101	Neutrophil count	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.15774e-101	Eosinophil counts	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.15774e-101	eosinophil cell count	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.18005e-99	White blood cell count	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.99986e-97	Never eat eggs, dairy, wheat, sugar: Wheat products	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	6.9952e-97	Neutrophill count (UKB data field 30140)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.90001e-94	Non-cancer illness code, self-reported: hyperthyroidism/thyrotoxicosis	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	7.01132e-94	Systemic lupus erythematosus	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.9002e-92	Hyperthyroidism or thyrotoxicosis	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.5698e-90	Membranous nephropathy	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	7.26775e-89	Aspartate aminotransferase levels	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	8.16018e-89	Aspartate aminotransferase	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.32495e-88	Type 1 diabetes	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	8.80035e-87	Eosinophil counts	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.35738e-85	Non-cancer illness code  self-reported: hyperthyroidism/thyrotoxicosis	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.84415e-85	ENSG00000137411	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.31131e-84	MHC class I polypeptide-related sequence B	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.28055e-84	Serum total protein level	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.7698e-84	Total protein	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.89045e-82	Neutrophil count	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.28943e-82	Neutrophill count	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.09991e-80	Sitting height	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.37083e-80	Autoimmune diseases	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	8.82877e-80	Total protein	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.06537e-79	ENSG00000137312	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.29987e-78	Reticulocyte count	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.29987e-78	Thyroid problem (not cancer)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.10742e-78	Eosinophill count (UKB data field 30150)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.11009e-69	Medication use (thyroid preparations)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	6.45357e-67	Mean reticulocyte volume	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.9662e-66	Type 1 diabetes	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.80011e-64	Diabetes or endocrine disease	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.99986e-60	Mean spheric corpuscular volume	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.60016e-59	Reticulocyte fraction of red cells	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.11995e-58	Hemoglobin concentration	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	6.32557e-58	Monocyte count	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.04136e-54	Sitting height	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	6.00897e-54	Eosinophil counts	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	9.517e-53	Myeloid white cell count	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.12047e-52	Hypothyroidism or myxoedema (Firth correction)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.69356e-52	Hypothyroidism or myxoedema (SPA correction)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.50003e-51	High light scatter reticulocyte count	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.70002e-50	Treatment/medication code: levothyroxine sodium	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.11106e-49	ENSG00000248290	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.18023e-49	Red blood cell count	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.70033e-49	Standing height	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	8.19974e-49	Hemoglobin	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	7.59976e-48	Started insulin within one year diagnosis of diabetes	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1e-47	Treatment/medication code: insulin product	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.16301e-47	Haemoglobin concentration (UKB data field 30020)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.03389e-46	Granulocyte count	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	9.77237e-46	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.36646e-45	Cystatin C levels (UKB data field 30720)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.41114e-45	Sum neutrophil eosinophil counts	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.85035e-45	Platelet count	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.55009e-45	Appendicular lean mass	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	6.1759e-45	Reticulocyte count	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	9.94947e-44	Sum eosinophil basophil counts	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.38676e-43	ENSG00000225059	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	8.94953e-43	Red cell distribution width	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.10994e-42	Peak expiratory flow	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.20005e-42	Non-cancer illness code, self-reported: hypothyroidism/myxoedema	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.7402e-42	Hematocrit	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	7.59976e-42	Hypothyroidism or myxedema	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.32862e-41	ENSG00000225851	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.04579e-41	ENSG00000196419	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	7.76247e-41	Glutamate receptor 4	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	7.92684e-41	Treatment/medication code: insulin product	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.74898e-40	Sum basophil neutrophil counts	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.92789e-40	Red blood cell (erythrocyte) distribution width	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	7.24436e-40	Early-onset myasthenia gravis	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	9.25763e-40	Started insulin within one year diagnosis of diabetes	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.29987e-39	High light scatter reticulocyte percentage of red cells	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.90239e-39	Platelet count (UKB data field 30080)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.29403e-39	Dermatitis herpetiformis	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.34909e-39	ENSG00000204536	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.60469e-39	Neutrophil count	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.36537e-39	Triglyceride levels (UKB data field 30870)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	6.14752e-39	Height	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.11712e-38	Reticulocyte count	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.48828e-38	ENSG00000213676	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.16009e-38	Eosinophil counts	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.47216e-38	Treatment/medication code: levothyroxine sodium	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	6.7936e-38	Hyperthyroidism	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	7.11869e-38	Hemoglobin	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	7.25939e-38	Haemoglobin concentration	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	7.39946e-38	Red blood cell count	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.10015e-37	Red cell distribution width	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	6.4998e-37	Thyrotoxicosis with diffuse goitre	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	9.92659e-37	ENSG00000211789	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.69981e-36	Platelet count	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.91999e-36	Lung function (FEV1/FVC)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.91021e-36	Reticulocyte percentage	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.99986e-35	Whole body fat-free mass	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.90001e-35	Whole body water mass	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.83619e-35	Hypothyroidism	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.86273e-35	Complement C2 measurement	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	6.89922e-35	Leg fat-free mass (right)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	7.17629e-35	Standing height	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.1259e-34	MICB	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.50003e-34	Leg predicted mass (right)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.69981e-34	Basophil count	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.69981e-34	basophil cell count	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.19989e-34	Leg fat-free mass (left)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.35505e-34	Non-cancer illness code  self-reported: hypothyroidism/myxoedema	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.80027e-34	Leg predicted mass (left)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.90001e-34	Autoimmune traits	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.0346e-34	Glycated haemoglobin HbA1c levels (UKB data field 30750)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.98412e-34	Graves' disease	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	7.38074e-34	Disorders of thyroid, IBD co-morbidities	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	7.59976e-34	Hematocrit	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.69981e-33	Basal metabolic rate	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.60016e-33	White blood cell count (lymphocyte)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.60016e-33	triglycerides	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.03729e-32	ENSG00000211797	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.11173e-32	Red blood cell erythrocyte count (UKB data field 30010)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.21507e-32	Other bullous disorders	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.50003e-32	ENSG00000211734	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.46207e-32	Cystatin C	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.80027e-32	Trunk fat-free mass	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.69999e-32	Autoimmune traits	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	6.96947e-32	Cystatin C	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	9.28966e-32	Triglycerides	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	9.43626e-32	Triglycerides	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.20005e-31	Trunk predicted mass	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.47096e-31	Platelet count	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.49142e-31	Platelet count	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.77828e-31	Complement C4	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.80011e-31	Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection, CLOZUK+PGC2	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	9.49948e-31	Arm predicted mass (left)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.28086e-30	Sarcoidosis (Lofgren's syndrome)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.3119e-30	Reticulocyte fraction of red cells	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.9002e-30	Arm fat-free mass (left)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.19129e-30	High light scatter reticulocyte count	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.49977e-30	Mean platelet volume	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.38454e-30	Aspartate aminotransferase	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.40008e-30	Mean platelet volume	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	9.74092e-30	Sarcoidosis	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.88935e-29	Gamma glutamyltransferase levels (UKB data field 30730)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.99985e-29	Lymphocyte count	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.50194e-29	Cholesterol levels (UKB data field 30690)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	6.15177e-29	Systemic connective tissue disorders	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.49977e-28	apolipoprotein A-I	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.80027e-28	Arm fat-free mass (right)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.90032e-28	Arm predicted mass (right)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.95003e-28	FEV1	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.70002e-28	Ankle spacing width	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	8.19974e-28	Hypothyroidism	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	8.52315e-28	Schizophrenia	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.735e-27	diastolic blood pressure	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.81593e-27	Schizophrenia	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.14141e-27	Leg fat-free mass (right)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.18408e-27	Mean platelet thrombocyte volume (UKB data field 30100)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.23239e-27	Leg predicted mass (right)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	8.8044e-27	Mean sphered cell volume	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.3326e-26	Whole body fat-free mass	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.83781e-26	Sj<U+00F6>gren's syndrome	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.87586e-26	Hemoglobin A1c levels	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.88973e-26	Glycated haemoglobin	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.07826e-26	Whole body water mass	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.11674e-26	Thyrotoxicosis	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.98655e-26	Leg fat-free mass (left)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.79829e-26	Glycated haemoglobin	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.79963e-26	Leg predicted mass (left)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	6.461e-26	Schizophrenia	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	8.99912e-26	Appendicular lean mass	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.41775e-25	Apolipoprotein A levels (UKB data field 30630)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.65959e-25	T-cell surface protein tactile	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.10475e-25	ENSG00000174807	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.80014e-25	HDL cholesterol	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.64408e-25	Sicca syndrome [Sj<c2><9a>gren]	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.85512e-25	Other diseases of the digestive system	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.75043e-25	Mean platelet volume	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	8.49963e-25	Weight	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	8.78618e-25	Triglycerides	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	9.482e-25	ENSG00000211746	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.16386e-24	Basal metabolic rate	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.69981e-24	Operative procedures - secondary OPCS: Z27.4 Duodenum	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.08161e-24	Apoliprotein A	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.10027e-24	Basophil count	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.38065e-24	Trunk fat-free mass	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.62701e-24	Thyrotoxicosis, other and/or unspecified	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	6.29941e-24	Weight	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	6.70656e-24	Other systemic involvement of connective tissue	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	7.32993e-24	Trunk predicted mass	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	9.30037e-24	Mean platelet volume	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.1508e-23	High light scatter reticulocyte percentage	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.21088e-23	Total cholesterol levels	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.21815e-23	Cholesterol	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.2517e-23	Cholesterol	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.66878e-23	ENSG00000204528	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.19989e-23	Age diabetes diagnosed	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.72477e-23	IGF 1 (UKB data field 30770)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.49987e-23	telomere length	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.35427e-23	ENSG00000204531	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	9.84238e-23	Other systemic involvement of connective tissue (FG)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.72145e-22	High density lipoprotein cholesterol levels (UKB data field 30760)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.2419e-22	IgA nephropathy	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.24265e-22	Red blood cell count	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.26437e-22	Red blood cell (erythrocyte) count	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	8.10028e-22	Connective tissue disorder	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	9.20026e-22	Diagnoses - secondary ICD10: E03.9 Hypothyroidism, unspecified	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	9.7499e-22	Mean platelet (thrombocyte) volume	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.71041e-21	Arm predicted mass (left)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.15576e-21	Estimated glomerular filtration rate (creatinine)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.34693e-21	Bullous disorders	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.408e-21	Hematocrit	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.42926e-21	Haematocrit percentage	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.80014e-21	Non-cancer illness code, self-reported: asthma	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.80014e-21	Operation code: thyroidectomy/partial thyroidectomy	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.60045e-21	Diagnoses - main ICD10: R31 Unspecified haematuria	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.3592e-21	Type 1 diabetes, wide definition, subgroup 1	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.92379e-21	Arm fat-free mass (right)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	6.14752e-21	Gamma glutamyl transpeptidase	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	6.19156e-21	Gamma glutamyltransferase	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	6.51778e-21	High light scatter reticulocyte count	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	6.55692e-21	Weight	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	7.2527e-21	ENSG00000204351	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	7.2711e-21	Arm fat-free mass (left)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1e-20	Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor: Asthma	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.31795e-20	Autoimmune hyperthyroidism	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.69356e-20	Apoliprotein A	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.38781e-20	ENSG00000226660	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.72772e-20	MICA	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.10527e-20	White blood cell count (basophil)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.34118e-20	ENSG00000204438	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.43558e-20	ENSG00000211782	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.99117e-20	HDL cholesterol	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.01791e-20	HDL cholesterol	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.07662e-20	Bread type: Other type of bread	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.45759e-20	Type 1 diabetes	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.48656e-20	Type 1 diabetes without complications	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	6.47739e-20	Estimated glomerular filtration rate (creatinine)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	9.06985e-20	IGF-1	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.10002e-19	Medication for cholesterol, blood pressure or diabetes: Insulin	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.21647e-19	Creatinine levels (UKB data field 30700)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.31311e-19	schizophrenia	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.39991e-19	Comparative body size at age 10	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.44644e-19	Arm predicted mass (right)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.45312e-19	Psoriasis	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.80011e-19	Bowel problem	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.80011e-19	Comparative body size at age 10, Males and Females	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.35342e-19	Varicella zoster virus glycoproteins E and I antibody levels	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.70023e-19	Plateletcrit	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.20406e-19	Blood clot  DVT  bronchitis  emphysema  asthma  rhinitis  eczema  allergy diagnosed by doctor: Asthma	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.00037e-19	Diastolic blood pressure, automated reading	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.00035e-19	Eosinophil percentage of white cells	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.10035e-19	Other serious medical condition/disability diagnosed by doctor	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.60015e-19	Time to complete round	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.67022e-19	Non-cancer illness code  self-reported: asthma	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.79963e-19	Asthma	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	7.59976e-19	Medication for pain relief, constipation, heartburn: Paracetamol	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	8.99912e-19	Hip circumference	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	9.19602e-19	Type 1 diabetes with ophthalmic complications	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	9.67609e-19	Platelet count	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.27409e-18	ENSG00000204444	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.39991e-18	Height	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.67379e-18	Lung cancer	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.9002e-18	Height	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.50026e-18	Medication for pain relief, constipation, heartburn: None of the above	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.62744e-18	IGF-1	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	8.42946e-18	Medication for cholesterol  blood pressure or diabetes: Insulin	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	8.79832e-18	Total bilirubin levels (UKB data field 30840)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.00972e-17	Total bilirubin levels (UKB data field 30840)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.12099e-17	Hemoglobin concentration	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.59993e-17	Polyunsaturated fatty acid levels	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.88582e-17	Cereal type: Other (e.g. Cornflakes, Frosties)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.9002e-17	Ankle spacing width (right)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.99434e-17	Weight	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.49632e-17	Asthma (Firth correction)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.6418e-17	Asthma (SPA correction)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.90001e-17	FEV1/FVC < 0.7	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.98401e-17	ENSG00000204308	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.25987e-17	Complement C4 levels	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.29989e-17	Operative procedures - main OPCS: M45.9 Unspecified diagnostic endoscopic examination of bladder	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.5416e-17	HDL cholesterol	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.80014e-17	Mouth/teeth dental problems: Dentures	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.84769e-17	Type 1 diabetes, wide definition	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.6957e-17	Squamous cell lung carcinoma	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.40381e-17	Mean corpuscular hemoglobin concentration	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.42375e-17	Mean corpuscular haemoglobin concentration	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.50047e-17	Mean corpuscular hemoglobin concentration	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.68722e-17	Type 1 diabetes (SPA correction)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.85194e-17	Type 1 diabetes (Firth correction)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	6.4998e-17	ENSG00000204304	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	6.57658e-17	Triglycerides	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	6.57658e-17	Triglycerides	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	9.57856e-17	Hip circumference (UKB data field 49)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.20005e-16	Age at menopause (last menstrual period)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.76604e-16	IDP_dMRI_TBSS_L1_Superior_longitudinal_fasciculus_L	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.86209e-16	HLA class II histocompatibility antigen, DQ alpha 2 chain	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.86294e-16	Type 1 diabetes with other specified/multiple/unspecified complications	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.09315e-16	Disorders of the thyroid gland	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.13993e-16	Diastolic blood pressure automated reading (UKB data field 4079)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.34909e-16	Other predominantly sexually transmitted diseases, not elsewhere classified	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.38013e-16	High light scatter reticulocyte percentage of red cells	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.71394e-16	ENSG00000211785	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.71193e-16	Psoriasis	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.81329e-16	Hypothyroidism, strict autoimmune	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.2658e-16	Trypsin-3	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.29298e-16	Systemic lupus erythematosus	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.60015e-16	Number of fluid intelligence questions attempted within time limit	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	6.79986e-16	Non-cancer illness code, self-reported: psoriasis	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	8.99912e-16	Hot drink temperature	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.03896e-15	Lichen planus	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.59993e-15	Ankle spacing width (left)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.52813e-15	Serum creatinine levels	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.53454e-15	Creatinine	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.80221e-15	ENSG00000204386	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.01439e-15	Other serious medical condition/disability diagnosed by doctor	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.38844e-15	Beta-defensin 119	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.58014e-15	Mean corpuscular hemoglobin concentration	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.61576e-15	Comparative body size at age 10	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.70254e-15	Platelet crit	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.80014e-15	Appendicular lean mass	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.19952e-15	Main speciality of consultant (recoded): Urology	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.37925e-15	Cholesterol, total	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.37925e-15	Total cholesterol	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.00035e-15	Neutrophil percentage of white cells	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.08511e-15	ENSG00000250535	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.30029e-15	Omega-6 fatty acid levels	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.32844e-15	Medication for pain relief  constipation  heartburn: None of the above	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.4325e-15	Type 1 diabetes, strict definition, subgroup 1	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.45758e-15	Non-cancer illness code  self-reported: psoriasis	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	7.22104e-15	Alanine aminotransferase levels (UKB data field 30620)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	7.51104e-15	Treatment/medication code: thyroxine product	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	7.8001e-15	Linoleic acid levels	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	8.33297e-15	Diastolic blood pressure	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.08393e-14	Intestinal malabsorbtion	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.10002e-14	Polyunsaturated fatty acids	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.1471e-14	Type 1 diabetes, strict (exclude DM2)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.31462e-14	ENSG00000204305	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.5209e-14	Type1 diabetes, definitions combined	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.54383e-14	Epstein-Barr virus ZEBRA antibody levels	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.59993e-14	Comparative body size at age 10, Females	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.74181e-14	SLE (Finngen)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.90414e-14	Diagnoses - main ICD10: R31 Unspecified haematuria	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.19989e-14	Low density lipoprotein cholesterol levels	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.43501e-14	Plateletcrit	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.45471e-14	Rac GTPase-activating protein 1	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.49977e-14	Never eat eggs, dairy, wheat, sugar: I eat all of the above	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.22478e-14	Type 1 diabetes, strict definition	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.91471e-14	Severe autoimmune type 2 diabetes	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.14477e-14	Basophil count	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.40048e-14	Long-standing illness, disability or infirmity	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.10035e-14	Treatment/medication code: thyroxine product	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.52968e-14	Diabetic ketoacidosis	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	7.02425e-14	Medication for pain relief  constipation  heartburn: Paracetamol	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	7.59976e-14	Phospholipids in medium HDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	7.71081e-14	Diastolic blood pressure  automated reading	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	9.65162e-14	Sjogren's syndrome (SPA correction)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	9.66051e-14	Sjogren's syndrome (Firth correction)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.10002e-13	Forced expiratory volume in 1-second (FEV1), predicted percentage	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.13292e-13	Red blood cell count	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.2782e-13	Peak expiratory flow (UKB data field 3064)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.39991e-13	Total fatty acid levels	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.47163e-13	Lung cancer in ever smokers	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.69981e-13	Phospholipid levels in medium HDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.79102e-13	Hypothyroidism,  other/unspecified	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.79308e-13	Proliferative diabetic retinopathy (DM_RETINA_PROLIF)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.80011e-13	Oily fish intake	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.80011e-13	Impedance of leg (left)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.84587e-13	Postprocedural endocrine and metabolic disorders, not elsewhere classified	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.07587e-13	Medication use (anilides)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.19989e-13	3mm weak meridian (left)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.2009e-13	ENSG00000211747	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.2532e-13	Hematocrit	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.36592e-13	Type 1 diabetes with coma	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.70023e-13	Linoleic acid	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.76885e-13	Medication use (drugs used in diabetes)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.09742e-13	IDP_dMRI_TBSS_L1_Sagittal_stratum_L	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.40017e-13	Phosphoglycerides levels	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.73766e-13	Hip circumference	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.80014e-13	3mm strong meridian (left)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.93641e-13	Diabetes-related co-morbidities/complications (more controls excluded)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.19952e-13	Platelet count	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.6752e-13	Diabetic hypoglycemia	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.89779e-13	Interleukin-21	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.34564e-13	IDP_dMRI_ProbtrackX_ICVF_ptr_r	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.70033e-13	Duration screen displayed	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	6.60237e-13	Diabetic retinopathy (DM_RETINOPATHY)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	6.70039e-13	3mm strong meridian (right)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	6.88018e-13	ENSG00000211810	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	7.4131e-13	ENSG00000204301	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	7.59976e-13	Omega-6 fatty acids	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	8.00018e-13	Total lipids in medium HDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	8.12082e-13	Glucose	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	8.69361e-13	SLE, strict definition	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.00925e-12	Eosinophill percentage	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.04472e-12	ThalamNuclei_rh_volume_LD	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.09774e-12	Forced expiratory volume in 1-second (FEV1)  predicted percentage	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.10002e-12	Respiratory or ear-nose-throat disease	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.20005e-12	Omega-3 fatty acid levels	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.20005e-12	Treatment/medication code: paracetamol	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.21899e-12	IDP_dMRI_TBSS_MD_Posterior_thalamic_radiation_L	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.29987e-12	Phospholipid levels in small HDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.37404e-12	Hypothyroidism, strict autoimmune, 3 medication purchases required	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.65806e-12	ENSG00000125843	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.69981e-12	Monounsaturated fatty acid levels	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.80011e-12	Total fatty acids	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.9002e-12	Asthma	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.9002e-12	Operation code: varicose vein surgery	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.99986e-12	Total lipid levels in medium HDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.99986e-12	Phosphoglycerides	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.99986e-12	3mm weak meridian (right)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.01419e-12	Systemic lupus erythematosus	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.09991e-12	Impedance of leg (right)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.25372e-12	C reactive protein levels (UKB data field 30710)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.69999e-12	Glycoprotein acetyls levels	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.86634e-12	Diabetic retinopathy (H7_RETINOPATHYDIAB)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.90032e-12	Esophageal disorder	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.43813e-12	Epstein-Barr virus EA-D antibody levels	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.7446e-12	ENSG00000186470	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.19996e-12	Concentration of medium HDL particles	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.60015e-12	Phospholipids in HDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	6.12774e-12	Polymyositis	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	6.20012e-12	Monounsaturated fatty acids	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	6.3314e-12	ENSG00000240053	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	6.74217e-12	ENSG00000206337	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	7.00003e-12	Omega-3 fatty acids	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	7.46449e-12	IDP_dMRI_TBSS_L1_Sagittal_stratum_R	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	7.48859e-12	ENSG00000211721	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	7.70016e-12	Free cholesterol levels in small HDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	8.2718e-12	Dermatopolymyositis (FG)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	8.30615e-12	Malignant lymphoma	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	8.4004e-12	Total cholines levels	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	8.55658e-12	Other metabolic disorders	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	8.63376e-12	Diabetes, several complications	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1e-11	Phospholipids in small HDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1e-11	Apolipoprotein A1	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.10205e-11	Dermatopolymyositis	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.45982e-11	Treatment/medication code: carbimazole	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.48902e-11	Medication use (adrenergics, inhalants)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.59993e-11	Phosphatidylcholine levels	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.6531e-11	Diabetic retinopathy (more controls excluded)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.80011e-11	Concentration of medium HDL particles	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.18776e-11	IDP_dMRI_TBSS_MD_Sagittal_stratum_R	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.19989e-11	Total lipid levels in small HDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.6485e-11	IDP_dMRI_TBSS_MD_Posterior_thalamic_radiation_R	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.78997e-11	Neutrophill percentage	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.19963e-11	6mm strong meridian (right)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.27341e-11	IDP_dMRI_TBSS_MD_Sagittal_stratum_L	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.29989e-11	Free cholesterol in medium HDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.50106e-11	Creatinine	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.59998e-11	Phospholipid levels in HDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.59998e-11	Total cholines	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.69403e-11	Hypothyroidism, drug reimbursement	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.69999e-11	Time to answer	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.80014e-11	Apolipoprotein A1 levels	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.80014e-11	Trunk fat mass	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.90032e-11	Total lipids in HDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.01976e-11	Eosinophil percentage of granulocytes	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.00035e-11	Platelet count	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.30029e-11	Total phospholipid levels in lipoprotein particles	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.56801e-11	Rheumatoid arthritis	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.60015e-11	Total concentration of lipoprotein particles	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.60015e-11	Phosphatidylcholines	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.68198e-11	Other retinal disorders	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.92652e-11	Infections with a predominantly sexual mode of transmission	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	6.11505e-11	Neutrophil percentage of granulocytes	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	6.18301e-11	Long-standing illness  disability or infirmity	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	6.28492e-11	ENSG00000211816	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	6.30231e-11	ENSG00000119535	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	6.4003e-11	Glycoprotein acetyls	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	6.58567e-11	Type 1 diabetes with neurological complications	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	6.74528e-11	IDP_dMRI_TBSS_ICVF_Posterior_thalamic_radiation_R	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	6.89922e-11	Concentration of HDL particles	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	7.04044e-11	ENSG00000211777	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	7.04693e-11	Systemic lupus erythematosus, unspecified	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	7.19946e-11	Salad / raw vegetable intake	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	7.70016e-11	Red cell distribution width	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	8.00018e-11	Lymphocyte percentage of white cells	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	8.00018e-11	Basophil count	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	8.19974e-11	Treatment speciality of consultant (recoded): Urology	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	8.60003e-11	Concentration of HDL particles	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	9.61612e-11	IDP_dMRI_TBSS_ICVF_Retrolenticular_part_of_internal_capsule_L	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	9.81296e-11	ENSG00000134193	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	9.83332e-11	Triglycerides	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	9.83332e-11	Triglycerides	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	9.90376e-11	ENSG00000041357	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.06013e-10	Comparative height size at age 10	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.09471e-10	Impedance of leg (left)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.09999e-10	Phospholipids to total lipids ratio in small LDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.10002e-10	IDP_dMRI_ProbtrackX_ICVF_cst_r	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.12616e-10	ThalamNuclei_rh_volume_CL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.15899e-10	Hashimoto thyroiditis	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.19757e-10	IDP_dMRI_TBSS_OD_Superior_longitudinal_fasciculus_L	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.2e-10	Free cholesterol in small HDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.273e-10	Nephrotic syndrome	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.29999e-10	6mm strong meridian (left)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.31768e-10	Any parental history of lung cancer (Firth correction)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.32041e-10	ENSG00000169507	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.32559e-10	ENSG00000211714	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.35985e-10	Any parental history of lung cancer (SPA correction)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.40001e-10	Free cholesterol levels in medium HDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.40001e-10	Peak expiratory flow (PEF)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.53522e-10	Mouth/teeth dental problems: Dentures	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.54099e-10	KELA_REIMBURSEMENT_202	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.54159e-10	ENSG00000211791	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.65158e-10	IDP_dMRI_ProbtrackX_L1_slf_l	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.77399e-10	Diabetic neuropathy	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.80401e-10	Medication use (drugs for peptic ulcer and gastro-oesophageal reflux disease)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.85695e-10	ThalamNuclei_rh_volume_LP	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.86089e-10	ENSG00000204315	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2e-10	Triglycerides in very small VLDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2e-10	Triglycerides in IDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2e-10	Cholesteryl esters to total lipids ratio in small LDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2e-10	Total concentration of lipoprotein particles	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.1e-10	Total lipids in small HDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.16651e-10	Impedance of leg (right)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.19842e-10	ENSG00000163463	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.27201e-10	Height	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.30001e-10	Total phospholipids in lipoprotein particles	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.34888e-10	ENSG00000090920	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.5e-10	Total lipid levels in HDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.59998e-10	Phospholipids to total lipids ratio in large LDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.59998e-10	Diabetes diagnosed by doctor	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.62579e-10	ENSG00000211801	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.65106e-10	Direct low density lipoprotein levels (UKB data field 30780)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.67424e-10	IDP_dMRI_TBSS_ICVF_Posterior_thalamic_radiation_L	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.69998e-10	Triglyceride levels in very small VLDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.80001e-10	Triglycerides in medium HDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.80001e-10	Non-oily fish intake	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.82163e-10	IDP_dMRI_ProbtrackX_ICVF_ptr_l	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.09999e-10	Triglyceride levels in IDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.29997e-10	Number of days/week of moderate physical activity 10+ minutes	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.43598e-10	Red cell distribution width	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.46059e-10	ENSG00000094916	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.46091e-10	Direct low density lipoprotein levels (UKB data field 30780)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.5752e-10	IDP_dMRI_TBSS_MD_Superior_longitudinal_fasciculus_L	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.71535e-10	Granulysin	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.95913e-10	IDP_dMRI_TBSS_L2_Posterior_thalamic_radiation_L	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4e-10	Phospholipids to total lipids ratio in large LDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.08442e-10	Diabetes diagnosed by doctor	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.09996e-10	6mm weak meridian (right)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.09996e-10	Seen a psychiatrist for nerves, anxiety, tension or depression	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.11803e-10	Epstein-Barr virus EBNA-1 antibody levels	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.20001e-10	Triglycerides in very large HDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.21638e-10	ENSG00000204520	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.33491e-10	C-reactive protein	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.03535e-10	ENSG00000228789	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.04173e-10	ENSG00000211814	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.30005e-10	Operative procedures - main OPCS: G45.1 Fibreoptic endoscopic examination of upper gastrointestinal tract and biopsy of lesion of upper gastrointestinal tract	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.47104e-10	Cholesterol, total	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.49997e-10	White blood cell count	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.91289e-10	IDP_dMRI_TBSS_ICVF_Pontine_crossing_tract	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.94812e-10	ENSG00000211751	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	6.4759e-10	IDP_dMRI_TBSS_L1_Posterior_corona_radiata_L	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	6.49995e-10	Seen doctor (GP) for nerves, anxiety, tension or depression	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	6.80002e-10	Triglycerides in HDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	7.21905e-10	Eosinophil percentage of white cells	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	7.59994e-10	6mm weak meridian (left)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	7.65949e-10	IDP_T1_FAST_ROIs_L_thalamus	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	7.73001e-10	Receptor for advanced glycosylation end products levels	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	7.79992e-10	Cholesteryl esters to total lipids ratio in small LDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	8e-10	Treatment/medication code: calcichew d3 tablet	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	8.10009e-10	Phospholipids to total lipids ratio in small LDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	8.37529e-10	IDP_dMRI_TBSS_MD_Retrolenticular_part_of_internal_capsule_L	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	8.41395e-10	C-reactive protein	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	8.4879e-10	aseg_rh_intensity_Pallidum	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	9.59997e-10	Free cholesterol to total lipids ratio in small LDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	9.72411e-10	Total bilirubin levels	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	9.73711e-10	Total bilirubin	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	9.80844e-10	IDP_dMRI_TBSS_MD_Retrolenticular_part_of_internal_capsule_R	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1e-09	Cholesterol in medium HDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.13815e-09	IDP_dMRI_TBSS_L3_Posterior_thalamic_radiation_R	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.17511e-09	ENSG00000211807	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.29999e-09	Triglycerides in large HDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.3128e-09	IDP_dMRI_ProbtrackX_ICVF_fma	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.34505e-09	Primary_lymphoid and hematopoietic malignant neoplasms	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.45569e-09	ENSG00000256039	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.49934e-09	IDP_dMRI_ProbtrackX_MD_ilf_l	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.7121e-09	ENSG00000177169	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.75198e-09	Neutrophil percentage of white cells	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.79999e-09	Illnesses of father: Lung cancer	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.837e-09	Autoimmune hepatitis	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2e-09	Height	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.02199e-09	Pediatric asthma	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.073e-09	Endocrine, nutritional and metabolic diseases	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.12701e-09	Type 1 diabetes with ketoacidosis	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.20039e-09	Calcium levels (UKB data field 30680)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.26564e-09	Cancer of primary lymphoid hematopoietic	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.34401e-09	Diabethic neuropathy	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.34585e-09	IDP_dMRI_TBSS_ICVF_Sagittal_stratum_R	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.3518e-09	aparc-DKTatlas_lh_thickness_insula	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.39502e-09	Alanine aminotransferase levels	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.3964e-09	Alanine aminotransferase	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.80001e-09	Triglyceride levels in medium HDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.96709e-09	Treatment/medication code: paracetamol	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.98538e-09	ENSG00000234745	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.09999e-09	haemotological cancer	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.09999e-09	Pain type(s) experienced in last month: Headache	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.1268e-09	ENSG00000204428	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.2e-09	Hearing difficulty/problems with background noise	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.40722e-09	IDP_dMRI_ProbtrackX_ICVF_ifo_r	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.56615e-09	IDP_dMRI_TBSS_ICVF_Retrolenticular_part_of_internal_capsule_R	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.59998e-09	Cholesterol levels in medium HDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.59998e-09	Cholesteryl esters in medium HDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.61402e-09	Other specified/unspecified systemic involvement of connective tissue	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.67875e-09	IDP_dMRI_TBSS_L3_Posterior_thalamic_radiation_L	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.79997e-09	Arm fat mass (left)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.86634e-09	IDP_dMRI_TBSS_MD_Superior_corona_radiata_L	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.16045e-09	Lymphomas	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.35813e-09	Crohn's disease	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.35813e-09	Crohn's disease	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.39491e-09	ENSG00000184613	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.67348e-09	ENSG00000211806	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.70002e-09	Triglycerides in small VLDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.05813e-09	Psoriasis	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.1e-09	Triglycerides in small LDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.78589e-09	Endocrine, nutritional and metabolic diseases	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.93882e-09	IDP_dMRI_TBSS_L3_Sagittal_stratum_R	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.99998e-09	Whole body fat mass	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	6.03254e-09	IDP_dMRI_ProbtrackX_L1_ilf_l	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	6.07785e-09	ENSG00000113088	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	6.10394e-09	Asthma	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	6.14186e-09	IDP_dMRI_ProbtrackX_L1_ilf_r	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	6.22702e-09	Crohn's disease	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	6.50429e-09	IDP_dMRI_TBSS_L1_Posterior_thalamic_radiation_L	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	6.55239e-09	IDP_dMRI_ProbtrackX_FA_ptr_r	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	7.1796e-09	aparc-a2009s_lh_area_S-temporal-sup	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	7.21938e-09	IDP_dMRI_ProbtrackX_ICVF_ifo_l	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	7.2512e-09	ENSG00000091129	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	7.53598e-09	Colitis, primary sclerosing	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	7.90005e-09	Triglyceride levels in HDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	7.90005e-09	Impedance of whole body	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	7.91152e-09	Urate levels (UKB data field 30880)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	7.9272e-09	ENSG00000144152	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	7.97425e-09	ENSG00000099284	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	8.03711e-09	IDP_dMRI_TBSS_L2_Anterior_corona_radiata_L	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	8.10009e-09	Triglyceride levels in LDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	8.50002e-09	Dried fruit intake	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	8.62383e-09	IDP_dMRI_ProbtrackX_MD_slf_l	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	8.931e-09	IDP_T1_FAST_ROIs_L_temp_fusif_cortex_post	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	9.42692e-09	Seen doctor for nerves anxiety tension or depression (UKB data field 2090) (SPA correction)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	9.44061e-09	aparc-DKTatlas_lh_area_middletemporal	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	9.48593e-09	Cholangitis (primary sclerosing, PSC), with reimbursement 202	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	9.4938e-09	Seen doctor for nerves anxiety tension or depression (UKB data field 2090) (Firth correction)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.032e-08	Bipolar disorder bip2021	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.09774e-08	IDP_dMRI_ProbtrackX_MD_ifo_l	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.09999e-08	Cholesteryl ester levels in medium HDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.09999e-08	Triglyceride levels in medium LDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.09999e-08	Triglycerides in LDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.1245e-08	ENSG00000087253	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.18168e-08	IDP_dMRI_TBSS_L3_Retrolenticular_part_of_internal_capsule_R	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.2e-08	Triglyceride levels in very large HDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.2e-08	Triglyceride levels in large LDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.2e-08	Triglyceride levels in small VLDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.2006e-08	IDP_dMRI_ProbtrackX_L2_ifo_l	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.27321e-08	IDP_dMRI_ProbtrackX_ICVF_ilf_l	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.27732e-08	aseg_lh_intensity_Pallidum	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.29999e-08	Moderate to vigorous physical activity levels	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.29999e-08	Asthma (adult onset)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.29999e-08	Triglycerides in large LDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.38803e-08	aparc-DKTatlas_rh_area_insula	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.40001e-08	Triglyceride levels in small LDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.43549e-08	IDP_dMRI_ProbtrackX_ICVF_ilf_r	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.5174e-08	IDP_dMRI_TBSS_L1_Posterior_thalamic_radiation_R	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.64699e-08	Hypothyroidism (congenital or acquired)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.66138e-08	ENSG00000204314	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.67571e-08	IDP_dMRI_ProbtrackX_ICVF_str_r	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.7e-08	Free cholesterol to total lipids ratio in small LDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.72862e-08	IDP_dMRI_ProbtrackX_ICVF_cst_l	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.75198e-08	Urate	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.76319e-08	IDP_dMRI_ProbtrackX_ICVF_ar_l	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.77869e-08	IDP_dMRI_ProbtrackX_L1_slf_r	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.79999e-08	Docosahexaenoic acid	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.81201e-08	Hypothyroidism and >3 levothyroxin purchases	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.81201e-08	Hypothyroidism, levothyroxin purchases	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.826e-08	CX3CL1 levels	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.86724e-08	IDP_dMRI_ProbtrackX_MD_ifo_r	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.91999e-08	Lung function (FVC)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.93241e-08	IDP_dMRI_TBSS_MD_Posterior_corona_radiata_L	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.01071e-08	Lymphocyte percentage	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.04174e-08	Ubiquitin-like protein ISG15	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.04202e-08	Bipolar disorder bip2021 noUKBB	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.1e-08	Total lipid levels in lipoprotein particles	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.25035e-08	Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.25424e-08	IDP_dMRI_ProbtrackX_ICVF_ar_r	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.30001e-08	Gastroesophageal reflux disease or gastric reflux	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.30887e-08	IDP_dMRI_ProbtrackX_L3_ilf_l	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.39999e-08	Triglyceride levels in large HDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.41602e-08	First line medication for Crohns disease	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.53379e-08	Number of incorrect matches in round	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.59998e-08	Triglycerides in medium LDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.6485e-08	IDP_dMRI_TBSS_ICVF_Posterior_corona_radiata_L	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.77588e-08	Seen psychiatrist for nerves anxiety tension or depression (UKB data field 2100) (SPA correction)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.8545e-08	Seen psychiatrist for nerves anxiety tension or depression (UKB data field 2100) (Firth correction)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.85601e-08	Sarcoidosis	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.98126e-08	wg_lh_intensity-contrast_superiorfrontal	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.99999e-08	Non-cancer illness code, self-reported: enlarged prostate	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.09999e-08	Illnesses of siblings: Diabetes	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.1703e-08	IDP_dMRI_TBSS_L1_Superior_corona_radiata_R	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.1886e-08	IDP_dMRI_ProbtrackX_ICVF_fmi	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.29997e-08	Number of incorrect matches in round	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.40001e-08	Free cholesterol in HDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.41201e-08	Iridocyclitis	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.79997e-08	Saturated fatty acid levels	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.79997e-08	Arm fat mass (right)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.08884e-08	IDP_dMRI_TBSS_MD_Anterior_corona_radiata_L	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.08978e-08	IDP_dMRI_TBSS_ICVF_Sagittal_stratum_L	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.18649e-08	ENSG00000112394	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.23448e-08	IDP_dMRI_ProbtrackX_MD_ilf_r	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.39997e-08	Ever depressed for a whole week	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.49997e-08	Tyrosine levels	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.70186e-08	Pain type(s) experienced in last month: Headache (UKB data field 6159_1) (SPA correction)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.77353e-08	Pain type(s) experienced in last month: Headache (UKB data field 6159_1) (Firth correction)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.79999e-08	Treatment speciality of consultant (recoded): General medicine	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.90343e-08	aparc-Desikan_lh_area_middletemporal	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.024e-08	Serum uric acid levels	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.02447e-08	Urate	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.35673e-08	IDP_dMRI_ProbtrackX_ICVF_cgc_r	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.37527e-08	wg_rh_intensity-contrast_superiorfrontal	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.50047e-08	IDP_dMRI_ProbtrackX_L2_fmi	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.69994e-08	Diabetes	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.70821e-08	IDP_dMRI_TBSS_MD_Superior_corona_radiata_R	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.7544e-08	Polypeptide N-acetylgalactosaminyltransferase 1	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.87003e-08	Colitis, primary sclerosing, strict definition	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.95525e-08	IDP_dMRI_TBSS_MD_Cingulum_cingulate_gyrus_L	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	6.10604e-08	Certain disorders involving the immune mechanism	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	6.30812e-08	HippSubfield_rh_volume_hippocampal-fissure	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	6.38852e-08	IDP_dMRI_ProbtrackX_L3_ifo_l	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	6.77439e-08	Peak expiratory flow (PEF)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	6.79829e-08	IDP_dMRI_TBSS_ICVF_Superior_corona_radiata_R	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	6.91194e-08	IDP_dMRI_TBSS_L1_Retrolenticular_part_of_internal_capsule_L	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	7.00003e-08	Nervous feelings	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	7.07408e-08	Peripheral artery disease	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	7.2144e-08	IDP_dMRI_TBSS_ICVF_Body_of_corpus_callosum	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	7.39673e-08	LDL direct	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	7.77678e-08	IDP_dMRI_ProbtrackX_L2_ilf_l	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	7.84404e-08	Finngen Rheumatological endpoints	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	8e-08	Saturated fatty acids	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	8.02694e-08	Disorders of choroid and retina	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	8.03341e-08	IDP_dMRI_TBSS_L3_Retrolenticular_part_of_internal_capsule_L	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	8.04785e-08	Diseases of the genitourinary system	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	8.14704e-08	IDP_dMRI_ProbtrackX_FA_fmi	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	8.29297e-08	Lymphocyte percentage of white cells	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	8.58499e-08	Calcium	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	8.58598e-08	Calcium levels	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	8.79995e-08	Respiratory or ear-nose-throat disease	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	8.82043e-08	Treatment/medication code: ventolin 100micrograms inhaler	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	9.30294e-08	Peripheral artery disease (no controls excluded)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	9.40005e-08	Docosahexaenoic acid levels	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	9.40005e-08	Lung function (FEV1/FVC)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	9.69996e-08	Triglycerides to total lipids ratio in small LDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	9.7051e-08	IDP_dMRI_TBSS_ICVF_Superior_corona_radiata_L	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	9.80009e-08	Cholesteryl esters in chylomicrons and extremely large VLDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	9.90809e-08	ENSG00000050165	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1e-07	Lung function (FEV1/FVC)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1e-07	Free cholesterol to total lipids ratio in large LDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.04299e-07	Ankylosing spondylitis	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.07275e-07	BA-exvivo_rh_volume_entorhinal	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.09069e-07	ThalamNuclei_rh_volume_PuM	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.09999e-07	Free cholesterol to total lipids ratio in medium LDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.09999e-07	Eye problems/disorders: Diabetes related eye disease	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.16977e-07	IDP_dMRI_TBSS_OD_Posterior_corona_radiata_L	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.17001e-07	Acute and subacute iridocyclitis	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.19501e-07	LDL cholesterol	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.19569e-07	LDL direct	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.2e-07	Concentration of small HDL particles	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.23501e-07	Psoriasis	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.26523e-07	Height	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.40001e-07	Free cholesterol levels in HDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.40001e-07	Childhood sunburn occasions	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.4568e-07	IDP_dMRI_ProbtrackX_FA_ifo_l	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.46994e-07	IDP_dMRI_TBSS_L1_Superior_corona_radiata_L	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.5e-07	Cholesterol levels in small HDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.5e-07	HDL cholesterol	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.5e-07	Frequency of light DIY in last 4 weeks	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.5e-07	Treatment/medication code: seretide 50 evohaler	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.5e-07	Treatment/medication code: ventolin 100micrograms inhaler	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.5144e-07	ENSG00000135074	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.55418e-07	aparc-a2009s_lh_thickness_Lat-Fis-ant-Vertical	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.6e-07	Mean reticulocyte volume	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.6e-07	Total lipids in lipoprotein particles	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.6e-07	Fluid intelligence score	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.6e-07	Operation code: appendicectomy	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.6e-07	Corneal hysteresis (left)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.60953e-07	IDP_dMRI_ProbtrackX_L2_unc_r	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.64097e-07	Non-cancer illness code  self-reported: diabetes	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.68229e-07	ENSG00000109943	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.7e-07	Cholesterol in chylomicrons and extremely large VLDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.74824e-07	IDP_dMRI_TBSS_L2_Anterior_corona_radiata_R	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.74908e-07	ENSG00000170545	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.76064e-07	Non-cancer illness code  self-reported: enlarged prostate	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.79999e-07	LDL cholesterol	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.81343e-07	IDP_dMRI_TBSS_L3_Anterior_corona_radiata_L	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.99848e-07	IDP_dMRI_ProbtrackX_L2_ifo_r	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2e-07	Cholesterol to total lipids ratio in IDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.11203e-07	IDP_dMRI_ProbtrackX_L3_ifo_r	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.1858e-07	ENSG00000135318	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.19999e-07	Cholesteryl ester levels in chylomicrons and extremely large VLDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.19999e-07	Psychological or psychiatric problem	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.22602e-07	ENSG00000163508	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.27599e-07	Medication use (anti-inflammatory and antirheumatic products, non-steroids)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.30001e-07	Non-cancer illness code, self-reported: gastro-oesophageal reflux (gord) / gastric reflux	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.30298e-07	Height	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.38056e-07	Number of days/week of moderate physical activity 10+ minutes	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.39999e-07	Triglyceride levels	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.46718e-07	IDP_dMRI_TBSS_ICVF_Genu_of_corpus_callosum	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.474e-07	Disorders of lacrimal system and orbit in diseases classified elsewhere	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.47765e-07	Eye problems/disorders: Diabetes related eye disease	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.5704e-07	Palmitoyl-protein thioesterase 1	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.63403e-07	Sarcoidosis	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.90001e-07	Leg fat mass (left)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.96838e-07	Illnesses of father: Lung cancer	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.99999e-07	Tyrosine	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.08603e-07	IDP_dMRI_TBSS_OD_Superior_corona_radiata_R	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.09999e-07	White blood cell count (monocyte)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.12104e-07	IDP_dMRI_TBSS_L3_Anterior_corona_radiata_R	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.14413e-07	IDP_dMRI_TBSS_MD_Anterior_corona_radiata_R	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.19198e-07	Worry	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.23266e-07	Potassium in urine	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.29003e-07	IDP_dMRI_TBSS_ICVF_Medial_lemniscus_R	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.3037e-07	IDP_dMRI_ProbtrackX_L2_slf_l	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.34118e-07	IDP_dMRI_TBSS_ICVF_Anterior_corona_radiata_L	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.35043e-07	IDP_dMRI_TBSS_L1_Cingulum_hippocampus_R	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.38065e-07	IDP_dMRI_TBSS_L1_Superior_longitudinal_fasciculus_R	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.6467e-07	aparc-Desikan_lh_thickness_insula	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.72735e-07	IDP_dMRI_ProbtrackX_L1_ifo_r	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.75301e-07	Peripheral artery disease	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.79997e-07	Forced expiratory volume in 1-second (FEV1), predicted	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.82226e-07	ENSG00000221988	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.87267e-07	Trunk fat mass	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.89045e-07	Spermatogenesis-associated protein 20	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.89996e-07	Cholesteryl esters in HDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.0879e-07	IDP_dMRI_ProbtrackX_OD_str_l	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.09996e-07	Total triglycerides	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.16649e-07	Illnesses of siblings: Diabetes	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.18707e-07	Familial combined hyperlipidemia defined by Consensus criteria	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.20001e-07	Lifetime number of sexual partners	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.20824e-07	IDP_dMRI_TBSS_MD_Superior_longitudinal_fasciculus_R	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.2658e-07	Granzyme A	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.30002e-07	Cholesterol levels in chylomicrons and extremely large VLDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.34911e-07	IDP_dMRI_ProbtrackX_L3_ilf_r	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.39602e-07	Peripheral atherosclerosis	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.60002e-07	Total testosterone levels	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.60002e-07	Cholesterol in small HDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.66015e-07	ENSG00000166278	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.70002e-07	Cholesteryl esters to total lipids ratio in large LDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.70002e-07	Waist-to-hip ratio adjusted for BMI	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.7687e-07	IDP_dMRI_TBSS_L3_Sagittal_stratum_L	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.80618e-07	IDP_dMRI_TBSS_ICVF_Superior_longitudinal_fasciculus_R	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.1e-07	Free cholesterol to total lipids ratio in large LDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.118e-07	IDP_T1_FAST_ROIs_R_temp_fusif_cortex_post	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.17297e-07	Feeling nervous	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.1892e-07	IDP_dMRI_TBSS_ICVF_Splenium_of_corpus_callosum	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.19996e-07	Triglycerides to total lipids ratio in small LDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.19996e-07	Bone disorder	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.21579e-07	ENSG00000184281	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.39225e-07	ENSG00000125901	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.42375e-07	Phosphate	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.56878e-07	ENSG00000092621	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.58547e-07	Apolipoprotein B levels (UKB data field 30640)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.6273e-07	IDP_dMRI_TBSS_L2_Genu_of_corpus_callosum	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.68696e-07	Arthropod-borne viral fevers and viral haemorrhagic fevers	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.72005e-07	aparc-DKTatlas_rh_thickness_insula	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.80003e-07	Concentration of small HDL particles	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.951e-07	ENSG00000112343	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.99998e-07	HDL cholesterol levels	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	6.02476e-07	Calcium	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	6.0256e-07	UDP-N-acetylhexosamine pyrophosphorylase	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	6.18073e-07	Impedance of whole body	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	6.187e-07	Varicose veins	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	6.4e-07	Ratio of omega-6 fatty acids to omega-3 fatty acids	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	6.4e-07	Suffer from 'nerves'	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	6.95024e-07	IDP_dMRI_ProbtrackX_ICVF_slf_l	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	7.09741e-07	IDP_dMRI_ProbtrackX_MD_unc_r	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	7.26073e-07	Treatment/medication code: seretide 50 evohaler	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	7.34548e-07	ENSG00000110881	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	7.49998e-07	Triglycerides in small HDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	7.58316e-07	Anti-varicella zoster virus IgG seropositivity	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	7.6366e-07	IDP_dMRI_TBSS_L2_Posterior_thalamic_radiation_R	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	7.9561e-07	IDP_dMRI_TBSS_ICVF_Superior_longitudinal_fasciculus_L	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	8.0783e-07	Epstein-Barr virus VCA p18 antibody levels	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	8.23569e-07	IDP_dMRI_ProbtrackX_MD_cgc_l	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	8.30004e-07	Hiatus hernia	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	8.47813e-07	BA-exvivo_rh_thickness_entorhinal	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	8.51334e-07	Seen doctor (GP) for nerves  anxiety  tension or depression	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	8.60003e-07	Leg fat mass (right)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	8.77607e-07	IDP_dMRI_TBSS_MD_Uncinate_fasciculus_L	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	8.788e-07	ENSG00000129484	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	8.8113e-07	Phosphate	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	8.99995e-07	Total lipid levels in small VLDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	9.13545e-07	ENSG00000211779	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	9.27193e-07	Medication use (glucocorticoids)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	9.29994e-07	Non-cancer illness code, self-reported: diabetes	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	9.31322e-07	IDP_dMRI_TBSS_FA_Middle_cerebellar_peduncle	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	9.32911e-07	Proheparin-binding EGF-like growth factor levels	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	9.40091e-07	Unspecified diabetic retinopathy	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	9.56533e-07	aparc-Desikan_rh_thickness_isthmuscingulate	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	9.58959e-07	IDP_dMRI_ProbtrackX_ICVF_str_l	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	9.80009e-07	Triglyceride levels in medium VLDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	9.97011e-07	IDP_dMRI_ProbtrackX_ICVF_ml_l	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	9.98596e-07	Lupus erythematosus	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.006e-06	IDP_T1_FAST_ROIs_R_paracing_gyrus	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.01761e-06	ENSG00000204469	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.035e-06	Type 1 diabetes with renal complications	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.05339e-06	ENSG00000136158	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.06601e-06	Glucose	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.06601e-06	Glucose levels	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.093e-06	Rheumatoid arthritis (M13_RHEUMA)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.09648e-06	Complement C1q tumor necrosis factor-related protein 5	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.09951e-06	aparc-a2009s_lh_volume_S-temporal-sup	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.09999e-06	Depression	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.09999e-06	Parental longevity (mother's attained age)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.09999e-06	Concentration of small VLDL particles	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.11327e-06	IDP_dMRI_ProbtrackX_MD_slf_r	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.18304e-06	IDP_dMRI_TBSS_ICVF_Middle_cerebellar_peduncle	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.19779e-06	ENSG00000204387	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.2e-06	Creatinine levels	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.2e-06	Parental longevity (combined parental attained age, Martingale residuals)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.2e-06	Free cholesterol to total lipids ratio in medium LDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.2e-06	Free cholesterol in chylomicrons and extremely large VLDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.2e-06	Cholesteryl esters to total lipids ratio in IDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.228e-06	wg_lh_intensity-contrast_insula	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.24451e-06	IDP_dMRI_TBSS_L3_Superior_longitudinal_fasciculus_R	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.26561e-06	rfMRI connectivity (ICA100 edge 356)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.29999e-06	Liver iron content	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.30347e-06	IDP_dMRI_ProbtrackX_L1_str_l	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.38401e-06	Frequency of light DIY in last 4 weeks	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.39351e-06	Childhood asthma (age<16)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.39351e-06	Asthma	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.40001e-06	Cholesterol to total lipids ratio in IDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.40001e-06	Creatinine	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.40602e-06	Cholangitis (primary sclerosing, PSC)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.42699e-06	Prostate cancer	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.42699e-06	Prostate cancer	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.42922e-06	aparc-pial_lh_area_middletemporal	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.43272e-06	ENSG00000206561	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.4873e-06	IDP_dMRI_TBSS_FA_Splenium_of_corpus_callosum	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.49001e-06	Iron deficiency anemia	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.5e-06	Cholesteryl ester levels in HDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.5e-06	Total triglycerides levels	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.5e-06	Cholesteryl esters to total lipids ratio in large LDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.5e-06	Waist-to-hip ratio	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.5195e-06	IDP_dMRI_ProbtrackX_ICVF_unc_r	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.53073e-06	wg_lh_intensity-contrast_inferiorparietal	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.56171e-06	IDP_dMRI_TBSS_L3_Superior_fronto-occipital_fasciculus_L	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.6e-06	Monocyte count	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.6e-06	Number of days/week of vigorous physical activity 10+ minutes	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.60668e-06	Potassium in urine (UKB data field 30520)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.62517e-06	Asthma, hospital admissions 1	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.65691e-06	IDP_dMRI_TBSS_L2_Splenium_of_corpus_callosum	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.6734e-06	wg_lh_intensity-contrast_supramarginal	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.69001e-06	Macrophage colony-stimulating factor 1 levels	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.70801e-06	Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.74301e-06	rfMRI connectivity (ICA100 edge 509)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.74582e-06	Diagnoses - main ICD10: J45 Asthma	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.77746e-06	wg_lh_intensity-contrast_superiortemporal	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.7775e-06	ENSG00000104419	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.78888e-06	Hearing difficulty/problems with background noise	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.82096e-06	IDP_dMRI_TBSS_ICVF_Tapetum_L	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.82936e-06	wg_rh_intensity-contrast_caudalmiddlefrontal	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.83e-06	Atherosclerosis, excluding cerebral, coronary and PAD	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.84633e-06	COPD, early/later onset	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.85097e-06	IDP_dMRI_TBSS_MD_Superior_fronto-occipital_fasciculus_L	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.88304e-06	Seen a psychiatrist for nerves  anxiety  tension or depression	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.89998e-06	Ratio of monounsaturated fatty acids to total fatty acids	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.93901e-06	Binding antibody response to interferon beta therapy in multiple sclerosis (antibody levels; IFN<U+03B2>-1a subcutaneous)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.93955e-06	wg_lh_intensity-contrast_parsorbitalis	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.95898e-06	Binding antibody response to interferon beta therapy in multiple sclerosis (antibody levels; all treatment preparations)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	1.963e-06	ENSG00000148468	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2e-06	Triglycerides in medium VLDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2e-06	Triglycerides to total lipids ratio in IDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.00198e-06	Seropositive rheumatoid arthritis	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.05636e-06	wg_rh_intensity-contrast_parsorbitalis	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.063e-06	Certain infectious and parasitic diseases	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.12701e-06	Diabetic maculopathy (H7_MACULOPATHYDIAB)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.17801e-06	Diabetic maculopathy (DM_MACULOPATHY)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.19999e-06	Age started hormone-replacement therapy (HRT)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.2079e-06	ENSG00000196924	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.26152e-06	IDP_dMRI_ProbtrackX_ICVF_slf_r	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.274e-06	Mean platelet volume	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.27677e-06	Major dietary changes in the last 5 years: Yes, because of illness	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.30001e-06	White blood cell count	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.32702e-06	IDP_dMRI_ProbtrackX_ICVF_unc_l	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.33938e-06	aparc-DKTatlas_rh_thickness_isthmuscingulate	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.34531e-06	IDP_dMRI_ProbtrackX_OD_ar_r	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.37602e-06	Proliferative diabetic retinopathy (H7_RETINOPATHYDIAB_PROLIF)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.3958e-06	ENSG00000100395	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.39999e-06	Ratio of omega-6 fatty acids to omega-3 fatty acids	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.39999e-06	Triglycerides to total lipids ratio in very small VLDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.41802e-06	DNA methylation Hannum age acceleration	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.55388e-06	IDP_dMRI_ProbtrackX_OD_slf_l	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.59998e-06	Non-cancer illness code, self-reported: hiatus hernia	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.63299e-06	Chronic obstructive pulmonary disease	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.69998e-06	Comparative body size at age 10, Males	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.69998e-06	Main speciality of consultant (recoded): General medicine	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.69998e-06	Why stopped smoking: Health precaution	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.72145e-06	IDP_dMRI_TBSS_L1_Retrolenticular_part_of_internal_capsule_R	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.73338e-06	aparc-a2009s_rh_area_S-pericallosal	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.76185e-06	wg_rh_intensity-contrast_rostralmiddlefrontal	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.76694e-06	aparc-a2009s_lh_thickness_S-circular-insula-sup	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.78099e-06	Diabetic maculopathy (more controls excluded)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.80001e-06	Free cholesterol levels in chylomicrons and extremely large VLDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.80001e-06	Free cholesterol to total lipids ratio in very large HDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.81598e-06	ENSG00000148346	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.82163e-06	ENSG00000119147	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.82813e-06	IDP_dMRI_TBSS_ICVF_Cingulum_cingulate_gyrus_R	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.83857e-06	wg_rh_intensity-contrast_parsopercularis	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.90402e-06	wg_lh_intensity-contrast_postcentral	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.90998e-06	Asthma	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.92523e-06	ENSG00000100448	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.94992e-06	Nervous feelings	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.95801e-06	wg_rh_intensity-contrast_parstriangularis	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	2.99999e-06	Diagnoses - secondary ICD10: J45.9 Asthma, unspecified	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.01995e-06	Cadherin-7	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.08319e-06	ENSG00000167671	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.0903e-06	T-cell surface glycoprotein CD3 epsilon chain	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.09999e-06	Mineral and other dietary supplements: Zinc	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.15261e-06	Glucose levels (UKB data field 30740)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.15718e-06	IDP_dMRI_ProbtrackX_L3_fmi	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.16373e-06	Myocardial fractal dimension (slice 6)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.20945e-06	Fluid intelligence score	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.2144e-06	IDP_dMRI_ProbtrackX_OD_ar_l	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.27997e-06	"""Atherosclerosis, excluding cerebral, coronary and PAD"" (no controls excluded)"	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.298e-06	C4	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.36899e-06	Pulse pressure	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.58344e-06	IDP_dMRI_TBSS_FA_Genu_of_corpus_callosum	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.59998e-06	Taking other prescription medications	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.69999e-06	Waist-to-hip ratio	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.80189e-06	PAX-interacting protein 1	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.8815e-06	IDP_dMRI_ProbtrackX_FA_ilf_l	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.93396e-06	Neurociticism	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.94003e-06	IDP_dMRI_TBSS_L1_Fornix_cres+Stria_terminalis_R	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	3.99604e-06	Thyroiditis	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.09996e-06	Triglycerides in VLDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.1261e-06	Ever had prolonged loss of interest in normal activities	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.16869e-06	Tapasin-related protein	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.18052e-06	ENSG00000044574	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.20001e-06	Forced expiratory volume in 1-second (FEV1)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.20727e-06	IDP_dMRI_TBSS_L3_Superior_corona_radiata_L	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.24131e-06	IDP_dMRI_ProbtrackX_MD_unc_l	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.25207e-06	IDP_dMRI_TBSS_FA_Anterior_corona_radiata_L	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.29705e-06	Ankylosing spondylitis, strict definition	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.30002e-06	Ratio of omega-3 fatty acids to total fatty acids	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.3411e-06	IDP_dMRI_TBSS_ICVF_Corticospinal_tract_R	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.3461e-06	IDP_dMRI_ProbtrackX_L3_slf_l	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.37603e-06	Prostate cancer	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.56142e-06	IDP_dMRI_ProbtrackX_L1_str_r	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.61424e-06	IDP_T1_FAST_ROIs_R_parahipp_gyrus_post	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.64205e-06	Respiratory disorders in diseases classified elsewhere	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.70002e-06	Forced Expiratory Volume (FEV1), adjusted for sex	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.70002e-06	HbA1C	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.74351e-06	IDP_dMRI_TBSS_ICVF_Anterior_corona_radiata_R	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.77134e-06	ENSG00000175730	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.79999e-06	Operation code: tonsillectomy +/- adenoids	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.88664e-06	ENSG00000173114	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.90004e-06	Bioavailable testosterone levels	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.91926e-06	ENSG00000211706	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	4.99022e-06	ENSG00000166532	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5e-06	Triglyceride levels in small HDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5e-06	Anemia	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.00841e-06	IDP_dMRI_TBSS_FA_Anterior_corona_radiata_R	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.05825e-06	IDP_dMRI_TBSS_OD_Cingulum_hippocampus_R	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.09577e-06	Endometrial cancer	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.10152e-06	IDP_dMRI_ProbtrackX_L2_ilf_r	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.10799e-06	Background diabetic retinopathy	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.12861e-06	17-beta-hydroxysteroid dehydrogenase 14	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.19996e-06	Renal or urological disease	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.30005e-06	Serum alkaline phosphatase levels	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.37155e-06	IDP_dMRI_ProbtrackX_L3_cgc_r	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.38505e-06	Other diabetic retinopathy	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.53541e-06	ENSG00000168824	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.77032e-06	IDP_T1_FAST_ROIs_R_thalamus	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.78096e-06	IDP_dMRI_TBSS_ICVF_Superior_fronto-occipital_fasciculus_L	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.80003e-06	sepsis	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.92066e-06	ENSG00000129270	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	5.93444e-06	Gamma glutamyltransferase	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	6.02241e-06	ENSG00000084234	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	6.04102e-06	Mean arterial pressure	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	6.1e-06	Vitamin and mineral supplements: Vitamin C	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	6.16595e-06	Vesicle-fusing ATPase	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	6.16879e-06	IDP_dMRI_ProbtrackX_FA_fma	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	6.17248e-06	Anti-human herpes<U+00A0>virus<U+00A0>6<U+00A0>IE1A IgG<U+00A0>seropositivity	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	6.32106e-06	Disorders of orbit	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	6.43873e-06	aparc-a2009s_rh_thickness_S-pericallosal	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	6.59994e-06	Cholesteryl esters to total lipids ratio in IDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	6.63437e-06	IDP_dMRI_ProbtrackX_L1_ar_r	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	6.70008e-06	ENSG00000204592	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	6.72899e-06	Mean corpuscular hemoglobin concentration	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	6.77018e-06	IDP_dMRI_TBSS_L3_Splenium_of_corpus_callosum	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	6.79047e-06	IDP_dMRI_TBSS_FA_Posterior_thalamic_radiation_L	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	6.95296e-06	Binding antibody response to interferon beta therapy in multiple sclerosis (antibody levels; IFN<U+03B2>-1a subcutaneous and intramuscular)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	7.12853e-06	IDP_dMRI_ProbtrackX_L3_ptr_r	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	7.15583e-06	ENSG00000149131	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	7.19996e-06	Vigorous physical activity	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	7.25722e-06	Prospective memory result	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	7.39997e-06	Diagnoses - main ICD10: N40 Hyperplasia of prostate	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	7.47601e-06	Rheumatoid arthritis	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	7.49204e-06	Unspecified diabetes	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	7.64716e-06	IDP_dMRI_TBSS_FA_Cerebral_peduncle_R	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	7.6913e-06	IDP_dMRI_TBSS_L2_Posterior_corona_radiata_L	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	7.69999e-06	Cholesterol to total lipids ratio in very small VLDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	7.77499e-06	Myocardial fractal dimension (slice 5)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	7.79992e-06	Free cholesterol to total lipids ratio in very large HDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	7.79992e-06	Prostate cancer	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	7.8529e-06	Whole body fat mass	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	7.955e-06	IBD (strict) with PSC	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	8.01309e-06	wg_rh_intensity-contrast_insula	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	8.09991e-06	Total lipid levels in VLDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	8.12007e-06	Mean corpuscular volume	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	8.1298e-06	Non-cancer illness code  self-reported: gastro-oesophageal reflux (gord) / gastric reflux	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	8.179e-06	Polyarthropathies	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	8.24974e-06	ENSG00000140995	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	8.47579e-06	ENSG00000007264	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	8.61906e-06	Rheumatoid arthritis (M13_RHEUMA_INCLAVO)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	8.6834e-06	ENSG00000091640	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	8.84667e-06	ENSG00000179627	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	8.9e-06	Ratio of monounsaturated fatty acids to total fatty acids	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	8.99995e-06	Phospholipids in chylomicrons and extremely large VLDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	8.99995e-06	Guilty feelings	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	9.01571e-06	IDP_dMRI_ProbtrackX_L1_ifo_l	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	9.03774e-06	ENSG00000179869	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	9.06296e-06	ENSG00000124226	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	9.18163e-06	ENSG00000087269	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	9.19179e-06	IDP_dMRI_TBSS_ICVF_External_capsule_R	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	9.25145e-06	Mineral and other dietary supplements: Zinc	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	9.39702e-06	ENSG00000092068	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	9.40005e-06	Triglycerides to total lipids ratio in IDL	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	9.49992e-06	Facial ageing	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	9.50167e-06	ThalamNuclei_lh_volume_VA	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	9.69795e-06	ENSG00000124469	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	9.76338e-06	aparc-a2009s_lh_area_G-temporal-middle	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094013	9.78318e-06	Arm fat mass (left)	6	50753	0.370840365120088	2.15070081658473e-08	EasActiv18mo	0.129194
rs3094012	0	Non-cancer illness code  self-reported: malabsorption/coeliac disease	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.27938e-301	ENSG00000204525	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.2388e-276	White blood cell count	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.2388e-276	white blood cell count	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	9.35406e-275	Lymphocyte count	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	9.35406e-275	lymphocyte cell count	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.93174e-241	ENSG00000224389	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.30144e-234	White blood cell count	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.59749e-229	Lymphocyte count	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.94089e-200	White blood cell leukocyte count (UKB data field 30000)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.09396e-197	Lymphocyte count (UKB data field 30120)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.54683e-179	Coeliac disease	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.62422e-172	Primary sclerosing cholangitis	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.00867e-169	Type 1 diabetes	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.48886e-166	White blood cell count	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.74111e-166	White blood cell (leukocyte) count	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.77011e-163	Lymphocyte count	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.61818e-163	Lymphocyte count	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.97852e-161	Monocyte count	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.97852e-161	monocyte cell count	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.87932e-159	ENSG00000244731	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	7.51623e-149	ENSG00000231852	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.52405e-130	Monocyte count (UKB data field 30130)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	9.57194e-126	ENSG00000214894	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.30017e-120	Mean reticulocyte volume	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.10408e-114	Type 1 diabetes	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	5.29663e-114	Neutrophil count	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	5.29663e-114	neutrophil cell count	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.75423e-106	Aspartate aminotransferase levels (UKB data field 30650)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.99226e-103	Monocyte count	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.49945e-103	Monocyte count	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.25893e-101	Lymphocyte counts	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.75423e-101	ENSG00000204338	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.00995e-98	Other diseases of the digestive system (K11_OTHDIG)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.59005e-98	White blood cell count	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.70002e-98	Neutrophil count	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.20005e-95	Never eat eggs, dairy, wheat, sugar: Wheat products	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.2844e-94	Neutrophill count (UKB data field 30140)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	8.00018e-94	Non-cancer illness code, self-reported: hyperthyroidism/thyrotoxicosis	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.287e-93	ENSG00000137331	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.90001e-90	Eosinophil counts	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.90001e-90	eosinophil cell count	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	9.8992e-89	Hyperthyroidism or thyrotoxicosis	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.28981e-88	ENSG00000137411	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.23623e-87	Non-cancer illness code  self-reported: hyperthyroidism/thyrotoxicosis	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.02023e-87	Aspartate aminotransferase levels	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.25061e-87	Aspartate aminotransferase	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.7949e-87	Membranous nephropathy	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.16118e-86	Systemic lupus erythematosus	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.9564e-82	Type 1 diabetes	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.70002e-80	Sitting height	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	5.49921e-80	Serum total protein level	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	6.09818e-80	Total protein	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.94984e-79	MHC class I polypeptide-related sequence B	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.97697e-79	Neutrophil count	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.16471e-79	Neutrophill count	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	6.94225e-79	Autoimmune diseases	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.90032e-77	Eosinophil counts	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.59993e-76	Reticulocyte count	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	7.22104e-76	Total protein	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.99986e-72	Thyroid problem (not cancer)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	5.75838e-72	Eosinophill count (UKB data field 30150)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.19373e-71	ENSG00000137312	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.50323e-68	Medication use (thyroid preparations)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.13845e-66	Mean reticulocyte volume	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.84512e-62	Type 1 diabetes	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.69981e-59	Mean spheric corpuscular volume	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.80011e-59	Diabetes or endocrine disease	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.30031e-58	Reticulocyte fraction of red cells	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.62422e-55	Monocyte count	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.80065e-55	Sitting height	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.25011e-54	Hemoglobin concentration	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	6.38557e-52	Myeloid white cell count	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	9.31751e-52	Hypothyroidism or myxoedema (Firth correction)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.41254e-51	Hypothyroidism or myxoedema (SPA correction)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.16884e-50	Eosinophil counts	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.19989e-49	High light scatter reticulocyte count	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	6.4003e-49	Treatment/medication code: levothyroxine sodium	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.81644e-48	ENSG00000248290	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	7.10068e-48	Standing height	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.42791e-46	Cystatin C levels (UKB data field 30720)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	6.29941e-46	Hemoglobin	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.10002e-45	Started insulin within one year diagnosis of diabetes	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.51008e-45	Granulocyte count	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.70023e-45	Treatment/medication code: insulin product	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	8.31955e-45	Red blood cell count	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.07572e-44	Haemoglobin concentration (UKB data field 30020)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.31009e-44	Platelet count	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.66303e-44	Sum neutrophil eosinophil counts	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	6.01866e-44	Appendicular lean mass	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.28825e-43	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	7.00487e-43	Reticulocyte count	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.89017e-42	Red cell distribution width	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.29989e-41	Non-cancer illness code, self-reported: hypothyroidism/myxoedema	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.48658e-41	ENSG00000225059	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.6099e-40	Peak expiratory flow	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.63005e-40	ENSG00000225851	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.41901e-40	Sum eosinophil basophil counts	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	8.18653e-40	Sum basophil neutrophil counts	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.58048e-39	Platelet count (UKB data field 30080)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.29989e-39	Hematocrit	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.25893e-39	Height	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	5.36414e-39	Dermatitis herpetiformis	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	7.65773e-39	Treatment/medication code: insulin product	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	7.81988e-39	Red blood cell (erythrocyte) distribution width	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	7.87952e-39	Neutrophil count	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.50003e-38	Hypothyroidism or myxedema	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.16869e-38	Glutamate receptor 4	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.73696e-38	Reticulocyte count	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	6.70039e-38	High light scatter reticulocyte percentage of red cells	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	8.01309e-38	Started insulin within one year diagnosis of diabetes	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.5332e-37	ENSG00000213676	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.94312e-37	Treatment/medication code: levothyroxine sodium	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.11982e-37	Lung function (FEV1/FVC)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.71394e-37	Early-onset myasthenia gravis	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.85693e-37	ENSG00000204536	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.23253e-37	Hyperthyroidism	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.0179e-36	Triglyceride levels (UKB data field 30870)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.64789e-36	Hemoglobin	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.69774e-36	Haemoglobin concentration	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.49987e-36	Platelet count	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	5.2808e-36	Complement C2 measurement	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	5.40505e-36	Thyrotoxicosis with diffuse goitre	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	6.20012e-36	Red cell distribution width	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	7.8001e-36	Red blood cell count	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	8.00018e-36	Whole body fat-free mass	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	9.79941e-36	Whole body water mass	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.04208e-35	Hypothyroidism	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.11718e-35	Eosinophil counts	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	5.83983e-35	Standing height	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.99986e-34	Leg fat-free mass (right)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.28244e-34	Glycated haemoglobin HbA1c levels (UKB data field 30750)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.68287e-34	Reticulocyte percentage	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.10027e-34	Leg predicted mass (left)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.29989e-34	Leg fat-free mass (left)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.40048e-34	Leg predicted mass (right)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	6.06038e-34	Basophil count	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	6.06038e-34	basophil cell count	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	6.8897e-34	Cystatin C	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	7.19946e-34	Basal metabolic rate	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.41189e-33	Cystatin C	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.01513e-33	Non-cancer illness code  self-reported: hypothyroidism/myxoedema	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.49987e-33	Trunk fat-free mass	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.93856e-33	Graves' disease	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.50904e-32	Other bullous disorders	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.69981e-32	Trunk predicted mass	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	6.20012e-32	Hematocrit	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	6.36942e-32	Disorders of thyroid, IBD co-morbidities	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.06316e-31	Red blood cell erythrocyte count (UKB data field 30010)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.39991e-31	White blood cell count (lymphocyte)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.50003e-31	Arm predicted mass (left)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.60694e-31	Platelet count	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.6293e-31	Platelet count	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.19963e-31	Arm fat-free mass (left)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	5.1606e-31	Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection, CLOZUK+PGC2	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.10027e-30	triglycerides	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.64334e-30	Reticulocyte fraction of red cells	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.01976e-30	Aspartate aminotransferase	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	7.24436e-30	Complement C4	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	8.30042e-30	apolipoprotein A-I	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.1259e-29	Triglycerides	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.1413e-29	Triglycerides	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.24079e-29	Gamma glutamyltransferase levels (UKB data field 30730)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.29985e-29	Arm fat-free mass (right)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.19963e-29	Arm predicted mass (right)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	8.10961e-29	Cholesterol levels (UKB data field 30690)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.51043e-28	High light scatter reticulocyte count	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.90108e-28	Systemic connective tissue disorders	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.40991e-28	FEV1	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.13006e-27	Schizophrenia	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.29987e-27	HDL cholesterol	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.4669e-27	Schizophrenia	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.19963e-27	Autoimmune traits	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.48578e-27	Leg fat-free mass (right)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.51336e-27	Whole body fat-free mass	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	6.21155e-27	Whole body water mass	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	6.89128e-27	Apolipoprotein A levels (UKB data field 30630)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	8.97222e-27	Leg predicted mass (right)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.19289e-26	Hemoglobin A1c levels	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.20642e-26	Glycated haemoglobin	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.79954e-26	Ankle spacing width	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	5.7306e-26	Leg predicted mass (left)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	6.87227e-26	Leg fat-free mass (left)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	7.0648e-26	Mean sphered cell volume	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.50522e-25	Mean platelet thrombocyte volume (UKB data field 30100)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.59111e-25	Apoliprotein A	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.80219e-25	Psoriasis	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.9002e-25	Autoimmune traits	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.29985e-25	Weight	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.2419e-25	Basal metabolic rate	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.20727e-25	Sj<U+00F6>gren's syndrome	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	5.41253e-25	Thyrotoxicosis	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	5.63638e-25	Trunk fat-free mass	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.25199e-24	Trunk predicted mass	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.30527e-24	Glycated haemoglobin	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.62181e-24	T-cell surface protein tactile	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.92619e-24	ENSG00000204528	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.31526e-24	Sicca syndrome [Sj<c2><9a>gren]	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.39994e-24	Weight	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.29989e-24	Basophil count	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.15432e-24	Schizophrenia	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.19952e-24	Appendicular lean mass	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	5.54881e-24	High density lipoprotein cholesterol levels (UKB data field 30760)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	9.56753e-24	ENSG00000204531	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.04689e-23	Total cholesterol levels	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.05487e-23	Cholesterol	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.09295e-23	Cholesterol	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.26009e-23	Mean platelet volume	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.26096e-23	Other systemic involvement of connective tissue	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.38007e-23	Other diseases of the digestive system	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.50003e-23	telomere length	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.51826e-23	Triglycerides	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.45382e-23	diastolic blood pressure	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.00037e-23	Operative procedures - secondary OPCS: Z27.4 Duodenum	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	9.20026e-23	Mean platelet volume	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.9002e-22	Hypothyroidism	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.19989e-22	Mean platelet volume	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.29456e-22	Arm predicted mass (left)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.3681e-22	Estimated glomerular filtration rate (creatinine)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.52e-22	Thyrotoxicosis, other and/or unspecified	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.49382e-22	Estimated glomerular filtration rate (creatinine)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.0879e-22	High light scatter reticulocyte percentage	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.52898e-22	Other systemic involvement of connective tissue (FG)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	6.60389e-22	Arm fat-free mass (right)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	8.54673e-22	Red blood cell count	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	8.59607e-22	Red blood cell (erythrocyte) count	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	8.9002e-22	Age diabetes diagnosed	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	9.11381e-22	Arm fat-free mass (left)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.27909e-21	Weight	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.33414e-21	Apoliprotein A	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.75914e-21	Gamma glutamyl transpeptidase	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.76563e-21	Gamma glutamyltransferase	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.19381e-21	HDL cholesterol	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.20902e-21	HDL cholesterol	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.41324e-21	IGF 1 (UKB data field 30770)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.80608e-21	Bullous disorders	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.9134e-21	ENSG00000204351	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	8.19974e-21	Diagnoses - secondary ICD10: E03.9 Hypothyroidism, unspecified	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	8.74581e-21	Arm predicted mass (right)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	9.09913e-21	Non-cancer illness code, self-reported: asthma	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.21647e-20	Creatinine levels (UKB data field 30700)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.29987e-20	Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor: Asthma	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.31311e-20	High light scatter reticulocyte count	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.99343e-20	Mean platelet (thrombocyte) volume	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.21411e-20	Hematocrit	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.22536e-20	Haematocrit percentage	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.75994e-20	IgA nephropathy	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.40017e-20	Diagnoses - main ICD10: R31 Unspecified haematuria	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.67113e-20	Bread type: Other type of bread	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.31023e-20	Autoimmune hyperthyroidism	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	6.4003e-20	Comparative body size at age 10	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	6.70039e-20	Other serious medical condition/disability diagnosed by doctor	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	8.9002e-20	Comparative body size at age 10, Males and Females	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	8.99912e-20	Plateletcrit	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.47605e-19	White blood cell count (basophil)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.50003e-19	Medication for cholesterol, blood pressure or diabetes: Insulin	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.85183e-19	Varicella zoster virus glycoproteins E and I antibody levels	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.9002e-19	Connective tissue disorder	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.8132e-19	ENSG00000204444	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.90001e-19	Hip circumference	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.19963e-19	Operation code: thyroidectomy/partial thyroidectomy	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.64083e-19	schizophrenia	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.92916e-19	Type 1 diabetes, wide definition, subgroup 1	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.70002e-19	Bowel problem	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	9.99079e-19	IGF-1	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.03395e-18	Platelet count	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.21311e-18	Type 1 diabetes without complications	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.03986e-18	Type 1 diabetes	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.29989e-18	Time to complete round	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.5229e-18	Blood clot  DVT  bronchitis  emphysema  asthma  rhinitis  eczema  allergy diagnosed by doctor: Asthma	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.5465e-18	HDL cholesterol	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.59998e-18	Asthma	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.61826e-18	ENSG00000204438	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	5.08511e-18	Weight	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	8.56841e-18	Non-cancer illness code  self-reported: asthma	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.31311e-17	Hemoglobin concentration	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.40443e-17	Medication for cholesterol  blood pressure or diabetes: Insulin	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.42102e-17	Hip circumference (UKB data field 49)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.69981e-17	Diastolic blood pressure, automated reading	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.9002e-17	Medication for pain relief, constipation, heartburn: Paracetamol	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.93598e-17	Type 1 diabetes with ophthalmic complications	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.99986e-17	FEV1/FVC < 0.7	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.29985e-17	Polyunsaturated fatty acid levels	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.25794e-17	IGF-1	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	5.10035e-17	Medication for pain relief, constipation, heartburn: None of the above	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	6.70039e-17	Non-cancer illness code, self-reported: psoriasis	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	7.17629e-17	Serum creatinine levels	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	7.20941e-17	Creatinine	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	7.71969e-17	Total bilirubin levels (UKB data field 30840)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	8.00018e-17	Height	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	8.95777e-17	Other predominantly sexually transmitted diseases, not elsewhere classified	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1e-16	Operative procedures - main OPCS: M45.9 Unspecified diagnostic endoscopic examination of bladder	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.05901e-16	Psoriasis	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.09522e-16	Asthma (Firth correction)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.15691e-16	Asthma (SPA correction)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.17788e-16	Total bilirubin levels (UKB data field 30840)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.29987e-16	Ankle spacing width (right)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.59993e-16	Mouth/teeth dental problems: Dentures	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.71989e-16	Hypothyroidism, strict autoimmune	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.74582e-16	IDP_dMRI_TBSS_L1_Superior_longitudinal_fasciculus_L	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.75995e-16	ENSG00000204308	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.94984e-16	HLA class II histocompatibility antigen, DQ alpha 2 chain	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.16073e-16	ENSG00000204304	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.25216e-16	Psoriasis	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.23221e-16	Type 1 diabetes (SPA correction)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.28473e-16	Type 1 diabetes (Firth correction)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.5059e-16	Disorders of the thyroid gland	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.0738e-16	Trypsin-3	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.7446e-16	High light scatter reticulocyte percentage of red cells	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	5.99929e-16	Cereal type: Other (e.g. Cornflakes, Frosties)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	6.95184e-16	Non-cancer illness code  self-reported: psoriasis	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	7.51623e-16	Mean corpuscular hemoglobin concentration	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	7.53876e-16	Mean corpuscular haemoglobin concentration	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	7.87227e-16	Platelet crit	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	7.89951e-16	Age at menopause (last menstrual period)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	8.9002e-16	Mean corpuscular hemoglobin concentration	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	9.56313e-16	Type 1 diabetes, wide definition	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.14895e-15	Systemic lupus erythematosus	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.38038e-15	Beta-defensin 119	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.50003e-15	Appendicular lean mass	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.99986e-15	Eosinophil percentage of white cells	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.52058e-15	ENSG00000204305	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.62361e-15	Diastolic blood pressure automated reading (UKB data field 4079)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.47856e-15	Other serious medical condition/disability diagnosed by doctor	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.10015e-15	Linoleic acid levels	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.12098e-15	Comparative body size at age 10	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.58564e-15	Lung cancer	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.60045e-15	Omega-6 fatty acid levels	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	5.03037e-15	Complement C4 levels	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	5.24807e-15	Rac GTPase-activating protein 1	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	5.50935e-15	Type 1 diabetes with other specified/multiple/unspecified complications	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	6.00067e-15	Ankle spacing width (left)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	6.09958e-15	Hot drink temperature	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	7.46965e-15	Alanine aminotransferase levels (UKB data field 30620)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	8.30042e-15	Number of fluid intelligence questions attempted within time limit	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	9.8787e-15	Treatment/medication code: thyroxine product	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.15425e-14	ENSG00000204386	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.20005e-14	Neutrophil percentage of white cells	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.28204e-14	ENSG00000206337	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.46791e-14	Lichen planus	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.56387e-14	ENSG00000250535	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.60583e-14	SLE (Finngen)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.69981e-14	Phospholipids in medium HDL	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.97697e-14	Plateletcrit	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.32648e-14	Basophil count	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.70023e-14	Polyunsaturated fatty acids	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.70645e-14	Squamous cell lung carcinoma	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.90001e-14	Never eat eggs, dairy, wheat, sugar: I eat all of the above	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.99985e-14	Comparative body size at age 10, Females	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.10027e-14	Phospholipid levels in medium HDL	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.23966e-14	Mean corpuscular hemoglobin concentration	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.76184e-14	Intestinal malabsorbtion	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.70002e-14	Long-standing illness, disability or infirmity	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	5.19996e-14	Treatment/medication code: thyroxine product	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	6.1235e-14	ENSG00000204301	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	8.00018e-14	Phosphoglycerides levels	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	8.45474e-14	Hip circumference	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	9.58959e-14	Epstein-Barr virus ZEBRA antibody levels	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1e-13	Forced expiratory volume in 1-second (FEV1), predicted percentage	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.02212e-13	Diastolic blood pressure	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.04906e-13	Hypothyroidism,  other/unspecified	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.10002e-13	Low density lipoprotein cholesterol levels	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.10002e-13	Main speciality of consultant (recoded): Urology	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.20005e-13	Total lipids in medium HDL	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.23027e-13	Medication for pain relief  constipation  heartburn: None of the above	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.39637e-13	Severe autoimmune type 2 diabetes	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.77992e-13	Red blood cell count	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.98198e-13	Hematocrit	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.49977e-13	Total lipid levels in medium HDL	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.49977e-13	Impedance of leg (left)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.67917e-13	Type 1 diabetes, strict (exclude DM2)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.76121e-13	Type 1 diabetes, strict definition, subgroup 1	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.80027e-13	Linoleic acid	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.1703e-13	Postprocedural endocrine and metabolic disorders, not elsewhere classified	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.2961e-13	IDP_dMRI_ProbtrackX_ICVF_ptr_r	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.66185e-13	Type1 diabetes, definitions combined	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.90032e-13	Total fatty acid levels	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.16869e-13	Medication use (drugs used in diabetes)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	5.10623e-13	Diastolic blood pressure  automated reading	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	5.6273e-13	Diabetic ketoacidosis	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	6.08555e-13	Medication for pain relief  constipation  heartburn: Paracetamol	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	6.29941e-13	Concentration of medium HDL particles	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	6.34892e-13	Hypothyroidism, strict autoimmune, 3 medication purchases required	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	6.49232e-13	Medication use (anilides)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	6.59933e-13	Phospholipid levels in small HDL	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	6.90876e-13	Diagnoses - main ICD10: R31 Unspecified haematuria	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	6.90876e-13	SLE, strict definition	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	7.47481e-13	Peak expiratory flow (UKB data field 3064)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	8.40621e-13	Type 1 diabetes, strict definition	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	8.9002e-13	Phosphoglycerides	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	9.70063e-13	Phospholipids in HDL	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	9.70063e-13	3mm weak meridian (left)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	9.81748e-13	Sjogren's syndrome (Firth correction)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	9.86052e-13	Sjogren's syndrome (SPA correction)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1e-12	Duration screen displayed	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.10002e-12	Apolipoprotein A1	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.10002e-12	Oily fish intake	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.20033e-12	Forced expiratory volume in 1-second (FEV1)  predicted percentage	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.29987e-12	Omega-6 fatty acids	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.35519e-12	IDP_dMRI_TBSS_MD_Posterior_thalamic_radiation_L	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.39991e-12	Total cholines levels	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.48594e-12	IDP_dMRI_TBSS_L1_Sagittal_stratum_L	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.59993e-12	Free cholesterol levels in small HDL	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.76482e-12	Systemic lupus erythematosus	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.79391e-12	Proliferative diabetic retinopathy (DM_RETINA_PROLIF)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.80011e-12	Concentration of medium HDL particles	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.9002e-12	Operation code: varicose vein surgery	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.90546e-12	Interleukin-21	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.09991e-12	3mm strong meridian (right)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.34477e-12	Diabetes-related co-morbidities/complications (more controls excluded)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.39994e-12	Phosphatidylcholine levels	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.39994e-12	3mm strong meridian (left)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.70271e-12	Type 1 diabetes with coma	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.1989e-12	ThalamNuclei_rh_volume_LD	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.19963e-12	Apolipoprotein A1 levels	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.10015e-12	Impedance of leg (right)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.15623e-12	Creatinine	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.30031e-12	Free cholesterol in medium HDL	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.40048e-12	Total concentration of lipoprotein particles	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.40961e-12	C reactive protein levels (UKB data field 30710)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.60045e-12	3mm weak meridian (right)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	5.10035e-12	Phospholipid levels in HDL	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	5.10035e-12	Treatment/medication code: paracetamol	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	5.19996e-12	Omega-3 fatty acid levels	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	5.19996e-12	Total lipids in HDL	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	5.30029e-12	Concentration of HDL particles	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	5.40008e-12	Phospholipids in small HDL	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	6.29506e-12	IDP_dMRI_TBSS_L1_Sagittal_stratum_R	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	6.44021e-12	Polymyositis	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	7.2711e-12	Malignant lymphoma	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	7.4559e-12	Epstein-Barr virus EA-D antibody levels	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	7.89951e-12	Total fatty acids	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	8.1358e-12	Lung cancer in ever smokers	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	8.49963e-12	Concentration of HDL particles	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	8.56052e-12	Diabetic retinopathy (DM_RETINOPATHY)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	9.60064e-12	Total lipid levels in small HDL	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1e-11	Asthma	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.10002e-11	Total cholines	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.19399e-11	Glucose	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.20005e-11	Total phospholipid levels in lipoprotein particles	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.20005e-11	Monounsaturated fatty acid levels	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.24108e-11	Other metabolic disorders	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.46555e-11	IDP_dMRI_TBSS_MD_Sagittal_stratum_R	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.50003e-11	Free cholesterol levels in medium HDL	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.59993e-11	Phosphatidylcholines	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.61994e-11	Diabetic hypoglycemia	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.70098e-11	Dermatopolymyositis (FG)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.79391e-11	Diabetic retinopathy (H7_RETINOPATHYDIAB)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.90546e-11	IDP_dMRI_TBSS_MD_Posterior_thalamic_radiation_R	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.99986e-11	Salad / raw vegetable intake	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.16123e-11	Dermatopolymyositis	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.19989e-11	Total concentration of lipoprotein particles	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.21106e-11	Other retinal disorders	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.25424e-11	IDP_dMRI_TBSS_MD_Sagittal_stratum_L	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.37684e-11	Receptor for advanced glycosylation end products levels	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.70023e-11	Respiratory or ear-nose-throat disease	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.70023e-11	Total lipid levels in HDL	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.29989e-11	Trunk fat mass	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.69999e-11	Free cholesterol in small HDL	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.69999e-11	Omega-3 fatty acids	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.80014e-11	Time to answer	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.10015e-11	Lymphocyte percentage of white cells	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.13238e-11	Hypothyroidism, drug reimbursement	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.19952e-11	Platelet count	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.39542e-11	IDP_dMRI_TBSS_ICVF_Posterior_thalamic_radiation_R	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.96249e-11	Neutrophill percentage	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	5.66761e-11	Diabetes, several complications	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	5.70033e-11	Phospholipids to total lipids ratio in large LDL	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	5.90065e-11	Monounsaturated fatty acids	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	5.91834e-11	Infections with a predominantly sexual mode of transmission	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	6.4998e-11	Phospholipids to total lipids ratio in large LDL	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	6.4998e-11	Esophageal disorder	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	6.74528e-11	IDP_dMRI_ProbtrackX_L1_slf_l	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	7.14825e-11	Treatment/medication code: carbimazole	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	7.66126e-11	Systemic lupus erythematosus, unspecified	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	9.09913e-11	Glycoprotein acetyls levels	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	9.1939e-11	Eosinophill percentage	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	9.33254e-11	IDP_dMRI_TBSS_ICVF_Retrolenticular_part_of_internal_capsule_L	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	9.57194e-11	Medication use (adrenergics, inhalants)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	9.97241e-11	Mouth/teeth dental problems: Dentures	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1e-10	Total phospholipids in lipoprotein particles	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1e-10	Total lipids in small HDL	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.06999e-10	Diabetic retinopathy (more controls excluded)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.09094e-10	IDP_dMRI_ProbtrackX_ICVF_cst_r	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.13201e-10	Hashimoto thyroiditis	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.17417e-10	Long-standing illness  disability or infirmity	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.2e-10	Cholesterol in medium HDL	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.2e-10	6mm strong meridian (right)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.24549e-10	Comparative height size at age 10	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.42502e-10	Medication use (drugs for peptic ulcer and gastro-oesophageal reflux disease)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.5e-10	6mm strong meridian (left)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.63531e-10	IDP_dMRI_TBSS_OD_Superior_longitudinal_fasciculus_L	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.7e-10	Red cell distribution width	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.84098e-10	Type 1 diabetes with neurological complications	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.068e-10	Basophil count	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.19999e-10	Phospholipids to total lipids ratio in small LDL	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.40752e-10	ENSG00000240053	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.6565e-10	Impedance of leg (left)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.6804e-10	IDP_dMRI_TBSS_ICVF_Posterior_thalamic_radiation_L	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.80867e-10	IDP_dMRI_TBSS_MD_Superior_longitudinal_fasciculus_L	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.82944e-10	ThalamNuclei_rh_volume_LP	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.96074e-10	IDP_dMRI_TBSS_MD_Retrolenticular_part_of_internal_capsule_R	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.99999e-10	Diabetes diagnosed by doctor	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.10957e-10	IDP_dMRI_TBSS_L2_Posterior_thalamic_radiation_L	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.22411e-10	ENSG00000228789	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.2337e-10	IDP_dMRI_ProbtrackX_ICVF_ptr_l	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.5229e-10	aparc-DKTatlas_lh_thickness_insula	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.89996e-10	Cholesterol levels in medium HDL	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.91021e-10	IDP_dMRI_TBSS_MD_Retrolenticular_part_of_internal_capsule_L	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.04781e-10	Direct low density lipoprotein levels (UKB data field 30780)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.08602e-10	Nephrotic syndrome	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.18023e-10	ThalamNuclei_rh_volume_CL	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.39997e-10	Cholesteryl esters in medium HDL	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.79999e-10	Cholesteryl esters to total lipids ratio in small LDL	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	5.49997e-10	Treatment speciality of consultant (recoded): Urology	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	5.7306e-10	IDP_dMRI_TBSS_L1_Posterior_corona_radiata_L	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	5.76395e-10	Direct low density lipoprotein levels (UKB data field 30780)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	5.87043e-10	Diabetes diagnosed by doctor	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	6.1e-10	6mm weak meridian (left)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	6.25965e-10	Impedance of leg (right)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	7.10003e-10	Peak expiratory flow (PEF)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	7.88951e-10	Epstein-Barr virus EBNA-1 antibody levels	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	7.99006e-10	KELA_REIMBURSEMENT_202	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	8.23493e-10	Diabetic neuropathy	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	8.79995e-10	Seen doctor (GP) for nerves, anxiety, tension or depression	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	8.92689e-10	aseg_rh_intensity_Pallidum	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	8.99891e-10	Eosinophil percentage of granulocytes	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	9.20005e-10	6mm weak meridian (right)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	9.59997e-10	Triglycerides in medium HDL	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	9.75439e-10	IDP_dMRI_TBSS_L3_Posterior_thalamic_radiation_R	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	9.75708e-10	Red cell distribution width	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	9.77597e-10	Rheumatoid arthritis	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	9.78363e-10	IDP_dMRI_ProbtrackX_MD_ilf_l	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	9.85394e-10	Primary_lymphoid and hematopoietic malignant neoplasms	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.02896e-09	IDP_T1_FAST_ROIs_L_thalamus	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.06001e-09	Endocrine, nutritional and metabolic diseases	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.09999e-09	Triglycerides in very large HDL	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.09999e-09	Treatment/medication code: calcichew d3 tablet	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.15189e-09	ENSG00000204315	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.16681e-09	IDP_dMRI_TBSS_ICVF_Pontine_crossing_tract	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.1938e-09	C-reactive protein	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.2e-09	Cholesteryl ester levels in medium HDL	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.28825e-09	Granulysin	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.29999e-09	Triglyceride levels in IDL	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.29999e-09	Impedance of whole body	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.40001e-09	Glycoprotein acetyls	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.40001e-09	Triglycerides in IDL	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.6e-09	Phospholipids to total lipids ratio in small LDL	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.6e-09	Triglycerides in large HDL	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.70962e-09	IDP_dMRI_TBSS_ICVF_Sagittal_stratum_R	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.72199e-09	Neutrophil percentage of granulocytes	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.79999e-09	Cholesteryl esters to total lipids ratio in small LDL	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.89998e-09	Triglyceride levels in very small VLDL	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2e-09	Triglycerides in very small VLDL	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.08353e-09	Any parental history of lung cancer (Firth correction)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.093e-09	Other specified/unspecified systemic involvement of connective tissue	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.11067e-09	Cancer of primary lymphoid hematopoietic	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.14107e-09	Any parental history of lung cancer (SPA correction)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.175e-09	C-reactive protein	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.30001e-09	Number of days/week of moderate physical activity 10+ minutes	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.39999e-09	Triglycerides in HDL	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.77102e-09	Total bilirubin levels	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.77389e-09	Total bilirubin	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.01162e-09	IDP_dMRI_ProbtrackX_ICVF_ifo_r	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.02002e-09	Alanine aminotransferase levels	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.02434e-09	Alanine aminotransferase	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.05e-09	IDP_dMRI_TBSS_L2_Anterior_corona_radiata_L	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.09999e-09	Arm fat mass (left)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.14123e-09	IDP_dMRI_TBSS_L3_Posterior_thalamic_radiation_L	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.2e-09	Non-oily fish intake	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.28852e-09	IDP_dMRI_TBSS_ICVF_Retrolenticular_part_of_internal_capsule_R	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.35699e-09	Calcium levels (UKB data field 30680)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.59253e-09	IDP_dMRI_TBSS_MD_Superior_corona_radiata_L	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.68383e-09	IDP_dMRI_TBSS_L3_Sagittal_stratum_R	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.71364e-09	IDP_dMRI_TBSS_L3_Retrolenticular_part_of_internal_capsule_R	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.72992e-09	IDP_dMRI_ProbtrackX_L1_ilf_r	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.02402e-09	Lymphomas	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.05695e-09	Pediatric asthma	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.14601e-09	Autoimmune hepatitis	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.30002e-09	Seen a psychiatrist for nerves, anxiety, tension or depression	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.44201e-09	Type 1 diabetes with ketoacidosis	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.44294e-09	ENSG00000204520	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.79999e-09	haemotological cancer	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	5.1e-09	Whole body fat mass	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	5.24204e-09	IDP_dMRI_ProbtrackX_FA_ptr_r	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	5.3064e-09	IDP_dMRI_ProbtrackX_MD_ifo_l	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	5.39995e-09	Dried fruit intake	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	5.60003e-09	Free cholesterol in HDL	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	5.62859e-09	IDP_dMRI_ProbtrackX_ICVF_ifo_l	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	5.79696e-09	aparc-DKTatlas_rh_area_insula	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	6.07295e-09	IDP_dMRI_ProbtrackX_ICVF_fma	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	6.21298e-09	IDP_dMRI_ProbtrackX_MD_ifo_r	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	6.468e-09	Neutrophil percentage of white cells	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	6.57204e-09	IDP_dMRI_ProbtrackX_L1_ilf_l	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	6.58688e-09	Urate	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	6.67268e-09	IDP_dMRI_ProbtrackX_L2_ifo_l	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	6.68036e-09	IDP_dMRI_ProbtrackX_MD_slf_l	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	6.69993e-09	Pain type(s) experienced in last month: Headache	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	7.05602e-09	First line medication for Crohns disease	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	7.39793e-09	Hypothyroidism (congenital or acquired)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	7.39997e-09	Operative procedures - main OPCS: G45.1 Fibreoptic endoscopic examination of upper gastrointestinal tract and biopsy of lesion of upper gastrointestinal tract	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	7.50395e-09	Treatment/medication code: paracetamol	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	7.91991e-09	Urate levels (UKB data field 30880)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	8.04804e-09	Hypothyroidism, levothyroxin purchases	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	8.04804e-09	Hypothyroidism and >3 levothyroxin purchases	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	8.09506e-09	Iridocyclitis	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	8.19993e-09	Triglyceride levels in medium HDL	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	8.84179e-09	Endocrine, nutritional and metabolic diseases	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	9.06985e-09	IDP_dMRI_ProbtrackX_ICVF_str_r	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	9.2794e-09	ENSG00000204314	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	9.54113e-09	IDP_dMRI_ProbtrackX_ICVF_ilf_l	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	9.59997e-09	Illnesses of father: Lung cancer	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	9.69996e-09	Free cholesterol to total lipids ratio in small LDL	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	9.77665e-09	Lymphocyte percentage	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.04376e-08	IDP_dMRI_TBSS_L1_Posterior_thalamic_radiation_L	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.05828e-08	IDP_dMRI_ProbtrackX_ICVF_cst_l	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.08101e-08	Asthma	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.11299e-08	Diabethic neuropathy	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.12331e-08	IDP_dMRI_TBSS_MD_Cingulum_cingulate_gyrus_L	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.17101e-08	Colitis, primary sclerosing	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.18659e-08	IDP_dMRI_ProbtrackX_L1_slf_r	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.2e-08	Total lipid levels in lipoprotein particles	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.20559e-08	IDP_dMRI_ProbtrackX_ICVF_ar_r	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.23101e-08	Bipolar disorder bip2021	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.28204e-08	IDP_dMRI_ProbtrackX_L3_ilf_l	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.344e-08	IDP_dMRI_ProbtrackX_ICVF_ilf_r	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.35329e-08	ENSG00000234745	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.49383e-08	IDP_dMRI_ProbtrackX_MD_ilf_r	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.54882e-08	IDP_dMRI_TBSS_MD_Posterior_corona_radiata_L	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.55099e-08	Eosinophil percentage of white cells	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.64399e-08	IDP_dMRI_TBSS_L1_Posterior_thalamic_radiation_R	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.7e-08	Triglyceride levels in very large HDL	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.7e-08	Free cholesterol levels in HDL	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.78238e-08	aseg_lh_intensity_Pallidum	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.79999e-08	Triglyceride levels in large HDL	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.8197e-08	Ubiquitin-like protein ISG15	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.87335e-08	Seen doctor for nerves anxiety tension or depression (UKB data field 2090) (SPA correction)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.88617e-08	Seen doctor for nerves anxiety tension or depression (UKB data field 2090) (Firth correction)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.89998e-08	Docosahexaenoic acid	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.93999e-08	Lung function (FVC)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2e-08	Illnesses of siblings: Diabetes	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.063e-08	Urate	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.063e-08	Serum uric acid levels	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.1e-08	HDL cholesterol	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.19999e-08	Triglyceride levels in HDL	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.21004e-08	IDP_dMRI_ProbtrackX_ICVF_ar_l	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.238e-08	Sarcoidosis	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.30001e-08	Asthma (adult onset)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.36755e-08	IDP_dMRI_TBSS_ICVF_Sagittal_stratum_L	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.39999e-08	Triglyceride levels in LDL	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.39999e-08	Hearing difficulty/problems with background noise	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.40492e-08	IDP_dMRI_TBSS_MD_Anterior_corona_radiata_L	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.53099e-08	Bipolar disorder bip2021 noUKBB	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.751e-08	Certain disorders involving the immune mechanism	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.80001e-08	Triglyceride levels in large LDL	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.80001e-08	Arm fat mass (right)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.82944e-08	IDP_dMRI_TBSS_L1_Superior_corona_radiata_R	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.91998e-08	Acute and subacute iridocyclitis	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.99089e-08	IDP_dMRI_TBSS_L3_Retrolenticular_part_of_internal_capsule_L	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.26663e-08	IDP_dMRI_ProbtrackX_L3_ifo_l	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.49301e-08	Disorders of choroid and retina	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.50002e-08	Triglycerides in small VLDL	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.59998e-08	Triglyceride levels in medium LDL	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.61501e-08	Ankylosing spondylitis	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.72598e-08	Cholangitis (primary sclerosing, PSC), with reimbursement 202	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.73603e-08	Crohn's disease	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.89996e-08	Triglycerides in small LDL	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.92103e-08	IDP_dMRI_ProbtrackX_FA_fmi	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.94366e-08	IDP_dMRI_TBSS_MD_Superior_corona_radiata_R	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.09996e-08	Tyrosine levels	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.16198e-08	wg_lh_intensity-contrast_superiorfrontal	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.20001e-08	White blood cell count	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.30002e-08	Concentration of small HDL particles	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.33511e-08	aparc-a2009s_lh_area_S-temporal-sup	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.49997e-08	Cholesterol levels in small HDL	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.60002e-08	Triglycerides in LDL	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.79999e-08	Triglycerides in large LDL	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.80286e-08	IDP_dMRI_TBSS_ICVF_Posterior_corona_radiata_L	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	5.16535e-08	IDP_dMRI_ProbtrackX_L2_ilf_l	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	5.49997e-08	Cholesteryl esters in HDL	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	5.7161e-08	IDP_dMRI_ProbtrackX_ICVF_fmi	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	5.87395e-08	Pain type(s) experienced in last month: Headache (UKB data field 6159_1) (SPA correction)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	5.96293e-08	Pain type(s) experienced in last month: Headache (UKB data field 6159_1) (Firth correction)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	6.06192e-08	Number of incorrect matches in round	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	6.4e-08	Moderate to vigorous physical activity levels	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	6.69993e-08	Saturated fatty acid levels	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	6.74373e-08	aparc-DKTatlas_lh_area_middletemporal	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	7.10003e-08	HDL cholesterol levels	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	7.25605e-08	IDP_dMRI_ProbtrackX_ICVF_cgc_r	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	7.28803e-08	Colitis, primary sclerosing, strict definition	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	7.29625e-08	HippSubfield_rh_volume_hippocampal-fissure	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	7.39997e-08	Triglyceride levels in small VLDL	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	7.4131e-08	Polypeptide N-acetylgalactosaminyltransferase 1	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	7.62272e-08	LDL direct	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	7.67185e-08	IDP_dMRI_TBSS_ICVF_Superior_corona_radiata_R	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	7.69999e-08	Childhood sunburn occasions	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	7.77678e-08	IDP_dMRI_ProbtrackX_L2_fmi	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	7.8343e-08	IDP_dMRI_TBSS_ICVF_Superior_corona_radiata_L	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	8e-08	Operation code: appendicectomy	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	8.19993e-08	Triglyceride levels in small LDL	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	8.19993e-08	Non-cancer illness code, self-reported: enlarged prostate	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	8.33681e-08	IDP_dMRI_ProbtrackX_L3_ifo_r	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	8.60003e-08	Docosahexaenoic acid levels	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	8.60003e-08	Diabetes	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	9.00534e-08	IDP_dMRI_TBSS_L1_Retrolenticular_part_of_internal_capsule_L	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	9.05107e-08	IDP_dMRI_ProbtrackX_L2_unc_r	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	9.0803e-08	IDP_dMRI_ProbtrackX_FA_ifo_l	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	9.09997e-08	Ever depressed for a whole week	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	9.19052e-08	Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	9.24698e-08	ThalamNuclei_rh_volume_PuM	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	9.46608e-08	Lymphocyte percentage of white cells	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.09999e-07	LDL cholesterol	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.1855e-07	IDP_dMRI_ProbtrackX_L2_ifo_r	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.2e-07	Triglycerides in medium LDL	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.214e-07	LDL cholesterol	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.21591e-07	LDL direct	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.22518e-07	IDP_T1_FAST_ROIs_L_temp_fusif_cortex_post	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.25574e-07	IDP_dMRI_ProbtrackX_L1_ifo_r	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.26561e-07	wg_rh_intensity-contrast_superiorfrontal	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.29999e-07	Cholesteryl esters to total lipids ratio in large LDL	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.29999e-07	Free cholesterol to total lipids ratio in small LDL	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.30599e-07	Medication use (anti-inflammatory and antirheumatic products, non-steroids)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.30599e-07	Calcium levels	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.3065e-07	Calcium	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.33199e-07	IDP_dMRI_TBSS_ICVF_Body_of_corpus_callosum	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.35145e-07	IDP_dMRI_TBSS_L1_Superior_corona_radiata_L	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.37057e-07	IDP_dMRI_TBSS_L3_Anterior_corona_radiata_L	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.37309e-07	aparc-Desikan_lh_thickness_insula	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.40001e-07	Cholesterol in small HDL	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.40001e-07	Total lipids in lipoprotein particles	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.40001e-07	Leg fat mass (left)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.47999e-07	Peripheral artery disease	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.49589e-07	IDP_dMRI_ProbtrackX_L3_ilf_r	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.521e-07	Height	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.6e-07	Nervous feelings	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.60901e-07	Sarcoidosis	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.61436e-07	IDP_dMRI_ProbtrackX_MD_cgc_l	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.61734e-07	IDP_dMRI_TBSS_L2_Anterior_corona_radiata_R	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.6819e-07	IDP_dMRI_TBSS_L1_Cingulum_hippocampus_R	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.7e-07	Gastroesophageal reflux disease or gastric reflux	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.7e-07	Total testosterone levels	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.71317e-07	BA-exvivo_rh_volume_entorhinal	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.79999e-07	Cholesteryl ester levels in HDL	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.79999e-07	Lifetime number of sexual partners	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.82684e-07	IDP_dMRI_TBSS_OD_Posterior_corona_radiata_L	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.84302e-07	Binding antibody response to interferon beta therapy in multiple sclerosis (antibody levels; IFN<U+03B2>-1a subcutaneous)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.86741e-07	Non-cancer illness code  self-reported: enlarged prostate	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.94048e-07	Seen psychiatrist for nerves anxiety tension or depression (UKB data field 2100) (SPA correction)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.95299e-07	aparc-a2009s_lh_thickness_Lat-Fis-ant-Vertical	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.98861e-07	Seen psychiatrist for nerves anxiety tension or depression (UKB data field 2100) (Firth correction)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2e-07	Saturated fatty acids	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.08944e-07	Trunk fat mass	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.09556e-07	IDP_dMRI_TBSS_L3_Sagittal_stratum_L	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.12902e-07	Varicose veins	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.14437e-07	aparc-Desikan_lh_area_middletemporal	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.19999e-07	Concentration of small HDL particles	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.238e-07	Peripheral artery disease (no controls excluded)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.32745e-07	Impedance of whole body	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.34423e-07	Palmitoyl-protein thioesterase 1	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.40941e-07	Peak expiratory flow (PEF)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.43052e-07	IDP_dMRI_TBSS_L3_Anterior_corona_radiata_R	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.52476e-07	Illnesses of siblings: Diabetes	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.5781e-07	IDP_dMRI_TBSS_MD_Superior_longitudinal_fasciculus_R	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.69998e-07	Tyrosine	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.75423e-07	Complement C1q tumor necrosis factor-related protein 5	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.82163e-07	IDP_dMRI_TBSS_MD_Anterior_corona_radiata_R	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.88503e-07	Prostate cancer	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.88503e-07	Prostate cancer	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.90001e-07	Treatment/medication code: ventolin 100micrograms inhaler	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.95298e-07	CX3CL1 levels	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.98607e-07	IDP_dMRI_TBSS_L1_Superior_longitudinal_fasciculus_R	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.09999e-07	Fluid intelligence score	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.19198e-07	Disorders of lacrimal system and orbit in diseases classified elsewhere	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.40001e-07	Treatment speciality of consultant (recoded): General medicine	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.4389e-07	Phosphate	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.53671e-07	IDP_dMRI_TBSS_ICVF_Superior_longitudinal_fasciculus_R	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.54675e-07	Treatment/medication code: ventolin 100micrograms inhaler	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.59584e-07	IDP_dMRI_ProbtrackX_OD_str_l	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.59998e-07	Number of incorrect matches in round	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.7499e-07	Potassium in urine	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.79997e-07	Leg fat mass (right)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.90931e-07	IDP_dMRI_ProbtrackX_MD_unc_r	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.01606e-07	IDP_dMRI_TBSS_MD_Uncinate_fasciculus_L	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.09166e-07	IDP_dMRI_TBSS_ICVF_Medial_lemniscus_R	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.09996e-07	Treatment/medication code: seretide 50 evohaler	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.10582e-07	IDP_dMRI_TBSS_ICVF_Genu_of_corpus_callosum	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.12003e-07	IDP_dMRI_TBSS_L2_Posterior_thalamic_radiation_R	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.15911e-07	IDP_dMRI_ProbtrackX_ICVF_str_l	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.29438e-07	IDP_dMRI_TBSS_ICVF_Anterior_corona_radiata_L	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.30923e-07	IDP_dMRI_TBSS_OD_Superior_corona_radiata_R	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.39997e-07	Creatinine levels	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.60002e-07	Cholesteryl esters to total lipids ratio in large LDL	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.63106e-07	ENSG00000221988	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.7152e-07	IDP_dMRI_ProbtrackX_L2_slf_l	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.80341e-07	Anti-varicella zoster virus IgG seropositivity	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	5.00288e-07	ENSG00000204428	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	5.08745e-07	IDP_dMRI_TBSS_ICVF_Middle_cerebellar_peduncle	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	5.1e-07	Creatinine	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	5.11305e-07	Peripheral atherosclerosis	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	5.19003e-07	Worry	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	5.19996e-07	Psychological or psychiatric problem	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	5.53567e-07	Phosphate	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	5.5515e-07	ENSG00000204469	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	5.67283e-07	IDP_dMRI_ProbtrackX_ICVF_slf_l	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	5.87679e-07	Non-cancer illness code  self-reported: diabetes	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	5.93062e-07	IDP_dMRI_TBSS_L3_Superior_fronto-occipital_fasciculus_L	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	5.938e-07	Peripheral artery disease	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	6.29999e-07	Eye problems/disorders: Diabetes related eye disease	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	6.49382e-07	IDP_dMRI_ProbtrackX_MD_slf_r	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	6.69993e-07	Corneal hysteresis (left)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	6.87053e-07	Illnesses of father: Lung cancer	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	6.96947e-07	IDP_dMRI_TBSS_ICVF_Superior_longitudinal_fasciculus_L	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	7.10003e-07	Free cholesterol to total lipids ratio in very large HDL	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	7.34007e-07	IDP_dMRI_ProbtrackX_L1_str_l	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	7.39997e-07	Triglycerides to total lipids ratio in small LDL	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	7.45006e-07	Finngen Rheumatological endpoints	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	7.58752e-07	IDP_dMRI_TBSS_L3_Superior_longitudinal_fasciculus_R	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	7.89951e-07	IDP_dMRI_ProbtrackX_ICVF_ml_l	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	7.94328e-07	Granzyme A	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	8.31381e-07	wg_lh_intensity-contrast_superiortemporal	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	8.33873e-07	aparc-a2009s_lh_thickness_S-circular-insula-sup	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	8.35603e-07	Eye problems/disorders: Diabetes related eye disease	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	8.40001e-07	Cholesteryl esters in chylomicrons and extremely large VLDL	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	8.42733e-07	ENSG00000166278	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	8.60003e-07	Parental longevity (mother's attained age)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	8.60003e-07	Respiratory or ear-nose-throat disease	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	8.63177e-07	wg_lh_intensity-contrast_insula	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	8.70001e-07	Comparative body size at age 10, Males	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	8.71024e-07	Apolipoprotein B levels (UKB data field 30640)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	9.01571e-07	IDP_T1_FAST_ROIs_R_temp_fusif_cortex_post	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	9.06129e-07	ENSG00000232810	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	9.28325e-07	IDP_dMRI_TBSS_FA_Middle_cerebellar_peduncle	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	9.29138e-07	Diseases of the genitourinary system	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	9.44496e-07	rfMRI connectivity (ICA100 edge 356)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	9.49992e-07	Free cholesterol to total lipids ratio in large LDL	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	9.94489e-07	IDP_dMRI_ProbtrackX_OD_slf_l	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1e-06	Bone disorder	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1e-06	Lung function (FEV1/FVC)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1e-06	Suffer from 'nerves'	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1e-06	Non-cancer illness code, self-reported: gastro-oesophageal reflux (gord) / gastric reflux	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.01065e-06	IDP_dMRI_TBSS_MD_Superior_fronto-occipital_fasciculus_L	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.03395e-06	IDP_dMRI_ProbtrackX_OD_ar_l	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.03777e-06	BA-exvivo_rh_thickness_entorhinal	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.0434e-06	Gamma glutamyltransferase	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.08071e-06	Calcium	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.09999e-06	Cholesterol to total lipids ratio in IDL	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.10469e-06	Major dietary changes in the last 5 years: Yes, because of illness	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.12202e-06	UDP-N-acetylhexosamine pyrophosphorylase	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.17839e-06	Number of days/week of moderate physical activity 10+ minutes	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.19647e-06	IDP_dMRI_ProbtrackX_MD_unc_l	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.2e-06	Depression	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.2e-06	Free cholesterol to total lipids ratio in medium LDL	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.20337e-06	IDP_dMRI_TBSS_FA_Cerebral_peduncle_R	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.21535e-06	wg_lh_intensity-contrast_supramarginal	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.217e-06	Feeling nervous	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.2785e-06	IDP_dMRI_ProbtrackX_ICVF_unc_r	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.29897e-06	IDP_dMRI_TBSS_L2_Splenium_of_corpus_callosum	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.32501e-06	Unspecified diabetic retinopathy	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.37183e-06	IDP_dMRI_TBSS_L2_Genu_of_corpus_callosum	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.40001e-06	Hiatus hernia	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.40001e-06	Cholesterol in chylomicrons and extremely large VLDL	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.41384e-06	IDP_dMRI_TBSS_L1_Retrolenticular_part_of_internal_capsule_R	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.49624e-06	wg_lh_intensity-contrast_inferiorparietal	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.49934e-06	aparc-DKTatlas_rh_thickness_insula	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.5e-06	Diagnoses - secondary ICD10: J45.9 Asthma, unspecified	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.59956e-06	IDP_dMRI_TBSS_ICVF_Splenium_of_corpus_callosum	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.65619e-06	Potassium in urine (UKB data field 30520)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.66725e-06	IDP_dMRI_TBSS_FA_Splenium_of_corpus_callosum	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.7e-06	Free cholesterol to total lipids ratio in very large HDL	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.7e-06	Cholesteryl ester levels in chylomicrons and extremely large VLDL	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.79999e-06	Frequency of light DIY in last 4 weeks	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.80426e-06	IDP_dMRI_ProbtrackX_L2_ilf_r	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.8197e-06	T-cell surface glycoprotein CD3 epsilon chain	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.84098e-06	Ankylosing spondylitis, strict definition	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.84999e-06	Arthropod-borne viral fevers and viral haemorrhagic fevers	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.883e-06	Type 1 diabetes with renal complications	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.89378e-06	Diagnoses - main ICD10: J45 Asthma	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.89998e-06	Parental longevity (combined parental attained age, Martingale residuals)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.90546e-06	IDP_dMRI_ProbtrackX_FA_ilf_l	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.90603e-06	Asthma	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.90603e-06	Childhood asthma (age<16)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.92988e-06	Treatment/medication code: seretide 50 evohaler	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.93068e-06	Glucose	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.93099e-06	Glucose levels	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	1.95479e-06	IDP_dMRI_ProbtrackX_ICVF_slf_r	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.053e-06	Certain infectious and parasitic diseases	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.12109e-06	Ever had prolonged loss of interest in normal activities	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.12373e-06	IDP_dMRI_ProbtrackX_ICVF_unc_l	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.12922e-06	Familial combined hyperlipidemia defined by Consensus criteria	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.13796e-06	Cadherin-7	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.15625e-06	wg_lh_intensity-contrast_postcentral	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.18927e-06	Asthma, hospital admissions 1	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.19999e-06	Ratio of omega-6 fatty acids to omega-3 fatty acids	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.19999e-06	Forced expiratory volume in 1-second (FEV1), predicted	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.28192e-06	IDP_dMRI_ProbtrackX_OD_ar_r	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.298e-06	Binding antibody response to interferon beta therapy in multiple sclerosis (antibody levels; all treatment preparations)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.39624e-06	Seen doctor (GP) for nerves  anxiety  tension or depression	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.39999e-06	Total lipid levels in small VLDL	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.39999e-06	Non-cancer illness code, self-reported: diabetes	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.47178e-06	Epstein-Barr virus VCA p18 antibody levels	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.58107e-06	IDP_dMRI_TBSS_FA_Anterior_corona_radiata_L	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.59998e-06	Total triglycerides	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.6218e-06	IDP_dMRI_TBSS_FA_Cerebral_peduncle_L	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.65901e-06	Diabetic maculopathy (H7_MACULOPATHYDIAB)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.67498e-06	DNA methylation Hannum age acceleration	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.75423e-06	Spermatogenesis-associated protein 20	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.78869e-06	IDP_dMRI_TBSS_ICVF_Superior_fronto-occipital_fasciculus_L	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.87501e-06	Diabetic maculopathy (DM_MACULOPATHY)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.90001e-06	Asthma (childhood onset)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.90536e-06	IDP_dMRI_ProbtrackX_L1_ar_r	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.94598e-06	Atherosclerosis, excluding cerebral, coronary and PAD	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	2.99999e-06	Cholesterol levels in chylomicrons and extremely large VLDL	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.00262e-06	IDP_dMRI_TBSS_ICVF_Cingulum_cingulate_gyrus_R	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.02761e-06	IDP_dMRI_ProbtrackX_L3_cgc_r	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.09599e-06	Diabetic maculopathy (more controls excluded)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.16009e-06	IDP_dMRI_ProbtrackX_L1_str_r	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.2e-06	Concentration of small VLDL particles	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.2e-06	Triglycerides in small HDL	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.20398e-06	Mean platelet volume	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.21603e-06	Lupus erythematosus	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.21959e-06	IDP_dMRI_ProbtrackX_L3_ptr_r	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.40001e-06	White blood cell count (monocyte)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.40001e-06	Forced expiratory volume in 1-second (FEV1)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.47696e-06	wg_rh_intensity-contrast_parsopercularis	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.48899e-06	IDP_dMRI_TBSS_FA_Anterior_corona_radiata_R	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.50002e-06	Triglycerides to total lipids ratio in small LDL	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.50002e-06	Taking other prescription medications	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.52899e-06	Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.53102e-06	rfMRI connectivity (ICA100 edge 509)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.58344e-06	wg_rh_intensity-contrast_parstriangularis	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.64502e-06	IDP_dMRI_ProbtrackX_L3_slf_l	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.80917e-06	Endometrial cancer	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.86367e-06	IDP_dMRI_ProbtrackX_L2_unc_l	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	3.89996e-06	Cholesteryl ester levels in small HDL	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.07756e-06	IDP_T1_FAST_ROIs_R_paracing_gyrus	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.101e-06	Medication use (glucocorticoids)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.13657e-06	ENSG00000204387	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.16294e-06	wg_rh_intensity-contrast_caudalmiddlefrontal	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.30002e-06	Cholesteryl esters to total lipids ratio in IDL	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.3843e-06	IDP_dMRI_TBSS_FA_Posterior_thalamic_radiation_L	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.39997e-06	Free cholesterol to total lipids ratio in large LDL	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.39997e-06	Age started hormone-replacement therapy (HRT)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.49997e-06	Triglyceride levels in medium VLDL	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.49997e-06	Number of days/week of vigorous physical activity 10+ minutes	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.52804e-06	Immunodeficiency with predominantly antibody defects	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.54465e-06	wg_lh_intensity-contrast_parsorbitalis	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.70002e-06	Liver iron content	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.70652e-06	IDP_dMRI_ProbtrackX_L3_fmi	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.79093e-06	Whole body fat mass	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.79999e-06	Forced Expiratory Volume (FEV1), adjusted for sex	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.79999e-06	HbA1C	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.86598e-06	Cholangitis (primary sclerosing, PSC)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.8854e-06	IDP_dMRI_ProbtrackX_L1_unc_l	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	4.97279e-06	aparc-a2009s_lh_volume_S-temporal-sup	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	5.12861e-06	Tapasin-related protein	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	5.19996e-06	Non-cancer illness code, self-reported: hiatus hernia	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	5.22516e-06	aparc-Desikan_rh_thickness_isthmuscingulate	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	5.25606e-06	Macrophage colony-stimulating factor 1 levels	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	5.31374e-06	IDP_dMRI_TBSS_ICVF_Corticospinal_tract_R	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	5.35427e-06	aparc-pial_lh_area_middletemporal	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	5.44001e-06	IDP_dMRI_ProbtrackX_L1_ifo_l	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	5.47697e-06	Myeloperoxidase levels	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	5.50935e-06	Myocardial fractal dimension (slice 6)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	5.52968e-06	IDP_dMRI_TBSS_L2_Posterior_corona_radiata_L	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	5.58175e-06	Hearing difficulty/problems with background noise	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	5.60003e-06	Cholesteryl esters in small HDL	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	5.66291e-06	ENSG00000206344	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	5.67205e-06	Glucose levels (UKB data field 30740)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	5.76926e-06	Phosphate levels (UKB data field 30810)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	5.96898e-06	"""Atherosclerosis, excluding cerebral, coronary and PAD"" (no controls excluded)"	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	6.03671e-06	IDP_T1_FAST_ROIs_R_thalamus	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	6.06178e-06	IDP_dMRI_TBSS_OD_Cingulum_hippocampus_R	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	6.08093e-06	Arm fat mass (left)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	6.09256e-06	IDP_dMRI_TBSS_L3_Splenium_of_corpus_callosum	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	6.16453e-06	wg_rh_intensity-contrast_parsorbitalis	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	6.188e-06	Chronic obstructive pulmonary disease	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	6.19998e-06	Renal or urological disease	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	6.28782e-06	IDP_dMRI_TBSS_L2_Retrolenticular_part_of_internal_capsule_R	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	6.29999e-06	Anemia	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	6.40206e-06	Neurociticism	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	6.41653e-06	IDP_dMRI_TBSS_L3_Superior_corona_radiata_L	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	6.49995e-06	Hand grip strength (right)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	6.90001e-06	Bioavailable testosterone levels	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	6.92803e-06	Proliferative diabetic retinopathy (H7_RETINOPATHYDIAB_PROLIF)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	6.94017e-06	Prospective memory result	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	7.19996e-06	Main speciality of consultant (recoded): General medicine	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	7.21307e-06	Thyroiditis	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	7.25404e-06	Prostate cancer	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	7.29995e-06	Total triglycerides levels	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	7.5024e-06	IDP_dMRI_TBSS_ICVF_Tapetum_L	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	7.53009e-06	wg_rh_intensity-contrast_insula	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	7.59994e-06	Cholesterol to total lipids ratio in IDL	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	7.60309e-06	Frequency of light DIY in last 4 weeks	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	7.69999e-06	Ratio of omega-6 fatty acids to omega-3 fatty acids	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	7.74997e-06	aparc-a2009s_rh_area_S-pericallosal	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	7.79992e-06	Diagnoses - main ICD10: N40 Hyperplasia of prostate	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	7.90005e-06	Facial ageing	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	7.96306e-06	Rheumatoid arthritis (M13_RHEUMA)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	8e-06	Prostate cancer	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	8.01678e-06	IDP_dMRI_TBSS_ICVF_Anterior_corona_radiata_R	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	8.10793e-06	Chronic hepatitis, not elsewhere classified	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	8.30309e-06	Binding antibody response to interferon beta therapy in multiple sclerosis (antibody levels; IFN<U+03B2>-1a subcutaneous and intramuscular)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	8.30309e-06	Haemorrhage from respiratory passages	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	8.36758e-06	IDP_dMRI_TBSS_L1_Fornix_cres+Stria_terminalis_R	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	8.40601e-06	Proheparin-binding EGF-like growth factor levels	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	8.41977e-06	IDP_dMRI_TBSS_FA_Genu_of_corpus_callosum	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	8.52511e-06	IDP_dMRI_ProbtrackX_FA_ifo_r	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	8.70001e-06	Mineral and other dietary supplements: Zinc	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	8.74903e-06	Unspecified diabetes	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	8.82673e-06	Nervous feelings	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	8.85727e-06	wg_rh_intensity-contrast_rostralmiddlefrontal	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	8.95983e-06	IDP_dMRI_ProbtrackX_L3_unc_r	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	8.99995e-06	Free cholesterol in chylomicrons and extremely large VLDL	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	9.05211e-06	Seen a psychiatrist for nerves  anxiety  tension or depression	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	9.20005e-06	Ratio of omega-3 fatty acids to total fatty acids	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	9.50211e-06	Fluid intelligence score	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	9.54773e-06	Myocardial fractal dimension (slice 5)	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	9.54993e-06	Vesicle-fusing ATPase	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	9.76495e-06	COPD, early/later onset	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	9.77237e-06	PAX-interacting protein 1	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3094012	9.90011e-06	Triglycerides in medium VLDL	6	50718	0.31246976443337	3.74420828565057e-08	EasActiv18mo	0.132162
rs3130908	0	Non-cancer illness code  self-reported: malabsorption/coeliac disease	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.1289039792536e-308	ENSG00000204525	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.25893e-287	White blood cell count	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.25893e-287	white blood cell count	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.04089e-272	Lymphocyte count	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.04089e-272	lymphocyte cell count	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.2735e-263	ENSG00000224389	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.49968e-242	White blood cell count	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.59758e-226	Lymphocyte count	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	6.57658e-204	White blood cell leukocyte count (UKB data field 30000)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1e-200	Primary sclerosing cholangitis	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.76766e-197	Type 1 diabetes	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.90841e-193	Lymphocyte count (UKB data field 30120)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.96592e-186	Coeliac disease	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.05116e-175	White blood cell count	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	6.223e-172	White blood cell (leukocyte) count	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.87932e-167	Monocyte count	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.87932e-167	monocyte cell count	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.38232e-167	ENSG00000244731	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.2106e-160	Lymphocyte count	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.29122e-159	Lymphocyte count	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	9.7949e-155	ENSG00000231852	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.83792e-135	ENSG00000137331	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	8.62979e-134	Monocyte count (UKB data field 30130)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.63633e-121	ENSG00000214894	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.50035e-120	Mean reticulocyte volume	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.07895e-119	Neutrophil count	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.07895e-119	neutrophil cell count	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	6.32412e-119	Type 1 diabetes	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.25598e-108	Monocyte count	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.38232e-107	Monocyte count	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.54882e-106	Aspartate aminotransferase levels (UKB data field 30650)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.97035e-106	Other diseases of the digestive system (K11_OTHDIG)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.98153e-104	ENSG00000204338	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	9.28966e-104	Neutrophil count	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	9.61612e-101	White blood cell count	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.50003e-100	Never eat eggs, dairy, wheat, sugar: Wheat products	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.77013e-98	Lymphocyte counts	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	9.71404e-98	Neutrophill count (UKB data field 30140)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	6.07995e-97	Eosinophil counts	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	6.07995e-97	eosinophil cell count	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.19996e-96	Non-cancer illness code, self-reported: hyperthyroidism/thyrotoxicosis	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	8.72971e-95	ENSG00000137312	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.41254e-93	MHC class I polypeptide-related sequence B	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.55848e-91	Systemic lupus erythematosus	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.50047e-91	Hyperthyroidism or thyrotoxicosis	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.60016e-90	Type 1 diabetes	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	6.51028e-88	Neutrophil count	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.39276e-87	Non-cancer illness code  self-reported: hyperthyroidism/thyrotoxicosis	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.1298e-86	Aspartate aminotransferase	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.20049e-86	Sitting height	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.84503e-85	Neutrophill count	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	7.74105e-85	Aspartate aminotransferase levels	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.80011e-83	Eosinophil counts	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.24251e-82	Total protein	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.11623e-82	Membranous nephropathy	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.17598e-80	Serum total protein level	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.39994e-80	Reticulocyte count	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	8.92072e-79	Autoimmune diseases	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.67456e-78	Total protein	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.79733e-73	Eosinophill count (UKB data field 30150)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.89068e-71	ENSG00000137411	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	8.89406e-69	Mean reticulocyte volume	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.1232e-68	Type 1 diabetes	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	6.00067e-65	Thyroid problem (not cancer)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.80027e-62	Mean spheric corpuscular volume	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.11995e-60	Hemoglobin concentration	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.10015e-60	Reticulocyte fraction of red cells	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.6959e-59	Medication use (thyroid preparations)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.83848e-59	Monocyte count	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	8.87973e-59	Sitting height	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.54626e-55	Myeloid white cell count	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	9.70063e-54	Diabetes or endocrine disease	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1e-53	Standing height	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	6.9199e-53	Red blood cell count	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	8.9002e-52	High light scatter reticulocyte count	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.29987e-51	Started insulin within one year diagnosis of diabetes	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.30152e-51	ENSG00000248290	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	6.09958e-51	Hemoglobin	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	7.32487e-51	Appendicular lean mass	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.91602e-50	Eosinophil counts	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	6.36209e-48	Granulocyte count	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.39991e-47	Treatment/medication code: insulin product	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.86209e-47	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.27982e-47	Haemoglobin concentration (UKB data field 30020)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	6.95024e-47	Sum neutrophil eosinophil counts	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.05779e-45	Cystatin C levels (UKB data field 30720)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.73023e-45	Hematocrit	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	7.48859e-45	Hypothyroidism or myxoedema (Firth correction)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.03538e-44	Hypothyroidism or myxoedema (SPA correction)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.22946e-44	Reticulocyte count	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.59005e-44	Height	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.26999e-43	Red cell distribution width	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	6.00067e-43	Treatment/medication code: levothyroxine sodium	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.58489e-42	Glutamate receptor 4	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.67485e-42	Sum eosinophil basophil counts	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.93472e-42	Started insulin within one year diagnosis of diabetes	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.06096e-41	Sum basophil neutrophil counts	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.49977e-41	Red blood cell count	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	9.00326e-41	Neutrophil count	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.10459e-40	ENSG00000225059	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.22999e-40	Peak expiratory flow	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.69083e-40	Treatment/medication code: insulin product	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.9467e-40	Red blood cell (erythrocyte) distribution width	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.01606e-40	Triglyceride levels (UKB data field 30870)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.00035e-40	Whole body fat-free mass	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	7.19946e-40	Whole body water mass	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	9.76338e-40	Dermatitis herpetiformis	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.55489e-39	Haemoglobin concentration	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.39994e-39	High light scatter reticulocyte percentage of red cells	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.41977e-39	Platelet count	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.03037e-39	ENSG00000225851	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.22096e-38	Reticulocyte count	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.64286e-38	Early-onset myasthenia gravis	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.80011e-38	Leg fat-free mass (right)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.9602e-38	Hemoglobin	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.74031e-38	Lung function (FEV1/FVC)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.80014e-38	Leg predicted mass (right)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	6.70039e-38	Standing height	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	7.8001e-38	Leg fat-free mass (left)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.20005e-37	Leg predicted mass (left)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.89017e-37	Complement C2 measurement	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.94895e-37	Thyrotoxicosis with diffuse goitre	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.70023e-37	Basal metabolic rate	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.64167e-37	Hyperthyroidism	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	8.30042e-37	Trunk fat-free mass	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	8.60796e-37	Eosinophil counts	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	9.77462e-37	Glycated haemoglobin HbA1c levels (UKB data field 30750)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.10002e-36	Red cell distribution width	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.30031e-36	Hematocrit	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.40048e-36	Trunk predicted mass	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.88315e-35	Reticulocyte percentage	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.79963e-35	triglycerides	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.59993e-34	Non-cancer illness code, self-reported: hypothyroidism/myxoedema	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.22382e-34	Platelet count (UKB data field 30080)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.91471e-34	Red blood cell erythrocyte count (UKB data field 30010)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.49987e-34	Arm predicted mass (left)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.16773e-34	Triglycerides	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	6.09958e-34	Arm fat-free mass (left)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.25011e-33	Disorders of thyroid, IBD co-morbidities	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	9.2406e-33	Basophil count	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	9.2406e-33	basophil cell count	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.10561e-32	Treatment/medication code: levothyroxine sodium	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.49417e-32	Other bullous disorders	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.20293e-32	Triglycerides	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	9.09913e-32	Arm predicted mass (right)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.50003e-31	Arm fat-free mass (right)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.99986e-31	Platelet count	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.29985e-31	Hypothyroidism or myxedema	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.64922e-31	ENSG00000204536	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.41627e-31	Hypothyroidism	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.13344e-30	Cystatin C	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.20088e-30	Cystatin C	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.59882e-30	ENSG00000213676	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.70681e-30	Reticulocyte fraction of red cells	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.94003e-30	Leg fat-free mass (right)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.36516e-30	Complement C4	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.37925e-30	Whole body fat-free mass	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	6.09958e-30	Appendicular lean mass	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	7.80369e-30	Whole body water mass	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	8.18653e-30	Leg predicted mass (right)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.07491e-29	Graves' disease	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.29985e-29	Autoimmune traits	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.9282e-29	Hemoglobin A1c levels	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.61243e-29	Gamma glutamyltransferase levels (UKB data field 30730)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.76011e-29	Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection, CLOZUK+PGC2	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.95367e-29	High light scatter reticulocyte count	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.30029e-29	White blood cell count (lymphocyte)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.33949e-29	FEV1	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	6.72822e-29	Aspartate aminotransferase	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	8.71766e-29	Leg fat-free mass (left)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	9.87416e-29	Leg predicted mass (left)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.59294e-28	Glycated haemoglobin	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.09604e-28	diastolic blood pressure	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.76501e-28	Non-cancer illness code  self-reported: hypothyroidism/myxoedema	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.02873e-27	Platelet count	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.11378e-27	Trunk fat-free mass	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.26067e-27	Basal metabolic rate	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.32862e-27	Mean sphered cell volume	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.7112e-27	Glycated haemoglobin	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.69401e-27	Trunk predicted mass	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.81838e-27	T-cell surface protein tactile	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.16301e-27	Thyrotoxicosis	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.49987e-27	Ankle spacing width	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.26502e-27	Cholesterol levels (UKB data field 30690)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	9.34975e-27	Platelet count	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.2249e-26	Triglycerides	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.80011e-26	Weight	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	9.09913e-26	Operative procedures - secondary OPCS: Z27.4 Duodenum	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.20005e-25	Weight	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.52792e-25	Thyrotoxicosis, other and/or unspecified	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.59993e-25	apolipoprotein A-I	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.71199e-25	Sj<U+00F6>gren's syndrome	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.72772e-25	Schizophrenia	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	8.23759e-25	Other diseases of the digestive system	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	9.93116e-25	Systemic connective tissue disorders	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.81681e-24	Red blood cell (erythrocyte) count	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.7665e-24	Bread type: Other type of bread	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	6.1038e-24	Arm predicted mass (left)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	7.54223e-24	Apolipoprotein A levels (UKB data field 30630)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.28795e-23	Weight	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.07826e-23	Arm fat-free mass (right)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.34261e-23	Arm fat-free mass (left)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.59418e-23	Red blood cell count	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.40017e-23	Age diabetes diagnosed	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.79954e-23	telomere length	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.70033e-23	Basophil count	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.97035e-23	Mean platelet thrombocyte volume (UKB data field 30100)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.7342e-22	Arm predicted mass (right)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.94312e-22	Type 1 diabetes, wide definition, subgroup 1	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.07874e-22	Haematocrit percentage	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.18022e-22	Gamma glutamyl transpeptidase	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.35776e-22	Autoimmune hyperthyroidism	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.03809e-22	High light scatter reticulocyte percentage	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.63162e-22	ENSG00000204531	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.68553e-22	Apoliprotein A	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.54988e-22	Mean platelet volume	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.56352e-22	IGF 1 (UKB data field 30770)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	6.13197e-22	Gamma glutamyltransferase	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	7.04693e-22	Cholesterol	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	8.04452e-22	Type 1 diabetes	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	8.15455e-22	Sicca syndrome [Sj<c2><9a>gren]	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	9.67164e-22	Cholesterol	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.35332e-21	ENSG00000204304	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.36994e-21	Hematocrit	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.89017e-21	Type 1 diabetes without complications	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.28876e-21	Creatinine levels (UKB data field 30700)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.44512e-21	Estimated glomerular filtration rate (creatinine)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.70023e-21	Mean platelet volume	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.79769e-21	Total cholesterol levels	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.90202e-21	ENSG00000204351	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.50026e-21	HDL cholesterol	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.85745e-21	IgA nephropathy	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.05293e-20	High light scatter reticulocyte count	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.29987e-20	Height	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.83316e-20	Other systemic involvement of connective tissue	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.54732e-20	Estimated glomerular filtration rate (creatinine)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.49987e-20	Bowel problem	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	6.05341e-20	Bullous disorders	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	6.09958e-20	Non-cancer illness code, self-reported: asthma	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	6.70039e-20	Hip circumference	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	7.23103e-20	Schizophrenia	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	8.09096e-20	Other systemic involvement of connective tissue (FG)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	8.26799e-20	ENSG00000204305	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	9.30037e-20	Comparative body size at age 10, Males and Females	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	9.60064e-20	Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor: Asthma	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.39991e-19	Autoimmune traits	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.59993e-19	Comparative body size at age 10	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.69083e-19	schizophrenia	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.80011e-19	Medication for cholesterol, blood pressure or diabetes: Insulin	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.03892e-19	White blood cell count (basophil)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.39111e-19	High density lipoprotein cholesterol levels (UKB data field 30760)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.60016e-19	Operation code: thyroidectomy/partial thyroidectomy	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.65889e-19	ENSG00000204438	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.80027e-19	Diagnoses - main ICD10: R31 Unspecified haematuria	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.03879e-19	Type 1 diabetes, wide definition	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.04649e-19	IGF-1	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.1798e-19	Weight	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.21662e-19	Varicella zoster virus glycoproteins E and I antibody levels	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.40017e-19	Time to complete round	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.25794e-19	Blood clot  DVT  bronchitis  emphysema  asthma  rhinitis  eczema  allergy diagnosed by doctor: Asthma	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.76102e-19	Type 1 diabetes with ophthalmic complications	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	7.64188e-19	Hemoglobin concentration	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	9.56533e-19	Hip circumference (UKB data field 49)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.22264e-18	Non-cancer illness code  self-reported: asthma	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.29987e-18	Diastolic blood pressure, automated reading	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.9002e-18	Diagnoses - secondary ICD10: E03.9 Hypothyroidism, unspecified	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.09991e-18	FEV1/FVC < 0.7	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.30197e-18	Mean platelet (thrombocyte) volume	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.3222e-18	Medication for cholesterol  blood pressure or diabetes: Insulin	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.60016e-18	Asthma	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.09599e-18	Apoliprotein A	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.10027e-18	Other serious medical condition/disability diagnosed by doctor	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.00037e-18	Mean platelet volume	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.10035e-18	Connective tissue disorder	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	8.62383e-18	IGF-1	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.07922e-17	Other predominantly sexually transmitted diseases, not elsewhere classified	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.09991e-17	Eosinophil percentage of white cells	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.99985e-17	Hot drink temperature	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.17468e-17	Schizophrenia	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.5678e-17	Disorders of the thyroid gland	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.04855e-17	HDL cholesterol	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.20727e-17	IDP_dMRI_TBSS_L1_Superior_longitudinal_fasciculus_L	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.67843e-17	Total bilirubin levels (UKB data field 30840)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.80065e-17	Intestinal malabsorbtion	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.92266e-17	HDL cholesterol	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.10035e-17	Age at menopause (last menstrual period)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.50554e-17	Mean corpuscular haemoglobin concentration	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	6.14469e-17	Serum creatinine levels	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	6.30812e-17	Total bilirubin levels (UKB data field 30840)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	6.54938e-17	Type 1 diabetes with other specified/multiple/unspecified complications	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	6.76862e-17	ENSG00000204528	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	8.00018e-17	Ankle spacing width (right)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	8.4004e-17	Appendicular lean mass	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	8.67561e-17	Platelet count	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.03896e-16	Mean corpuscular hemoglobin concentration	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.14419e-16	Type 1 diabetes (SPA correction)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.18905e-16	Type 1 diabetes (Firth correction)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.47911e-16	HLA class II histocompatibility antigen, DQ alpha 2 chain	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.49977e-16	Mean corpuscular hemoglobin concentration	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.66624e-16	Hypothyroidism, strict autoimmune	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.70023e-16	Operative procedures - main OPCS: M45.9 Unspecified diagnostic endoscopic examination of bladder	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.80027e-16	Non-cancer illness code, self-reported: psoriasis	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.06267e-16	Asthma (Firth correction)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.0903e-16	Trypsin-3	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.15137e-16	Cereal type: Other (e.g. Cornflakes, Frosties)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.22329e-16	Asthma (SPA correction)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.00037e-16	Plateletcrit	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.15623e-16	Lung cancer	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	6.02282e-16	Creatinine	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	6.04784e-16	Psoriasis	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	6.0562e-16	Type 1 diabetes, strict (exclude DM2)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	6.24166e-16	Diastolic blood pressure automated reading (UKB data field 4079)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	6.50729e-16	Type1 diabetes, definitions combined	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	6.52229e-16	Type 1 diabetes, strict definition, subgroup 1	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	6.55541e-16	High light scatter reticulocyte percentage of red cells	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	7.19449e-16	IDP_dMRI_ProbtrackX_ICVF_ptr_r	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	8.13205e-16	ENSG00000250535	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.044e-15	Systemic lupus erythematosus	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.5449e-15	Diastolic blood pressure	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.91117e-15	Diabetic ketoacidosis	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.09991e-15	Polyunsaturated fatty acid levels	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.29985e-15	Mouth/teeth dental problems: Dentures	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.73023e-15	Type 1 diabetes, strict definition	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.10027e-15	Medication for pain relief, constipation, heartburn: None of the above	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.19963e-15	Medication for pain relief, constipation, heartburn: Paracetamol	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.25162e-15	Non-cancer illness code  self-reported: psoriasis	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.53509e-15	Complement C4 levels	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.19952e-15	Impedance of leg (left)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.2658e-15	Beta-defensin 119	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.31618e-15	ENSG00000204444	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.60045e-15	Ankle spacing width (left)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.24807e-15	Rac GTPase-activating protein 1	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.99653e-15	Comparative body size at age 10	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	6.89922e-15	Number of fluid intelligence questions attempted within time limit	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	7.53529e-15	Hematocrit	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	7.89951e-15	Hypothyroidism	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	8.2699e-15	Red blood cell count	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	8.70362e-15	Lichen planus	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	8.84097e-15	Severe autoimmune type 2 diabetes	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.08143e-14	IDP_dMRI_TBSS_L1_Sagittal_stratum_L	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.10002e-14	Comparative body size at age 10, Females	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.10917e-14	IDP_dMRI_TBSS_MD_Posterior_thalamic_radiation_L	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.15664e-14	Epstein-Barr virus ZEBRA antibody levels	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.20809e-14	Hypothyroidism,  other/unspecified	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.44911e-14	Hip circumference	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.5021e-14	SLE (Finngen)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.19989e-14	Diabetic hypoglycemia	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.29985e-14	Main speciality of consultant (recoded): Urology	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.61216e-14	IDP_dMRI_TBSS_MD_Posterior_thalamic_radiation_R	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.87276e-14	Psoriasis	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.9255e-14	HDL cholesterol	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.38221e-14	Diagnoses - main ICD10: R31 Unspecified haematuria	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.46737e-14	Interleukin-21	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.53183e-14	IDP_dMRI_TBSS_MD_Sagittal_stratum_R	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.89404e-14	Proliferative diabetic retinopathy (DM_RETINA_PROLIF)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.17638e-14	Type 1 diabetes with coma	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.19952e-14	Forced expiratory volume in 1-second (FEV1), predicted percentage	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.4157e-14	Other serious medical condition/disability diagnosed by doctor	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.60045e-14	Impedance of leg (right)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.50047e-14	Never eat eggs, dairy, wheat, sugar: I eat all of the above	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	6.70039e-14	Low density lipoprotein cholesterol levels	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	7.41822e-14	Hypothyroidism, strict autoimmune, 3 medication purchases required	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	9.01986e-14	Mean corpuscular hemoglobin concentration	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	9.54993e-14	Platelet crit	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	9.75439e-14	Sjogren's syndrome (SPA correction)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	9.81748e-14	IDP_dMRI_TBSS_L1_Sagittal_stratum_R	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	9.9106e-14	Sjogren's syndrome (Firth correction)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.37467e-13	Squamous cell lung carcinoma	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.54882e-13	IDP_dMRI_TBSS_ICVF_Posterior_thalamic_radiation_R	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.10426e-13	ENSG00000204386	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.66011e-13	Postprocedural endocrine and metabolic disorders, not elsewhere classified	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.66686e-13	Medication for pain relief  constipation  heartburn: None of the above	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.66686e-13	Plateletcrit	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.68844e-13	Alanine aminotransferase levels (UKB data field 30620)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.86814e-13	Diastolic blood pressure  automated reading	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.99985e-13	Oily fish intake	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.13329e-13	SLE, strict definition	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.71279e-13	Basophil count	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.83707e-13	IDP_dMRI_TBSS_MD_Sagittal_stratum_L	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.00037e-13	Polyunsaturated fatty acids	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.50047e-13	Neutrophil percentage of white cells	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.91425e-13	Diabetes-related co-morbidities/complications (more controls excluded)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	6.79986e-13	Omega-6 fatty acid levels	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	6.89922e-13	Linoleic acid levels	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	9.15377e-13	Forced expiratory volume in 1-second (FEV1)  predicted percentage	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	9.20026e-13	Long-standing illness, disability or infirmity	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	9.60064e-13	Glycoprotein acetyls levels	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.03205e-12	C reactive protein levels (UKB data field 30710)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.23197e-12	Epstein-Barr virus EA-D antibody levels	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.83485e-12	Systemic lupus erythematosus	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.8412e-12	Medication use (adrenergics, inhalants)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.85012e-12	Treatment/medication code: thyroxine product	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.9002e-12	Esophageal disorder	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.99986e-12	Total fatty acid levels	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.69774e-12	IDP_dMRI_TBSS_ICVF_Posterior_thalamic_radiation_L	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.8035e-12	Glucose	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.27265e-12	Diabetic retinopathy (H7_RETINOPATHYDIAB)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.40017e-12	Omega-3 fatty acid levels	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.46258e-12	Impedance of leg (left)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.50026e-12	3mm weak meridian (left)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.79665e-12	Peak expiratory flow (UKB data field 3064)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.83178e-12	Treatment/medication code: carbimazole	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.93731e-12	ENSG00000204301	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.19952e-12	Asthma	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.30725e-12	Hypothyroidism, drug reimbursement	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.75335e-12	IDP_dMRI_TBSS_MD_Superior_longitudinal_fasciculus_L	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.80507e-12	Dermatopolymyositis (FG)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.98884e-12	IDP_dMRI_ProbtrackX_L1_slf_l	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.00035e-12	Monounsaturated fatty acid levels	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.28932e-12	Other metabolic disorders	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.40754e-12	IDP_dMRI_TBSS_ICVF_Sagittal_stratum_R	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.86138e-12	IDP_dMRI_TBSS_L3_Posterior_thalamic_radiation_R	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	6.58567e-12	Dermatopolymyositis	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	6.65733e-12	Medication use (drugs used in diabetes)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	8.07235e-12	IDP_dMRI_ProbtrackX_ICVF_ptr_l	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	8.19785e-12	Diabetic retinopathy (DM_RETINOPATHY)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	8.51138e-12	IDP_dMRI_TBSS_L2_Posterior_thalamic_radiation_L	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	8.72168e-12	Impedance of leg (right)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	8.99498e-12	IDP_dMRI_ProbtrackX_ICVF_cst_r	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	9.70063e-12	Omega-3 fatty acids	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.10002e-11	Glycoprotein acetyls	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.1885e-11	IDP_dMRI_TBSS_ICVF_Retrolenticular_part_of_internal_capsule_L	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.22011e-11	Polymyositis	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.2694e-11	Lung cancer in ever smokers	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.29987e-11	Treatment/medication code: thyroxine product	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.30768e-11	Creatinine	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.50107e-11	Infections with a predominantly sexual mode of transmission	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.54099e-11	Hashimoto thyroiditis	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.59993e-11	Phospholipids in medium HDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.59993e-11	Total fatty acids	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.61808e-11	Endocrine, nutritional and metabolic diseases	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.68267e-11	IDP_dMRI_ProbtrackX_ICVF_ifo_r	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.80011e-11	Red cell distribution width	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.80011e-11	Linoleic acid	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.80011e-11	Monounsaturated fatty acids	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.99986e-11	3mm strong meridian (left)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.22433e-11	Any parental history of lung cancer (Firth correction)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.25476e-11	Comparative height size at age 10	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.30144e-11	Any parental history of lung cancer (SPA correction)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.30675e-11	Malignant lymphoma	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.49747e-11	Medication for pain relief  constipation  heartburn: Paracetamol	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.49977e-11	Operation code: varicose vein surgery	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.60016e-11	Respiratory or ear-nose-throat disease	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.64241e-11	IDP_dMRI_TBSS_ICVF_Retrolenticular_part_of_internal_capsule_R	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.70023e-11	Duration screen displayed	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.70023e-11	Trunk fat mass	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.90202e-11	Diabetes, several complications	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.97852e-11	IDP_dMRI_TBSS_L3_Sagittal_stratum_R	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.05492e-11	IDP_dMRI_ProbtrackX_ICVF_ilf_r	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.12536e-11	Systemic lupus erythematosus, unspecified	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.38065e-11	IDP_dMRI_ProbtrackX_MD_ilf_l	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.10015e-11	Omega-6 fatty acids	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.35512e-11	ThalamNuclei_rh_volume_LD	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.13925e-11	Eosinophill percentage	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.90065e-11	Triglycerides in very small VLDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	6.70039e-11	Phospholipid levels in medium HDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	7.17794e-11	IDP_dMRI_TBSS_MD_Retrolenticular_part_of_internal_capsule_R	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	7.39946e-11	Medication use (anilides)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	7.50067e-11	Free cholesterol to total lipids ratio in small LDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	7.70016e-11	Triglyceride levels in very small VLDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	7.70016e-11	Phosphoglycerides levels	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	7.72681e-11	IDP_dMRI_ProbtrackX_ICVF_ifo_l	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	7.94694e-11	C-reactive protein	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	8.14892e-11	C-reactive protein	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	8.60003e-11	Treatment speciality of consultant (recoded): Urology	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	8.73575e-11	Diabetic retinopathy (more controls excluded)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.12409e-10	IDP_dMRI_ProbtrackX_L1_ilf_r	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.1259e-10	ENSG00000240053	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.2e-10	Triglycerides in IDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.29003e-10	IDP_dMRI_ProbtrackX_FA_ptr_r	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.38676e-10	IDP_dMRI_ProbtrackX_ICVF_ilf_l	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.40001e-10	Total lipids in medium HDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.48594e-10	IDP_dMRI_ProbtrackX_MD_slf_l	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.5e-10	Treatment/medication code: paracetamol	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.51705e-10	IDP_dMRI_TBSS_MD_Superior_corona_radiata_L	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.69278e-10	IDP_dMRI_TBSS_L1_Posterior_corona_radiata_L	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.69746e-10	IDP_dMRI_TBSS_L1_Posterior_thalamic_radiation_R	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.7e-10	Phospholipid levels in small HDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.7e-10	Phospholipids to total lipids ratio in large LDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.77133e-10	IDP_dMRI_ProbtrackX_MD_ifo_r	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.79999e-10	Triglycerides in very large HDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.79999e-10	3mm strong meridian (right)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.91752e-10	Diabetes diagnosed by doctor	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2e-10	3mm weak meridian (right)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.04786e-10	IDP_dMRI_ProbtrackX_MD_ifo_l	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.16302e-10	Type 1 diabetes with neurological complications	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.16641e-10	Total bilirubin	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.19999e-10	Phosphoglycerides	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.39999e-10	Triglyceride levels in IDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.39999e-10	Operative procedures - main OPCS: G45.1 Fibreoptic endoscopic examination of upper gastrointestinal tract and biopsy of lesion of upper gastrointestinal tract	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.4322e-10	IDP_dMRI_ProbtrackX_MD_ilf_r	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.49058e-10	IDP_dMRI_TBSS_L3_Posterior_thalamic_radiation_L	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.51131e-10	IDP_dMRI_ProbtrackX_L2_ifo_l	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.59998e-10	Illnesses of father: Lung cancer	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.6872e-10	IDP_dMRI_TBSS_ICVF_Sagittal_stratum_L	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.69998e-10	Diabetes diagnosed by doctor	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.95999e-10	Red cell distribution width	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.20398e-10	Other retinal disorders	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.28246e-10	Epstein-Barr virus EBNA-1 antibody levels	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.29997e-10	Impedance of whole body	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.29997e-10	Seen a psychiatrist for nerves, anxiety, tension or depression	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.34996e-10	Total bilirubin levels	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.50002e-10	Phospholipids to total lipids ratio in large LDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.50002e-10	Phospholipids to total lipids ratio in small LDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.59203e-10	ENSG00000204592	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.59998e-10	Cholesteryl esters to total lipids ratio in small LDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.67697e-10	Eosinophil percentage of granulocytes	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.75578e-10	IDP_dMRI_ProbtrackX_ICVF_fma	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.02532e-10	IDP_dMRI_TBSS_L1_Posterior_thalamic_radiation_L	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.0332e-10	Long-standing illness  disability or infirmity	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.60002e-10	Triglycerides in medium HDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.65833e-10	Endocrine, nutritional and metabolic diseases	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.84206e-10	Diabetic neuropathy	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.18561e-10	IDP_dMRI_ProbtrackX_L1_slf_r	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.37403e-10	IDP_dMRI_ProbtrackX_L3_ilf_l	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.60003e-10	Time to answer	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	6.09818e-10	IDP_dMRI_TBSS_ICVF_Posterior_corona_radiata_L	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	6.27191e-10	IDP_dMRI_ProbtrackX_ICVF_ar_r	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	6.49995e-10	Total lipid levels in medium HDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	6.49995e-10	Triglycerides in HDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	6.64814e-10	IDP_dMRI_ProbtrackX_ICVF_str_r	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	6.69993e-10	Phospholipids in HDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	7.17464e-10	IDP_dMRI_TBSS_MD_Retrolenticular_part_of_internal_capsule_L	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	7.69999e-10	Concentration of medium HDL particles	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	7.79992e-10	Phospholipids in small HDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	8e-10	Neutrophil percentage of granulocytes	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	8.55461e-10	IDP_dMRI_TBSS_OD_Superior_longitudinal_fasciculus_L	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	8.88587e-10	IDP_dMRI_TBSS_MD_Posterior_corona_radiata_L	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	9.40005e-10	Salad / raw vegetable intake	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	9.47894e-10	Hypothyroidism (congenital or acquired)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	9.53147e-10	Mouth/teeth dental problems: Dentures	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	9.80844e-10	IDP_dMRI_ProbtrackX_L2_ilf_l	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1e-09	Free cholesterol levels in small HDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.0875e-09	Calcium levels (UKB data field 30680)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.09999e-09	Free cholesterol to total lipids ratio in small LDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.09999e-09	Cholesterol to total lipids ratio in IDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.11442e-09	Primary_lymphoid and hematopoietic malignant neoplasms	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.2e-09	Cholesteryl esters to total lipids ratio in small LDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.293e-09	Hypothyroidism, levothyroxin purchases	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.293e-09	Hypothyroidism and >3 levothyroxin purchases	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.29999e-09	Hearing difficulty/problems with background noise	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.38484e-09	IDP_dMRI_ProbtrackX_L1_ilf_l	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.38995e-09	IDP_dMRI_ProbtrackX_ICVF_cst_l	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.39348e-09	aparc-DKTatlas_lh_thickness_insula	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.39927e-09	IDP_dMRI_TBSS_L3_Retrolenticular_part_of_internal_capsule_R	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.40001e-09	Apolipoprotein A1	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.40001e-09	Arm fat mass (left)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.48149e-09	IDP_dMRI_TBSS_L2_Anterior_corona_radiata_L	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.49727e-09	IDP_dMRI_ProbtrackX_ICVF_ar_l	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.5e-09	Total cholines levels	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.60398e-09	Type 1 diabetes with ketoacidosis	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.61659e-09	ThalamNuclei_rh_volume_CL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.66188e-09	IDP_dMRI_ProbtrackX_L3_ifo_l	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.66299e-09	Colitis, primary sclerosing	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.7e-09	Phospholipids to total lipids ratio in small LDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.7e-09	Cholesteryl esters to total lipids ratio in IDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.7e-09	Number of days/week of moderate physical activity 10+ minutes	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.79999e-09	Triglycerides in small VLDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.89998e-09	Triglycerides in large HDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2e-09	Total lipid levels in small HDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.04221e-09	IDP_dMRI_ProbtrackX_L3_ifo_r	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.07587e-09	aparc-DKTatlas_rh_area_insula	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.31579e-09	aparc-DKTatlas_lh_area_middletemporal	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.34185e-09	Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.5e-09	Triglycerides in small LDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.50438e-09	IDP_dMRI_ProbtrackX_L2_fmi	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.51768e-09	IDP_dMRI_ProbtrackX_L2_ifo_r	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.56035e-09	IDP_dMRI_TBSS_ICVF_Superior_corona_radiata_R	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.64058e-09	IDP_dMRI_ProbtrackX_L3_ilf_r	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.66134e-09	IDP_dMRI_ProbtrackX_ICVF_fmi	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.69998e-09	Seen doctor (GP) for nerves, anxiety, tension or depression	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.78901e-09	Nephrotic syndrome	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.84905e-09	IDP_dMRI_TBSS_MD_Cingulum_cingulate_gyrus_L	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.939e-09	Autoimmune hepatitis	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.1067e-09	IDP_dMRI_ProbtrackX_ICVF_ml_l	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.16672e-09	Direct low density lipoprotein levels (UKB data field 30780)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.19301e-09	aparc-a2009s_lh_area_S-temporal-sup	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.2e-09	6mm strong meridian (left)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.2e-09	Whole body fat mass	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.2144e-09	IDP_dMRI_TBSS_ICVF_Body_of_corpus_callosum	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.23147e-09	aseg_rh_intensity_Pallidum	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.23817e-09	IDP_dMRI_TBSS_MD_Anterior_corona_radiata_L	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.29997e-09	Phosphatidylcholine levels	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.40001e-09	Total cholines	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.49543e-09	Direct low density lipoprotein levels (UKB data field 30780)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.50002e-09	Triglyceride levels in small VLDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.79752e-09	IDP_dMRI_TBSS_MD_Superior_longitudinal_fasciculus_R	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.89996e-09	Total lipids in HDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.99853e-09	IDP_dMRI_TBSS_L2_Anterior_corona_radiata_R	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4e-09	Triglyceride levels in medium HDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4e-09	Free cholesterol in medium HDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.20901e-09	Medication use (drugs for peptic ulcer and gastro-oesophageal reflux disease)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.31609e-09	ENSG00000228789	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.56773e-09	IDP_dMRI_TBSS_ICVF_Superior_corona_radiata_L	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.89666e-09	IDP_dMRI_TBSS_ICVF_Pontine_crossing_tract	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.89779e-09	Ubiquitin-like protein ISG15	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.97302e-09	Diabethic neuropathy	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5e-09	Concentration of medium HDL particles	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.10399e-09	Eosinophil percentage of white cells	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.39995e-09	Triglyceride levels in small LDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.39995e-09	Total phospholipid levels in lipoprotein particles	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.47016e-09	ENSG00000204308	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.57596e-09	Neutrophill percentage	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.60003e-09	Lymphocyte percentage of white cells	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.65718e-09	IDP_T1_FAST_ROIs_L_thalamus	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.69994e-09	Triglyceride levels in medium LDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.80003e-09	Triglyceride levels in LDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.89997e-09	Phosphatidylcholines	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	6.36063e-09	IDP_dMRI_ProbtrackX_FA_ifo_l	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	6.49995e-09	Triglycerides in LDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	6.67606e-09	Colitis, primary sclerosing, strict definition	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	6.80002e-09	White blood cell count	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	6.93426e-09	aparc-Desikan_lh_area_middletemporal	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	7.01617e-09	IDP_dMRI_TBSS_MD_Superior_corona_radiata_R	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	7.10003e-09	Triglycerides to total lipids ratio in small LDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	7.47137e-09	IDP_dMRI_ProbtrackX_L2_slf_l	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	7.59994e-09	Non-oily fish intake	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	7.67591e-09	Alanine aminotransferase levels	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	7.68192e-09	Receptor for advanced glycosylation end products levels	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	7.69999e-09	Triglyceride levels in HDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	7.69999e-09	Free cholesterol in small HDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	7.79992e-09	Triglyceride levels in very large HDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	7.94328e-09	Granulysin	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	8.19993e-09	Phospholipid levels in HDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	8.79995e-09	Cholesterol to total lipids ratio in IDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	9.29994e-09	6mm strong meridian (right)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	9.43409e-09	wg_lh_intensity-contrast_superiorfrontal	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	9.69996e-09	White blood cell count (monocyte)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	9.69996e-09	Apolipoprotein A1 levels	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	9.87507e-09	Crohn's disease	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	9.90011e-09	Triglycerides in large LDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.014e-08	Iridocyclitis	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.01669e-08	Alanine aminotransferase	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.024e-08	IDP_dMRI_ProbtrackX_ICVF_cgc_r	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.06846e-08	Lymphomas	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.09999e-08	Triglyceride levels in large LDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.09999e-08	Arm fat mass (right)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.10739e-08	IDP_dMRI_ProbtrackX_FA_fmi	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.11378e-08	ThalamNuclei_rh_volume_LP	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.1648e-08	ENSG00000204314	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.2e-08	Total lipids in small HDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.2e-08	Peak expiratory flow (PEF)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.2e-08	Treatment/medication code: calcichew d3 tablet	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.29449e-08	IDP_dMRI_TBSS_L3_Sagittal_stratum_L	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.29999e-08	Concentration of HDL particles	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.29999e-08	Total phospholipids in lipoprotein particles	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.29999e-08	Free cholesterol to total lipids ratio in large LDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.31432e-08	aparc-a2009s_lh_thickness_Lat-Fis-ant-Vertical	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.34803e-08	IDP_dMRI_TBSS_L1_Superior_corona_radiata_R	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.40001e-08	Triglycerides in medium LDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.40001e-08	Free cholesterol to total lipids ratio in medium LDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.47096e-08	IDP_dMRI_TBSS_MD_Anterior_corona_radiata_R	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.5e-08	Cholesteryl esters to total lipids ratio in IDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.50076e-08	Seen psychiatrist for nerves anxiety tension or depression (UKB data field 2100) (SPA correction)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.52475e-08	IDP_dMRI_TBSS_ICVF_Superior_longitudinal_fasciculus_R	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.5449e-08	Seen psychiatrist for nerves anxiety tension or depression (UKB data field 2100) (Firth correction)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.60657e-08	IDP_dMRI_TBSS_L1_Superior_longitudinal_fasciculus_R	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.79999e-08	Total concentration of lipoprotein particles	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.79999e-08	6mm weak meridian (right)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.82869e-08	Cancer of primary lymphoid hematopoietic	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.98335e-08	wg_rh_intensity-contrast_superiorfrontal	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.09701e-08	IDP_dMRI_TBSS_L3_Anterior_corona_radiata_R	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.1e-08	Concentration of HDL particles	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.1e-08	Dried fruit intake	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.19999e-08	Pain type(s) experienced in last month: Headache	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.20201e-08	Basophil count	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.20999e-08	Lung function (FVC)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.21259e-08	IDP_dMRI_TBSS_L2_Posterior_thalamic_radiation_R	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.28902e-08	Pediatric asthma	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.30001e-08	6mm weak meridian (left)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.38451e-08	IDP_dMRI_TBSS_L3_Superior_longitudinal_fasciculus_R	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.38946e-08	IDP_dMRI_TBSS_L1_Superior_corona_radiata_L	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.5e-08	Illnesses of siblings: Diabetes	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.50265e-08	IDP_dMRI_ProbtrackX_MD_slf_r	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.64868e-08	ENSG00000204315	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.714e-08	Cholangitis (primary sclerosing, PSC), with reimbursement 202	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.73968e-08	BA-exvivo_rh_volume_entorhinal	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.76885e-08	IDP_dMRI_TBSS_L3_Anterior_corona_radiata_L	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.80001e-08	Ever depressed for a whole week	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.81203e-08	Acute and subacute iridocyclitis	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.81384e-08	IDP_dMRI_ProbtrackX_ICVF_slf_l	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.90001e-08	Total concentration of lipoprotein particles	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.9134e-08	IDP_dMRI_ProbtrackX_MD_cgc_l	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.15355e-08	IDP_dMRI_ProbtrackX_L1_ifo_r	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.22916e-08	Calcium	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.29997e-08	Triglycerides to total lipids ratio in small LDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.40001e-08	Free cholesterol levels in medium HDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.65006e-08	IDP_dMRI_ProbtrackX_L2_unc_r	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.69999e-08	Tyrosine levels	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.85123e-08	IDP_dMRI_TBSS_ICVF_Anterior_corona_radiata_L	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.01421e-08	IDP_dMRI_TBSS_ICVF_Superior_longitudinal_fasciculus_L	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.09996e-08	Free cholesterol to total lipids ratio in large LDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.22931e-08	ENSG00000166278	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.26383e-08	IDP_dMRI_TBSS_ICVF_Genu_of_corpus_callosum	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.30002e-08	Cholesteryl esters in chylomicrons and extremely large VLDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.4825e-08	Seen doctor for nerves anxiety tension or depression (UKB data field 2090) (SPA correction)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.49904e-08	CX3CL1 levels	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.49997e-08	Gastroesophageal reflux disease or gastric reflux	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.51087e-08	Seen doctor for nerves anxiety tension or depression (UKB data field 2090) (Firth correction)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.70002e-08	Total lipid levels in HDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.70002e-08	Moderate to vigorous physical activity levels	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.76804e-08	KELA_REIMBURSEMENT_202	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.79999e-08	Docosahexaenoic acid	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.81504e-08	IDP_dMRI_ProbtrackX_ICVF_str_l	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.90004e-08	haemotological cancer	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.99356e-08	Impedance of whole body	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.08698e-08	Calcium levels	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.2348e-08	IDP_dMRI_TBSS_L3_Retrolenticular_part_of_internal_capsule_L	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.34897e-08	Neutrophil percentage of white cells	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.40008e-08	IDP_T1_FAST_ROIs_L_temp_fusif_cortex_post	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.53223e-08	IDP_dMRI_ProbtrackX_FA_ilf_l	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.60003e-08	Cholesteryl ester levels in chylomicrons and extremely large VLDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.69994e-08	Triglyceride levels in large HDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.69994e-08	Forced expiratory volume in 1-second (FEV1), predicted	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.94361e-08	Pain type(s) experienced in last month: Headache (UKB data field 6159_1) (SPA correction)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	6.03212e-08	Pain type(s) experienced in last month: Headache (UKB data field 6159_1) (Firth correction)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	6.21298e-08	IDP_dMRI_TBSS_ICVF_Splenium_of_corpus_callosum	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	6.44407e-08	Bipolar disorder bip2021	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	6.57794e-08	Asthma	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	7.093e-08	ENSG00000204520	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	7.29995e-08	Triglycerides to total lipids ratio in IDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	7.34683e-08	BA-exvivo_rh_thickness_entorhinal	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	7.69999e-08	Creatinine levels	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	7.69999e-08	Cholesterol in chylomicrons and extremely large VLDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	7.74105e-08	IDP_dMRI_ProbtrackX_ICVF_slf_r	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	7.90005e-08	Cholesterol in medium HDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	8.02398e-08	Disorders of lacrimal system and orbit in diseases classified elsewhere	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	8.34296e-08	Arthropod-borne viral fevers and viral haemorrhagic fevers	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	9.08343e-08	Treatment/medication code: paracetamol	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1e-07	Polypeptide N-acetylgalactosaminyltransferase 1	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.024e-07	IDP_dMRI_ProbtrackX_L2_ilf_r	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.03968e-07	wg_lh_intensity-contrast_insula	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.09999e-07	Cholesterol levels in chylomicrons and extremely large VLDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.09999e-07	Free cholesterol to total lipids ratio in medium LDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.09999e-07	Non-cancer illness code, self-reported: enlarged prostate	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.09999e-07	Treatment speciality of consultant (recoded): General medicine	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.10469e-07	ENSG00000204428	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.1329e-07	ENSG00000204469	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.15904e-07	IDP_dMRI_TBSS_ICVF_Medial_lemniscus_R	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.2e-07	Creatinine	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.29999e-07	Nervous feelings	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.29999e-07	Leg fat mass (left)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.30677e-07	IDP_dMRI_TBSS_FA_Splenium_of_corpus_callosum	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.335e-07	Bipolar disorder bip2021 noUKBB	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.38899e-07	IDP_dMRI_TBSS_L3_Superior_fronto-occipital_fasciculus_L	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.39547e-07	Number of incorrect matches in round	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.39669e-07	IDP_dMRI_ProbtrackX_MD_unc_r	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.40001e-07	Number of incorrect matches in round	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.43781e-07	aparc-Desikan_rh_thickness_isthmuscingulate	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.50904e-07	IDP_dMRI_TBSS_L2_Splenium_of_corpus_callosum	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.546e-07	Rheumatoid arthritis	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.58099e-07	Ankylosing spondylitis	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.61102e-07	ENSG00000206337	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.61102e-07	ENSG00000232810	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.63546e-07	Treatment/medication code: ventolin 100micrograms inhaler	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.64199e-07	Cholangitis (primary sclerosing, PSC)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.64699e-07	Height	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.66253e-07	Urate levels (UKB data field 30880)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.66498e-07	Sarcoidosis	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.66725e-07	IDP_T1_FAST_ROIs_R_paracing_gyrus	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.70801e-07	Certain infectious and parasitic diseases	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.7187e-07	IDP_dMRI_TBSS_L2_Genu_of_corpus_callosum	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.7378e-07	IDP_dMRI_TBSS_ICVF_Tapetum_L	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.74735e-07	Trunk fat mass	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.79999e-07	Saturated fatty acid levels	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.84417e-07	IDP_dMRI_TBSS_OD_Posterior_corona_radiata_L	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.89998e-07	Basal metabolic rate	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.09894e-07	IDP_dMRI_TBSS_ICVF_Middle_cerebellar_peduncle	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.1e-07	Hiatus hernia	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.19999e-07	Tyrosine	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.30001e-07	Cholesteryl esters in medium HDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.30001e-07	Treatment/medication code: ventolin 100micrograms inhaler	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.30202e-07	First line medication for Crohns disease	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.32959e-07	Illnesses of siblings: Diabetes	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.39999e-07	Ratio of omega-6 fatty acids to omega-3 fatty acids	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.40547e-07	IDP_dMRI_ProbtrackX_FA_ifo_r	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.41046e-07	aparc-Desikan_lh_thickness_insula	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.50697e-07	Feeling nervous	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.52e-07	IDP_dMRI_ProbtrackX_ICVF_unc_r	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.55447e-07	aseg_lh_intensity_Pallidum	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.68392e-07	Calcium	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.69998e-07	Triglycerides to total lipids ratio in very small VLDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.72647e-07	IDP_dMRI_ProbtrackX_L3_slf_l	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.77703e-07	Medication use (glucocorticoids)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.80925e-07	Non-cancer illness code  self-reported: enlarged prostate	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.83988e-07	aparc-DKTatlas_rh_thickness_isthmuscingulate	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.86075e-07	Non-cancer illness code  self-reported: diabetes	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.90001e-07	Saturated fatty acids	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.95903e-07	Other specified/unspecified systemic involvement of connective tissue	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.99999e-07	Total triglycerides	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.99999e-07	Frequency of light DIY in last 4 weeks	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.09999e-07	Operation code: appendicectomy	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.13473e-07	IDP_dMRI_TBSS_MD_Superior_fronto-occipital_fasciculus_L	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.2e-07	Triglycerides to total lipids ratio in IDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.23996e-07	Type 1 diabetes with renal complications	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.25912e-07	IDP_dMRI_TBSS_L2_Posterior_corona_radiata_L	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.29997e-07	Diabetes	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.34811e-07	IDP_dMRI_ProbtrackX_L3_fmi	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.37443e-07	Familial combined hyperlipidemia defined by Consensus criteria	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.46003e-07	Worry	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.59998e-07	Docosahexaenoic acid levels	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.68791e-07	ENSG00000198563	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.69999e-07	Leg fat mass (right)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.71535e-07	Palmitoyl-protein thioesterase 1	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.77225e-07	aparc-pial_lh_area_middletemporal	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.79997e-07	Asthma (adult onset)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.90301e-07	IDP_dMRI_ProbtrackX_L3_ptr_r	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.93097e-07	Certain disorders involving the immune mechanism	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.98107e-07	UDP-N-acetylhexosamine pyrophosphorylase	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.98107e-07	Granzyme A	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.00959e-07	IDP_dMRI_TBSS_FA_Middle_cerebellar_peduncle	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.06256e-07	wg_lh_intensity-contrast_supramarginal	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.15145e-07	IDP_dMRI_TBSS_ICVF_Anterior_corona_radiata_R	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.26678e-07	IDP_dMRI_TBSS_L1_Cingulum_hippocampus_R	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.29536e-07	IDP_dMRI_TBSS_ICVF_Cingulum_cingulate_gyrus_R	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.32972e-07	Epstein-Barr virus VCA p18 antibody levels	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.37925e-07	IDP_dMRI_TBSS_OD_Superior_corona_radiata_R	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.432e-07	IDP_dMRI_TBSS_FA_Anterior_corona_radiata_R	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.49997e-07	Total lipid levels in lipoprotein particles	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.49997e-07	Triglycerides in small HDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.52481e-07	wg_lh_intensity-contrast_parsorbitalis	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.66799e-07	LDL direct	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.70002e-07	Non-cancer illness code, self-reported: gastro-oesophageal reflux (gord) / gastric reflux	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.79999e-07	Free cholesterol in chylomicrons and extremely large VLDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.90343e-07	IDP_dMRI_TBSS_L1_Retrolenticular_part_of_internal_capsule_L	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5e-07	Cholesterol levels in medium HDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.08862e-07	IDP_dMRI_TBSS_ICVF_Posterior_corona_radiata_R	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.1e-07	Treatment/medication code: seretide 50 evohaler	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.12625e-07	IDP_dMRI_ProbtrackX_ICVF_unc_l	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.29883e-07	Illnesses of father: Lung cancer	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.39995e-07	Lifetime number of sexual partners	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.39995e-07	Eye problems/disorders: Diabetes related eye disease	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.49997e-07	Bioavailable testosterone levels	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.56506e-07	Binding antibody response to interferon beta therapy in multiple sclerosis (antibody levels; all treatment preparations)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.77697e-07	IDP_dMRI_TBSS_L3_Superior_corona_radiata_L	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.80003e-07	Respiratory or ear-nose-throat disease	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	6.11223e-07	wg_lh_intensity-contrast_superiortemporal	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	6.26095e-07	Medication use (anti-inflammatory and antirheumatic products, non-steroids)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	6.30812e-07	wg_rh_intensity-contrast_parstriangularis	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	6.49995e-07	Cholesterol to total lipids ratio in very small VLDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	6.66316e-07	LDL direct	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	6.67114e-07	IDP_dMRI_TBSS_MD_Uncinate_fasciculus_L	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	6.7733e-07	wg_lh_intensity-contrast_inferiorparietal	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	7.00003e-07	Concentration of small VLDL particles	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	7.25605e-07	HippSubfield_rh_volume_hippocampal-fissure	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	7.31392e-07	LDL cholesterol	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	7.34007e-07	IDP_dMRI_TBSS_L2_Retrolenticular_part_of_internal_capsule_R	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	7.34852e-07	IDP_dMRI_ProbtrackX_L3_cgc_r	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	7.4817e-07	IDP_dMRI_TBSS_MD_Posterior_corona_radiata_R	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	7.49894e-07	Diseases of the genitourinary system	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	7.57426e-07	Urate	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	7.59994e-07	Free cholesterol levels in chylomicrons and extremely large VLDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	7.59994e-07	Corneal hysteresis (left)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	7.71667e-07	ENSG00000137310	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	7.79992e-07	Total testosterone levels	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	7.90005e-07	Total lipid levels in small VLDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	8.01493e-07	aparc-a2009s_lh_thickness_S-circular-insula-sup	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	8.0904e-07	Peak expiratory flow (PEF)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	8.12831e-07	Spermatogenesis-associated protein 20	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	8.19993e-07	Total triglycerides levels	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	8.19993e-07	Diagnoses - main ICD10: N40 Hyperplasia of prostate	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	8.43393e-07	Disorders of choroid and retina	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	8.82877e-07	IDP_dMRI_TBSS_FA_Posterior_thalamic_radiation_L	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	8.9e-07	Parental longevity (mother's attained age)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	8.99995e-07	Phospholipids to total lipids ratio in IDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	9.12011e-07	aparc-a2009s_rh_area_S-pericallosal	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	9.17698e-07	wg_rh_intensity-contrast_parsorbitalis	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	9.31108e-07	IDP_dMRI_ProbtrackX_ICVF_ml_r	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	9.38858e-07	IDP_dMRI_ProbtrackX_L3_slf_r	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	9.80393e-07	Diabetic maculopathy (H7_MACULOPATHYDIAB)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	9.90011e-07	Fluid intelligence score	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	9.95108e-07	Diabetic maculopathy (DM_MACULOPATHY)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1e-06	Triglyceride levels in medium VLDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1e-06	Triglycerides to total lipids ratio in very small VLDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1e-06	Ratio of monounsaturated fatty acids to total fatty acids	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.08218e-06	wg_rh_intensity-contrast_caudalmiddlefrontal	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.08583e-06	Apolipoprotein B levels (UKB data field 30640)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.09999e-06	Cholesteryl esters to total lipids ratio in very small VLDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.12101e-06	Finngen Rheumatological endpoints	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.1246e-06	IDP_dMRI_ProbtrackX_MD_fmi	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.15282e-06	Asthma	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.15282e-06	Childhood asthma (age<16)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.17964e-06	Seen a psychiatrist for nerves  anxiety  tension or depression	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.184e-06	Diabetic maculopathy (more controls excluded)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.2e-06	Cholesteryl ester levels in medium HDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.2e-06	Mineral and other dietary supplements: Zinc	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.25519e-06	Glucose	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.27565e-06	Lymphocyte percentage	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.28677e-06	IDP_dMRI_ProbtrackX_L1_ifo_l	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.29808e-06	IDP_dMRI_TBSS_OD_Sagittal_stratum_L	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.29939e-06	Anti-varicella zoster virus IgG seropositivity	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.29999e-06	Triglycerides to total lipids ratio in medium LDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.3326e-06	rfMRI connectivity (ICA100 edge 356)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.35385e-06	Asthma, hospital admissions 1	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.388e-06	Proliferative diabetic retinopathy (H7_RETINOPATHYDIAB_PROLIF)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.40001e-06	Ratio of omega-6 fatty acids to omega-3 fatty acids	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.40001e-06	Free cholesterol in HDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.41384e-06	rfMRI connectivity (ICA100 edge 509)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.42001e-06	Mean corpuscular volume	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.4243e-06	aparc-a2009s_lh_volume_S-temporal-sup	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.43199e-06	Binding antibody response to interferon beta therapy in multiple sclerosis (antibody levels; IFN<U+03B2>-1a subcutaneous)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.51461e-06	IDP_dMRI_TBSS_L3_Superior_longitudinal_fasciculus_L	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.539e-06	Peripheral artery disease	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.555e-06	Unspecified diabetes	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.55593e-06	Diagnoses - main ICD10: J45 Asthma	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.56099e-06	IDP_dMRI_TBSS_L3_Posterior_corona_radiata_L	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.59225e-06	Seen doctor (GP) for nerves  anxiety  tension or depression	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.6e-06	Childhood sunburn occasions	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.6e-06	Non-cancer illness code, self-reported: hiatus hernia	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.61102e-06	IDP_dMRI_TBSS_ICVF_Fornix_cres+Stria_terminalis_L	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.64199e-06	Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.64904e-06	Major dietary changes in the last 5 years: Yes, because of illness	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.67494e-06	wg_rh_intensity-contrast_parsopercularis	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.7e-06	Parental longevity (combined parental attained age, Martingale residuals)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.7e-06	LDL cholesterol	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.7378e-06	PAX-interacting protein 1	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.77623e-06	IDP_dMRI_TBSS_FA_Genu_of_corpus_callosum	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.79999e-06	Cholesterol to total lipids ratio in very small VLDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.79999e-06	Triglyceride levels in small HDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.82642e-06	aparc-a2009s_lh_area_G-temporal-middle	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.83738e-06	wg_lh_intensity-contrast_postcentral	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.89099e-06	Peripheral artery disease (no controls excluded)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.89998e-06	Non-cancer illness code, self-reported: diabetes	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.94518e-06	Hearing difficulty/problems with background noise	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.95641e-06	Urate	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.97606e-06	IDP_dMRI_TBSS_ICVF_External_capsule_R	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	1.98902e-06	Lupus erythematosus	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.02255e-06	IDP_dMRI_ProbtrackX_OD_slf_l	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.02325e-06	Frequency of light DIY in last 4 weeks	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.04301e-06	Disorders of orbit	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.05921e-06	IDP_dMRI_TBSS_FA_Anterior_corona_radiata_L	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.083e-06	Glucose levels	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.0893e-06	Complement C1q tumor necrosis factor-related protein 5	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.1e-06	Ratio of omega-3 fatty acids to total fatty acids	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.11885e-06	ThalamNuclei_rh_volume_PuM	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.12598e-06	Sarcoidosis	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.15179e-06	IDP_dMRI_ProbtrackX_OD_str_l	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.19999e-06	Total lipids in lipoprotein particles	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.23198e-06	Mean arterial pressure	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.27562e-06	IDP_dMRI_ProbtrackX_L1_str_l	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.31633e-06	IDP_dMRI_ProbtrackX_MD_unc_l	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.32563e-06	Number of days/week of moderate physical activity 10+ minutes	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.39999e-06	Bioavailable Testosterone	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.49799e-06	Lymphocyte percentage of white cells	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.49919e-06	IDP_dMRI_TBSS_L2_Superior_corona_radiata_L	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.5e-06	Triglycerides in medium VLDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.55859e-06	IDP_dMRI_TBSS_L1_Retrolenticular_part_of_internal_capsule_R	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.58167e-06	IDP_dMRI_ProbtrackX_FA_ilf_r	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.59998e-06	Cholesteryl esters to total lipids ratio in large LDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.60669e-06	ENSG00000234745	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.64667e-06	wg_rh_intensity-contrast_rostralmiddlefrontal	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.66624e-06	IDP_dMRI_ProbtrackX_OD_ar_r	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.69998e-06	Ratio of monounsaturated fatty acids to total fatty acids	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.69998e-06	Diagnoses - secondary ICD10: J45.9 Asthma, unspecified	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.73357e-06	Treatment/medication code: seretide 50 evohaler	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.73798e-06	Eye problems/disorders: Diabetes related eye disease	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.75423e-06	Vesicle-fusing ATPase	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.7948e-06	Arm fat mass (left)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.80001e-06	Comparative body size at age 10, Males	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.80001e-06	Taking other prescription medications	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.83531e-06	IDP_dMRI_TBSS_ICVF_Posterior_limb_of_internal_capsule_L	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.83792e-06	IDP_dMRI_TBSS_L3_Splenium_of_corpus_callosum	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.84971e-06	IDP_dMRI_TBSS_FA_Posterior_thalamic_radiation_R	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	2.88403e-06	Background diabetic retinopathy	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.02086e-06	Whole body fat mass	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.0474e-06	ENSG00000204475	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.04789e-06	IDP_dMRI_ProbtrackX_ICVF_atr_l	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.09999e-06	Triglycerides in VLDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.10742e-06	IDP_dMRI_TBSS_ICVF_Superior_fronto-occipital_fasciculus_L	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.2e-06	Cholesteryl esters to total lipids ratio in very small VLDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.25087e-06	IDP_dMRI_TBSS_L1_Fornix_cres+Stria_terminalis_R	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.29329e-06	Diagnoses - main ICD10: D64 Other anaemias	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.29329e-06	Other anaemias	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.29997e-06	Lung function (FEV1/FVC)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.36488e-06	Other and unspecified anaemias	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.43558e-06	IDP_dMRI_ProbtrackX_ICVF_mcp	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.46737e-06	Promotilin	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.51237e-06	IDP_dMRI_ProbtrackX_ICVF_atr_r	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.54193e-06	ENSG00000168477	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.76201e-06	Other disorders of glucose regulation and pancreatic internal secretion	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.78303e-06	Oral cavity cancer	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.78303e-06	Oral cavity cancer	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.78791e-06	IDP_dMRI_ProbtrackX_L3_unc_r	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.80715e-06	IDP_dMRI_TBSS_OD_Sagittal_stratum_R	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.84902e-06	Binding antibody response to interferon beta therapy in multiple sclerosis (antibody levels; IFN<U+03B2>-1a subcutaneous and intramuscular)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.85949e-06	COPD, early/later onset	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.88204e-06	Other diabetic retinopathy	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	3.983e-06	Chronic obstructive pulmonary disease	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.0738e-06	T-cell surface glycoprotein CD3 epsilon chain	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.09996e-06	Operation code: tonsillectomy +/- adenoids	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.19295e-06	Peripheral artery disease	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.21599e-06	IDP_T1_FAST_ROIs_R_temp_fusif_cortex_post	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.24405e-06	Varicose veins	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.3431e-06	rfMRI connectivity (ICA100 edge 955)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.38834e-06	aparc-DKTatlas_rh_thickness_insula	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.45092e-06	Nervous feelings	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.49997e-06	Phospholipids to total lipids ratio in IDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.53701e-06	Unspecified diabetic retinopathy	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.61328e-06	Gamma glutamyltransferase	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.64312e-06	Glucose levels (UKB data field 30740)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.68058e-06	IDP_dMRI_ProbtrackX_L1_str_r	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.70002e-06	Diagnoses - main ICD10: D64.9 Anaemia, unspecified	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.70598e-06	IBD (strict) with PSC	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.82103e-06	Prostate cancer	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.82103e-06	Prostate cancer	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.83604e-06	Proheparin-binding EGF-like growth factor levels	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.96798e-06	Pulse pressure	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	4.97199e-06	Potassium in urine	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.1e-06	Main speciality of consultant (recoded): General medicine	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.10999e-06	Peripheral atherosclerosis	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.11446e-06	IDP_dMRI_TBSS_ICVF_Posterior_limb_of_internal_capsule_R	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.30005e-06	Concentration of small HDL particles	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.39995e-06	Bone disorder	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.49997e-06	Asthma (childhood onset)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.50098e-06	HLA DR on HLA DR+ Natural Killer	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.54115e-06	IDP_dMRI_TBSS_FA_Cerebral_peduncle_R	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.60003e-06	Triglyceride levels in VLDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.60015e-06	Arm fat mass (right)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.69994e-06	Phospholipids in chylomicrons and extremely large VLDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.71202e-06	Serum uric acid levels	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.72005e-06	IDP_dMRI_TBSS_ICVF_Corticospinal_tract_R	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.79696e-06	IDP_dMRI_ProbtrackX_FA_ptr_l	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.80203e-06	DNA methylation Hannum age acceleration	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.89997e-06	Triglycerides to total lipids ratio in medium LDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.89997e-06	Sex hormone-binding globulin levels adjusted for BMI	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.89997e-06	Platelet count	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	5.96596e-06	Diabetic background retinopathy	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	6.59994e-06	Cholesteryl esters to total lipids ratio in small HDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	6.59994e-06	HDL cholesterol	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	6.64707e-06	Gastrointestinal diseases	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	6.76706e-06	IDP_dMRI_ProbtrackX_L2_unc_l	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	6.80002e-06	Operative procedures - main OPCS: T20.2 Primary repair of inguinal hernia using insert of prosthetic material	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	6.90001e-06	Total lipid levels in VLDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	7.01294e-06	IDP_dMRI_ProbtrackX_MD_ptr_r	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	7.14069e-06	Diagnoses - main ICD10: N40 Hyperplasia of prostate	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	7.15979e-06	wg_rh_intensity-contrast_insula	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	7.25772e-06	IDP_dMRI_TBSS_L3_Cingulum_cingulate_gyrus_L	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	7.40287e-06	IDP_dMRI_ProbtrackX_L2_cgc_r	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	7.4073e-06	Fluid intelligence score	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	7.43807e-06	Macrophage colony-stimulating factor 1 levels	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	7.49998e-06	Prostate cancer	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	7.59994e-06	Mean corpuscular volume	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	7.69999e-06	Concentration of small VLDL particles	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	7.79992e-06	Cholesteryl esters to total lipids ratio in large LDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	7.79992e-06	Age started hormone-replacement therapy (HRT)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	7.8001e-06	IDP_dMRI_TBSS_ICVF_Fornix_cres+Stria_terminalis_R	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	7.94145e-06	IDP_dMRI_TBSS_L2_Posterior_corona_radiata_R	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	8.09991e-06	Total testosterone levels	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	8.09991e-06	Phospholipid levels in chylomicrons and extremely large VLDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	8.09991e-06	Impedance of arm (right)	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	8.28896e-06	IDP_dMRI_ProbtrackX_MD_ptr_l	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	8.32914e-06	BA-exvivo_lh_volume_entorhinal	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	8.40001e-06	Cholesterol levels in small HDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	8.6139e-06	IDP_dMRI_ProbtrackX_FA_cgc_r	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	8.74098e-06	Barrett's esophagus	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	8.74581e-06	aparc-Desikan_rh_thickness_posteriorcingulate	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	8.9929e-06	IDP_dMRI_ProbtrackX_L2_slf_r	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	8.99995e-06	Free cholesterol levels in HDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	9.40005e-06	Total lipids in small VLDL	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	9.58606e-06	Ankylosing spondylitis, strict definition	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	9.77237e-06	Killer cell immunoglobulin-like receptor 2DS2	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130908	9.9977e-06	IDP_dMRI_TBSS_L2_Body_of_corpus_callosum	6	50774	0.296539123805372	2.10576547039534e-08	EasActiv18mo	0.128609
rs3130614	0	Non-cancer illness code  self-reported: malabsorption/coeliac disease	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.30957e-296	ENSG00000204525	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	9.07821e-290	White blood cell count	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	9.07821e-290	white blood cell count	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.27563e-279	ENSG00000253570	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.37088e-271	Lymphocyte count	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.37088e-271	lymphocyte cell count	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.20869e-266	ENSG00000224389	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.30017e-243	White blood cell count	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	8.79023e-226	Lymphocyte count	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.33045e-209	Type 1 diabetes	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.02717e-204	White blood cell leukocyte count (UKB data field 30000)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1e-200	Primary sclerosing cholangitis	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.53131e-192	Lymphocyte count (UKB data field 30120)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.98232e-188	Coeliac disease	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.29087e-173	White blood cell count	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.56451e-173	White blood cell (leukocyte) count	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.1695e-171	Monocyte count	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.1695e-171	monocyte cell count	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.53109e-159	Lymphocyte count	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.2182e-159	Lymphocyte count	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.06196e-137	Monocyte count (UKB data field 30130)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	7.76247e-129	ENSG00000214894	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.17607e-127	Type 1 diabetes	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.49541e-122	Mean reticulocyte volume	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	7.24436e-121	Neutrophil count	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	7.24436e-121	neutrophil cell count	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.25424e-120	ENSG00000244731	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.0797e-113	ENSG00000137331	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.46893e-110	Monocyte count	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.75388e-110	Monocyte count	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.76766e-110	Aspartate aminotransferase levels (UKB data field 30650)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.72796e-109	ENSG00000204338	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.04789e-106	Other diseases of the digestive system (K11_OTHDIG)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.29536e-104	Neutrophil count	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.09742e-103	Never eat eggs, dairy, wheat, sugar: Wheat products	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.31519e-102	Eosinophil counts	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.31519e-102	eosinophil cell count	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.07004e-100	Type 1 diabetes	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.63005e-100	White blood cell count	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.20049e-100	Non-cancer illness code, self-reported: hyperthyroidism/thyrotoxicosis	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.60045e-99	Hyperthyroidism or thyrotoxicosis	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.9002e-97	Neutrophill count (UKB data field 30140)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.63027e-97	Lymphocyte counts	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.91831e-95	MHC class I polypeptide-related sequence B	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.39637e-93	Systemic lupus erythematosus	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.00262e-93	ENSG00000255899	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.43557e-90	Non-cancer illness code  self-reported: hyperthyroidism/thyrotoxicosis	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.88979e-90	Aspartate aminotransferase levels	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.60998e-90	Aspartate aminotransferase	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.10002e-88	Sitting height	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.50003e-88	Eosinophil counts	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.2939e-85	Serum total protein level	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.4568e-85	Total protein	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.48799e-85	Membranous nephropathy	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.2269e-85	Neutrophil count	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.47343e-85	Neutrophill count	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.37598e-81	Total protein	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.68722e-81	Autoimmune diseases	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	7.89951e-80	Reticulocyte count	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.84619e-78	Eosinophill count (UKB data field 30150)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	7.88678e-77	ENSG00000137312	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	7.89951e-72	Thyroid problem (not cancer)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.72333e-71	Type 1 diabetes	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.5209e-68	Mean reticulocyte volume	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.91073e-68	ENSG00000231852	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.49977e-64	Mean spheric corpuscular volume	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.82653e-64	Medication use (thyroid preparations)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.52e-62	Hemoglobin concentration	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.44318e-61	Sitting height	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.49692e-60	Monocyte count	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	8.99912e-60	Diabetes or endocrine disease	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.39994e-59	Reticulocyte fraction of red cells	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.69083e-55	Myeloid white cell count	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.32967e-55	Red blood cell count	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	9.49948e-55	Standing height	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.03205e-54	Eosinophil counts	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.36942e-53	Appendicular lean mass	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.80027e-52	Started insulin within one year diagnosis of diabetes	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.70002e-51	Hemoglobin	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	7.29962e-51	High light scatter reticulocyte count	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.26663e-50	ENSG00000248290	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.49977e-49	Treatment/medication code: insulin product	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	7.76247e-49	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.74864e-48	Haemoglobin concentration (UKB data field 30020)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.96074e-48	Granulocyte count	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.53997e-48	Hypothyroidism or myxoedema (Firth correction)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.03037e-48	Hypothyroidism or myxoedema (SPA correction)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.52939e-47	Sum neutrophil eosinophil counts	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.08718e-46	ENSG00000137411	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.77971e-46	Hematocrit	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.40008e-46	Treatment/medication code: levothyroxine sodium	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	8.2054e-45	Cystatin C levels (UKB data field 30720)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.70595e-44	Reticulocyte count	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.75992e-44	Red cell distribution width	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	8.91251e-44	Glutamate receptor 4	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	9.03025e-44	Platelet count	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.89668e-43	Started insulin within one year diagnosis of diabetes	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.18933e-43	Height	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.30231e-43	Sum eosinophil basophil counts	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.10002e-42	Red blood cell count	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.36678e-42	ENSG00000225059	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.29985e-42	Whole body fat-free mass	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.19952e-42	Whole body water mass	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	8.21675e-42	Sum basophil neutrophil counts	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.5073e-41	Treatment/medication code: insulin product	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	7.53182e-41	Neutrophil count	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	9.2045e-41	Triglyceride levels (UKB data field 30870)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.10002e-40	Leg fat-free mass (right)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.03002e-40	ENSG00000213676	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.29985e-40	Leg predicted mass (right)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.39938e-40	Thyrotoxicosis with diffuse goitre	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.60911e-40	Red blood cell (erythrocyte) distribution width	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.83707e-40	Hemoglobin	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.92464e-40	Haemoglobin concentration	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.49987e-40	Leg fat-free mass (left)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	7.50067e-40	Leg predicted mass (left)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.21004e-39	Peak expiratory flow	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.29985e-39	Basal metabolic rate	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.09813e-39	Platelet count (UKB data field 30080)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.3037e-39	Early-onset myasthenia gravis	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.69658e-39	Standing height	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.80014e-39	Trunk fat-free mass	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.84117e-39	Dermatitis herpetiformis	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	7.77857e-39	Complement C2 measurement	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	8.65964e-39	ENSG00000225851	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.93019e-38	Lung function (FEV1/FVC)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.03189e-38	Hyperthyroidism	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.39994e-38	Trunk predicted mass	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.60016e-38	High light scatter reticulocyte percentage of red cells	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.76822e-38	Reticulocyte count	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.91562e-38	Eosinophil counts	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.79986e-38	Non-cancer illness code, self-reported: hypothyroidism/myxoedema	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	7.55266e-37	Glycated haemoglobin HbA1c levels (UKB data field 30750)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	9.79941e-37	Red cell distribution width	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.37911e-36	Graves' disease	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.10027e-36	Hematocrit	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.90032e-36	Platelet count	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.8776e-36	ENSG00000196419	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	9.76787e-36	ENSG00000211789	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.39991e-35	Arm predicted mass (left)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.70216e-35	Red blood cell erythrocyte count (UKB data field 30010)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.9002e-35	Arm fat-free mass (left)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.99986e-35	Hypothyroidism or myxedema	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.19398e-35	Treatment/medication code: levothyroxine sodium	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.20012e-35	triglycerides	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.11276e-34	Reticulocyte percentage	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.29985e-34	Autoimmune traits	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.3142e-34	Triglycerides	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.34747e-34	Triglycerides	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.13789e-33	Disorders of thyroid, IBD co-morbidities	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.90032e-33	Arm predicted mass (right)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.00867e-33	ENSG00000211797	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.40048e-33	Arm fat-free mass (right)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.28706e-32	Hypothyroidism	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.32809e-32	ENSG00000211734	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.19007e-32	Basophil count	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.19007e-32	basophil cell count	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.3861e-32	Other bullous disorders	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.95114e-32	Leg fat-free mass (right)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.28203e-32	Whole body fat-free mass	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	7.87952e-32	Platelet count	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	7.9873e-32	Platelet count	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.07152e-31	Complement C4	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.26736e-31	Whole body water mass	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.28795e-31	Leg predicted mass (right)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	8.91251e-31	ENSG00000196230	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.17301e-30	Cystatin C	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.20005e-30	Appendicular lean mass	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.516e-30	Cystatin C	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.75509e-30	Non-cancer illness code  self-reported: hypothyroidism/myxoedema	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.02255e-30	Leg fat-free mass (left)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.24078e-30	Leg predicted mass (left)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.58014e-30	Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection, CLOZUK+PGC2	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.92645e-30	Estimated glomerular filtration rate (cystatin c)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.59629e-30	FEV1	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.78496e-30	Aspartate aminotransferase	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.38995e-29	Reticulocyte fraction of red cells	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.68694e-29	Trunk fat-free mass	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.78356e-29	Gamma glutamyltransferase levels (UKB data field 30730)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.07474e-29	Trunk predicted mass	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.35612e-29	Basal metabolic rate	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.55407e-29	diastolic blood pressure	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.05706e-28	High light scatter reticulocyte count	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.05803e-28	ENSG00000206337	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.69981e-28	Ankle spacing width	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.22998e-28	Thyrotoxicosis	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.29192e-28	ENSG00000204351	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.67793e-28	Hemoglobin A1c levels	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.70583e-28	Glycated haemoglobin	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.79228e-28	Cholesterol levels (UKB data field 30690)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.98107e-28	T-cell surface protein tactile	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.9238e-28	Mean sphered cell volume	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.42392e-28	Glycated haemoglobin	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.59993e-27	Weight	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.59179e-27	Estimated glomerular filtration rate (creatinine)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	8.58025e-27	ENSG00000211746	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.17788e-26	Sj<U+00F6>gren's syndrome	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.29987e-26	Weight	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.56423e-26	Triglycerides	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.88866e-26	Mean platelet thrombocyte volume (UKB data field 30100)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.30031e-26	Operative procedures - secondary OPCS: Z27.4 Duodenum	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.47404e-26	Systemic connective tissue disorders	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.60015e-26	White blood cell count (lymphocyte)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	8.03526e-26	Thyrotoxicosis, other and/or unspecified	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	8.49963e-26	apolipoprotein A-I	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.16446e-25	Arm predicted mass (left)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.29989e-25	Autoimmune traits	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.84592e-25	Red blood cell count	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.85035e-25	Mean platelet volume	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.87793e-25	Red blood cell (erythrocyte) count	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	7.15319e-25	Other diseases of the digestive system	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	8.8736e-25	Schizophrenia	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	8.8736e-25	Schizophrenia	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.15213e-24	Arm fat-free mass (right)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.68422e-24	Arm fat-free mass (left)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.99985e-24	Age diabetes diagnosed	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.50026e-24	Mean platelet volume	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.60045e-24	Mean platelet volume	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.44911e-24	ENSG00000204536	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.10103e-23	Schizophrenia	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.50003e-23	Arm predicted mass (right)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.74703e-23	Apolipoprotein A levels (UKB data field 30630)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.5398e-23	Sicca syndrome [Sj<c2><9a>gren]	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.66691e-23	Bread type: Other type of bread	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.60893e-23	IGF 1 (UKB data field 30770)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.56032e-23	Autoimmune hyperthyroidism	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.82653e-23	Hematocrit	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.87385e-23	Haematocrit percentage	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.35988e-22	Total cholesterol levels	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.36678e-22	Cholesterol	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.59698e-22	Cholesterol	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.59809e-22	Weight	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.61622e-22	ENSG00000226660	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.76807e-22	Type 1 diabetes, wide definition, subgroup 1	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.49977e-22	telomere length	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.19963e-22	Basophil count	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.1606e-22	ENSG00000204531	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.79029e-22	ENSG00000204528	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.09537e-22	Other systemic involvement of connective tissue	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.09958e-22	HDL cholesterol	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	8.89201e-22	Apoliprotein A	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	9.10332e-22	ENSG00000174807	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	9.22784e-22	Gamma glutamyl transpeptidase	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	9.29822e-22	Gamma glutamyltransferase	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1e-21	Height	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.02967e-21	High light scatter reticulocyte percentage	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.21899e-21	Type 1 diabetes	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.8239e-21	ENSG00000204438	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.05589e-21	IgA nephropathy	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.78997e-21	Type 1 diabetes without complications	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.57684e-21	Other systemic involvement of connective tissue (FG)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.37522e-21	Creatinine levels (UKB data field 30700)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.30376e-21	Estimated glomerular filtration rate (creatinine)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.4003e-21	Operation code: thyroidectomy/partial thyroidectomy	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	8.60994e-21	Mean platelet (thrombocyte) volume	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	8.69961e-21	Hypothyroidism	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.27087e-20	Bullous disorders	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.29987e-20	Bowel problem	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.19989e-20	Diagnoses - secondary ICD10: E03.9 Hypothyroidism, unspecified	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.39994e-20	Medication for cholesterol, blood pressure or diabetes: Insulin	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.70023e-20	Hip circumference	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.10027e-20	Non-cancer illness code, self-reported: asthma	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.19963e-20	Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor: Asthma	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.40048e-20	IGF-1	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.07107e-20	High light scatter reticulocyte count	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.10035e-20	Time to complete round	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.46764e-20	Varicella zoster virus glycoproteins E and I antibody levels	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	7.27277e-20	Estimated glomerular filtration rate (creatinine)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	8.4004e-20	Diagnoses - main ICD10: R31 Unspecified haematuria	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	8.69961e-20	Eosinophil percentage of white cells	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.64816e-19	Weight	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.80011e-19	Comparative body size at age 10, Males and Females	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.05921e-19	Complement C4 levels	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.12667e-19	Blood clot  DVT  bronchitis  emphysema  asthma  rhinitis  eczema  allergy diagnosed by doctor: Asthma	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.24905e-19	Hemoglobin concentration	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.29985e-19	Connective tissue disorder	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.39994e-19	Comparative body size at age 10	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.47514e-19	High density lipoprotein cholesterol levels (UKB data field 30760)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.15937e-19	ENSG00000211782	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.29306e-19	Type 1 diabetes with ophthalmic complications	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.07943e-19	ENSG00000204308	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.89892e-19	Type 1 diabetes, wide definition	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.67421e-19	Schizophrenia	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.67421e-19	schizophrenia	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	8.43723e-19	Medication for cholesterol  blood pressure or diabetes: Insulin	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	9.20026e-19	Diastolic blood pressure, automated reading	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	9.54113e-19	Non-cancer illness code  self-reported: asthma	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	9.60064e-19	Plateletcrit	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.22208e-18	Platelet count	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.59038e-18	IGF-1	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.59661e-18	Hip circumference (UKB data field 49)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.40017e-18	Other serious medical condition/disability diagnosed by doctor	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.69999e-18	Appendicular lean mass	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.95564e-18	ENSG00000204304	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.70033e-18	Ankle spacing width (right)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	8.22811e-18	Apoliprotein A	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	8.31572e-18	White blood cell count (basophil)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.06121e-17	Lung cancer	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.06121e-17	Lung cancer	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.20005e-17	FEV1/FVC < 0.7	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.59993e-17	Asthma	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.99986e-17	Hot drink temperature	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.29298e-17	Disorders of the thyroid gland	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.37739e-17	Total bilirubin levels (UKB data field 30840)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.40658e-17	Total bilirubin levels (UKB data field 30840)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.5704e-17	HLA class II histocompatibility antigen, DQ alpha 2 chain	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.64606e-17	Type 1 diabetes with other specified/multiple/unspecified complications	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.06902e-17	IDP_dMRI_TBSS_L1_Superior_longitudinal_fasciculus_L	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.78268e-17	Other predominantly sexually transmitted diseases, not elsewhere classified	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.02254e-17	HDL cholesterol	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.03738e-17	HDL cholesterol	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.93335e-17	Systemic lupus erythematosus	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.34892e-17	Type 1 diabetes (SPA correction)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.62217e-17	Type 1 diabetes (Firth correction)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	7.10068e-17	Medication for pain relief, constipation, heartburn: Paracetamol	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	7.59976e-17	Operative procedures - main OPCS: M45.9 Unspecified diagnostic endoscopic examination of bladder	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	8.30042e-17	Impedance of leg (left)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	8.59805e-17	Mean corpuscular hemoglobin concentration	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	8.6278e-17	Mean corpuscular haemoglobin concentration	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.25777e-16	Cereal type: Other (e.g. Cornflakes, Frosties)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.50003e-16	Non-cancer illness code, self-reported: psoriasis	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.69981e-16	Medication for pain relief, constipation, heartburn: None of the above	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.93197e-16	Squamous cell lung cancer	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.93197e-16	Squamous cell lung cancer	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.95794e-16	Lung cancer	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.98198e-16	Asthma (Firth correction)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.08545e-16	Asthma (SPA correction)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.1702e-16	Hypothyroidism, strict autoimmune	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.30994e-16	ENSG00000204444	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.70023e-16	Mean corpuscular hemoglobin concentration	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.19816e-16	ENSG00000250535	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.30031e-16	Ankle spacing width (left)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.00035e-16	Mouth/teeth dental problems: Dentures	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.18203e-16	Serum creatinine levels	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.20116e-16	Creatinine	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.68344e-16	Platelet crit	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.70039e-16	Age at menopause (last menstrual period)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	9.01779e-16	Diabetic ketoacidosis	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	9.50605e-16	IDP_dMRI_ProbtrackX_ICVF_ptr_r	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.05269e-15	Diastolic blood pressure automated reading (UKB data field 4079)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.10002e-15	Polyunsaturated fatty acid levels	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.27791e-15	Type 1 diabetes, strict (exclude DM2)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.3471e-15	ENSG00000204386	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.39316e-15	Squamous cell lung carcinoma	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.44012e-15	Red blood cell count	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.46589e-15	Type 1 diabetes, strict definition, subgroup 1	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.58489e-15	Trypsin-3	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.75106e-15	Type1 diabetes, definitions combined	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.20191e-15	ENSG00000204305	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.48428e-15	Psoriasis	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.48428e-15	Psoriasis	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.90001e-15	Impedance of leg (right)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.94849e-15	Non-cancer illness code  self-reported: psoriasis	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.23817e-15	Intestinal malabsorbtion	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.40408e-15	High light scatter reticulocyte percentage of red cells	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.60081e-15	Hematocrit	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.80014e-15	Number of fluid intelligence questions attempted within time limit	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.4157e-15	Lichen planus	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.87304e-15	Type 1 diabetes, strict definition	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.19039e-15	ENSG00000240053	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.43626e-15	Comparative body size at age 10	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.65886e-15	Epstein-Barr virus ZEBRA antibody levels	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	7.10559e-15	Severe autoimmune type 2 diabetes	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	8.27752e-15	Triglycerides	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	8.27752e-15	Triglycerides	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	8.31764e-15	Beta-defensin 119	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	9.20026e-15	Low density lipoprotein cholesterol levels	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.09648e-14	Interleukin-21	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.19399e-14	IDP_dMRI_TBSS_L1_Sagittal_stratum_L	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.34896e-14	Rac GTPase-activating protein 1	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.39605e-14	Postprocedural endocrine and metabolic disorders, not elsewhere classified	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.39991e-14	Main speciality of consultant (recoded): Urology	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.82474e-14	Other serious medical condition/disability diagnosed by doctor	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.8681e-14	ENSG00000211785	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.95704e-14	Hypothyroidism,  other/unspecified	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.05589e-14	IDP_dMRI_TBSS_MD_Posterior_thalamic_radiation_L	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.07014e-14	SLE (Finngen)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.1732e-14	Hip circumference	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.19989e-14	Comparative body size at age 10, Females	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.28087e-14	Plateletcrit	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.6872e-14	Type 1 diabetes with coma	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.87144e-14	HDL cholesterol	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.15283e-14	Diastolic blood pressure	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.16082e-14	Lung cancer	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.16082e-14	Lung cancer	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.19963e-14	Never eat eggs, dairy, wheat, sugar: I eat all of the above	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.43005e-14	Proliferative diabetic retinopathy (DM_RETINA_PROLIF)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.78704e-14	Sjogren's syndrome (SPA correction)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.8699e-14	Sjogren's syndrome (Firth correction)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.54046e-14	Mean corpuscular hemoglobin concentration	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.93742e-14	Medication for pain relief  constipation  heartburn: None of the above	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.97737e-14	IDP_dMRI_TBSS_MD_Posterior_thalamic_radiation_R	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	7.09088e-14	Diagnoses - main ICD10: R31 Unspecified haematuria	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	8.37529e-14	IDP_dMRI_TBSS_MD_Sagittal_stratum_R	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	8.64968e-14	IDP_dMRI_TBSS_L1_Sagittal_stratum_R	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	8.93305e-14	ENSG00000166278	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.02212e-13	Diabetic hypoglycemia	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.43549e-13	IDP_dMRI_TBSS_ICVF_Posterior_thalamic_radiation_R	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.50003e-13	Forced expiratory volume in 1-second (FEV1), predicted percentage	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.52405e-13	Hypothyroidism, strict autoimmune, 3 medication purchases required	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.59258e-13	ENSG00000211747	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.83189e-13	Impedance of leg (left)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.86123e-13	Lung cancer in ever smokers	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.88365e-13	Treatment/medication code: thyroxine product	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.39994e-13	Omega-6 fatty acid levels	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.49977e-13	Linoleic acid levels	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.5781e-13	Alanine aminotransferase levels (UKB data field 30620)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.58107e-13	Diabetes-related co-morbidities/complications (more controls excluded)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.90001e-13	Asthma	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.99985e-13	Polyunsaturated fatty acids	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.01301e-13	ENSG00000211801	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.50671e-13	Medication use (drugs used in diabetes)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.80014e-13	Neutrophil percentage of white cells	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.3431e-13	Diastolic blood pressure  automated reading	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.62381e-13	IDP_dMRI_TBSS_MD_Sagittal_stratum_L	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.12035e-13	Basophil count	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.21915e-13	Diabetic retinopathy (DM_RETINOPATHY)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.39138e-13	SLE, strict definition	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.79963e-13	Esophageal disorder	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.19869e-13	Eosinophill percentage	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.69885e-13	Height	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	7.17464e-13	Impedance of leg (right)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	7.61728e-13	Diabetic retinopathy (H7_RETINOPATHYDIAB)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	9.45148e-13	Other metabolic disorders	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	9.70063e-13	Treatment/medication code: thyroxine product	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	9.9793e-13	Glucose	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.10002e-12	Oily fish intake	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.14868e-12	ENSG00000186470	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.20005e-12	3mm weak meridian (left)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.39991e-12	Long-standing illness, disability or infirmity	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.49383e-12	C reactive protein levels (UKB data field 30710)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.50003e-12	Glycoprotein acetyls levels	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.64816e-12	ENSG00000125843	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.87327e-12	ENSG00000204428	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.9002e-12	Respiratory or ear-nose-throat disease	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.27405e-12	Medication use (adrenergics, inhalants)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.29985e-12	Total fatty acid levels	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.31953e-12	ENSG00000211810	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.6903e-12	Systemic lupus erythematosus	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.80737e-12	Medication for pain relief  constipation  heartburn: Paracetamol	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.90001e-12	3mm strong meridian (left)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.20553e-12	Forced expiratory volume in 1-second (FEV1)  predicted percentage	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.39313e-12	ENSG00000211721	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.50752e-12	IDP_dMRI_TBSS_ICVF_Sagittal_stratum_R	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.69999e-12	Operation code: varicose vein surgery	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.0281e-12	ENSG00000211777	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.42588e-12	IDP_dMRI_TBSS_ICVF_Posterior_thalamic_radiation_L	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.74351e-12	Treatment/medication code: carbimazole	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.59933e-12	Duration screen displayed	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.7733e-12	Hashimoto thyroiditis	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.96627e-12	Epstein-Barr virus EA-D antibody levels	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	7.00003e-12	Linoleic acid	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	7.24436e-12	IDP_dMRI_ProbtrackX_L1_slf_l	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	7.59976e-12	Phospholipids in medium HDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	7.78933e-12	Diabetic retinopathy (more controls excluded)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	7.92684e-12	Hypothyroidism, drug reimbursement	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	8.60003e-12	Monounsaturated fatty acid levels	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	8.79427e-12	Nephrotic syndrome	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	8.90225e-12	Any parental history of lung cancer (Firth correction)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	9.17487e-12	Medication use (anilides)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	9.22359e-12	Any parental history of lung cancer (SPA correction)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.09648e-11	IDP_dMRI_ProbtrackX_ICVF_ptr_l	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.1995e-11	IDP_dMRI_ProbtrackX_ICVF_cst_r	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.20005e-11	Omega-3 fatty acid levels	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.20005e-11	Treatment/medication code: paracetamol	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.20754e-11	Comparative height size at age 10	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.37658e-11	Creatinine	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.40702e-11	Cholesterol, total	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.40702e-11	Total cholesterol	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.45881e-11	IDP_dMRI_TBSS_ICVF_Retrolenticular_part_of_internal_capsule_L	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.57507e-11	Diabetes, several complications	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.60657e-11	Peak expiratory flow (UKB data field 3064)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.63946e-11	ENSG00000211814	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.64437e-11	IDP_dMRI_TBSS_MD_Superior_longitudinal_fasciculus_L	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.65959e-11	IDP_dMRI_TBSS_L3_Posterior_thalamic_radiation_R	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.66495e-11	Endocrine, nutritional and metabolic diseases	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.80011e-11	Omega-6 fatty acids	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.80011e-11	Impedance of whole body	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.81552e-11	IDP_dMRI_ProbtrackX_ICVF_ifo_r	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.09991e-11	Glycoprotein acetyls	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.09991e-11	Total fatty acids	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.39994e-11	Phospholipid levels in medium HDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.46888e-11	Polymyositis	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.70023e-11	Red cell distribution width	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.90001e-11	Monounsaturated fatty acids	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.90001e-11	3mm strong meridian (right)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.97167e-11	IDP_dMRI_ProbtrackX_ICVF_ilf_r	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.04369e-11	Infections with a predominantly sexual mode of transmission	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.07114e-11	Other retinal disorders	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.11172e-11	IDP_dMRI_TBSS_ICVF_Retrolenticular_part_of_internal_capsule_R	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.19963e-11	Trunk fat mass	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.50026e-11	Phospholipid levels in small HDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.74973e-11	IDP_dMRI_TBSS_L2_Posterior_thalamic_radiation_L	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.00221e-11	Malignant lymphoma	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.08319e-11	ThalamNuclei_rh_volume_LD	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.19952e-11	3mm weak meridian (right)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.68382e-11	Diabetic neuropathy	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.7687e-11	ENSG00000163463	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.90004e-11	Phosphoglycerides levels	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.40008e-11	Omega-3 fatty acids	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.50047e-11	Total lipids in medium HDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.60015e-11	Age at menopause	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.79963e-11	Phospholipids to total lipids ratio in small LDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.91698e-11	C-reactive protein	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.03949e-11	IDP_dMRI_TBSS_L3_Sagittal_stratum_R	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.70039e-11	ENSG00000211791	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.70039e-11	Treatment speciality of consultant (recoded): Urology	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	7.46449e-11	IDP_dMRI_ProbtrackX_MD_ilf_l	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	7.70371e-11	Dermatopolymyositis (FG)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	7.74283e-11	Systemic lupus erythematosus, unspecified	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	7.86321e-11	ENSG00000211807	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	8.00018e-11	Cholesteryl esters to total lipids ratio in small LDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	8.9002e-11	Time to answer	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	9.40156e-11	Eosinophil percentage of granulocytes	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	9.41456e-11	Type 1 diabetes with neurological complications	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	9.7051e-11	IDP_dMRI_TBSS_MD_Retrolenticular_part_of_internal_capsule_R	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	9.77462e-11	Dermatopolymyositis	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.09999e-10	Illnesses of father: Lung cancer	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.09999e-10	Operative procedures - main OPCS: G45.1 Fibreoptic endoscopic examination of upper gastrointestinal tract and biopsy of lesion of upper gastrointestinal tract	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.1652e-10	ENSG00000169507	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.17193e-10	IDP_dMRI_TBSS_L1_Posterior_thalamic_radiation_R	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.24997e-10	IDP_dMRI_ProbtrackX_ICVF_ifo_l	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.5e-10	Height	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.58701e-10	C-reactive protein	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.6e-10	Triglycerides in very small VLDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.68306e-10	IDP_dMRI_ProbtrackX_L1_ilf_r	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.74221e-10	IDP_dMRI_TBSS_OD_Superior_longitudinal_fasciculus_L	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.76401e-10	ENSG00000119535	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.79999e-10	Platelet count	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.79999e-10	Phosphoglycerides	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.79999e-10	Free cholesterol to total lipids ratio in small LDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.79999e-10	Diabetes diagnosed by doctor	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.81761e-10	IDP_dMRI_TBSS_L1_Posterior_corona_radiata_L	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.86939e-10	IDP_dMRI_ProbtrackX_ICVF_ilf_l	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2e-10	Total lipid levels in medium HDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.1e-10	Triglyceride levels in very small VLDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.1e-10	Phospholipids in small HDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.192e-10	Receptor for advanced glycosylation end products levels	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.20882e-10	Diabetes diagnosed by doctor	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.25398e-10	Red cell distribution width	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.49e-10	Total bilirubin levels	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.4927e-10	Total bilirubin	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.5e-10	Cholesteryl esters to total lipids ratio in small LDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.67301e-10	IDP_dMRI_TBSS_L1_Posterior_thalamic_radiation_L	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.75867e-10	IDP_dMRI_ProbtrackX_MD_ifo_r	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.7919e-10	IDP_dMRI_ProbtrackX_MD_slf_l	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.80001e-10	Seen a psychiatrist for nerves, anxiety, tension or depression	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.90001e-10	Concentration of medium HDL particles	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.01898e-10	ENSG00000211751	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.09999e-10	Phospholipids to total lipids ratio in small LDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.2e-10	Cognitive performance	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.22404e-10	Autoimmune hepatitis	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.40001e-10	Free cholesterol levels in small HDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.40197e-10	Neutrophil percentage of granulocytes	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.6266e-10	IDP_dMRI_TBSS_ICVF_Sagittal_stratum_L	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.63915e-10	IDP_dMRI_TBSS_MD_Superior_corona_radiata_L	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4e-10	Total lipid levels in small HDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4e-10	Triglycerides in IDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4e-10	Phospholipids in HDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.20001e-10	Triglycerides in medium HDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.44529e-10	IDP_dMRI_ProbtrackX_ICVF_ar_r	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.94561e-10	Long-standing illness  disability or infirmity	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.03617e-10	IDP_dMRI_ProbtrackX_MD_ilf_r	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.05022e-10	Calcium levels (UKB data field 30680)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.39995e-10	Triglycerides in very large HDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.4325e-10	IDP_dMRI_ProbtrackX_FA_ptr_r	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.46009e-10	IDP_dMRI_ProbtrackX_MD_ifo_l	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.67153e-10	IDP_dMRI_TBSS_L3_Posterior_thalamic_radiation_L	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.69994e-10	Apolipoprotein A1	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.70847e-10	Endocrine, nutritional and metabolic diseases	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.09425e-10	Direct low density lipoprotein levels (UKB data field 30780)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.33199e-10	Triglycerides	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.33199e-10	Triglycerides	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.52499e-10	Hypothyroidism (congenital or acquired)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.62979e-10	IDP_dMRI_ProbtrackX_ICVF_fma	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.8355e-10	Mouth/teeth dental problems: Dentures	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.90001e-10	Number of days/week of moderate physical activity 10+ minutes	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.9456e-10	Direct low density lipoprotein levels (UKB data field 30780)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.99198e-10	IDP_dMRI_TBSS_ICVF_Posterior_corona_radiata_L	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	7.00003e-10	Triglycerides in HDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	7.39997e-10	Triglyceride levels in IDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	7.73357e-10	Primary_lymphoid and hematopoietic malignant neoplasms	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	7.77678e-10	IDP_dMRI_ProbtrackX_L2_ifo_l	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	7.87771e-10	IDP_dMRI_TBSS_MD_Retrolenticular_part_of_internal_capsule_L	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	7.90005e-10	Arm fat mass (left)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	8.046e-10	Type 1 diabetes with ketoacidosis	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	8.09208e-10	Hypothyroidism, levothyroxin purchases	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	8.09208e-10	Hypothyroidism and >3 levothyroxin purchases	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	8.18295e-10	Diabethic neuropathy	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	8.70362e-10	IDP_dMRI_ProbtrackX_L1_slf_r	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	8.79995e-10	Total cholines levels	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	9.04066e-10	IDP_dMRI_ProbtrackX_ICVF_str_r	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	9.09997e-10	Salad / raw vegetable intake	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.00399e-09	Basophil count	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.05584e-09	IDP_dMRI_TBSS_MD_Posterior_corona_radiata_L	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.07771e-09	ThalamNuclei_rh_volume_CL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.09999e-09	6mm strong meridian (left)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.12202e-09	aseg_rh_intensity_Pallidum	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.14578e-09	aparc-DKTatlas_lh_area_middletemporal	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.15398e-09	IDP_dMRI_ProbtrackX_L3_ilf_l	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.17706e-09	IDP_dMRI_ProbtrackX_ICVF_ar_l	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.2099e-09	Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.21989e-09	ENSG00000211806	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.23501e-09	Eosinophil percentage of white cells	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.29563e-09	Epstein-Barr virus EBNA-1 antibody levels	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.40001e-09	Concentration of medium HDL particles	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.69161e-09	aparc-a2009s_lh_area_S-temporal-sup	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.7e-09	White blood cell count (monocyte)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.7358e-09	IDP_T1_FAST_ROIs_L_thalamus	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.78813e-09	IDP_dMRI_ProbtrackX_L1_ilf_l	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.96101e-09	Colitis, primary sclerosing	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2e-09	Phosphatidylcholine levels	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2e-09	Free cholesterol in medium HDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2e-09	Total lipids in HDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.02209e-09	IDP_dMRI_ProbtrackX_ICVF_cst_l	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.1e-09	Triglycerides in large HDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.17701e-09	Medication use (drugs for peptic ulcer and gastro-oesophageal reflux disease)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.197e-09	Rheumatoid arthritis	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.2475e-09	IDP_dMRI_TBSS_L3_Retrolenticular_part_of_internal_capsule_R	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.39999e-09	Total cholines	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.39999e-09	Phospholipids to total lipids ratio in large LDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.39999e-09	Hearing difficulty/problems with background noise	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.57537e-09	ENSG00000211816	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.64728e-09	IDP_dMRI_TBSS_ICVF_Superior_corona_radiata_R	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.69998e-09	Triglycerides in small VLDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.80001e-09	Apolipoprotein A1 levels	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.80001e-09	Free cholesterol in small HDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.80001e-09	Total lipids in small HDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.80001e-09	Seen doctor (GP) for nerves, anxiety, tension or depression	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.80479e-09	IDP_dMRI_ProbtrackX_L2_ilf_l	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.82748e-09	IDP_dMRI_TBSS_L2_Anterior_corona_radiata_L	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.84315e-09	Neutrophill percentage	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.95257e-09	IDP_dMRI_ProbtrackX_L3_ifo_r	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.99999e-09	6mm strong meridian (right)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.09999e-09	Whole body fat mass	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.27341e-09	aparc-DKTatlas_rh_area_insula	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.29997e-09	Total phospholipid levels in lipoprotein particles	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.40001e-09	Free cholesterol to total lipids ratio in small LDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.59998e-09	Phospholipid levels in HDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.66151e-09	ENSG00000134193	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.75578e-09	aparc-Desikan_lh_area_middletemporal	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.89996e-09	Concentration of HDL particles	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.94912e-09	aparc-DKTatlas_lh_thickness_insula	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.20001e-09	Triglyceride levels in medium HDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.30002e-09	Total concentration of lipoprotein particles	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.30002e-09	Phosphatidylcholines	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.38632e-09	wg_lh_intensity-contrast_superiorfrontal	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.49128e-09	ENSG00000113088	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.60002e-09	Concentration of HDL particles	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.70002e-09	Phospholipids to total lipids ratio in large LDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.71455e-09	Impedance of whole body	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.7457e-09	IDP_dMRI_ProbtrackX_ICVF_fmi	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.79999e-09	Basal metabolic rate	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.89892e-09	IDP_dMRI_ProbtrackX_L3_ifo_l	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.90004e-09	Pain type(s) experienced in last month: Headache	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.05941e-09	IDP_dMRI_ProbtrackX_L2_ifo_r	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.16654e-09	IDP_dMRI_TBSS_ICVF_Pontine_crossing_tract	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.39995e-09	Cholesterol to total lipids ratio in IDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.39995e-09	Arm fat mass (right)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.56276e-09	ENSG00000094916	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.62989e-09	IDP_dMRI_ProbtrackX_L3_ilf_r	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.75241e-09	ENSG00000091129	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.80003e-09	Triglyceride levels in small VLDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.99377e-09	IDP_dMRI_TBSS_ICVF_Superior_corona_radiata_L	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.00897e-09	Calcium levels	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.0116e-09	Calcium	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.20155e-09	aparc-a2009s_lh_thickness_Lat-Fis-ant-Vertical	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.29999e-09	Triglycerides in small LDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.45208e-09	IDP_dMRI_TBSS_MD_Cingulum_cingulate_gyrus_L	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.61302e-09	IDP_dMRI_TBSS_ICVF_Body_of_corpus_callosum	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.8124e-09	IDP_dMRI_ProbtrackX_ICVF_ml_l	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	7.07946e-09	ThalamNuclei_rh_volume_LP	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	7.28954e-09	IDP_dMRI_TBSS_L1_Superior_corona_radiata_R	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	7.55945e-09	ENSG00000234745	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	7.69999e-09	6mm weak meridian (right)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	7.86683e-09	IDP_dMRI_TBSS_MD_Superior_corona_radiata_R	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	8.19993e-09	Forced expiratory volume in 1-second (FEV1), predicted	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	8.34795e-09	Pediatric asthma	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	8.84464e-09	Lymphomas	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	9.05733e-09	IDP_dMRI_TBSS_MD_Anterior_corona_radiata_L	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	9.20005e-09	Triglyceride levels in HDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	9.2747e-09	wg_rh_intensity-contrast_superiorfrontal	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	9.29994e-09	Total concentration of lipoprotein particles	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	9.92522e-09	ENSG00000041357	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1e-08	Total phospholipids in lipoprotein particles	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.02896e-08	IDP_dMRI_ProbtrackX_L2_fmi	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.08778e-08	Cancer of primary lymphoid hematopoietic	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.09999e-08	Lymphocyte percentage of white cells	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.09999e-08	Cholesteryl esters to total lipids ratio in IDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.09999e-08	6mm weak meridian (left)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.15001e-08	Lung function (FVC)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.16399e-08	Crohn's disease	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.17201e-08	Colitis, primary sclerosing, strict definition	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.2e-08	Free cholesterol levels in medium HDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.2e-08	Dried fruit intake	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.20226e-08	Ubiquitin-like protein ISG15	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.2598e-08	IDP_dMRI_TBSS_MD_Superior_longitudinal_fasciculus_R	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.278e-08	Cholangitis (primary sclerosing, PSC), with reimbursement 202	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.28991e-08	ENSG00000211714	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.295e-08	Alanine aminotransferase levels	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.29509e-08	Alanine aminotransferase	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.40001e-08	Triglyceride levels in small LDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.424e-08	Disorders of lacrimal system and orbit in diseases classified elsewhere	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.4737e-08	ENSG00000177169	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.54e-08	KELA_REIMBURSEMENT_202	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.55382e-08	IDP_dMRI_ProbtrackX_FA_ifo_l	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.56571e-08	ENSG00000144152	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.58489e-08	Granulysin	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.6e-08	Triglyceride levels in medium LDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.7e-08	Triglyceride levels in LDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.7e-08	Triglycerides to total lipids ratio in small LDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.7e-08	Ever depressed for a whole week	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.70098e-08	IDP_dMRI_TBSS_L3_Sagittal_stratum_L	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.73061e-08	IDP_dMRI_TBSS_L2_Anterior_corona_radiata_R	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.79999e-08	Total lipid levels in HDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.80838e-08	ENSG00000228789	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.81681e-08	ENSG00000221988	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.82432e-08	BA-exvivo_rh_volume_entorhinal	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.8514e-08	IDP_dMRI_ProbtrackX_L2_slf_l	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.89998e-08	Triglyceride levels in very large HDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.89998e-08	Triglycerides in LDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2e-08	Free cholesterol to total lipids ratio in medium LDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.05017e-08	Treatment/medication code: paracetamol	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.05447e-08	IDP_dMRI_TBSS_ICVF_Superior_longitudinal_fasciculus_R	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.09991e-08	IDP_dMRI_ProbtrackX_ICVF_cgc_r	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.13599e-08	Asthma	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.175e-08	Iridocyclitis	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.23152e-08	IDP_T1_FAST_ROIs_L_temp_fusif_cortex_post	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.25772e-08	ENSG00000090920	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.28349e-08	IDP_dMRI_TBSS_L1_Superior_longitudinal_fasciculus_R	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.30001e-08	Moderate to vigorous physical activity levels	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.3832e-08	ENSG00000204520	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.5e-08	Nervous feelings	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.62313e-08	Seen psychiatrist for nerves anxiety tension or depression (UKB data field 2100) (SPA correction)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.69668e-08	Seen psychiatrist for nerves anxiety tension or depression (UKB data field 2100) (Firth correction)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.86926e-08	Number of incorrect matches in round	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.89561e-08	Pain type(s) experienced in last month: Headache (UKB data field 6159_1) (SPA correction)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.90001e-08	Triglycerides in large LDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.90001e-08	Peak expiratory flow (PEF)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.94056e-08	Pain type(s) experienced in last month: Headache (UKB data field 6159_1) (Firth correction)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.99999e-08	Cholesterol in medium HDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.09386e-08	IDP_dMRI_ProbtrackX_FA_fmi	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.09999e-08	Triglyceride levels in large LDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.17176e-08	IDP_dMRI_ProbtrackX_ICVF_slf_l	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.18053e-08	ENSG00000087253	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.29997e-08	Number of incorrect matches in round	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.38174e-08	Urate levels (UKB data field 30880)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.46298e-08	Bipolar disorder bip2021	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.4914e-08	IDP_dMRI_TBSS_L1_Superior_corona_radiata_L	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.49784e-08	IDP_dMRI_ProbtrackX_L1_ifo_r	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.50002e-08	Triglycerides in medium LDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.79997e-08	Treatment/medication code: calcichew d3 tablet	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4e-08	Free cholesterol to total lipids ratio in large LDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.08e-08	Lung cancer	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.09996e-08	Non-oily fish intake	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.30002e-08	Cholesteryl esters in chylomicrons and extremely large VLDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.32116e-08	IDP_dMRI_ProbtrackX_MD_cgc_l	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.49997e-08	Creatinine levels	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.77749e-08	ENSG00000256039	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.79999e-08	Diabetes	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.93515e-08	IDP_dMRI_ProbtrackX_MD_slf_r	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.03269e-08	IDP_dMRI_TBSS_L2_Posterior_thalamic_radiation_R	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.09695e-08	Acute and subacute iridocyclitis	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.098e-08	IDP_dMRI_TBSS_ICVF_Superior_longitudinal_fasciculus_L	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.10799e-08	CX3CL1 levels	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.30005e-08	Gastroesophageal reflux disease or gastric reflux	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.30005e-08	Cholesterol to total lipids ratio in IDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.34687e-08	IDP_dMRI_TBSS_MD_Anterior_corona_radiata_R	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.49997e-08	Hiatus hernia	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.56634e-08	ENSG00000204315	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.76806e-08	Neutrophil percentage of white cells	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.80003e-08	Creatinine	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.89997e-08	haemotological cancer	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.90895e-08	Certain infectious and parasitic diseases	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.12491e-08	IDP_dMRI_TBSS_L3_Retrolenticular_part_of_internal_capsule_L	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.41505e-08	Arthropod-borne viral fevers and viral haemorrhagic fevers	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.45654e-08	Spermatogenesis-associated protein 20	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.49995e-08	Triglyceride levels in large HDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.60693e-08	IDP_dMRI_ProbtrackX_L2_unc_r	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.624e-08	Disorders of choroid and retina	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.76706e-08	IDP_dMRI_TBSS_ICVF_Splenium_of_corpus_callosum	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.88177e-08	Calcium	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.90001e-08	Cholesteryl ester levels in chylomicrons and extremely large VLDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	7.01294e-08	Bipolar disorder bip2021 noUKBB	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	7.13247e-08	Seen doctor for nerves anxiety tension or depression (UKB data field 2090) (SPA correction)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	7.17596e-08	Seen doctor for nerves anxiety tension or depression (UKB data field 2090) (Firth correction)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	7.28115e-08	IDP_dMRI_TBSS_ICVF_Genu_of_corpus_callosum	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	7.39997e-08	Frequency of light DIY in last 4 weeks	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	7.67008e-08	Other specified/unspecified systemic involvement of connective tissue	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	7.80405e-08	Cholesterol, total	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	7.8759e-08	BA-exvivo_rh_thickness_entorhinal	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	7.89769e-08	aseg_lh_intensity_Pallidum	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	7.91353e-08	Treatment/medication code: ventolin 100micrograms inhaler	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	8.12194e-08	ENSG00000204475	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	8.30004e-08	Cholesteryl esters in medium HDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	8.35411e-08	IDP_dMRI_TBSS_L3_Superior_longitudinal_fasciculus_R	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	8.39615e-08	ENSG00000204387	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	8.60003e-08	Non-cancer illness code, self-reported: enlarged prostate	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	8.70001e-08	Cholesterol in chylomicrons and extremely large VLDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	8.71164e-08	IDP_dMRI_TBSS_ICVF_Anterior_corona_radiata_L	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	9.09997e-08	Illnesses of siblings: Diabetes	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	9.2151e-08	IDP_dMRI_ProbtrackX_ICVF_slf_r	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	9.78363e-08	IDP_dMRI_ProbtrackX_ICVF_str_l	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	9.80009e-08	Cholesteryl esters to total lipids ratio in IDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	9.81296e-08	Familial combined hyperlipidemia defined by Consensus criteria	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1e-07	Treatment/medication code: ventolin 100micrograms inhaler	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.02492e-07	Illnesses of father: Lung cancer	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.03371e-07	IDP_dMRI_TBSS_L3_Anterior_corona_radiata_R	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.09999e-07	Triglycerides to total lipids ratio in small LDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.15638e-07	IDP_dMRI_TBSS_L3_Anterior_corona_radiata_L	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.17725e-07	Non-cancer illness code  self-reported: enlarged prostate	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.19399e-07	IDP_dMRI_TBSS_FA_Splenium_of_corpus_callosum	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.2e-07	Tyrosine levels	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.242e-07	ENSG00000204469	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.25343e-07	IDP_dMRI_TBSS_ICVF_Medial_lemniscus_R	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.28825e-07	IDP_dMRI_ProbtrackX_FA_ilf_l	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.28825e-07	Polypeptide N-acetylgalactosaminyltransferase 1	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.35831e-07	wg_lh_intensity-contrast_insula	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.42659e-07	aparc-pial_lh_area_middletemporal	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.43499e-07	Certain disorders involving the immune mechanism	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.5e-07	Cholesterol levels in medium HDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.5e-07	Leg fat mass (left)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.51078e-07	IDP_dMRI_TBSS_L2_Splenium_of_corpus_callosum	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.54277e-07	IDP_dMRI_TBSS_OD_Superior_corona_radiata_R	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.54401e-07	First line medication for Crohns disease	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.575e-07	Feeling nervous	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.58307e-07	IDP_dMRI_TBSS_OD_Posterior_corona_radiata_L	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.6e-07	Cholesterol levels in chylomicrons and extremely large VLDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.6e-07	Treatment speciality of consultant (recoded): General medicine	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.626e-07	LDL direct	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.7e-07	Free cholesterol to total lipids ratio in large LDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.75102e-07	Worry	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.79999e-07	Free cholesterol to total lipids ratio in medium LDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.79999e-07	Docosahexaenoic acid	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.86595e-07	IDP_dMRI_ProbtrackX_L2_ilf_r	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.88999e-07	Mean corpuscular volume	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2e-07	Triglycerides to total lipids ratio in IDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.02815e-07	aparc-Desikan_rh_thickness_isthmuscingulate	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.1e-07	Saturated fatty acid levels	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.24388e-07	IDP_dMRI_TBSS_ICVF_Middle_cerebellar_peduncle	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.30001e-07	Asthma (adult onset)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.37799e-07	Height	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.42941e-07	IDP_dMRI_TBSS_L1_Retrolenticular_part_of_internal_capsule_L	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.524e-07	LDL cholesterol	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.5279e-07	LDL direct	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.61048e-07	Apolipoprotein B levels (UKB data field 30640)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.64503e-07	Type 1 diabetes with renal complications	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.73571e-07	ENSG00000175730	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.77204e-07	IDP_T1_FAST_ROIs_R_paracing_gyrus	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.80001e-07	White blood cell count	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.81514e-07	Non-cancer illness code  self-reported: diabetes	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.93731e-07	Urate	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.95876e-07	Diseases of the genitourinary system	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.04369e-07	wg_lh_intensity-contrast_parsorbitalis	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.13798e-07	Sarcoidosis	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.15e-07	Ankylosing spondylitis	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.2e-07	Total lipid levels in lipoprotein particles	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.28246e-07	IDP_dMRI_TBSS_L2_Posterior_corona_radiata_L	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.29686e-07	wg_lh_intensity-contrast_supramarginal	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.29746e-07	ENSG00000135074	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.29997e-07	Treatment/medication code: seretide 50 evohaler	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.40001e-07	Operation code: appendicectomy	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.44001e-07	Squamous cell lung cancer	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.46737e-07	Granzyme A	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.50002e-07	Cholesteryl ester levels in medium HDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.50002e-07	Eye problems/disorders: Diabetes related eye disease	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.52371e-07	IDP_dMRI_ProbtrackX_MD_unc_r	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.54813e-07	wg_lh_intensity-contrast_superiortemporal	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.59998e-07	Bioavailable testosterone levels	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.63773e-07	ENSG00000136158	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.69999e-07	Leg fat mass (right)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.83972e-07	aparc-DKTatlas_rh_thickness_isthmuscingulate	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.85301e-07	IDP_dMRI_TBSS_L2_Genu_of_corpus_callosum	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.89996e-07	Saturated fatty acids	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.91562e-07	IDP_dMRI_ProbtrackX_FA_ifo_r	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.95713e-07	Trunk fat mass	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.29398e-07	Medication use (glucocorticoids)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.32195e-07	ENSG00000099284	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.343e-07	Diabetic maculopathy (H7_MACULOPATHYDIAB)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.3471e-07	IDP_dMRI_ProbtrackX_L3_slf_l	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.39997e-07	Total testosterone levels	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.39997e-07	Total triglycerides	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.42996e-07	aparc-Desikan_lh_thickness_insula	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.46684e-07	UDP-N-acetylhexosamine pyrophosphorylase	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.46684e-07	Palmitoyl-protein thioesterase 1	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.49997e-07	Triglycerides to total lipids ratio in very small VLDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.54203e-07	Binding antibody response to interferon beta therapy in multiple sclerosis (antibody levels; all treatment preparations)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.58036e-07	IDP_dMRI_ProbtrackX_ICVF_unc_r	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.649e-07	Diabetic maculopathy (DM_MACULOPATHY)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.70002e-07	Fluid intelligence score	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.72705e-07	Cholangitis (primary sclerosing, PSC)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.9023e-07	IDP_dMRI_TBSS_L1_Cingulum_hippocampus_R	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.93969e-07	wg_lh_intensity-contrast_inferiorparietal	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.01603e-07	Diabetic maculopathy (more controls excluded)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.07119e-07	ENSG00000129484	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.13701e-07	Finngen Rheumatological endpoints	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.30005e-07	Triglycerides in small HDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.32353e-07	aparc-a2009s_lh_volume_S-temporal-sup	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.44666e-07	Epstein-Barr virus VCA p18 antibody levels	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.59242e-07	IDP_dMRI_TBSS_ICVF_Tapetum_L	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.65067e-07	wg_rh_intensity-contrast_parsorbitalis	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.99998e-07	Free cholesterol in chylomicrons and extremely large VLDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.99998e-07	Tyrosine	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.23304e-07	IDP_dMRI_TBSS_ICVF_Posterior_corona_radiata_R	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.29999e-07	LDL cholesterol	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.29999e-07	Non-cancer illness code, self-reported: hiatus hernia	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.38896e-07	Disorders of orbit	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.59933e-07	ENSG00000125901	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.615e-07	Serum uric acid levels	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.61927e-07	Urate	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.64508e-07	IDP_dMRI_TBSS_MD_Uncinate_fasciculus_L	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.69993e-07	Non-cancer illness code, self-reported: gastro-oesophageal reflux (gord) / gastric reflux	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.95344e-07	IDP_dMRI_ProbtrackX_L3_ptr_r	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.95505e-07	IDP_dMRI_ProbtrackX_ICVF_unc_l	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	7.07946e-07	Complement C1q tumor necrosis factor-related protein 5	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	7.33331e-07	aparc-a2009s_rh_area_S-pericallosal	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	7.49998e-07	Concentration of small VLDL particles	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	7.84007e-07	Background diabetic retinopathy	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	7.86502e-07	IDP_dMRI_TBSS_L3_Superior_fronto-occipital_fasciculus_L	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	7.8886e-07	IDP_dMRI_TBSS_ICVF_Anterior_corona_radiata_R	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	7.97995e-07	rfMRI connectivity (ICA100 edge 356)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	8.19993e-07	Total lipid levels in small VLDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	8.31496e-07	Lupus erythematosus	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	8.53159e-07	ENSG00000184613	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	8.60994e-07	wg_rh_intensity-contrast_caudalmiddlefrontal	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	8.78011e-07	IDP_dMRI_ProbtrackX_L3_cgc_r	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	8.96892e-07	Peripheral artery disease	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	8.99995e-07	Docosahexaenoic acid levels	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	9.08448e-07	IDP_dMRI_TBSS_MD_Superior_fronto-occipital_fasciculus_L	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	9.12011e-07	PAX-interacting protein 1	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	9.12851e-07	wg_rh_intensity-contrast_parstriangularis	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	9.21043e-07	ENSG00000204301	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	9.26105e-07	Unspecified diabetes	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	9.35104e-07	Peripheral artery disease	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	9.55432e-07	ENSG00000100395	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	9.59997e-07	Free cholesterol in HDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	9.59997e-07	Mineral and other dietary supplements: Zinc	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	9.64495e-07	Binding antibody response to interferon beta therapy in multiple sclerosis (antibody levels; IFN<U+03B2>-1a subcutaneous)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	9.72702e-07	Peripheral artery disease (no controls excluded)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	9.72926e-07	Illnesses of siblings: Diabetes	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	9.85349e-07	Anti-varicella zoster virus IgG seropositivity	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1e-06	Triglyceride levels in medium VLDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.0145e-06	ENSG00000109943	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.01719e-06	IDP_T1_FAST_ROIs_R_temp_fusif_cortex_post	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.031e-06	Glucose levels	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.0329e-06	Glucose	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.04376e-06	IDP_dMRI_TBSS_MD_Posterior_corona_radiata_R	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.08718e-06	aparc-a2009s_lh_area_G-temporal-middle	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.09999e-06	Concentration of small HDL particles	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.09999e-06	Free cholesterol levels in chylomicrons and extremely large VLDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.09999e-06	Non-cancer illness code, self-reported: diabetes	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.1079e-06	HippSubfield_rh_volume_hippocampal-fissure	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.108e-06	Sarcoidosis	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.1359e-06	Number of days/week of moderate physical activity 10+ minutes	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.1471e-06	IDP_dMRI_TBSS_ICVF_Cingulum_cingulate_gyrus_R	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.18277e-06	IDP_dMRI_ProbtrackX_L3_fmi	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.187e-06	ENSG00000163508	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.19627e-06	Oral cavity cancer	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.19627e-06	Oral cavity cancer	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.2e-06	Triglycerides to total lipids ratio in IDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.21843e-06	IDP_dMRI_TBSS_OD_Sagittal_stratum_L	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.224e-06	Macrophage colony-stimulating factor 1 levels	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.22942e-06	aparc-a2009s_lh_thickness_S-circular-insula-sup	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.29999e-06	Total triglycerides levels	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.29999e-06	Ratio of omega-6 fatty acids to omega-3 fatty acids	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.36301e-06	IDP_dMRI_TBSS_L2_Retrolenticular_part_of_internal_capsule_R	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.3736e-06	ENSG00000211779	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.392e-06	Other diabetic retinopathy	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.40001e-06	Mean corpuscular volume	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.40001e-06	Childhood sunburn occasions	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.40595e-06	Childhood asthma (age<16)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.40595e-06	Asthma	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.40702e-06	ThalamNuclei_rh_volume_PuM	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.43989e-06	ENSG00000117228	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.5e-06	Cholesterol to total lipids ratio in very small VLDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.5e-06	Lifetime number of sexual partners	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.53851e-06	rfMRI connectivity (ICA100 edge 509)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.55776e-06	IDP_dMRI_ProbtrackX_L3_slf_r	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.6e-06	Cholesterol levels in small HDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.6e-06	Respiratory or ear-nose-throat disease	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.6e-06	Diagnoses - secondary ICD10: J45.9 Asthma, unspecified	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.63501e-06	Triglycerides	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.64585e-06	Eye problems/disorders: Diabetes related eye disease	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.64699e-06	Prostate cancer	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.64699e-06	Prostate cancer	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.6628e-06	ENSG00000237254	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.66556e-06	Asthma, hospital admissions 1	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.6661e-06	IDP_dMRI_ProbtrackX_ICVF_ml_r	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.66974e-06	Peak expiratory flow (PEF)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.67225e-06	IDP_dMRI_TBSS_L3_Superior_corona_radiata_L	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.7e-06	Ratio of monounsaturated fatty acids to total fatty acids	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.7e-06	Corneal hysteresis (left)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.704e-06	Diabetic background retinopathy	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.739e-06	Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.74261e-06	wg_rh_intensity-contrast_parsopercularis	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.74824e-06	wg_lh_intensity-contrast_postcentral	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.76539e-06	Diagnoses - main ICD10: J45 Asthma	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.79999e-06	Total lipids in lipoprotein particles	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.83e-06	Proliferative diabetic retinopathy (H7_RETINOPATHYDIAB_PROLIF)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.86681e-06	IDP_dMRI_ProbtrackX_L1_ifo_l	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.90546e-06	Vesicle-fusing ATPase	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.91201e-06	Peripheral atherosclerosis	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.91792e-06	Treatment/medication code: seretide 50 evohaler	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.91867e-06	IDP_dMRI_TBSS_FA_Anterior_corona_radiata_R	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.95029e-06	IDP_dMRI_ProbtrackX_OD_slf_l	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.97151e-06	IDP_dMRI_TBSS_L1_Retrolenticular_part_of_internal_capsule_R	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	1.99756e-06	wg_rh_intensity-contrast_rostralmiddlefrontal	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2e-06	Bioavailable Testosterone	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.03049e-06	IDP_dMRI_TBSS_L3_Splenium_of_corpus_callosum	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.06334e-06	Major dietary changes in the last 5 years: Yes, because of illness	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.067e-06	Unspecified diabetic retinopathy	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.09214e-06	Lymphocyte percentage	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.09508e-06	IDP_dMRI_ProbtrackX_OD_str_l	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.1e-06	Parental longevity (mother's attained age)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.1e-06	Diagnoses - main ICD10: N40 Hyperplasia of prostate	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.115e-06	Pulse pressure	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.13511e-06	ENSG00000136250	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.19381e-06	IDP_dMRI_ProbtrackX_ICVF_mcp	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.19999e-06	Triglycerides to total lipids ratio in very small VLDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.29662e-06	ENSG00000211788	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.34936e-06	Other anaemias	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.34936e-06	Diagnoses - main ICD10: D64 Other anaemias	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.39894e-06	COPD, early/later onset	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.39999e-06	Triglycerides in medium VLDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.39999e-06	Suffer from 'nerves'	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.39999e-06	Impedance of arm (right)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.40702e-06	Other and unspecified anaemias	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.41952e-06	ENSG00000112394	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.44906e-06	IDP_dMRI_TBSS_OD_Sagittal_stratum_R	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.46065e-06	Potassium in urine	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.46377e-06	IDP_dMRI_TBSS_FA_Middle_cerebellar_peduncle	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.5e-06	Triglyceride levels in small HDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.5e-06	Cholesteryl esters to total lipids ratio in very small VLDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.52319e-06	Hearing difficulty/problems with background noise	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.53425e-06	Seen a psychiatrist for nerves  anxiety  tension or depression	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.5704e-06	17-beta-hydroxysteroid dehydrogenase 14	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.63451e-06	IDP_dMRI_ProbtrackX_MD_unc_l	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.69302e-06	Binding antibody response to interferon beta therapy in multiple sclerosis (antibody levels; IFN<U+03B2>-1a subcutaneous and intramuscular)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.78317e-06	ENSG00000100448	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.79235e-06	Frequency of light DIY in last 4 weeks	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.82683e-06	IDP_dMRI_ProbtrackX_L1_str_l	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.8327e-06	IDP_dMRI_TBSS_L3_Posterior_corona_radiata_L	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.90001e-06	Comparative body size at age 10, Males	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.93968e-06	IDP_dMRI_TBSS_FA_Posterior_thalamic_radiation_L	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.95393e-06	ENSG00000184281	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	2.99999e-06	HDL cholesterol	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.09999e-06	Prostate cancer	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.10249e-06	Phosphate	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.11172e-06	IDP_dMRI_TBSS_ICVF_External_capsule_R	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.1839e-06	Seen doctor (GP) for nerves  anxiety  tension or depression	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.2e-06	Psychological or psychiatric problem	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.2e-06	Diagnoses - main ICD10: D64.9 Anaemia, unspecified	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.33073e-06	Glucose levels (UKB data field 30740)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.35174e-06	ENSG00000112343	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.37987e-06	IDP_dMRI_TBSS_L2_Superior_corona_radiata_L	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.39102e-06	Mean platelet volume	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.40001e-06	Parental longevity (combined parental attained age, Martingale residuals)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.4272e-06	ENSG00000110881	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.47736e-06	ENSG00000149131	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.50002e-06	Taking other prescription medications	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.57849e-06	IDP_dMRI_ProbtrackX_MD_fmi	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.57973e-06	ENSG00000104490	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.59998e-06	Total testosterone levels	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.67367e-06	IDP_dMRI_TBSS_FA_Genu_of_corpus_callosum	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.69999e-06	Cholesterol in small HDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.8212e-06	IDP_dMRI_TBSS_ICVF_Fornix_cres+Stria_terminalis_L	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.89332e-06	ENSG00000170545	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.89996e-06	Triglycerides in VLDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.97009e-06	IDP_dMRI_TBSS_L3_Superior_longitudinal_fasciculus_L	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.97466e-06	IDP_dMRI_ProbtrackX_ICVF_atr_r	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	3.9954e-06	Nervous feelings	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4e-06	Sex hormone-binding globulin levels adjusted for BMI	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4e-06	Concentration of small HDL particles	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.00738e-06	ENSG00000092068	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.10091e-06	ENSG00000148468	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.15403e-06	IBD (strict) with PSC	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.26187e-06	IDP_dMRI_ProbtrackX_L1_str_r	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.28983e-06	Arm fat mass (left)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.38601e-06	ENSG00000084234	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.39855e-06	ENSG00000109065	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.39896e-06	Medication use (anti-inflammatory and antirheumatic products, non-steroids)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.39997e-06	Impedance of arm (left)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.4157e-06	IDP_dMRI_ProbtrackX_FA_ilf_r	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.48704e-06	Proheparin-binding EGF-like growth factor levels	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.49573e-06	IDP_dMRI_ProbtrackX_ICVF_atr_l	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.50703e-06	Lymphocyte percentage of white cells	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.58775e-06	IDP_dMRI_TBSS_ICVF_Corticospinal_tract_R	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.70002e-06	Cholesteryl esters to total lipids ratio in large LDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.78333e-06	Phosphate	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.79999e-06	Liver iron content	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.90004e-06	Ratio of omega-6 fatty acids to omega-3 fatty acids	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.93856e-06	IDP_dMRI_TBSS_FA_Anterior_corona_radiata_L	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	4.98896e-06	Chronic obstructive pulmonary disease	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.19996e-06	Free cholesterol levels in HDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.19996e-06	Cholesterol to total lipids ratio in very small VLDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.22866e-06	ENSG00000187118	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.377e-06	Other disorders of glucose regulation and pancreatic internal secretion	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.60003e-06	Triglycerides to total lipids ratio in medium LDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.69994e-06	Main speciality of consultant (recoded): General medicine	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.7544e-06	T-cell surface glycoprotein CD3 epsilon chain	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.76581e-06	ENSG00000135318	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.80003e-06	Ratio of monounsaturated fatty acids to total fatty acids	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.89997e-06	Bone disorder	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.89997e-06	Phospholipids to total lipids ratio in IDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.89997e-06	Type of cancer: ICD10: C61 Malignant neoplasm of prostate	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.95937e-06	IDP_dMRI_ProbtrackX_OD_ar_r	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.98288e-06	Whole body fat mass	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	5.99998e-06	Renal or urological disease	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.03393e-06	IDP_dMRI_TBSS_ICVF_Posterior_limb_of_internal_capsule_L	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.1e-06	Asthma (childhood onset)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.24022e-06	aparc-Desikan_lh_area_bankssts	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.29999e-06	Cholesteryl esters in HDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.44793e-06	Neurociticism	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.45506e-06	IDP_dMRI_ProbtrackX_L3_unc_r	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.49501e-06	ENSG00000167671	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.49995e-06	Phospholipids in chylomicrons and extremely large VLDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.61302e-06	IDP_dMRI_TBSS_L2_Posterior_corona_radiata_R	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.63606e-06	Iron deficiency anemia	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.78172e-06	Gamma glutamyltransferase	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.80816e-06	ENSG00000204314	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	6.99633e-06	ENSG00000107874	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	7.00003e-06	Psoriasis	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	7.05001e-06	Viral haemorrhagic fevers, not elsewhere classified/unspecified	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	7.05424e-06	Arm fat mass (right)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	7.11557e-06	ENSG00000168477	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	7.14661e-06	IDP_dMRI_TBSS_FA_Posterior_thalamic_radiation_R	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	7.40167e-06	ENSG00000137757	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	7.46449e-06	HippSubfield_rh_volume_presubiculum-body	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	7.58193e-06	Major Depressive Disorder	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	7.61307e-06	Varicose veins	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	7.69999e-06	Triglyceride levels in VLDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	7.7564e-06	ENSG00000211706	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	7.78556e-06	ENSG00000179698	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	7.83249e-06	IDP_dMRI_TBSS_L1_Fornix_cres+Stria_terminalis_R	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	7.86321e-06	rfMRI connectivity (ICA100 edge 955)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	7.89605e-06	Atherosclerosis, excluding cerebral, coronary and PAD	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	7.91407e-06	IDP_dMRI_ProbtrackX_L2_cgc_r	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	7.93725e-06	Forced expiratory volume in 1-second (FEV1)  predicted	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	7.9561e-06	IDP_dMRI_TBSS_FA_Cerebral_peduncle_R	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	7.96526e-06	BA-exvivo_lh_volume_entorhinal	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	7.9919e-06	ENSG00000196924	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	8.06863e-06	IDP_dMRI_ProbtrackX_L2_unc_l	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	8.09991e-06	Age started hormone-replacement therapy (HRT)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	8.16545e-06	ENSG00000260822	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	8.19993e-06	Ratio of omega-3 fatty acids to total fatty acids	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	8.40001e-06	Total lipid levels in VLDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	8.43257e-06	Fluid intelligence score	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	8.46642e-06	IDP_dMRI_TBSS_ICVF_Superior_fronto-occipital_fasciculus_L	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	8.47618e-06	IDP_dMRI_TBSS_ICVF_Posterior_limb_of_internal_capsule_R	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	8.50002e-06	Concentration of small VLDL particles	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	8.70001e-06	Worrier / anxious feelings	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	8.71606e-06	Familial combined hyperlipidemia defined by Dutch criteria	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	8.79995e-06	Lung function (FEV1/FVC)	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	8.84708e-06	IDP_dMRI_ProbtrackX_MD_ptr_r	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	8.86993e-06	Type 1 diabetes with peripheral circulatory complications	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	8.9e-06	Cholesteryl esters to total lipids ratio in very small VLDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	8.99995e-06	Phospholipids to total lipids ratio in chylomicrons and extremely large VLDL	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	9.05191e-06	Mean corpuscular hemoglobin concentration	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	9.11297e-06	Thyroiditis	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	9.40005e-06	Facial ageing	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	9.62498e-06	IDP_dMRI_ProbtrackX_MD_ptr_l	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	9.80618e-06	IDP_dMRI_ProbtrackX_L1_unc_l	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	9.81974e-06	IDP_T1_FAST_ROIs_R_thalamus	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	9.84351e-06	Ever had prolonged loss of interest in normal activities	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs3130614	9.98022e-06	ENSG00000096080	6	50726	0.25077081996515	1.42988134448138e-08	EasActiv18mo	0.126779
rs10922922	7.75532e-11	IGF 1 (UKB data field 30770)	1	58636	0.509126848615929	1.13836097772866e-09	IcqFussi6mo	0.495054
rs10922922	3.12047e-08	IGF-1	1	58636	0.509126848615929	1.13836097772866e-09	IcqFussi6mo	0.495054
rs10922922	2.38517e-07	IGF-1	1	58636	0.509126848615929	1.13836097772866e-09	IcqFussi6mo	0.495054
rs61770469	3.70254e-11	IGF 1 (UKB data field 30770)	1	58778	0.595268635051173	1.64672090927488e-09	IcqFussi6mo	0.497933
rs61770469	3.19448e-08	IGF-1	1	58778	0.595268635051173	1.64672090927488e-09	IcqFussi6mo	0.497933
rs61770469	2.0416e-07	IGF-1	1	58778	0.595268635051173	1.64672090927488e-09	IcqFussi6mo	0.497933
rs814546	1.63418e-11	IGF 1 (UKB data field 30770)	1	58786	0.591635193282558	2.37476150294228e-09	IcqFussi6mo	0.49835
rs814546	1.63599e-08	IGF-1	1	58786	0.591635193282558	2.37476150294228e-09	IcqFussi6mo	0.49835
rs814546	1.0694e-07	IGF-1	1	58786	0.591635193282558	2.37476150294228e-09	IcqFussi6mo	0.49835
rs814545	1.94312e-11	IGF 1 (UKB data field 30770)	1	58788	0.615922401568851	2.01163878334329e-09	IcqFussi6mo	0.498563
rs814545	2.0931e-08	IGF-1	1	58788	0.615922401568851	2.01163878334329e-09	IcqFussi6mo	0.498563
rs814545	1.30581e-07	IGF-1	1	58788	0.615922401568851	2.01163878334329e-09	IcqFussi6mo	0.498563
rs2954561	1.51461e-11	IGF 1 (UKB data field 30770)	1	58790	0.621588541519221	1.97797136479261e-09	IcqFussi6mo	0.498563
rs2954561	3.40017e-11	Insulin-like growth factor 1 levels	1	58790	0.621588541519221	1.97797136479261e-09	IcqFussi6mo	0.498563
rs2954561	1.49861e-08	IGF-1	1	58790	0.621588541519221	1.97797136479261e-09	IcqFussi6mo	0.498563
rs2954561	9.39658e-08	IGF-1	1	58790	0.621588541519221	1.97797136479261e-09	IcqFussi6mo	0.498563
rs1342555	8.78031e-06	Diagnoses - main ICD10: M20 Acquired deformities of fingers and toes	1	40660	0.167708471196458	4.76025261191659e-09	ItseaExter3yr	0.0719503
rs1342555	8.78031e-06	Diagnoses - main ICD10: M20 Acquired deformities of fingers and toes	1	40881	0.900046401750249	4.55879433578425e-09	ItseaFull3yr	0.0720261
rs1342555	8.78031e-06	Diagnoses - main ICD10: M20 Acquired deformities of fingers and toes	1	40660	0.167708471196458	4.76025261191659e-09	ItseaExter3yr	0.0719503
rs1342555	8.78031e-06	Diagnoses - main ICD10: M20 Acquired deformities of fingers and toes	1	40881	0.900046401750249	4.55879433578425e-09	ItseaFull3yr	0.0720261
rs11255890	9.59997e-10	Respiratory or ear-nose-throat disease	10	30932	0.00394148610613848	8.45337236971098e-09	RsdbdHyper8yr	0.348054
rs11255890	4.39997e-09	Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor: None of the above	10	30932	0.00394148610613848	8.45337236971098e-09	RsdbdHyper8yr	0.348054
rs11255890	2e-08	Respiratory or ear-nose-throat disease	10	30932	0.00394148610613848	8.45337236971098e-09	RsdbdHyper8yr	0.348054
rs11255890	2.59998e-08	Wheeze or whistling in the chest in last year	10	30932	0.00394148610613848	8.45337236971098e-09	RsdbdHyper8yr	0.348054
rs11255890	2.5e-07	Smoking status	10	30932	0.00394148610613848	8.45337236971098e-09	RsdbdHyper8yr	0.348054
rs11255890	5.0151e-07	Blood clot  DVT  bronchitis  emphysema  asthma  rhinitis  eczema  allergy diagnosed by doctor: None of the above	10	30932	0.00394148610613848	8.45337236971098e-09	RsdbdHyper8yr	0.348054
rs11255890	5.09202e-07	Asthma	10	30932	0.00394148610613848	8.45337236971098e-09	RsdbdHyper8yr	0.348054
rs11255890	1.23299e-06	ADHD	10	30932	0.00394148610613848	8.45337236971098e-09	RsdbdHyper8yr	0.348054
rs11255890	1.89998e-06	Risk taking	10	30932	0.00394148610613848	8.45337236971098e-09	RsdbdHyper8yr	0.348054
rs11255890	2.69998e-06	Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor: Hayfever, allergic rhinitis or eczema	10	30932	0.00394148610613848	8.45337236971098e-09	RsdbdHyper8yr	0.348054
rs11255890	3.50687e-06	Blood clot  DVT  bronchitis  emphysema  asthma  rhinitis  eczema  allergy diagnosed by doctor: Asthma	10	30932	0.00394148610613848	8.45337236971098e-09	RsdbdHyper8yr	0.348054
rs11255890	3.69999e-06	Overall health rating	10	30932	0.00394148610613848	8.45337236971098e-09	RsdbdHyper8yr	0.348054
rs11255890	4.06996e-06	smoking initiation	10	30932	0.00394148610613848	8.45337236971098e-09	RsdbdHyper8yr	0.348054
rs11255890	4.45574e-06	Non-cancer illness code  self-reported: asthma	10	30932	0.00394148610613848	8.45337236971098e-09	RsdbdHyper8yr	0.348054
rs11255890	4.49997e-06	Eczema	10	30932	0.00394148610613848	8.45337236971098e-09	RsdbdHyper8yr	0.348054
rs11255890	4.70002e-06	Non-cancer illness code, self-reported: asthma	10	30932	0.00394148610613848	8.45337236971098e-09	RsdbdHyper8yr	0.348054
rs11255890	5.03002e-06	Schizophrenia	10	30932	0.00394148610613848	8.45337236971098e-09	RsdbdHyper8yr	0.348054
rs11255890	5.45695e-06	Attention deficit hyperactivity disorder	10	30932	0.00394148610613848	8.45337236971098e-09	RsdbdHyper8yr	0.348054
rs11255890	6.1e-06	Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor: Asthma	10	30932	0.00394148610613848	8.45337236971098e-09	RsdbdHyper8yr	0.348054
rs11255890	6.14879e-06	Risk taking (UKB data field 2040) (Firth correction)	10	30932	0.00394148610613848	8.45337236971098e-09	RsdbdHyper8yr	0.348054
rs11255890	6.15234e-06	Risk taking (UKB data field 2040) (SPA correction)	10	30932	0.00394148610613848	8.45337236971098e-09	RsdbdHyper8yr	0.348054
rs11255890	7.49998e-06	Frequency of tiredness / lethargy in last 2 weeks	10	30932	0.00394148610613848	8.45337236971098e-09	RsdbdHyper8yr	0.348054
rs11255890	7.69999e-06	Mood swings	10	30932	0.00394148610613848	8.45337236971098e-09	RsdbdHyper8yr	0.348054
rs11255890	8.06065e-06	Mood swings (UKB data field 1920) (Firth correction)	10	30932	0.00394148610613848	8.45337236971098e-09	RsdbdHyper8yr	0.348054
rs11255890	8.06158e-06	Mood swings (UKB data field 1920) (SPA correction)	10	30932	0.00394148610613848	8.45337236971098e-09	RsdbdHyper8yr	0.348054
rs11255890	8.40001e-06	Current tobacco smoking	10	30932	0.00394148610613848	8.45337236971098e-09	RsdbdHyper8yr	0.348054
rs11255890	9.29694e-06	Schizophrenia	10	30932	0.00394148610613848	8.45337236971098e-09	RsdbdHyper8yr	0.348054
rs11255891	1.29999e-09	Respiratory or ear-nose-throat disease	10	30934	0.00388499084749526	6.42273494776882e-09	RsdbdHyper8yr	0.347821
rs11255891	6.29999e-09	Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor: None of the above	10	30934	0.00388499084749526	6.42273494776882e-09	RsdbdHyper8yr	0.347821
rs11255891	1.89998e-08	Respiratory or ear-nose-throat disease	10	30934	0.00388499084749526	6.42273494776882e-09	RsdbdHyper8yr	0.347821
rs11255891	2.59998e-08	Wheeze or whistling in the chest in last year	10	30934	0.00388499084749526	6.42273494776882e-09	RsdbdHyper8yr	0.347821
rs11255891	2.59998e-07	Smoking status	10	30934	0.00388499084749526	6.42273494776882e-09	RsdbdHyper8yr	0.347821
rs11255891	5.00495e-07	Asthma	10	30934	0.00388499084749526	6.42273494776882e-09	RsdbdHyper8yr	0.347821
rs11255891	6.31277e-07	Blood clot  DVT  bronchitis  emphysema  asthma  rhinitis  eczema  allergy diagnosed by doctor: None of the above	10	30934	0.00388499084749526	6.42273494776882e-09	RsdbdHyper8yr	0.347821
rs11255891	1.59901e-06	ADHD	10	30934	0.00388499084749526	6.42273494776882e-09	RsdbdHyper8yr	0.347821
rs11255891	2.39999e-06	Risk taking	10	30934	0.00388499084749526	6.42273494776882e-09	RsdbdHyper8yr	0.347821
rs11255891	3.35212e-06	Blood clot  DVT  bronchitis  emphysema  asthma  rhinitis  eczema  allergy diagnosed by doctor: Asthma	10	30934	0.00388499084749526	6.42273494776882e-09	RsdbdHyper8yr	0.347821
rs11255891	3.44001e-06	smoking initiation	10	30934	0.00388499084749526	6.42273494776882e-09	RsdbdHyper8yr	0.347821
rs11255891	3.89996e-06	Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor: Hayfever, allergic rhinitis or eczema	10	30934	0.00388499084749526	6.42273494776882e-09	RsdbdHyper8yr	0.347821
rs11255891	4e-06	Overall health rating	10	30934	0.00388499084749526	6.42273494776882e-09	RsdbdHyper8yr	0.347821
rs11255891	4.30002e-06	Non-cancer illness code, self-reported: asthma	10	30934	0.00388499084749526	6.42273494776882e-09	RsdbdHyper8yr	0.347821
rs11255891	4.36848e-06	Non-cancer illness code  self-reported: asthma	10	30934	0.00388499084749526	6.42273494776882e-09	RsdbdHyper8yr	0.347821
rs11255891	4.65297e-06	Schizophrenia	10	30934	0.00388499084749526	6.42273494776882e-09	RsdbdHyper8yr	0.347821
rs11255891	5.19996e-06	Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor: Asthma	10	30934	0.00388499084749526	6.42273494776882e-09	RsdbdHyper8yr	0.347821
rs11255891	5.69994e-06	Eczema	10	30934	0.00388499084749526	6.42273494776882e-09	RsdbdHyper8yr	0.347821
rs11255891	7.03024e-06	Risk taking (UKB data field 2040) (Firth correction)	10	30934	0.00388499084749526	6.42273494776882e-09	RsdbdHyper8yr	0.347821
rs11255891	7.03429e-06	Risk taking (UKB data field 2040) (SPA correction)	10	30934	0.00388499084749526	6.42273494776882e-09	RsdbdHyper8yr	0.347821
rs11255891	7.377e-06	Attention deficit hyperactivity disorder	10	30934	0.00388499084749526	6.42273494776882e-09	RsdbdHyper8yr	0.347821
rs11255891	7.39827e-06	Mood swings (UKB data field 1920) (Firth correction)	10	30934	0.00388499084749526	6.42273494776882e-09	RsdbdHyper8yr	0.347821
rs11255891	7.39912e-06	Mood swings (UKB data field 1920) (SPA correction)	10	30934	0.00388499084749526	6.42273494776882e-09	RsdbdHyper8yr	0.347821
rs11255891	8.17617e-06	Current tobacco smoking	10	30934	0.00388499084749526	6.42273494776882e-09	RsdbdHyper8yr	0.347821
rs11255891	8.37896e-06	Schizophrenia	10	30934	0.00388499084749526	6.42273494776882e-09	RsdbdHyper8yr	0.347821
rs11255891	8.50002e-06	Mood swings	10	30934	0.00388499084749526	6.42273494776882e-09	RsdbdHyper8yr	0.347821
rs11255891	9.09997e-06	Frequency of tiredness / lethargy in last 2 weeks	10	30934	0.00388499084749526	6.42273494776882e-09	RsdbdHyper8yr	0.347821
rs11255891	9.49992e-06	Current tobacco smoking	10	30934	0.00388499084749526	6.42273494776882e-09	RsdbdHyper8yr	0.347821
rs7923068	1.09999e-08	Respiratory or ear-nose-throat disease	10	30962	0.00530017244597225	6.22386265069904e-09	RsdbdHyper8yr	0.344632
rs7923068	1.7e-08	Wheeze or whistling in the chest in last year	10	30962	0.00530017244597225	6.22386265069904e-09	RsdbdHyper8yr	0.344632
rs7923068	9.59997e-08	Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor: None of the above	10	30962	0.00530017244597225	6.22386265069904e-09	RsdbdHyper8yr	0.344632
rs7923068	2.19999e-07	Respiratory or ear-nose-throat disease	10	30962	0.00530017244597225	6.22386265069904e-09	RsdbdHyper8yr	0.344632
rs7923068	4.30002e-07	Smoking status	10	30962	0.00530017244597225	6.22386265069904e-09	RsdbdHyper8yr	0.344632
rs7923068	9.28902e-07	Asthma	10	30962	0.00530017244597225	6.22386265069904e-09	RsdbdHyper8yr	0.344632
rs7923068	1.03901e-06	ADHD	10	30962	0.00530017244597225	6.22386265069904e-09	RsdbdHyper8yr	0.344632
rs7923068	1.98999e-06	smoking initiation	10	30962	0.00530017244597225	6.22386265069904e-09	RsdbdHyper8yr	0.344632
rs7923068	2e-06	Risk taking	10	30962	0.00530017244597225	6.22386265069904e-09	RsdbdHyper8yr	0.344632
rs7923068	3.50002e-06	Overall health rating	10	30962	0.00530017244597225	6.22386265069904e-09	RsdbdHyper8yr	0.344632
rs7923068	4.35001e-06	Attention deficit hyperactivity disorder	10	30962	0.00530017244597225	6.22386265069904e-09	RsdbdHyper8yr	0.344632
rs7923068	4.40291e-06	Blood clot  DVT  bronchitis  emphysema  asthma  rhinitis  eczema  allergy diagnosed by doctor: None of the above	10	30962	0.00530017244597225	6.22386265069904e-09	RsdbdHyper8yr	0.344632
rs7923068	5.19266e-06	Risk taking (UKB data field 2040) (Firth correction)	10	30962	0.00530017244597225	6.22386265069904e-09	RsdbdHyper8yr	0.344632
rs7923068	5.19589e-06	Risk taking (UKB data field 2040) (SPA correction)	10	30962	0.00530017244597225	6.22386265069904e-09	RsdbdHyper8yr	0.344632
rs7923068	5.30005e-06	Frequency of tiredness / lethargy in last 2 weeks	10	30962	0.00530017244597225	6.22386265069904e-09	RsdbdHyper8yr	0.344632
rs7923068	6.02907e-06	Schizophrenia	10	30962	0.00530017244597225	6.22386265069904e-09	RsdbdHyper8yr	0.344632
rs7923068	9.30101e-06	Schizophrenia	10	30962	0.00530017244597225	6.22386265069904e-09	RsdbdHyper8yr	0.344632
rs34166411	2.90001e-08	Respiratory or ear-nose-throat disease	10	30925	0.00534035342965006	1.12909374113291e-08	RsdbdHyper8yr	0.345934
rs34166411	2.90001e-08	Wheeze or whistling in the chest in last year	10	30925	0.00534035342965006	1.12909374113291e-08	RsdbdHyper8yr	0.345934
rs34166411	2.39999e-07	Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor: None of the above	10	30925	0.00534035342965006	1.12909374113291e-08	RsdbdHyper8yr	0.345934
rs34166411	3.40001e-07	Smoking status	10	30925	0.00534035342965006	1.12909374113291e-08	RsdbdHyper8yr	0.345934
rs34166411	3.79997e-07	Respiratory or ear-nose-throat disease	10	30925	0.00534035342965006	1.12909374113291e-08	RsdbdHyper8yr	0.345934
rs34166411	7.79992e-07	Risk taking	10	30925	0.00534035342965006	1.12909374113291e-08	RsdbdHyper8yr	0.345934
rs34166411	2.19999e-06	Overall health rating	10	30925	0.00534035342965006	1.12909374113291e-08	RsdbdHyper8yr	0.345934
rs34166411	2.44771e-06	Risk taking (UKB data field 2040) (Firth correction)	10	30925	0.00534035342965006	1.12909374113291e-08	RsdbdHyper8yr	0.345934
rs34166411	2.44918e-06	Risk taking (UKB data field 2040) (SPA correction)	10	30925	0.00534035342965006	1.12909374113291e-08	RsdbdHyper8yr	0.345934
rs34166411	6.94912e-06	Blood clot  DVT  bronchitis  emphysema  asthma  rhinitis  eczema  allergy diagnosed by doctor: None of the above	10	30925	0.00534035342965006	1.12909374113291e-08	RsdbdHyper8yr	0.345934
rs34166411	8.50002e-06	Frequency of tiredness / lethargy in last 2 weeks	10	30925	0.00534035342965006	1.12909374113291e-08	RsdbdHyper8yr	0.345934
rs7088921	1.5e-09	Respiratory or ear-nose-throat disease	10	31009	0.00549806664684144	8.64728952323367e-09	RsdbdHyper8yr	0.346174
rs7088921	1e-08	Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor: None of the above	10	31009	0.00549806664684144	8.64728952323367e-09	RsdbdHyper8yr	0.346174
rs7088921	4.20001e-08	Wheeze or whistling in the chest in last year	10	31009	0.00549806664684144	8.64728952323367e-09	RsdbdHyper8yr	0.346174
rs7088921	5e-08	Respiratory or ear-nose-throat disease	10	31009	0.00549806664684144	8.64728952323367e-09	RsdbdHyper8yr	0.346174
rs7088921	1.6e-07	Smoking status	10	31009	0.00549806664684144	8.64728952323367e-09	RsdbdHyper8yr	0.346174
rs7088921	2.95502e-07	Asthma	10	31009	0.00549806664684144	8.64728952323367e-09	RsdbdHyper8yr	0.346174
rs7088921	4.59558e-07	Blood clot  DVT  bronchitis  emphysema  asthma  rhinitis  eczema  allergy diagnosed by doctor: None of the above	10	31009	0.00549806664684144	8.64728952323367e-09	RsdbdHyper8yr	0.346174
rs7088921	6.23606e-07	ADHD	10	31009	0.00549806664684144	8.64728952323367e-09	RsdbdHyper8yr	0.346174
rs7088921	1.22e-06	smoking initiation	10	31009	0.00549806664684144	8.64728952323367e-09	RsdbdHyper8yr	0.346174
rs7088921	2.80001e-06	Overall health rating	10	31009	0.00549806664684144	8.64728952323367e-09	RsdbdHyper8yr	0.346174
rs7088921	3.50002e-06	Risk taking	10	31009	0.00549806664684144	8.64728952323367e-09	RsdbdHyper8yr	0.346174
rs7088921	3.67003e-06	Attention deficit hyperactivity disorder	10	31009	0.00549806664684144	8.64728952323367e-09	RsdbdHyper8yr	0.346174
rs7088921	3.97027e-06	Blood clot  DVT  bronchitis  emphysema  asthma  rhinitis  eczema  allergy diagnosed by doctor: Asthma	10	31009	0.00549806664684144	8.64728952323367e-09	RsdbdHyper8yr	0.346174
rs7088921	4.12496e-06	Schizophrenia	10	31009	0.00549806664684144	8.64728952323367e-09	RsdbdHyper8yr	0.346174
rs7088921	4.39997e-06	Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor: Hayfever, allergic rhinitis or eczema	10	31009	0.00549806664684144	8.64728952323367e-09	RsdbdHyper8yr	0.346174
rs7088921	5.71913e-06	Non-cancer illness code  self-reported: asthma	10	31009	0.00549806664684144	8.64728952323367e-09	RsdbdHyper8yr	0.346174
rs7088921	5.80003e-06	Mood swings	10	31009	0.00549806664684144	8.64728952323367e-09	RsdbdHyper8yr	0.346174
rs7088921	5.99998e-06	Frequency of tiredness / lethargy in last 2 weeks	10	31009	0.00549806664684144	8.64728952323367e-09	RsdbdHyper8yr	0.346174
rs7088921	6.69993e-06	Eczema	10	31009	0.00549806664684144	8.64728952323367e-09	RsdbdHyper8yr	0.346174
rs7088921	6.71707e-06	Schizophrenia	10	31009	0.00549806664684144	8.64728952323367e-09	RsdbdHyper8yr	0.346174
rs7088921	8e-06	Non-cancer illness code, self-reported: asthma	10	31009	0.00549806664684144	8.64728952323367e-09	RsdbdHyper8yr	0.346174
rs7088921	8.6852e-06	Mood swings (UKB data field 1920) (Firth correction)	10	31009	0.00549806664684144	8.64728952323367e-09	RsdbdHyper8yr	0.346174
rs7088921	8.6862e-06	Mood swings (UKB data field 1920) (SPA correction)	10	31009	0.00549806664684144	8.64728952323367e-09	RsdbdHyper8yr	0.346174
rs7088921	9.09997e-06	Educational attainment (college completion)	10	31009	0.00549806664684144	8.64728952323367e-09	RsdbdHyper8yr	0.346174
rs7088921	9.20005e-06	Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor: Asthma	10	31009	0.00549806664684144	8.64728952323367e-09	RsdbdHyper8yr	0.346174
rs10795674	1.89998e-09	Respiratory or ear-nose-throat disease	10	31006	0.00559963861808754	8.68000549274492e-09	RsdbdHyper8yr	0.346175
rs10795674	1.09999e-08	Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor: None of the above	10	31006	0.00559963861808754	8.68000549274492e-09	RsdbdHyper8yr	0.346175
rs10795674	4.09996e-08	Wheeze or whistling in the chest in last year	10	31006	0.00559963861808754	8.68000549274492e-09	RsdbdHyper8yr	0.346175
rs10795674	4.79999e-08	Respiratory or ear-nose-throat disease	10	31006	0.00559963861808754	8.68000549274492e-09	RsdbdHyper8yr	0.346175
rs10795674	1.6e-07	Smoking status	10	31006	0.00559963861808754	8.68000549274492e-09	RsdbdHyper8yr	0.346175
rs10795674	3.17497e-07	Asthma	10	31006	0.00559963861808754	8.68000549274492e-09	RsdbdHyper8yr	0.346175
rs10795674	4.73925e-07	Blood clot  DVT  bronchitis  emphysema  asthma  rhinitis  eczema  allergy diagnosed by doctor: None of the above	10	31006	0.00559963861808754	8.68000549274492e-09	RsdbdHyper8yr	0.346175
rs10795674	5.95594e-07	ADHD	10	31006	0.00559963861808754	8.68000549274492e-09	RsdbdHyper8yr	0.346175
rs10795674	1.29999e-06	smoking initiation	10	31006	0.00559963861808754	8.68000549274492e-09	RsdbdHyper8yr	0.346175
rs10795674	2.69998e-06	Overall health rating	10	31006	0.00559963861808754	8.68000549274492e-09	RsdbdHyper8yr	0.346175
rs10795674	3.40001e-06	Risk taking	10	31006	0.00559963861808754	8.68000549274492e-09	RsdbdHyper8yr	0.346175
rs10795674	3.48602e-06	Attention deficit hyperactivity disorder	10	31006	0.00559963861808754	8.68000549274492e-09	RsdbdHyper8yr	0.346175
rs10795674	3.697e-06	Schizophrenia	10	31006	0.00559963861808754	8.68000549274492e-09	RsdbdHyper8yr	0.346175
rs10795674	4.2715e-06	Blood clot  DVT  bronchitis  emphysema  asthma  rhinitis  eczema  allergy diagnosed by doctor: Asthma	10	31006	0.00559963861808754	8.68000549274492e-09	RsdbdHyper8yr	0.346175
rs10795674	4.79999e-06	Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor: Hayfever, allergic rhinitis or eczema	10	31006	0.00559963861808754	8.68000549274492e-09	RsdbdHyper8yr	0.346175
rs10795674	5.49997e-06	Frequency of tiredness / lethargy in last 2 weeks	10	31006	0.00559963861808754	8.68000549274492e-09	RsdbdHyper8yr	0.346175
rs10795674	5.78149e-06	Non-cancer illness code  self-reported: asthma	10	31006	0.00559963861808754	8.68000549274492e-09	RsdbdHyper8yr	0.346175
rs10795674	6.61302e-06	Schizophrenia	10	31006	0.00559963861808754	8.68000549274492e-09	RsdbdHyper8yr	0.346175
rs10795674	6.80002e-06	Mood swings	10	31006	0.00559963861808754	8.68000549274492e-09	RsdbdHyper8yr	0.346175
rs10795674	7.10003e-06	Eczema	10	31006	0.00559963861808754	8.68000549274492e-09	RsdbdHyper8yr	0.346175
rs10795674	7.69999e-06	Non-cancer illness code, self-reported: asthma	10	31006	0.00559963861808754	8.68000549274492e-09	RsdbdHyper8yr	0.346175
rs10795674	8.30004e-06	Educational attainment (college completion)	10	31006	0.00559963861808754	8.68000549274492e-09	RsdbdHyper8yr	0.346175
rs10795674	9.20005e-06	Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor: Asthma	10	31006	0.00559963861808754	8.68000549274492e-09	RsdbdHyper8yr	0.346175
rs10795674	9.62432e-06	Mood swings (UKB data field 1920) (Firth correction)	10	31006	0.00559963861808754	8.68000549274492e-09	RsdbdHyper8yr	0.346175
rs10795674	9.62543e-06	Mood swings (UKB data field 1920) (SPA correction)	10	31006	0.00559963861808754	8.68000549274492e-09	RsdbdHyper8yr	0.346175
rs4749820	1.40001e-09	Respiratory or ear-nose-throat disease	10	30995	0.00562043591123392	9.15250553090537e-09	RsdbdHyper8yr	0.34612
rs4749820	1.29999e-08	Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor: None of the above	10	30995	0.00562043591123392	9.15250553090537e-09	RsdbdHyper8yr	0.34612
rs4749820	3.89996e-08	Wheeze or whistling in the chest in last year	10	30995	0.00562043591123392	9.15250553090537e-09	RsdbdHyper8yr	0.34612
rs4749820	4.30002e-08	Respiratory or ear-nose-throat disease	10	30995	0.00562043591123392	9.15250553090537e-09	RsdbdHyper8yr	0.34612
rs4749820	1.5e-07	Smoking status	10	30995	0.00562043591123392	9.15250553090537e-09	RsdbdHyper8yr	0.34612
rs4749820	2.943e-07	Asthma	10	30995	0.00562043591123392	9.15250553090537e-09	RsdbdHyper8yr	0.34612
rs4749820	5.03547e-07	Blood clot  DVT  bronchitis  emphysema  asthma  rhinitis  eczema  allergy diagnosed by doctor: None of the above	10	30995	0.00562043591123392	9.15250553090537e-09	RsdbdHyper8yr	0.34612
rs4749820	5.70795e-07	ADHD	10	30995	0.00562043591123392	9.15250553090537e-09	RsdbdHyper8yr	0.34612
rs4749820	7.38992e-07	smoking initiation	10	30995	0.00562043591123392	9.15250553090537e-09	RsdbdHyper8yr	0.34612
rs4749820	2.69998e-06	Overall health rating	10	30995	0.00562043591123392	9.15250553090537e-09	RsdbdHyper8yr	0.34612
rs4749820	2.99999e-06	Risk taking	10	30995	0.00562043591123392	9.15250553090537e-09	RsdbdHyper8yr	0.34612
rs4749820	3.10199e-06	Attention deficit hyperactivity disorder	10	30995	0.00562043591123392	9.15250553090537e-09	RsdbdHyper8yr	0.34612
rs4749820	3.83001e-06	Schizophrenia	10	30995	0.00562043591123392	9.15250553090537e-09	RsdbdHyper8yr	0.34612
rs4749820	4.06125e-06	Blood clot  DVT  bronchitis  emphysema  asthma  rhinitis  eczema  allergy diagnosed by doctor: Asthma	10	30995	0.00562043591123392	9.15250553090537e-09	RsdbdHyper8yr	0.34612
rs4749820	5.65301e-06	Non-cancer illness code  self-reported: asthma	10	30995	0.00562043591123392	9.15250553090537e-09	RsdbdHyper8yr	0.34612
rs4749820	5.80003e-06	Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor: Hayfever, allergic rhinitis or eczema	10	30995	0.00562043591123392	9.15250553090537e-09	RsdbdHyper8yr	0.34612
rs4749820	5.89997e-06	Mood swings	10	30995	0.00562043591123392	9.15250553090537e-09	RsdbdHyper8yr	0.34612
rs4749820	6.19998e-06	Frequency of tiredness / lethargy in last 2 weeks	10	30995	0.00562043591123392	9.15250553090537e-09	RsdbdHyper8yr	0.34612
rs4749820	7.00003e-06	Non-cancer illness code, self-reported: asthma	10	30995	0.00562043591123392	9.15250553090537e-09	RsdbdHyper8yr	0.34612
rs4749820	7.07392e-06	Mood swings (UKB data field 1920) (Firth correction)	10	30995	0.00562043591123392	9.15250553090537e-09	RsdbdHyper8yr	0.34612
rs4749820	7.07473e-06	Mood swings (UKB data field 1920) (SPA correction)	10	30995	0.00562043591123392	9.15250553090537e-09	RsdbdHyper8yr	0.34612
rs4749820	7.29995e-06	Educational attainment (college completion)	10	30995	0.00562043591123392	9.15250553090537e-09	RsdbdHyper8yr	0.34612
rs4749820	8.09991e-06	Eczema	10	30995	0.00562043591123392	9.15250553090537e-09	RsdbdHyper8yr	0.34612
rs4749820	8.30004e-06	Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor: Asthma	10	30995	0.00562043591123392	9.15250553090537e-09	RsdbdHyper8yr	0.34612
rs10795677	1.09999e-09	Respiratory or ear-nose-throat disease	10	30998	0.00475006989383119	9.89623500738335e-09	RsdbdHyper8yr	0.346216
rs10795677	1.2e-08	Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor: None of the above	10	30998	0.00475006989383119	9.89623500738335e-09	RsdbdHyper8yr	0.346216
rs10795677	4.20001e-08	Respiratory or ear-nose-throat disease	10	30998	0.00475006989383119	9.89623500738335e-09	RsdbdHyper8yr	0.346216
rs10795677	4.79999e-08	Wheeze or whistling in the chest in last year	10	30998	0.00475006989383119	9.89623500738335e-09	RsdbdHyper8yr	0.346216
rs10795677	1.2e-07	Smoking status	10	30998	0.00475006989383119	9.89623500738335e-09	RsdbdHyper8yr	0.346216
rs10795677	2.60699e-07	Asthma	10	30998	0.00475006989383119	9.89623500738335e-09	RsdbdHyper8yr	0.346216
rs10795677	4.76639e-07	Blood clot  DVT  bronchitis  emphysema  asthma  rhinitis  eczema  allergy diagnosed by doctor: None of the above	10	30998	0.00475006989383119	9.89623500738335e-09	RsdbdHyper8yr	0.346216
rs10795677	5.23396e-07	ADHD	10	30998	0.00475006989383119	9.89623500738335e-09	RsdbdHyper8yr	0.346216
rs10795677	9.54004e-07	smoking initiation	10	30998	0.00475006989383119	9.89623500738335e-09	RsdbdHyper8yr	0.346216
rs10795677	2.80001e-06	Risk taking	10	30998	0.00475006989383119	9.89623500738335e-09	RsdbdHyper8yr	0.346216
rs10795677	2.90001e-06	Overall health rating	10	30998	0.00475006989383119	9.89623500738335e-09	RsdbdHyper8yr	0.346216
rs10795677	2.98298e-06	Schizophrenia	10	30998	0.00475006989383119	9.89623500738335e-09	RsdbdHyper8yr	0.346216
rs10795677	2.98999e-06	Attention deficit hyperactivity disorder	10	30998	0.00475006989383119	9.89623500738335e-09	RsdbdHyper8yr	0.346216
rs10795677	3.86652e-06	Blood clot  DVT  bronchitis  emphysema  asthma  rhinitis  eczema  allergy diagnosed by doctor: Asthma	10	30998	0.00475006989383119	9.89623500738335e-09	RsdbdHyper8yr	0.346216
rs10795677	4.79999e-06	Frequency of tiredness / lethargy in last 2 weeks	10	30998	0.00475006989383119	9.89623500738335e-09	RsdbdHyper8yr	0.346216
rs10795677	5.19589e-06	Non-cancer illness code  self-reported: asthma	10	30998	0.00475006989383119	9.89623500738335e-09	RsdbdHyper8yr	0.346216
rs10795677	5.19996e-06	Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor: Hayfever, allergic rhinitis or eczema	10	30998	0.00475006989383119	9.89623500738335e-09	RsdbdHyper8yr	0.346216
rs10795677	5.39995e-06	Mood swings	10	30998	0.00475006989383119	9.89623500738335e-09	RsdbdHyper8yr	0.346216
rs10795677	5.54204e-06	Schizophrenia	10	30998	0.00475006989383119	9.89623500738335e-09	RsdbdHyper8yr	0.346216
rs10795677	7.29995e-06	Non-cancer illness code, self-reported: asthma	10	30998	0.00475006989383119	9.89623500738335e-09	RsdbdHyper8yr	0.346216
rs10795677	7.49998e-06	Educational attainment (college completion)	10	30998	0.00475006989383119	9.89623500738335e-09	RsdbdHyper8yr	0.346216
rs10795677	7.689e-06	Mood swings (UKB data field 1920) (Firth correction)	10	30998	0.00475006989383119	9.89623500738335e-09	RsdbdHyper8yr	0.346216
rs10795677	7.68971e-06	Mood swings (UKB data field 1920) (SPA correction)	10	30998	0.00475006989383119	9.89623500738335e-09	RsdbdHyper8yr	0.346216
rs10795677	7.69999e-06	Eczema	10	30998	0.00475006989383119	9.89623500738335e-09	RsdbdHyper8yr	0.346216
rs10795677	8.50002e-06	Ever smoked	10	30998	0.00475006989383119	9.89623500738335e-09	RsdbdHyper8yr	0.346216
rs10795677	8.70001e-06	Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor: Asthma	10	30998	0.00475006989383119	9.89623500738335e-09	RsdbdHyper8yr	0.346216
rs10795677	9.09432e-06	Risk taking (UKB data field 2040) (Firth correction)	10	30998	0.00475006989383119	9.89623500738335e-09	RsdbdHyper8yr	0.346216
rs10795677	9.09934e-06	Risk taking (UKB data field 2040) (SPA correction)	10	30998	0.00475006989383119	9.89623500738335e-09	RsdbdHyper8yr	0.346216
rs10795677	9.59997e-06	Asthma	10	30998	0.00475006989383119	9.89623500738335e-09	RsdbdHyper8yr	0.346216
rs11255912	1.5e-09	Respiratory or ear-nose-throat disease	10	30987	0.00516594763973021	1.10115891703763e-08	RsdbdHyper8yr	0.346129
rs11255912	5.69994e-09	Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor: None of the above	10	30987	0.00516594763973021	1.10115891703763e-08	RsdbdHyper8yr	0.346129
rs11255912	4.39997e-08	Smoking status	10	30987	0.00516594763973021	1.10115891703763e-08	RsdbdHyper8yr	0.346129
rs11255912	4.70002e-08	Wheeze or whistling in the chest in last year	10	30987	0.00516594763973021	1.10115891703763e-08	RsdbdHyper8yr	0.346129
rs11255912	5.39995e-08	Respiratory or ear-nose-throat disease	10	30987	0.00516594763973021	1.10115891703763e-08	RsdbdHyper8yr	0.346129
rs11255912	1.68e-07	Asthma	10	30987	0.00516594763973021	1.10115891703763e-08	RsdbdHyper8yr	0.346129
rs11255912	3.31757e-07	Blood clot  DVT  bronchitis  emphysema  asthma  rhinitis  eczema  allergy diagnosed by doctor: None of the above	10	30987	0.00516594763973021	1.10115891703763e-08	RsdbdHyper8yr	0.346129
rs11255912	4.75905e-07	ADHD	10	30987	0.00516594763973021	1.10115891703763e-08	RsdbdHyper8yr	0.346129
rs11255912	1.02e-06	smoking initiation	10	30987	0.00516594763973021	1.10115891703763e-08	RsdbdHyper8yr	0.346129
rs11255912	1.79999e-06	Risk taking	10	30987	0.00516594763973021	1.10115891703763e-08	RsdbdHyper8yr	0.346129
rs11255912	2.78503e-06	Attention deficit hyperactivity disorder	10	30987	0.00516594763973021	1.10115891703763e-08	RsdbdHyper8yr	0.346129
rs11255912	2.80001e-06	Overall health rating	10	30987	0.00516594763973021	1.10115891703763e-08	RsdbdHyper8yr	0.346129
rs11255912	3.1007e-06	Blood clot  DVT  bronchitis  emphysema  asthma  rhinitis  eczema  allergy diagnosed by doctor: Asthma	10	30987	0.00516594763973021	1.10115891703763e-08	RsdbdHyper8yr	0.346129
rs11255912	4.15011e-06	Non-cancer illness code  self-reported: asthma	10	30987	0.00516594763973021	1.10115891703763e-08	RsdbdHyper8yr	0.346129
rs11255912	4.27799e-06	Schizophrenia	10	30987	0.00516594763973021	1.10115891703763e-08	RsdbdHyper8yr	0.346129
rs11255912	4.30002e-06	Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor: Hayfever, allergic rhinitis or eczema	10	30987	0.00516594763973021	1.10115891703763e-08	RsdbdHyper8yr	0.346129
rs11255912	4.70002e-06	Eczema	10	30987	0.00516594763973021	1.10115891703763e-08	RsdbdHyper8yr	0.346129
rs11255912	6.59994e-06	Educational attainment (college completion)	10	30987	0.00516594763973021	1.10115891703763e-08	RsdbdHyper8yr	0.346129
rs11255912	6.59994e-06	Ever smoked	10	30987	0.00516594763973021	1.10115891703763e-08	RsdbdHyper8yr	0.346129
rs11255912	7.19996e-06	Current tobacco smoking	10	30987	0.00516594763973021	1.10115891703763e-08	RsdbdHyper8yr	0.346129
rs11255912	7.56206e-06	Asthma (Firth correction)	10	30987	0.00516594763973021	1.10115891703763e-08	RsdbdHyper8yr	0.346129
rs11255912	7.5692e-06	Asthma (SPA correction)	10	30987	0.00516594763973021	1.10115891703763e-08	RsdbdHyper8yr	0.346129
rs11255912	7.59994e-06	Non-cancer illness code, self-reported: asthma	10	30987	0.00516594763973021	1.10115891703763e-08	RsdbdHyper8yr	0.346129
rs11255912	7.8739e-06	Risk taking (UKB data field 2040) (Firth correction)	10	30987	0.00516594763973021	1.10115891703763e-08	RsdbdHyper8yr	0.346129
rs11255912	7.87825e-06	Risk taking (UKB data field 2040) (SPA correction)	10	30987	0.00516594763973021	1.10115891703763e-08	RsdbdHyper8yr	0.346129
rs11255912	8.09991e-06	Frequency of tiredness / lethargy in last 2 weeks	10	30987	0.00516594763973021	1.10115891703763e-08	RsdbdHyper8yr	0.346129
rs11255912	8.22621e-06	Mood swings (UKB data field 1920) (Firth correction)	10	30987	0.00516594763973021	1.10115891703763e-08	RsdbdHyper8yr	0.346129
rs11255912	8.22716e-06	Mood swings (UKB data field 1920) (SPA correction)	10	30987	0.00516594763973021	1.10115891703763e-08	RsdbdHyper8yr	0.346129
rs11255912	8.40001e-06	Mood swings	10	30987	0.00516594763973021	1.10115891703763e-08	RsdbdHyper8yr	0.346129
rs11255912	8.50002e-06	Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor: Asthma	10	30987	0.00516594763973021	1.10115891703763e-08	RsdbdHyper8yr	0.346129
rs11255912	9.59997e-06	Qualifications: College or University degree	10	30987	0.00516594763973021	1.10115891703763e-08	RsdbdHyper8yr	0.346129
rs11255914	8.19993e-10	Respiratory or ear-nose-throat disease	10	30998	0.00448838394269654	1.0622335152035e-08	RsdbdHyper8yr	0.346426
rs11255914	1e-08	Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor: None of the above	10	30998	0.00448838394269654	1.0622335152035e-08	RsdbdHyper8yr	0.346426
rs11255914	3.29997e-08	Respiratory or ear-nose-throat disease	10	30998	0.00448838394269654	1.0622335152035e-08	RsdbdHyper8yr	0.346426
rs11255914	5.1e-08	Wheeze or whistling in the chest in last year	10	30998	0.00448838394269654	1.0622335152035e-08	RsdbdHyper8yr	0.346426
rs11255914	1.2e-07	Smoking status	10	30998	0.00448838394269654	1.0622335152035e-08	RsdbdHyper8yr	0.346426
rs11255914	1.78501e-07	Asthma	10	30998	0.00448838394269654	1.0622335152035e-08	RsdbdHyper8yr	0.346426
rs11255914	3.44501e-07	ADHD	10	30998	0.00448838394269654	1.0622335152035e-08	RsdbdHyper8yr	0.346426
rs11255914	4.302e-07	Blood clot  DVT  bronchitis  emphysema  asthma  rhinitis  eczema  allergy diagnosed by doctor: None of the above	10	30998	0.00448838394269654	1.0622335152035e-08	RsdbdHyper8yr	0.346426
rs11255914	1.29e-06	smoking initiation	10	30998	0.00448838394269654	1.0622335152035e-08	RsdbdHyper8yr	0.346426
rs11255914	2.64302e-06	Attention deficit hyperactivity disorder	10	30998	0.00448838394269654	1.0622335152035e-08	RsdbdHyper8yr	0.346426
rs11255914	2.69998e-06	Overall health rating	10	30998	0.00448838394269654	1.0622335152035e-08	RsdbdHyper8yr	0.346426
rs11255914	2.80001e-06	Risk taking	10	30998	0.00448838394269654	1.0622335152035e-08	RsdbdHyper8yr	0.346426
rs11255914	3.36783e-06	Blood clot  DVT  bronchitis  emphysema  asthma  rhinitis  eczema  allergy diagnosed by doctor: Asthma	10	30998	0.00448838394269654	1.0622335152035e-08	RsdbdHyper8yr	0.346426
rs11255914	3.44302e-06	Schizophrenia	10	30998	0.00448838394269654	1.0622335152035e-08	RsdbdHyper8yr	0.346426
rs11255914	3.69999e-06	Frequency of tiredness / lethargy in last 2 weeks	10	30998	0.00448838394269654	1.0622335152035e-08	RsdbdHyper8yr	0.346426
rs11255914	4.30903e-06	Non-cancer illness code  self-reported: asthma	10	30998	0.00448838394269654	1.0622335152035e-08	RsdbdHyper8yr	0.346426
rs11255914	4.92595e-06	Schizophrenia	10	30998	0.00448838394269654	1.0622335152035e-08	RsdbdHyper8yr	0.346426
rs11255914	5.1e-06	Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor: Hayfever, allergic rhinitis or eczema	10	30998	0.00448838394269654	1.0622335152035e-08	RsdbdHyper8yr	0.346426
rs11255914	5.49997e-06	Mood swings	10	30998	0.00448838394269654	1.0622335152035e-08	RsdbdHyper8yr	0.346426
rs11255914	5.49997e-06	Non-cancer illness code, self-reported: asthma	10	30998	0.00448838394269654	1.0622335152035e-08	RsdbdHyper8yr	0.346426
rs11255914	6.80002e-06	Asthma	10	30998	0.00448838394269654	1.0622335152035e-08	RsdbdHyper8yr	0.346426
rs11255914	6.80002e-06	Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor: Asthma	10	30998	0.00448838394269654	1.0622335152035e-08	RsdbdHyper8yr	0.346426
rs11255914	7.79992e-06	Eczema	10	30998	0.00448838394269654	1.0622335152035e-08	RsdbdHyper8yr	0.346426
rs11255914	8.24081e-06	Asthma (Firth correction)	10	30998	0.00448838394269654	1.0622335152035e-08	RsdbdHyper8yr	0.346426
rs11255914	8.24347e-06	Mood swings (UKB data field 1920) (Firth correction)	10	30998	0.00448838394269654	1.0622335152035e-08	RsdbdHyper8yr	0.346426
rs11255914	8.24442e-06	Mood swings (UKB data field 1920) (SPA correction)	10	30998	0.00448838394269654	1.0622335152035e-08	RsdbdHyper8yr	0.346426
rs11255914	8.2486e-06	Asthma (SPA correction)	10	30998	0.00448838394269654	1.0622335152035e-08	RsdbdHyper8yr	0.346426
rs11255914	8.40001e-06	Educational attainment (college completion)	10	30998	0.00448838394269654	1.0622335152035e-08	RsdbdHyper8yr	0.346426
rs11255914	8.82104e-06	Risk taking (UKB data field 2040) (Firth correction)	10	30998	0.00448838394269654	1.0622335152035e-08	RsdbdHyper8yr	0.346426
rs11255914	8.82612e-06	Risk taking (UKB data field 2040) (SPA correction)	10	30998	0.00448838394269654	1.0622335152035e-08	RsdbdHyper8yr	0.346426
rs11255914	8.99995e-06	Ever smoked	10	30998	0.00448838394269654	1.0622335152035e-08	RsdbdHyper8yr	0.346426
rs2039495	2.1e-09	Respiratory or ear-nose-throat disease	10	30973	0.00422980162774375	1.49716615198585e-08	RsdbdHyper8yr	0.346624
rs2039495	1.7e-08	Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor: None of the above	10	30973	0.00422980162774375	1.49716615198585e-08	RsdbdHyper8yr	0.346624
rs2039495	5.30005e-08	Wheeze or whistling in the chest in last year	10	30973	0.00422980162774375	1.49716615198585e-08	RsdbdHyper8yr	0.346624
rs2039495	5.49997e-08	Respiratory or ear-nose-throat disease	10	30973	0.00422980162774375	1.49716615198585e-08	RsdbdHyper8yr	0.346624
rs2039495	1e-07	Smoking status	10	30973	0.00422980162774375	1.49716615198585e-08	RsdbdHyper8yr	0.346624
rs2039495	1.93602e-07	Asthma	10	30973	0.00422980162774375	1.49716615198585e-08	RsdbdHyper8yr	0.346624
rs2039495	4.25099e-07	ADHD	10	30973	0.00422980162774375	1.49716615198585e-08	RsdbdHyper8yr	0.346624
rs2039495	5.50402e-07	Blood clot  DVT  bronchitis  emphysema  asthma  rhinitis  eczema  allergy diagnosed by doctor: None of the above	10	30973	0.00422980162774375	1.49716615198585e-08	RsdbdHyper8yr	0.346624
rs2039495	8.96004e-07	smoking initiation	10	30973	0.00422980162774375	1.49716615198585e-08	RsdbdHyper8yr	0.346624
rs2039495	1.79999e-06	Risk taking	10	30973	0.00422980162774375	1.49716615198585e-08	RsdbdHyper8yr	0.346624
rs2039495	2.1e-06	Overall health rating	10	30973	0.00422980162774375	1.49716615198585e-08	RsdbdHyper8yr	0.346624
rs2039495	2.70302e-06	Attention deficit hyperactivity disorder	10	30973	0.00422980162774375	1.49716615198585e-08	RsdbdHyper8yr	0.346624
rs2039495	4.55701e-06	Schizophrenia	10	30973	0.00422980162774375	1.49716615198585e-08	RsdbdHyper8yr	0.346624
rs2039495	4.70002e-06	Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor: Hayfever, allergic rhinitis or eczema	10	30973	0.00422980162774375	1.49716615198585e-08	RsdbdHyper8yr	0.346624
rs2039495	4.83738e-06	Blood clot  DVT  bronchitis  emphysema  asthma  rhinitis  eczema  allergy diagnosed by doctor: Asthma	10	30973	0.00422980162774375	1.49716615198585e-08	RsdbdHyper8yr	0.346624
rs2039495	5e-06	Educational attainment (college completion)	10	30973	0.00422980162774375	1.49716615198585e-08	RsdbdHyper8yr	0.346624
rs2039495	5.33396e-06	Schizophrenia	10	30973	0.00422980162774375	1.49716615198585e-08	RsdbdHyper8yr	0.346624
rs2039495	5.39995e-06	Frequency of tiredness / lethargy in last 2 weeks	10	30973	0.00422980162774375	1.49716615198585e-08	RsdbdHyper8yr	0.346624
rs2039495	6.26859e-06	Risk taking (UKB data field 2040) (Firth correction)	10	30973	0.00422980162774375	1.49716615198585e-08	RsdbdHyper8yr	0.346624
rs2039495	6.27206e-06	Risk taking (UKB data field 2040) (SPA correction)	10	30973	0.00422980162774375	1.49716615198585e-08	RsdbdHyper8yr	0.346624
rs2039495	6.29289e-06	Non-cancer illness code  self-reported: asthma	10	30973	0.00422980162774375	1.49716615198585e-08	RsdbdHyper8yr	0.346624
rs2039495	6.69993e-06	Mood swings	10	30973	0.00422980162774375	1.49716615198585e-08	RsdbdHyper8yr	0.346624
rs2039495	7.90005e-06	Eczema	10	30973	0.00422980162774375	1.49716615198585e-08	RsdbdHyper8yr	0.346624
rs2039495	8.19993e-06	Non-cancer illness code, self-reported: asthma	10	30973	0.00422980162774375	1.49716615198585e-08	RsdbdHyper8yr	0.346624
rs2039495	9.12494e-06	Mood swings (UKB data field 1920) (Firth correction)	10	30973	0.00422980162774375	1.49716615198585e-08	RsdbdHyper8yr	0.346624
rs2039495	9.12578e-06	Mood swings (UKB data field 1920) (SPA correction)	10	30973	0.00422980162774375	1.49716615198585e-08	RsdbdHyper8yr	0.346624
rs2039495	9.29994e-06	Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor: Asthma	10	30973	0.00422980162774375	1.49716615198585e-08	RsdbdHyper8yr	0.346624
rs2986300	2.69998e-09	Respiratory or ear-nose-throat disease	10	30969	0.00430863792673757	1.62117538111538e-08	RsdbdHyper8yr	0.346023
rs2986300	1.7e-08	Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor: None of the above	10	30969	0.00430863792673757	1.62117538111538e-08	RsdbdHyper8yr	0.346023
rs2986300	3.09999e-08	Wheeze or whistling in the chest in last year	10	30969	0.00430863792673757	1.62117538111538e-08	RsdbdHyper8yr	0.346023
rs2986300	5e-08	Respiratory or ear-nose-throat disease	10	30969	0.00430863792673757	1.62117538111538e-08	RsdbdHyper8yr	0.346023
rs2986300	1.09999e-07	Smoking status	10	30969	0.00430863792673757	1.62117538111538e-08	RsdbdHyper8yr	0.346023
rs2986300	2.76802e-07	Asthma	10	30969	0.00430863792673757	1.62117538111538e-08	RsdbdHyper8yr	0.346023
rs2986300	3.79997e-07	ADHD	10	30969	0.00430863792673757	1.62117538111538e-08	RsdbdHyper8yr	0.346023
rs2986300	6.34147e-07	Blood clot  DVT  bronchitis  emphysema  asthma  rhinitis  eczema  allergy diagnosed by doctor: None of the above	10	30969	0.00430863792673757	1.62117538111538e-08	RsdbdHyper8yr	0.346023
rs2986300	2.635e-06	Attention deficit hyperactivity disorder	10	30969	0.00430863792673757	1.62117538111538e-08	RsdbdHyper8yr	0.346023
rs2986300	2.69998e-06	Risk taking	10	30969	0.00430863792673757	1.62117538111538e-08	RsdbdHyper8yr	0.346023
rs2986300	2.90001e-06	Overall health rating	10	30969	0.00430863792673757	1.62117538111538e-08	RsdbdHyper8yr	0.346023
rs2986300	3.97457e-06	Blood clot  DVT  bronchitis  emphysema  asthma  rhinitis  eczema  allergy diagnosed by doctor: Asthma	10	30969	0.00430863792673757	1.62117538111538e-08	RsdbdHyper8yr	0.346023
rs2986300	4.90004e-06	Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor: Hayfever, allergic rhinitis or eczema	10	30969	0.00430863792673757	1.62117538111538e-08	RsdbdHyper8yr	0.346023
rs2986300	5.07096e-06	Non-cancer illness code  self-reported: asthma	10	30969	0.00430863792673757	1.62117538111538e-08	RsdbdHyper8yr	0.346023
rs2986300	5.30005e-06	Educational attainment (college completion)	10	30969	0.00430863792673757	1.62117538111538e-08	RsdbdHyper8yr	0.346023
rs2986300	5.99998e-06	Non-cancer illness code, self-reported: asthma	10	30969	0.00430863792673757	1.62117538111538e-08	RsdbdHyper8yr	0.346023
rs2986300	6.70548e-06	Mood swings (UKB data field 1920) (Firth correction)	10	30969	0.00430863792673757	1.62117538111538e-08	RsdbdHyper8yr	0.346023
rs2986300	6.70625e-06	Mood swings (UKB data field 1920) (SPA correction)	10	30969	0.00430863792673757	1.62117538111538e-08	RsdbdHyper8yr	0.346023
rs2986300	7.10003e-06	Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor: Asthma	10	30969	0.00430863792673757	1.62117538111538e-08	RsdbdHyper8yr	0.346023
rs2986300	7.19996e-06	Eczema	10	30969	0.00430863792673757	1.62117538111538e-08	RsdbdHyper8yr	0.346023
rs2986300	8.09991e-06	Mood swings	10	30969	0.00430863792673757	1.62117538111538e-08	RsdbdHyper8yr	0.346023
rs2986300	8.40001e-06	Frequency of tiredness / lethargy in last 2 weeks	10	30969	0.00430863792673757	1.62117538111538e-08	RsdbdHyper8yr	0.346023
rs2986300	9.02153e-06	Risk taking (UKB data field 2040) (Firth correction)	10	30969	0.00430863792673757	1.62117538111538e-08	RsdbdHyper8yr	0.346023
rs2986300	9.02672e-06	Risk taking (UKB data field 2040) (SPA correction)	10	30969	0.00430863792673757	1.62117538111538e-08	RsdbdHyper8yr	0.346023
rs2986300	9.80009e-06	Qualifications: College or University degree	10	30969	0.00430863792673757	1.62117538111538e-08	RsdbdHyper8yr	0.346023
rs2991809	2.90001e-09	Respiratory or ear-nose-throat disease	10	30968	0.00437965599806798	1.48173315948061e-08	RsdbdHyper8yr	0.346002
rs2991809	1.79999e-08	Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor: None of the above	10	30968	0.00437965599806798	1.48173315948061e-08	RsdbdHyper8yr	0.346002
rs2991809	3.09999e-08	Wheeze or whistling in the chest in last year	10	30968	0.00437965599806798	1.48173315948061e-08	RsdbdHyper8yr	0.346002
rs2991809	5.30005e-08	Respiratory or ear-nose-throat disease	10	30968	0.00437965599806798	1.48173315948061e-08	RsdbdHyper8yr	0.346002
rs2991809	1.09999e-07	Smoking status	10	30968	0.00437965599806798	1.48173315948061e-08	RsdbdHyper8yr	0.346002
rs2991809	2.94002e-07	Asthma	10	30968	0.00437965599806798	1.48173315948061e-08	RsdbdHyper8yr	0.346002
rs2991809	3.88803e-07	ADHD	10	30968	0.00437965599806798	1.48173315948061e-08	RsdbdHyper8yr	0.346002
rs2991809	6.29057e-07	Blood clot  DVT  bronchitis  emphysema  asthma  rhinitis  eczema  allergy diagnosed by doctor: None of the above	10	30968	0.00437965599806798	1.48173315948061e-08	RsdbdHyper8yr	0.346002
rs2991809	1.37e-06	smoking initiation	10	30968	0.00437965599806798	1.48173315948061e-08	RsdbdHyper8yr	0.346002
rs2991809	2.61601e-06	Attention deficit hyperactivity disorder	10	30968	0.00437965599806798	1.48173315948061e-08	RsdbdHyper8yr	0.346002
rs2991809	2.69998e-06	Risk taking	10	30968	0.00437965599806798	1.48173315948061e-08	RsdbdHyper8yr	0.346002
rs2991809	2.90001e-06	Overall health rating	10	30968	0.00437965599806798	1.48173315948061e-08	RsdbdHyper8yr	0.346002
rs2991809	4.22912e-06	Blood clot  DVT  bronchitis  emphysema  asthma  rhinitis  eczema  allergy diagnosed by doctor: Asthma	10	30968	0.00437965599806798	1.48173315948061e-08	RsdbdHyper8yr	0.346002
rs2991809	5e-06	Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor: Hayfever, allergic rhinitis or eczema	10	30968	0.00437965599806798	1.48173315948061e-08	RsdbdHyper8yr	0.346002
rs2991809	5.39436e-06	Non-cancer illness code  self-reported: asthma	10	30968	0.00437965599806798	1.48173315948061e-08	RsdbdHyper8yr	0.346002
rs2991809	5.49997e-06	Educational attainment (college completion)	10	30968	0.00437965599806798	1.48173315948061e-08	RsdbdHyper8yr	0.346002
rs2991809	6.36151e-06	Mood swings (UKB data field 1920) (Firth correction)	10	30968	0.00437965599806798	1.48173315948061e-08	RsdbdHyper8yr	0.346002
rs2991809	6.36209e-06	Mood swings (UKB data field 1920) (SPA correction)	10	30968	0.00437965599806798	1.48173315948061e-08	RsdbdHyper8yr	0.346002
rs2991809	6.59994e-06	Non-cancer illness code, self-reported: asthma	10	30968	0.00437965599806798	1.48173315948061e-08	RsdbdHyper8yr	0.346002
rs2991809	7.39997e-06	Eczema	10	30968	0.00437965599806798	1.48173315948061e-08	RsdbdHyper8yr	0.346002
rs2991809	7.79992e-06	Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor: Asthma	10	30968	0.00437965599806798	1.48173315948061e-08	RsdbdHyper8yr	0.346002
rs2991809	7.90005e-06	Mood swings	10	30968	0.00437965599806798	1.48173315948061e-08	RsdbdHyper8yr	0.346002
rs2991809	8.50002e-06	Frequency of tiredness / lethargy in last 2 weeks	10	30968	0.00437965599806798	1.48173315948061e-08	RsdbdHyper8yr	0.346002
rs2991809	9.01426e-06	Risk taking (UKB data field 2040) (Firth correction)	10	30968	0.00437965599806798	1.48173315948061e-08	RsdbdHyper8yr	0.346002
rs2991809	9.01924e-06	Risk taking (UKB data field 2040) (SPA correction)	10	30968	0.00437965599806798	1.48173315948061e-08	RsdbdHyper8yr	0.346002
rs2104525	1.40001e-09	Respiratory or ear-nose-throat disease	10	30976	0.00463980789982126	2.22961562898828e-08	RsdbdHyper8yr	0.346026
rs2104525	1.7e-08	Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor: None of the above	10	30976	0.00463980789982126	2.22961562898828e-08	RsdbdHyper8yr	0.346026
rs2104525	5e-08	Wheeze or whistling in the chest in last year	10	30976	0.00463980789982126	2.22961562898828e-08	RsdbdHyper8yr	0.346026
rs2104525	5.99998e-08	Respiratory or ear-nose-throat disease	10	30976	0.00463980789982126	2.22961562898828e-08	RsdbdHyper8yr	0.346026
rs2104525	8.30004e-08	Smoking status	10	30976	0.00463980789982126	2.22961562898828e-08	RsdbdHyper8yr	0.346026
rs2104525	2.43002e-07	Asthma	10	30976	0.00463980789982126	2.22961562898828e-08	RsdbdHyper8yr	0.346026
rs2104525	4.028e-07	ADHD	10	30976	0.00463980789982126	2.22961562898828e-08	RsdbdHyper8yr	0.346026
rs2104525	5.62652e-07	Blood clot  DVT  bronchitis  emphysema  asthma  rhinitis  eczema  allergy diagnosed by doctor: None of the above	10	30976	0.00463980789982126	2.22961562898828e-08	RsdbdHyper8yr	0.346026
rs2104525	1.03999e-06	smoking initiation	10	30976	0.00463980789982126	2.22961562898828e-08	RsdbdHyper8yr	0.346026
rs2104525	1.6e-06	Risk taking	10	30976	0.00463980789982126	2.22961562898828e-08	RsdbdHyper8yr	0.346026
rs2104525	2.5e-06	Overall health rating	10	30976	0.00463980789982126	2.22961562898828e-08	RsdbdHyper8yr	0.346026
rs2104525	2.57697e-06	Attention deficit hyperactivity disorder	10	30976	0.00463980789982126	2.22961562898828e-08	RsdbdHyper8yr	0.346026
rs2104525	4.70002e-06	Frequency of tiredness / lethargy in last 2 weeks	10	30976	0.00463980789982126	2.22961562898828e-08	RsdbdHyper8yr	0.346026
rs2104525	4.79999e-06	Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor: Hayfever, allergic rhinitis or eczema	10	30976	0.00463980789982126	2.22961562898828e-08	RsdbdHyper8yr	0.346026
rs2104525	5.05068e-06	Blood clot  DVT  bronchitis  emphysema  asthma  rhinitis  eczema  allergy diagnosed by doctor: Asthma	10	30976	0.00463980789982126	2.22961562898828e-08	RsdbdHyper8yr	0.346026
rs2104525	5.67492e-06	Risk taking (UKB data field 2040) (Firth correction)	10	30976	0.00463980789982126	2.22961562898828e-08	RsdbdHyper8yr	0.346026
rs2104525	5.67806e-06	Risk taking (UKB data field 2040) (SPA correction)	10	30976	0.00463980789982126	2.22961562898828e-08	RsdbdHyper8yr	0.346026
rs2104525	5.89997e-06	Educational attainment (college completion)	10	30976	0.00463980789982126	2.22961562898828e-08	RsdbdHyper8yr	0.346026
rs2104525	6.85915e-06	Non-cancer illness code  self-reported: asthma	10	30976	0.00463980789982126	2.22961562898828e-08	RsdbdHyper8yr	0.346026
rs2104525	7.47894e-06	Schizophrenia	10	30976	0.00463980789982126	2.22961562898828e-08	RsdbdHyper8yr	0.346026
rs2104525	7.69999e-06	Eczema	10	30976	0.00463980789982126	2.22961562898828e-08	RsdbdHyper8yr	0.346026
rs2104525	8.99995e-06	Mood swings	10	30976	0.00463980789982126	2.22961562898828e-08	RsdbdHyper8yr	0.346026
rs2104525	9.20005e-06	Non-cancer illness code, self-reported: asthma	10	30976	0.00463980789982126	2.22961562898828e-08	RsdbdHyper8yr	0.346026
rs7068268	1.5e-09	Respiratory or ear-nose-throat disease	10	30905	0.00452511895190274	1.47363524494056e-08	RsdbdHyper8yr	0.345931
rs7068268	2.80001e-08	Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor: None of the above	10	30905	0.00452511895190274	1.47363524494056e-08	RsdbdHyper8yr	0.345931
rs7068268	5.1e-08	Wheeze or whistling in the chest in last year	10	30905	0.00452511895190274	1.47363524494056e-08	RsdbdHyper8yr	0.345931
rs7068268	5.80003e-08	Respiratory or ear-nose-throat disease	10	30905	0.00452511895190274	1.47363524494056e-08	RsdbdHyper8yr	0.345931
rs7068268	2e-07	Smoking status	10	30905	0.00452511895190274	1.47363524494056e-08	RsdbdHyper8yr	0.345931
rs7068268	3.25402e-07	Asthma	10	30905	0.00452511895190274	1.47363524494056e-08	RsdbdHyper8yr	0.345931
rs7068268	7.03947e-07	Blood clot  DVT  bronchitis  emphysema  asthma  rhinitis  eczema  allergy diagnosed by doctor: None of the above	10	30905	0.00452511895190274	1.47363524494056e-08	RsdbdHyper8yr	0.345931
rs7068268	8.37394e-07	ADHD	10	30905	0.00452511895190274	1.47363524494056e-08	RsdbdHyper8yr	0.345931
rs7068268	1.5e-06	Risk taking	10	30905	0.00452511895190274	1.47363524494056e-08	RsdbdHyper8yr	0.345931
rs7068268	1.75001e-06	smoking initiation	10	30905	0.00452511895190274	1.47363524494056e-08	RsdbdHyper8yr	0.345931
rs7068268	2.1e-06	Overall health rating	10	30905	0.00452511895190274	1.47363524494056e-08	RsdbdHyper8yr	0.345931
rs7068268	3.89996e-06	Educational attainment (college completion)	10	30905	0.00452511895190274	1.47363524494056e-08	RsdbdHyper8yr	0.345931
rs7068268	4.31499e-06	Attention deficit hyperactivity disorder	10	30905	0.00452511895190274	1.47363524494056e-08	RsdbdHyper8yr	0.345931
rs7068268	4.70002e-06	Frequency of tiredness / lethargy in last 2 weeks	10	30905	0.00452511895190274	1.47363524494056e-08	RsdbdHyper8yr	0.345931
rs7068268	5.11835e-06	Risk taking (UKB data field 2040) (Firth correction)	10	30905	0.00452511895190274	1.47363524494056e-08	RsdbdHyper8yr	0.345931
rs7068268	5.12118e-06	Risk taking (UKB data field 2040) (SPA correction)	10	30905	0.00452511895190274	1.47363524494056e-08	RsdbdHyper8yr	0.345931
rs7068268	5.19996e-06	Mood swings	10	30905	0.00452511895190274	1.47363524494056e-08	RsdbdHyper8yr	0.345931
rs7068268	5.43551e-06	Blood clot  DVT  bronchitis  emphysema  asthma  rhinitis  eczema  allergy diagnosed by doctor: Asthma	10	30905	0.00452511895190274	1.47363524494056e-08	RsdbdHyper8yr	0.345931
rs7068268	6.19998e-06	Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor: Hayfever, allergic rhinitis or eczema	10	30905	0.00452511895190274	1.47363524494056e-08	RsdbdHyper8yr	0.345931
rs7068268	6.92405e-06	Schizophrenia	10	30905	0.00452511895190274	1.47363524494056e-08	RsdbdHyper8yr	0.345931
rs7068268	7.46655e-06	Non-cancer illness code  self-reported: asthma	10	30905	0.00452511895190274	1.47363524494056e-08	RsdbdHyper8yr	0.345931
rs7068268	7.79902e-06	Schizophrenia	10	30905	0.00452511895190274	1.47363524494056e-08	RsdbdHyper8yr	0.345931
rs7068268	8.18013e-06	Mood swings (UKB data field 1920) (Firth correction)	10	30905	0.00452511895190274	1.47363524494056e-08	RsdbdHyper8yr	0.345931
rs7068268	8.18088e-06	Mood swings (UKB data field 1920) (SPA correction)	10	30905	0.00452511895190274	1.47363524494056e-08	RsdbdHyper8yr	0.345931
rs7068268	9.40005e-06	Eczema	10	30905	0.00452511895190274	1.47363524494056e-08	RsdbdHyper8yr	0.345931
rs7068268	9.49992e-06	Qualifications: College or University degree	10	30905	0.00452511895190274	1.47363524494056e-08	RsdbdHyper8yr	0.345931
rs7068268	9.80009e-06	Asthma	10	30905	0.00452511895190274	1.47363524494056e-08	RsdbdHyper8yr	0.345931
rs12769121	1e-09	Respiratory or ear-nose-throat disease	10	30924	0.00521086713730248	1.88161167885929e-08	RsdbdHyper8yr	0.345977
rs12769121	2.5e-08	Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor: None of the above	10	30924	0.00521086713730248	1.88161167885929e-08	RsdbdHyper8yr	0.345977
rs12769121	4.49997e-08	Wheeze or whistling in the chest in last year	10	30924	0.00521086713730248	1.88161167885929e-08	RsdbdHyper8yr	0.345977
rs12769121	4.90004e-08	Respiratory or ear-nose-throat disease	10	30924	0.00521086713730248	1.88161167885929e-08	RsdbdHyper8yr	0.345977
rs12769121	2e-07	Smoking status	10	30924	0.00521086713730248	1.88161167885929e-08	RsdbdHyper8yr	0.345977
rs12769121	3.19897e-07	Asthma	10	30924	0.00521086713730248	1.88161167885929e-08	RsdbdHyper8yr	0.345977
rs12769121	6.7146e-07	Blood clot  DVT  bronchitis  emphysema  asthma  rhinitis  eczema  allergy diagnosed by doctor: None of the above	10	30924	0.00521086713730248	1.88161167885929e-08	RsdbdHyper8yr	0.345977
rs12769121	1.166e-06	ADHD	10	30924	0.00521086713730248	1.88161167885929e-08	RsdbdHyper8yr	0.345977
rs12769121	1.29999e-06	Risk taking	10	30924	0.00521086713730248	1.88161167885929e-08	RsdbdHyper8yr	0.345977
rs12769121	1.75999e-06	smoking initiation	10	30924	0.00521086713730248	1.88161167885929e-08	RsdbdHyper8yr	0.345977
rs12769121	1.79999e-06	Overall health rating	10	30924	0.00521086713730248	1.88161167885929e-08	RsdbdHyper8yr	0.345977
rs12769121	3.79997e-06	Educational attainment (college completion)	10	30924	0.00521086713730248	1.88161167885929e-08	RsdbdHyper8yr	0.345977
rs12769121	4.78311e-06	Risk taking (UKB data field 2040) (Firth correction)	10	30924	0.00521086713730248	1.88161167885929e-08	RsdbdHyper8yr	0.345977
rs12769121	4.78586e-06	Risk taking (UKB data field 2040) (SPA correction)	10	30924	0.00521086713730248	1.88161167885929e-08	RsdbdHyper8yr	0.345977
rs12769121	4.98242e-06	Blood clot  DVT  bronchitis  emphysema  asthma  rhinitis  eczema  allergy diagnosed by doctor: Asthma	10	30924	0.00521086713730248	1.88161167885929e-08	RsdbdHyper8yr	0.345977
rs12769121	5e-06	Mood swings	10	30924	0.00521086713730248	1.88161167885929e-08	RsdbdHyper8yr	0.345977
rs12769121	5e-06	Frequency of tiredness / lethargy in last 2 weeks	10	30924	0.00521086713730248	1.88161167885929e-08	RsdbdHyper8yr	0.345977
rs12769121	5.38704e-06	Attention deficit hyperactivity disorder	10	30924	0.00521086713730248	1.88161167885929e-08	RsdbdHyper8yr	0.345977
rs12769121	6.49995e-06	Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor: Hayfever, allergic rhinitis or eczema	10	30924	0.00521086713730248	1.88161167885929e-08	RsdbdHyper8yr	0.345977
rs12769121	6.88954e-06	Non-cancer illness code  self-reported: asthma	10	30924	0.00521086713730248	1.88161167885929e-08	RsdbdHyper8yr	0.345977
rs12769121	7.24619e-06	Mood swings (UKB data field 1920) (Firth correction)	10	30924	0.00521086713730248	1.88161167885929e-08	RsdbdHyper8yr	0.345977
rs12769121	7.24703e-06	Mood swings (UKB data field 1920) (SPA correction)	10	30924	0.00521086713730248	1.88161167885929e-08	RsdbdHyper8yr	0.345977
rs12769121	7.61798e-06	Schizophrenia	10	30924	0.00521086713730248	1.88161167885929e-08	RsdbdHyper8yr	0.345977
rs12769121	8.40001e-06	Asthma	10	30924	0.00521086713730248	1.88161167885929e-08	RsdbdHyper8yr	0.345977
rs12769121	9.40005e-06	Eczema	10	30924	0.00521086713730248	1.88161167885929e-08	RsdbdHyper8yr	0.345977
rs12769121	9.80009e-06	Qualifications: College or University degree	10	30924	0.00521086713730248	1.88161167885929e-08	RsdbdHyper8yr	0.345977
rs56022301	2.13403e-30	ENSG00000151247	4	25144	2.00456433883888e-05	3.80452112580041e-08	SprakSeman5yr	0.184179
rs56022301	3.27567e-18	Alkaline phosphatase levels (UKB data field 30610)	4	25144	2.00456433883888e-05	3.80452112580041e-08	SprakSeman5yr	0.184179
rs56022301	1.48799e-12	Serum alkaline phosphatase levels	4	25144	2.00456433883888e-05	3.80452112580041e-08	SprakSeman5yr	0.184179
rs56022301	2.11934e-12	Alkaline phosphatase	4	25144	2.00456433883888e-05	3.80452112580041e-08	SprakSeman5yr	0.184179
rs56022301	1.25777e-10	IGF 1 (UKB data field 30770)	4	25144	2.00456433883888e-05	3.80452112580041e-08	SprakSeman5yr	0.184179
rs56022301	5.25969e-10	Alkaline phosphatase	4	25144	2.00456433883888e-05	3.80452112580041e-08	SprakSeman5yr	0.184179
rs56022301	7.29995e-10	HDL cholesterol	4	25144	2.00456433883888e-05	3.80452112580041e-08	SprakSeman5yr	0.184179
rs56022301	2e-09	Sex hormone-binding globulin levels adjusted for BMI	4	25144	2.00456433883888e-05	3.80452112580041e-08	SprakSeman5yr	0.184179
rs56022301	6.35141e-09	High density lipoprotein cholesterol levels (UKB data field 30760)	4	25144	2.00456433883888e-05	3.80452112580041e-08	SprakSeman5yr	0.184179
rs56022301	6.37691e-09	IGF-1	4	25144	2.00456433883888e-05	3.80452112580041e-08	SprakSeman5yr	0.184179
rs56022301	6.93697e-09	IGF-1	4	25144	2.00456433883888e-05	3.80452112580041e-08	SprakSeman5yr	0.184179
rs56022301	9.69996e-09	Sex hormone-binding globulin levels	4	25144	2.00456433883888e-05	3.80452112580041e-08	SprakSeman5yr	0.184179
rs56022301	1.40001e-08	Sex hormone-binding globulin levels	4	25144	2.00456433883888e-05	3.80452112580041e-08	SprakSeman5yr	0.184179
rs56022301	7.00003e-08	Sex hormone binding globulin (SHBG)	4	25144	2.00456433883888e-05	3.80452112580041e-08	SprakSeman5yr	0.184179
rs56022301	1.09999e-07	Sex hormone-binding globulin levels adjusted for BMI	4	25144	2.00456433883888e-05	3.80452112580041e-08	SprakSeman5yr	0.184179
rs56022301	7.50084e-07	Cystatin C levels (UKB data field 30720)	4	25144	2.00456433883888e-05	3.80452112580041e-08	SprakSeman5yr	0.184179
rs56022301	7.63291e-07	HDL cholesterol	4	25144	2.00456433883888e-05	3.80452112580041e-08	SprakSeman5yr	0.184179
rs56022301	8.89795e-07	HDL cholesterol	4	25144	2.00456433883888e-05	3.80452112580041e-08	SprakSeman5yr	0.184179
rs56022301	9.74384e-07	Sex hormone binding globulin levels (UKB data field 30830)	4	25144	2.00456433883888e-05	3.80452112580041e-08	SprakSeman5yr	0.184179
rs56022301	1.09999e-06	apolipoprotein A-I	4	25144	2.00456433883888e-05	3.80452112580041e-08	SprakSeman5yr	0.184179
rs56022301	1.73676e-06	Apolipoprotein A levels (UKB data field 30630)	4	25144	2.00456433883888e-05	3.80452112580041e-08	SprakSeman5yr	0.184179
rs56022301	2.1079e-06	HDL cholesterol	4	25144	2.00456433883888e-05	3.80452112580041e-08	SprakSeman5yr	0.184179
rs56022301	2.59998e-06	Platelet distribution width	4	25144	2.00456433883888e-05	3.80452112580041e-08	SprakSeman5yr	0.184179
rs56022301	3.21603e-06	SHBG	4	25144	2.00456433883888e-05	3.80452112580041e-08	SprakSeman5yr	0.184179
